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Eukaryotes have developed evolutionarily conserved mechanisms to respond
to diverse ranges of internal and external perturbations e.g., changes in
oxygen/nutrient levels, temperature oscillations, protein folding load, vi-
ral/bacterial attacks and graft implants. Alterations and malfunctions within
these core regulatory architectures provide a peek into shifts towards cancer-
ous and disease states. These core architectures include signal integrators and
actuators, positive and negative feedback mechanisms which mediate the ef-
fectiveness and ultimate outcome of the response. Contemporary modeling
approaches in the era of genomics revolution and high-throughput technology
presents a unique systems level insight into many areas of biology, ecology, de-
velopmental biology and immunology. In my research, I have used a combi-
nation of bottom-up analysis (signaling networks based analysis) and a top-down
analysis (using microarray/high throughput experimental data) to investigate
stress responses in eukaryotes. Using the bottom-up analysis scheme, we assem-
bled a series of molecular modules describing different aspects of the cellular
response to stress. Some of these modules included the Unfolded Protein Re-
sponse (UPR), Hypoxic Response (HR) and Tumor Angiogenesis, Epithelial to
Mesenchymal Transition (EMT), Translation Initiation and Renal Allograft Fail-
ure. These modules were modeled using mass action kinetics with an Ordinary
Differential Equation (ODE) based framework to investigate the internal regula-
tory cores. For example, in UPR we identified the differential negative feedback
of activating transcription factor 4 (ATF4) as the key in the adaptation phase via
regulation of binding immunoglobulin protein (BiP). Similarly in HR, we iden-
tified the role of activator protein 1 (AP1) in mediating the autocrine response
via vascular endothelial growth factor (VEGF) and interleukin 8 (IL8) signaling
modules. Model generation was done using UNIVERSAL, an in house software
freely available at google code. We addressed issues pertaining to uncertainties
within these models by developing POETs, a multi-objective optimizing algo-
rithm which allowed us to train our models with experimental data from the
literature. POETs presented us with an advantage by generating an ensemble
of models consistent with experimental data. The diversity within these ensem-
bles were used to study different operational paradigms within these modules.
For example, in EMT we identified the differential modes of crosstalk between
mitogen-activated protein kinase (MAPK) and SMADs in mediating the cellu-
lar transformation. These different modes of operation suggest insights into
different diseases and irregularities in cellular adaptation. We subsequently an-
alyzed these models using parameter independent structural analysis tools like
extreme pathways and parameter dependent tools such as fragility and robust-
ness to identify targets relevant to therapeutic interventions. These configura-
tions represent experimentally testable hypothesis and potentially new strate-
gies to manipulate the cellular responses. At an intermediate (length-scale)
level, we developed multiscale modeling strategies by inductively extrapolating
the consequences of cell signaling to tissue/organ function. We employed this
(signaling assisted multiscale modeling (SAMM)) strategy to investigate tumor
growth and angiogenesis. Using a top down strategy, we used microarray data-
sets to investigate cellular signaling, identify malfunctions and create predictive
models to infer patient outcome in case of hypoxia induced tumor growth and
angiogenesis.
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sion of chaperone proteins, attenuating translation by regulat-
ing eIF2α, and promoting the degradation of misfolded proteins
through ER-associated degradation (ERAD). If UPR is unable
to restore the folding balance, ER stress will eventually lead to
apoptotic cell-death. B: The three signal transduction pathways
mediating the unfolded protein response in higher eukaryotes.
First, the PRKR-like ER kinase (PERK) pathway is initiated after
BiP dissociation from PERK. While PERK transduces both pro-
and anti-apoptotic signals, its main function is translation atten-
uation through the phosphorylation of eIF2α. Next, the activat-
ing transcription factor 6 (ATF6) pathway is activated follow-
ing BiP dissociation. ATF6 induces the expression of chaperones
e.g., BiP as well as apoptosis effectors such as CHOP. Lastly, the
inositol-requiring kinase 1 (IRE1) pathway is activated following
BiP dissociation from IRE1. Activated IRE1 has both an endori-
bonuclease and a serine-threonine kinase activity that drive can
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The problem of unfolded or misfolded proteins in the ER is
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regulation of the expression of chaperone proteins, attenuating
translation by regulating eIF2α, and promoting the degrada-
tion of misfolded proteins through ER-associated degradation
(ERAD). If UPR is unable to restore the folding balance, ER
stress will eventually lead to apoptotic cell-death. The three sig-
nal transduction pathways mediating the unfolded protein re-
sponse in higher eukaryotes. First, the PRKR-like ER kinase
(PERK) pathway is initiated after BiP dissociation from PERK.
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tion. A:UPR induction was controlled by manipulating the gen-
eration rate of unfolded or misfolded protein (qP) in the ER com-
partment. A step-change in qP from qP = 0.1 to qP = 100 was is-
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for the 59 genes in the model. The symbol UPROT denotes the
level of unfolded protein. . . . . . . . . . . . . . . . . . . . . . . . 57
3.6 Signal flow analysis using simulated knockout (KO) of key pro-
teins on the UPR system: Simulation results suggest that the
three branches in UPR fire simultaneously with varying rates
and the state of the cell in terms of adaptation, alarm or apoptosis
is a result of counteracting effects of these three prongs of UPR
signaling. (A-C) The counteracting effects is seen when knock-
out of one ER stress transducer leads to enhancement of the other
branches of UPR. (D) ATF4, cleaved ATF6 and XBP1s act as inte-
grators of the signals coming from all the three branches of UPR
and furthermore leads to regulation of BiP, thereby leading to a
negative feedback or control of UPR signal. PERK and ATF4 KO
studies revealed a slower and lower amount of BiP production
(∼ 50%) as compared to WT. However, ATF6 or IRE1 KO did not
affect BiP regulation as compared to WT. (E) Regulation of BiP
was the critical regulator of spliced XBP1 (XBP1s), which in turn
acts as a key marker of progression through different stages of
UPR. (F) PERK and ATF4 KO lead to delay in the onset of apop-
tosis (marked by slower and lower reduction of Bcl2 levels. This
effect could be attributed to the lack of CHOP mediated branch
of Bcl2 regulation. On the other hand, IRE1 and CHOP KO leads
to drastic reduction in apoptosis (marked by little or no change
of Bcl2 levels). CHOP KO, implicated the importance of CHOP
in the down-regulation of Bcl2. IRE1 KO implicated the critical
role of IRE1-TRAF2 mediated route of apoptosis. Overall flux
analysis highlighted the extensive amount of crosstalk within the
three branches of the UPR network. . . . . . . . . . . . . . . . . . 58
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3.7 Cross plot of the fluxes at P1-P5 as denoted in Fig. 3.5: We tried
to see is how the system behaves and how the system can recu-
perate from UPR dose when it is in the adaptation phase as com-
pared to the apoptosis phase. (D) As compared to P1 (No-UPR
Steady State), we see that early on at 1 hr after UPR dose there is a
marked increase in ATF4 and CHOP regulation, ATF6 signaling
along with unfolded protein sensing and degradation. These are
hallmarks of the adaptation-alarm phase of the UPR response.
(A) If we continue with the dose of UPR till around 25 hrs, we see
the fluxes reach a steady state. This state is marked by increased
BiP regulation, enhanced ATF4 transcriptional activity, increased
mitochondrial membrane permeability and increased apoptotic
fluxes. This state is similar to the Apoptotic phase of UPR, where
in the cell has committed itself to apoptosis mediated cell death.
(B) and (C) If we reduce the UPR load after the cell has com-
mitted to apoptosis (as in P3), we find that the cell continues to
function similar to the UPR state even upon UPR load reduc-
tion after 25 hrs. There are certain aspects which are seen to re-
duce like IRE1-TRAF2 signaling, ASK1 activation. However not
much difference is seen in terms of apoptotic fluxes, denoting
the cell has committed itself to death and is in a point of no re-
turn. (E)-(F) On the contrary if we reduce the load of UPR in the
adaptation-alarm phase (P4), we see that the cell can recuperate
using its ERAD machinery and the regulation of BiP. . . . . . . . 60
3.8 Plot of species sensitivity at earlier (0-2 hrs) versus later (6-8
hrs) time points: Sensitivity analysis was conducted over dis-
crete two hour time windows thereby revealing the time evo-
lution of the importance of UPR network modules. We found
that signal integration via the transcriptional activity of ATF6,
ATF4 and XBP1s along with RCAN1 and cIAP role in apoptosis
were significantly more important at 6-8 hrs as compared to 0-2
hrs time window. This is consistent with the dominant role of
the negative feedback via the transcriptional regulation of BiP in
UPR. Interestingly, the majority of species rankings were similar
as seen in the cluster in the grey box. . . . . . . . . . . . . . . . . 62
3.9 Rank-ordering of species sensitivities in the presence of UPR as
a function of time. Inset: Rank-ordering of parameter sensitiv-
ity for UPR-induced versus normal conditions. Points denote
the mean ranking computed over N = 5 parameter sets from the
model population, while error bars denote one standard devia-
tion. Points are color-coded based based upon biological function. 64
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3.10 Plot of parameter sensitivity with APAF-1 feedback KO and all
BiP feedback KO: Upon knockout of any individual feedback
branch like that of ATF4, ATF6 and XBP1s, the system overall
remains equally robust. However the sensitivity of the alternate
feedback components increases. This was most evident upon
ATF4 feedback KO. (A) We saw increase in sensitivity of feed-
back components associated with XBP1s and ATF6. Upon ATF6
and XBP1s feedback KO, there wasn’t much change in terms
of sensitivity of the system (data not shown). This further at-
tests the key regulatory effect of ATF4 in mediating the positive
BiP feedback which is an essential component of the adaptation
phase of UPR. (B) When we completely knockout all the feed-
back branches of BiP in the adaptation phase, the system overall
becomes relatively more robust. We distinctly saw a major shift
of sensitivity of BiP upon removal of positive feedback. Overall
∼ 54 % of the parameters were differentially less sensitive upon
removal of BiP feedback as compared to WT. This brings to light
how the presence of BiP feedback makes the system more sus-
ceptible/sensitive to perturbations. . . . . . . . . . . . . . . . . . 66
3.11 Robustness analysis of the UPR network: A-B Phenotypic phase
plane analysis for the the UPR model following structural per-
turbations. Coupling coefficients (area under the curve from the
simulation with species removed dived by the wild-type simu-
lation) for all 636 model species were calculated for the nomi-
nal parameter set following gene overexpression/knockout (A)
and deletion of single network edges (B). Coupling coefficients
of one indicate no change in a marker level following a pertur-
bation, while values less (greater) than one denote decreased (in-
creases) marker levels. C Structural distinguishability analysis:
We computed the dendrogram of the coupling coefficients for
single GKO of model species. Individual coupling coefficients
were clustered, where the euclidean norm was used as the dis-
tance metric and the linkage function was the inner square prod-
uct (variance minimization algorithm). Each additional cluster
was chosen to reduce the overall variance (y-axis). A general
description of the biological function of the clusters were indi-
cated by each group. Insets: Distinguishability as the magnitude
of the orthogonal components for all knockout species. Species
were ordered from largest to smallest magnitudes. Red markers
indicate species which were statistically significant. . . . . . . . . 68
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3.12 Simulations with translation attenuation built in the model: One
of the key aspects which was not included in the current model
was translation attenuation. So we simulated that to identify that
there isnt much of a change overall in the system except for the
tad bit delay in the onset of the responses. . . . . . . . . . . . . . 70
3.13 Survival-death phenotypic plane for APAF-1 and CHOP KOs
over the entire ensemble: (A) With APAF-1 KO, we found that
there were two populations of cells in the ensemble: popula-
tion 1 where APAF-1 was the dominant regulator of cell-death
(marked by enhanced reduction in caspase 3 upon APAF-1 KO)
and population 2 where APAF-1 is not the most dominant reg-
ulator (marked by reduced effect on Caspase 3 upon APAF-1
KO). (B) Upon CHOP KO, we identified two distinct popula-
tions within the ensembles. One with a strong effect of CHOP
mediated down-regulation of Bcl2 (marked by ∼ 10 fold increase
in Bcl2 levels) and the other with very little effect of CHOP on
Bcl2 levels. This behavior could be attributed to other conflict-
ing means of regulation of Bcl2 levels. . . . . . . . . . . . . . . . . 71
3.14 To further investigate the implications of the feedback regulation
of BiP via ATF4/ATF6/XBP1s, we simulated KOs of these com-
ponents over the entire ensemble. (A) Upon KO of all branches
of BiP feedback, we found overall reductions of BiP levels. How-
ever, there were two distinct sub-populations. One with a ∼ 10
fold reduction in BiP levels while the other had ∼ 1000 fold re-
duction in BiP levels. These two populations could resemble two
distinct operational paradigms within UPR. In the first mode of
operation feedback regulation of BiP is really strong so when we
knockout BiP feedback we have drastic reductions in BiP levels
and ultimately a stronger and faster UPR response. (B) ATF4 me-
diated feedback KO led to significant amount of reduction in BiP
levels thereby highlighting the significance of ATF4 in BiP feed-
back. (C-D) However, KO of ATF6 and XBP1s mediated feed-
back of BiP was seen to have little effect (as marked by robust-
ness coefficients for BiP). . . . . . . . . . . . . . . . . . . . . . . . 72
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4.1 Schematic of the translation initiation signaling network.
Growth factors trigger receptor dimerization and the formation
of adaptor complexes which activate PI3K. PI3K then signals
through PIP2/3 to activate Akt. Activated Akt can then activate
mTORC1 either directly or by phosphorylating TSC1/2, an in-
hibitor of Rheb. Activated mTORC1 can phosphorylate 4EBP1
and activate S6K1, two necessary checkpoints for translation ini-
tiation. mTORC1 can also phosphorylate IRS-1, a negative feed-
back which inhibits formation of the adaptor complex and atten-
uates insulin signaling. . . . . . . . . . . . . . . . . . . . . . . . . 94
4.2 The scaled simulation error (SSE) for selected objective function
pairs for N = 5818 rank zero initiation models. The SSEs for ob-
jective functions chosen by cross-validation for prediction was
set to zero and disregarded when ranking other sets. The red
point denotes the performance of the nominal parameter set. . . 97
4.3 Ensemble performance against selected training objectives (N =
400). Dotted lines represent the simulation mean of the ensem-
ble, while the shaded region denotes the 99.9% confidence esti-
mate for the mean. The solid dots represent the scaled experi-
mental data. A. Time course data for p70S6K1 phosphorylation
in response to insulin stimulation (L6 Myotubes). B. Time course
data for c4EBP1 phosphorylation in response to FBS (RhoE 3T3
cells). C. In vitro time course of the 80S complex measured by
puromycin assay (rabbit reticulocyte). D. pAkt(Ser473) levels at
20 minutes in the presence and absence of insulin and wortman-
nin (393T cells). E,F. pAkt(Set473) and activated p70S6K1 levels
at 15 minutes in the presence and absence of insulin-like growth
factor (IGF) and rapamycin (C2C12 myotubes). . . . . . . . . . . 101
4.4 Blind model predictions for the ensemble (N = 400). The pre-
dictive ability of model ensemble was assessed by comparing
model performance with novel experimental data. Dotted lines
represent the simulation mean of the ensemble, while the shaded
region denotes the 99.9% confidence estimate for the mean.The
solid dots represent the scaled experimental data. A. In vitro
time course for formation of 43S-mRNA complex. A slowly-
hydrolyzable GTP homologue (GMP-PNP) was used in place of
GTP to isolate formation of this intermediate complex. GMP-
PNP data was used for training while GTP data was used for
validation. B. Percent of Rheb-GTP to Rheb-GDP in the presence
of insulin, wortmannin and rapamycin (A14 NIH 3T3 cells). C.
Percent of Rheb-GTP to Rheb-GDP in wildtype and TSC2 lack-
ing cells (MEF cells). D. 4EBP1 bound EIF4E in the presence of
heat shock (CHO.K1 cells). . . . . . . . . . . . . . . . . . . . . . . 103
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4.5 Sensitivity analysis of a population of initiation models (N = 40).
Species with a high sensitivity ranking are considered fragile
while species with a low sensitivity ranking are considered ro-
bust. A. Sensitivity ranking of network species in the presence
and absence of insulin. B. Time-course sensitivity ranking of net-
work species. C,D. Sensitivity ranking of network species in the
presence and absence of IRS-1 feedback. Black fill denoted com-
plexes containing IRS-1, grey fill denotes PI3K/Akt associated
signaling components. Sensitivity values were time averaged
over 0-100 minutes and 0-5 minutes, respectively. Error bars de-
note one standard error in the sensitivity ranking computed over
a family of uncorrelated (mean correlation of approximately 0.6)
parameter sets selected for the analysis. . . . . . . . . . . . . . . 105
4.6 Species knockdown simulations for a population of translation
initiation models (N = 400). Simulated knockdowns were per-
formed by removing nodes from the stoichiometric matrix. The
relative change in 80S formation resulting from the removal of
a species was used to quantify the impact of the knockdown.
A. Species knockdowns in the presence of insulin. Simulated
knockdowns resulted in increased (black), constant (white),
moderately decreased (dark grey) or severely decreased (light
grey) translational levels. B. Species knockouts in the absence
of insulin. Simulated knockdowns resulted in increased (black),
constant (white), or decreased (grey) translational levels. C. His-
togram of translation levels across each member of parameter
ensemble. Asterisk index indicates parameter sets that were se-
lected for further analysis. D. Alternative modes of network op-
eration. For a subset of the ensemble, initiation increased fol-
lowing Rheb or mTORC2 disruption. Asterisk indicates rate-
limiting step. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
4.7 Effect of the ensemble size on the knockdown simulations. Fold
change of the translational activity was calculated for ensemble
sizes of N = 50 (white fill), N = 100 (light grey), N = 200 (dark
grey) and N= 400 (black) randomly selected parameter sets in
the presence and absence of insulin. For the majority of the per-
turbations, the robustness coefficients converged for as few as
50 parameter sets. In a small number of other cases, the robust-
ness coefficients varied significantly up to 200 parameter sets.
Between 200 - 400 sets the robustness coefficients largely con-
verged to qualitatively and quantitatively similar answers. . . . . 121
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5.1 Schematic overview of the interaction network used in modeling
the TGFβ induced EMT phenomenon. The model describes acti-
vation of the MAPK cascade through TGFβ2 followed by and au-
tocrine response of TGFβ3 stimulating the Smad cascade. Cross-
talk between MAPK and Smads has been shown at both the cy-
tosolic and nuclear levels. . . . . . . . . . . . . . . . . . . . . . . 128
5.2 Eleven different objective functions used to train our model. Our
model was able to effectively predict the simulated experiments
85 percent of the time. The high predictability can be contributed
to the leave-one-out cross validation scheme, objective functions
with overlapping data, and multi-objective optimization (PO-
ETs) algorithm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
5.3 Selected objective value plot for the ensemble of EMT mod-
els: POETs generated more than 15,000 probable models. We
selected models with pareto rank one or less (N = 1091)
for further study. POETs was successful in identifying con-
flicts/relationships between the objective functions which were
used for training/predictions. Pareto fronts developed between
several objectives, e.g., O3×O5, O7×O8, and O5×O8. These
fronts indicated conflicts in the training data and/or an inability
of the model to simultaneously capture different aspects of the
training data. On the other hand, a linear relationship developed
between several objective functions, e.g., O2×O9 and O8×O11.
These fronts indicated strong relationships between the training
data and was effectively captured by the model . . . . . . . . . . 131
5.4 Signal flow analysis of key species at steady state, TGFβ2 stimu-
lation, and blocking the TGFβ3 autocrine response. (A) TGFβ2
stimulates the MAPK pathway to activate transcription factor
AP1 (5-10hr). (B) The MAPK cascade is directly responsible
for rapid expression of snail and slug and downstream TGFβ3
formation (1hr). (C) TGFβ2 reduces membrane affinity for b-
catenin, allowing rapid free-cytosolic b-catenin to accumulate
(1hr). Blocking TGFβ3 increases membrane bound b-catenin
(10hr). (D) TGFβ3 activates the Smad cascade. Nuclear local-
ization of the pSmad2/4 complex (10hr) is dependent upon both
the phosphorylation of Smad2 (1hr) and complexing with Smad4
(5hr). (E) TGFβ2 rapidly reduces the E-cadherin complex, while
upregulating Vimentin (5-10 hours). Blocking TGFβ3 increases
E-cadherin (10hr) and Vimentin is significantly reduced. (F) Ex-
pression of the E-cadherin complex (10hr) is positively regulated
by the TF-1 transcription factor. . . . . . . . . . . . . . . . . . . . 134
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5.5 Using POETs and cross-validation, our ensemble of parameter
sets recapitulates the core signaling pathways associated with
TGFβ induced EMT. (A-B) TGFβ2 (10 a.u.) signals through the
MAPK pathway to upregulate expression of snail and slug and
downstream effectors, such as LEF1. (C-F) Overexpression of
snail and slug indirectly upregulated the autocrine response of
TGFβ3 through the β-catenin-TCF4 complex. In contrast, over-
expression of the E-cadherin complex was able to inhibit the
epithelial transformation by sequestering available cytosolic β
block EMT. Likewise, DN-LEF1 and TGFβ3-Ab inhibited the ep-
ithelial transformation. (G-I) TGFβ3 signals through the Smad
pathway to upregulate expression of LEF1 and downstream ef-
fectors. This was captured through a (10 a.u.) stimulation of
TGFβ3 and inhibitory studies using the DN-Smad4 and DN-
LEF1 complex. Expression of both Vimentin and E-cadherin
were shown dependent upon these complexes. (J-L) The model
was also compared against untrained temporal data, to measure
the effectiveness as a pure prediction. E-cadherin expression
reduced exponentially over 72 hours, pSMAD2 production in-
creased linearly over a 72 hours and, LEF1 production increased
over a 72 hours, but could only be captured after effectively after
the 48hr time point. . . . . . . . . . . . . . . . . . . . . . . . . . . 136
5.6 Using POETs we generated N=1091. (A) The coefficient of varia-
tion (CV) for the parameters in the model ensemble ranged from
0.9 - 2.8 (black dots). 55 parameter sets were chosen for subse-
quent analysis (purple dots). (B-D) The 55 parameter sets were
chosen based on diversity from the nominal parameter set (as
seen by the histogram of the second norm in C-D). Approxi-
mately % of parameter sets its coefficient of variation, and low
correlation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
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5.7 First order sensitivity coefficients were computed for the
temporal response of TGFβ2 stimulation, and blocking the
TGFβ3 autocrine response. (A) During TGFβ2 stimulation pS-
mad2/4/LEF1 complex and pSmad3/4 were the most impor-
tant at later times (10-48 hrs) followed by the AP1 and SP1
complexes. (B) When blocking the TGFβ3 autocrine response
mRNA expression levels of E-cadherin were seen at early (0-2
hrs) times, however, at later time frames (10-48 hr), activated
ERK, SP1, and AP1 were shown to be important. Degradation
of pSmad2/3 and expression of TF1mRNAs also transpire. (C)
Overall time-averaged sensitivity revealed differential regula-
tion of key complexes. pSmad2/Smad4/LEF1 was most impor-
tant in the TGFβ2 perturbed case. In both cases, the transcrip-
tion factor SMAD3 was ranked among the highest followed by
membrane bound β-catenin, YREG1, RasGTP, and MAPK phos-
phatases. This suggests the importance of sustained activation
of the both MAPK/Smad pathways, potential negative feedback
through the ERK cascade, and pSMAD2/4/LEF1 as a critical
complex within the TGFβ2 perturbed case. . . . . . . . . . . . . . 139
5.8 Analysis on all 88 elemental genes revealed a key species in-
volved in shifting cellular phenotype. (A) Gene knockdowns
with TGFβ2 perturbation for the 88 elemental species were com-
puted using 55 parameter sets from the ensemble. Phenotypic
behavior of the population was analyzed using downstream
markers Vimentin (mesenchymal) and E-cadherin (epithelial).
YREG1, AP1, SP1, and TGFβ3 were just a few of the important
species for regulating phenotype. (B) A dendrogram of the single
gene knockouts was used to reveal clusters with inherent func-
tional relationships. The most distinct separation was between
the receptor components of the MAPK pathway and TGFβ3 sig-
nal induction through β-catenin/LEF1. . . . . . . . . . . . . . . . 141
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5.9 Using signal flow, sensitivity, and robustness analysis, we iden-
tified three important areas of regulation. (A) The differential
role of AP1/SP1 throughout the ensemble of parameter sets may
prove as an important transformation aspect between normal
and cancerous cells. Both AP1/SP1 knockouts revealed distinct
subpopulations of parameter sets capable of shifting towards a
mesenchymal phenotype. (B) A balance between the ERK cas-
cade and inhibition of Smads plays an important role in a posi-
tive feedback of the TGFβ3 autocrine response. Over-expression
of ERK phosphatase lead to a decline of inhibited Smads po-
tentially through a selective dephosphorylation of MAPK/ERK
cascade targeting Smad proteins. (C) The availability of LEF1
limits the induction of EMT and takes precedent in forming the
Psmad2/LEF1 complex over other complexes. YREG1 knock-
downs revealed distinct subpopulations of parameter sets capa-
ble of shifting towards a mesenchymal phenotype through ex-
pression of Vimentin. . . . . . . . . . . . . . . . . . . . . . . . . . 144
5.10 Selected phosphorylation through MAPK phosphatases may
plan an important role in facilitating a positive feedback mecha-
nism. (A) Sub-population of parameter sets lead to an increase to
phosphorylated pSmad2. (B) To confirm that the increase of pS-
mad2 was a function of reduced ERK inhibition and not from an-
other source, we found that the total levels of inhibited pSmad2
through targeted ERK was less. (C) As a positive control, we
double over-expressed ERK and MEK phosphatase which shut-
down of the MAPK cascade and thus, mesenchymal shift. . . . . 145
6.1 The Eukaryotic Hypoxic Response: Low cellular oxygen marks
the increased stability of HIF1α and ROS production. Via the role
of transcription factors like AP1, NF-κβ and HIF1, VEGF and IL8
signaling cascades lead to the critical balance mediating tumor
(regular cell) growth and angiogenic signaling. Nomenclature:
HIF1 - Hypoxia Inducible Factor 1, VEGFa - Vascular Endothe-
lial Growth Factor A, VEGFR2 - Vascular Endothelial Growth
Factor Receptor 2, IL8 - Interleukin -8, CXCR1 - IL-8 (or CXCL8)
chemokine receptors, PKC - Protein Kinase C, PI3K - Phospho-
inositide 3-kinase, p38MAPK - p38 Mitogen-Activated Protein
Kinases, p50 p65 - Nuclear Factor κ -light-chain-enhancer of ac-
tivated B cells. Species (proteins and protein-protein complexes)
and corresponding interactions making up the Eukaryotic Hy-
poxic Response (EHR) model (Top Left). . . . . . . . . . . . . . . 159
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6.2 Selected objective value plot for the ensemble of EHR models:
The grid is a compilation of 2-dimensional plots of the objective
values obtained using POETs [504]. Multi-objective optimization
scheme allowed us to obtain trade-offs between diverse data sets
as seen in O18-O19, O12-O13 and O13-O14. Inset: O18-O19 plot
states how we obtain a trade-off between objective functions for
BNIP3 in MCF-7 cells and HEK293 cells. This allows us to ad-
dress qualitative differences in the behavior of BNIP3 in the two
cell lines. This figure suggests how POETs was successful in ad-
dressing conflicts (due to cell type, experimental protocols etc.)
in the data-sets while searching the parameter space. . . . . . . . 161
6.3 Average model performance against data for selected species in
the model: Average model performance with one standard error
is shown for four key species in the network ((A) HIF-1 data and
(B) CXCR1 data used from studies performed by Maxwell et. al.
on hypoxic PC3 cells [343], (C) VEGFa data used from studies
performed by Romero-Ramirez et. al. on MEFs [454], (D) VEGFa
data used from IL-8 induced studies done by Martin et. al. on
SVEC cells [336]). Overall the model recapitulated the behavior
of species (both upstream and downstream) across diverse data
sets [601, 267, 336, 343, 264, 312, 241, 170, 454]. . . . . . . . . . . . 163
6.4 Flux analysis of EHR: (A) Plot of the scaled flux (0-1) of HIF-
1/NF-κβ transcription factors and secreted VEGFA/IL8 over
time. At hypoxic conditions, there was a two-phased response
demarcating the onset of a later autocrine mediated signal am-
plification. VEGF signaling branch was the first to respond, me-
diated by the activity of HIF-1 and ROS mediated NF-κβ acti-
vation. Around 24 hours into hypoxia, we saw a second incre-
ment in VEGF and IL-8 signaling. However upon induction of
normoxic (∼17% O2) conditions, we did not see a difference in
terms of time of recovery between VEGF and IL-8 signaling cas-
cades. HIF-1 and NF-κβ activity dropped down within a few
hours of induction of normoxic conditions. On the contrary
VEGF and IL-8 took around 10-15 hrs to recover. (B-D) Fluxes at
P1 (∼10% O2) when compared to P2 (∼1% O2 after 60 hrs) show
increased VEGF and IL8 signaling leading to enhanced MAPK
activity along with increased NF-κβ activity both via ROS and
downstream of receptor signaling cascades. . . . . . . . . . . . . 166
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6.5 Comparison of experimental data (ELISA measurements) versus
simulation predictions for secreted VEGF and IL-8 in 1% and
17% O2 samples in MDA-MB231 cells: At hypoxic (1% O2) con-
ditions, secreted VEGF levels almost reach steady state values
by day 1 as compared to day 3 and 5, indicating that the major
fold change in the VEGF signaling occurs in the first phase of the
hypoxic response consistent with the prediction by the model
simulations. However at normoxic (∼17% O2) conditions, we see
a decrease in VEGF levels at day 3 and 5 as compared to day
1, which is a result of reduced levels of HIF-1 and ROS medi-
ated VEGF activation. In case of IL-8, at hypoxic conditions we
found experimentally that secreted IL-8 levels rose slowly and
reached steady state values around day 3 to day 5. However
model predictions showed a faster rate for IL-8 production. In-
terestingly, it was observed both experimentally and predicted
by the model that under normoxic conditions secreted IL-8 lev-
els increased with time. . . . . . . . . . . . . . . . . . . . . . . . . 169
6.6 Structural analysis of the EHR model: EHR model was ana-
lyzed by the Extreme pathway analysis (Details in Materials and
methods) to identify the critical structural components. (A-C)
Extreme pathway analysis revealed the VEGF module as struc-
turally most important followed by the transcription factor (AP1
and NF-κβ) module. (D) Analysis of the EP’s of the EHR net-
work showed presence of significant crosstalk and redundancy.
For both 1% and 10% O2 conditions, we found that ∼60% of the
EPs had a disjoint output sets and a similar/same input sets, sug-
gesting a divergent nature of the network. For example, oxygen
sensing lead to HIF-1 and ROS mediated activation of VEGF and
IL-8 signals, subsequently leading to multiple outputs like active
PI3K, active MAPK components, active transcription factors e.g.
NF-κβ, AP-1. We found that ∼5% of the EPs exhibit redundancy.
This exhibited redundant routes within the EHR, for example:
VEGF could lead to AP-1 activation either directly via MAPK
or via p38MAPK. The crosstalk and redundancy observed in the
EPs could be the structural basis of complex behaviors such as
synergy. On the other hand, the redundant EPs identified the
structural basis of EHR robustness, i.e., which interactions could
be removed while simultaneously maintaining network function. 172
xxvi
6.7 Ranked NSS index for species and parameters in the EHR mod-
els: Temporal changes in the rank of the species is plotted for
5 time bands (0-6, 6-12, 12-18, 18-24 and 24-30 hrs) in hypoxic
(∼1% O2) case. In terms of species in the case of 1% O2, MAPK
components were seen to be more important at later (24-30 hrs)
time band as compared to earlier (0-6 hrs) times of EHR. MAPK
is a critical regulator of AP-1 activation, which in turn plays an
important role at later times (> 24 hrs) leading to autocrine medi-
ated IL-8 signal amplification. AP-1 and NF-κβ regulatory mod-
ule was the second group of species which was relatively more
important at later time points. Inset - Ranks of the parameters
are plotted with one standard deviation for ∼1% against ∼10%
O2 case. In terms of parameters, infrastructure parameters e.g.
nuclear transport, RNA polymerase or Ribosome binding were
globally critical components. Interactions governing the regula-
tion of VEGFR2 and VEGFA were the most fragile in both 1%
and 10% O2 conditions. Regulation of the expression and acti-
vation of transcription factors like AP-1, HIF-1 and NF-κβ was
in the top 25 fragile species and parameters. In terms of a mod-
ular comparison, the transcription factor module was the most
fragile, closely followed by the HIF1, VEGF and IL8 modules.
Comparatively, the MAPK module was relatively robust. . . . . . 174
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6.8 Robustness Analysis of EHR models: (A) Dendrogram of the
single gene knockouts revealed clusters with inherent functional
relationships. For example, the most distinct separation was be-
tween the MAPK, PKC and VEGF signal initiation segment from
the rest of the knockouts. MAPK and PKC are one of the few
pillars mediating the crosstalk between VEGF and IL-8 signal-
ing and also regulating signal amplification. On the other hand,
functional groups like regulation of NF-κβ, regulation of AP-1,
HIF-1 regulation and IL-8 signal initiation were all rightly clas-
sified as having similar grouped responses. Inset - A: Plot of the
orthogonal components of each knockout so as to identify the
uniqueness of the knockout. All the single gene knockouts were
found to have orthogonal components greater than one with a
95% confidence. Knockout of HIF-1α, p38MAPK, p65, PLCγ
and VEGFA were some of the knockouts which produced the
most unique knockouts. (B) Phenotypic analysis (pro-death as
elevated BNIP3 levels or pro-survival as elevated Bcl2 levels) of
dual gene knockouts using three cases: case 1 - CXCR1 & PHD
KO, case 2 - VEGFR1 & PI3K KO and case 3 - RAFPase & p65 KO.
In case 1, there was a diverse distribution of response in terms of
pro-death phenotype (marked by log of robustness coefficients
of BNIP3 both > and < 1). We found two populations, one set of
ensembles (∼25%) revealed a pro-death phenotype marked by a
ten-fold increment in BNIP3 levels. On the other hand, there was
a population of the ensemble (∼50%) which did not have much
effect over the BNIP3 levels. This attested the fact that we have
a diversity in terms of cellular behavior in the ensemble of our
EHR models. In case 3, RAFPase and p65 KO lead to a dominant
pro-death phenotype. . . . . . . . . . . . . . . . . . . . . . . . . . 178
7.1 (A) Signaling networks implicated in Breast Cancer: EGFR Sig-
naling, VEGF Signaling and IL8 Signaling. These signaling cas-
cades independently or in combination leads to activation of ki-
nases which further downstream leads to activation of transcrip-
tion factors. These active transcription factors lead to transcrip-
tional regulation of genes in the nucleus. Arrows indicate direc-
tion of signal flow. A representative transcription factor is shown
to demonstrate transcription. (B) Cancer is a complex process
bridging spatial and temporal scales involving many different
cell types and processes. The interplay of these cells, extracellu-
lar environment and other cues orchestrate cancer growth and
progression. Multiscale modeling incorporating multiple pro-
cesses over wide range of scales in a quantitative manner holds
great promise in unraveling the mysteries in case of cancer. . . . 202
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7.2 Overview of SAMM: (A) A 3D virtual microenvironment com-
prising of a discrete space with 20×20×5 grid points was created.
In this grid, we placed the growth factor source and seeded cells
at specific positions at the start of the simulation. In the current
study, the GF source was a constant source (Ginput, in the current
study Ginput = 10 A.U.) of VEGF and/or IL-8 from the side face
as shown. The tumor/endothelial cells were seeded in the op-
posite face, with a maximum of NCmax ( NCmax = 20 in the current
study) per grid element. Each cell in a grid element has a self-
maintained signaling network with a randomly assigned param-
eter vector from the ensemble (details in materials and methods).
(B) Over the course of the simulation, cells respond to cellular
and environmental cues and accordingly adjust their phenotype
at each time step. Intracellular protein marker levels coupled
with probabilistic rules were used to characterize proliferation,
survival and death phenotypes. AP1 dependent CYCLIND ex-
pression was used as a marker of proliferation [557]. NF-κβ de-
pendent BCL2 expression was used to characterize cell survival
while HIF-1α dependent BNIP3 expression was used as a cell
death marker [523, 58]. (C) Cellular mobility decisions addition-
ally took into account both number of available neighbors and
the cellular densities at neighbors. (D) External diffusive chem-
ical cues (VEGF, IL-8, O2 in the current study) are regulated via
initial seeding, source terms and consumption/production via
cells. Throughout the simulation, the three chemical cues are
continuously updated at a fixed rate. . . . . . . . . . . . . . . . . 208
7.3 Selection for Growth and Death rates: (A) According to the cellu-
lar phenotypic ”decision” algorithm (discussed in the materials
and methods), growth was dependent on the levels of CYCLIND
(phosphorylated ERK (ppERK) in one simulation) and a factor
Gα. We sampled four orders of magnitude variations in Gα. Fi-
nal selection of Gα was made so as to have growth behavior in
the shaded grey region. (B) Similarly, cell death decision was de-
pendent on the intracellular levels of BNIP3 and a factor Dα. We
sampled four orders of magnitude variations in Dα. Final selec-
tion of Dα was made so as to have death behavior in the shaded
grey region. Both selections were done with the other decision
(growth/death) happening as an unbiased random move. . . . . 209
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7.4 Investigating growth/death dynamics and migratory behavior
of cells upon a dose of growth factors (GF) using SAMM. (A)
Constant source of VEGF and/or IL8 was allowed to diffuse
from one side face of the construct (grid of 20×20×5) while tu-
mor/endothelial cells (maximum of 20 cells per grid element)
were seeded on the opposite face in the beginning of the simu-
lation. (B) Base case simulation with VEGF (10 au dose, details
in materials and methods with rule 2): Growth profile is shown
along the left part of panel B, while the external GF (VEGF) levels
are shown in the right part of panel B. First row in panel B cor-
responds to time step 1 while last row in panel B corresponds to
time step 250 (end of simulation). (C) Control 1: Simulation with
GF (VEGF) receptor inhibition in all cells/at every location in the
construct. (D) Control 2: Simulation with no external dose of GF
(VEGF) coupled with no initial seeding of GF in the construct. . 213
7.5 Supporting simulations: (A) Growth profile upon VEGF dose
with moves based on at least one empty neighbor. (B) Growth
profile upon IL8 dose to demonstrate crosstalk between VEGF
and IL8 signaling. . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
7.6 Spatio-temporal phenotypic differences during growth: (A)
Contour plot (interpolated colors) of cells across the 3rd z-slice
at the last time point of simulation (Dose: VEGF, Rule 2). We
look at three positions (abbreviated as P1, P2 and P3) to ana-
lyze the functional states of the cells. (B)-(F) Averaged (average
of the position and its 6 corresponding neighbors) internal and
external marker levels at P1, P2 and P3. (B) Scaled extracellu-
lar VEGFA levels. (C) Scaled intracellular CYCLIND (marker for
proliferation) levels. (D) Scaled intracellular BNIP3 (marker for
cell death) levels. (E) Scaled intracellular BCL2 (marker for cell
survival) levels. (F) Scaled extracellular IL8 levels. . . . . . . . . 216
7.7 Exploring variations in growth profile by altering internal make-
up of the cells: Column A - Growth profile upon VEGF dose
under hypoxic conditions (O2 levels ≤ 2%). Column B - Growth
profile upon VEGF dose with no autocrine signaling within cells.
Column C - Growth profile upon VEGF dose with ERK KO in
cells. Column D - Growth profile upon VEGF dose with ATF2
KO in cells. Images in the first row correspond to initial time
point, while images at third row correspond to last time point of
simulation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
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7.8 Exploring variations in growth profile due to probabilistic rules
and alternate use of cellular markers: Column A - Rule 0:
Growth profile upon VEGF dose with complete unbiased moves.
Column B - Rule 2: Growth profile upon VEGF dose with moves
based on at least two empty neighbors. Column C - Rule 3:
Growth profile upon VEGF dose with moves based on at least
three empty neighbors. Column D - Rule 2 + ERK: Growth pro-
file upon VEGF dose with moves based on phosphorylated ERK
levels instead of CYCLIND levels. Images in the first row corre-
spond to initial time point, while images at third row correspond
to last time point of simulation. Images in the fourth row corre-
spond to the contour plot of cells across the 3rd z-slice at the last
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7.9 Repeatability check: We simulated multiple repeats (10 repeats)
for rule 1 and rule 3 to check for reproducibility and consistency.
(A) Number of growth events for rule 1 (mean of 10 simulations
as black line and shaded light grey area demarcating one stan-
dard deviation) and rule 3 (mean of 10 simulations as red line
and shaded dark grey area demarcating one standard deviation)
over the simulation time. We clearly see differences between the
two different rules over multiple repeats while seeing consistent
behavior over repeats. (B) Number of death events. . . . . . . . . 221
7.10 Growth and death dynamics across simulations: (A-C)
Growth/death characteristics upon intracellular perturbations.
(D-F) Growth/death characteristics upon probabilistic rule vari-
ations. In general, growth dynamics (linear growth rate) was
observed overall consistently throughout each simulation. We
do see differences between individual cases with respect to time
of start of growth, total volume of growth, e.g., at low O2 growth
was faster and more pronounced due to additional effects medi-
ated by the ROS and HIF1 signaling axis. . . . . . . . . . . . . . . 222
8.1 Histogram of 2D and 3D fold changes in mRNA components
(hypoxia/normoxia): We see a wider distribution in case of 2D
experiment as compared to 3D experiment. Details of the exper-
imental protocols are in the materials and methods. . . . . . . . . 238
8.2 Microarray arrays have multiple probes for the same IDs. First
step was to remove repetitions in order to reduce dimensions.
This allowed us to consolidate multiple probes for the same
species and reduce the dimensionality of the problem from 54675
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8.3 Qualitative comparisons of genes in 2D and 3D experiments
based on fold changes (hypoxia/normoxia) in mRNA levels:
Against our intuition that genes might be regulated in a corre-
lated manner in 2D and 3D experiments (Quadrant 2 and 3), we
find that the number of differentially regulated genes are more
widespread in number (Quadrant 1 and 4). As seen in quad-
rant 1, MMP1/10/13, BNIP3, ANG, PDGFB are some of the key
species which are differentially seen to be up-regulated in 3D as
compared to 2D (down-regulated). As seen in quadrant 2, BMP5,
EPHA6 are some of the key species which are consistently seen
to be up-regulated in 3D as well as 2D. As seen in quadrant 3,
IL11, ICAM1, IL32 are some of the key species which are consis-
tently seen to be down-regulated in 3D as well as 2D. . . . . . . . 240
8.4 Finding natural combinations of the responses within the genes
using Singular Value Decomposition (SVD) allows us to identify
key regulators mediating the hypoxic response. . . . . . . . . . . 241
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pared to 2D experiments. . . . . . . . . . . . . . . . . . . . . . . . 242
8.6 Matching the Probe IDs to the Gene names, we curated a set
of 124 pathways with their corresponding participating com-
ponents to investigate the differences and critical components
within each pathway. For each pathway, this allowed us to
identify differences within pathway components under differ-
ent cases (2D and 3D) and use SVD to mine the key regulators
as well. This analysis supplemented what we learned from the
pathway analysis using Ingenuity Pathway Analysis. . . . . . . . 243
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8.7 Performance of HIF1 Signaling Cascade: A) Heatmap of the
components involved in the pathway. Left column - Fold change
in mRNA levels in 2D experiment. Right column - Fold change
in mRNA levels in 3D experiment. Color: Black - no change, Red
> 1 and Green < 1. B) Cross plot of fold changes of mRNA lev-
els in 2D (x axis) vs 3D (y axis). Each point indicates the mean
of the ratio across multiple measurement sets. The quadrants of
the plot indicate the similarly or differentially regulated compo-
nents. C) Cross plot of importance based on the first principle
direction using SVD analysis 2D (x axis) vs 3D (y axis). Values
range from 0 (less important) - 1 (more important). D) Tabulation
of the 5 most important components for the corresponding path-
way (using absolute change in expression levels and SVD based
importance). We see that MMP1/10/12 and VEGFA are some of
the components differentially regulated in 2D (fold change < 1)
and 3D (fold change > 1). Interestingly, HIF1α is implicated via
SVD analysis to equally contribute in both cases. . . . . . . . . . 244
8.8 Performance of VEGF Signaling Cascade: We see that
VEGFA/C, PDGFC, PGF are some of the components differen-
tially regulated in 2D (fold change < 1) and 3D (fold change >
1). Interestingly BCL2 is differentially upregulated in 2D (fold
change > 1) suggesting that the cells are more pro-survival in 2D
or struggling to stay alive in 2D as compared to 3D. . . . . . . . 246
8.9 Performance of IL-8 Signaling Cascade: We see that several com-
ponents like CCND3, BAX, HBEGF are differentially regulated.
Interestingly, CXCL1 is downregulated in both cases (greater
magnitude change in 3D). . . . . . . . . . . . . . . . . . . . . . . 247
8.10 Performance of Inhibition of Angiogenesis Signaling Cascade:
We see that SDC1/2 are differentially upregulated in case of
3D. We see an interesting behavior within components in the
TGFβ signaling cascade, for example TGFβ1 is upregulated in 3D
(downregulated in 2D) where as the opposite was seen in case of
TGFβR2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
8.11 Performance of TGFβ Signaling Cascade: In 3D, we saw that
BMP2, SMAD9/7, TGFβ1 were differentially upregulated while
SMAD1/2/6, TGFβR2/3, BMPR1A/B were differentially upreg-
ulated in 2D. However, BMPR2 was upregulated in both the cases.249
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CHAPTER 1
INTRODUCTION
Eukaryotes have developed evolutionarily conserved mechanisms to respond
to diverse ranges of internal and external perturbations, e.g. changes in
oxygen/nutrient levels, temperature oscillations, protein folding load, vi-
ral/bacterial attacks and graft implants ([237, 492, 627, 625, 626, 628, 220, 15]
to name a few). Alterations and malfunctions within these core regulatory
mechanisms provide a peek into shifts towards cancerous and disease states.
These core architectures include signal integrators and actuators, and positive
and negative feedback mechanisms which mediate the effectiveness and ulti-
mate outcome of the response. Contemporary modeling approaches in the era
of genomics revolution and high-throughput technology offer a unique systems
level insight into many areas of biology, ecology, developmental biology and im-
munology [327]. Systemic understanding of disease initiation and progression,
by incorporating conventional wet experiments and modeling to predict and
optimize therapies over a wide range of length scales, could help identify strate-
gies for personalized medicine [100]. Computational systems biology presents
us with tools and strategies to do just this [258, 257, 141]. It is poised to per-
form large number of in-silico experiments, faithfully which otherwise would
have been very time/money/resources consuming. Also, using tools of knowl-
edge discovery and data-mining it can be used to guide experiments and obtain
valuable insight into biological systems.
However, biological systems involve intricate symbiotic/asymbiotic rela-
tionships and crosstalk between several length scales. Biological complexity
is an exponential function of number of components and interactions, thereby
1
escalates rapidly with each increment in level of organization [59]. This opens
up several directions of research commonly aiming at probing and understand-
ing biological complexity, ultimately influencing drug discovery. In a bottom-up
approach, systems biology research focusses on understanding/investigating
physiology and disease from a level of molecular pathways and regulatory
pathways [59] (Fig. 1.1). From targeting specific areas of cellular signaling,
e.g. modeling apoptosis [286, 285] to whole disease states, e.g. breast cancer
[425, 272, 18]; this approach is widely being used. Hyduke et. al. are even
working towards reconstructing genome-scale signaling networks [221]. While
attractive, this area comes with several inherent challenges as well.
In a top-down approach, the attempt is to reverse-engineer integrative mod-
els of human physiology and disease using high-throughput data. Broadly,
this task could be divided to two sub-tasks: extract relevant sub-data and in-
fer connectivity. To address the area of inferring connectivity from such high-
throughput data, several groups are working to identify strategies for the same
[136, 52, 51, 96, 95, 503, 594, 528, 169]. Here size is a big issue. Researchers use
clustering or correlation based techniques to reduce the complexity of these data
sets by identifying clusters of components [528, 169, 303, 594, 24, 293]. However
these techniques are insufficient to determine the kinetic or dynamic parameters
required to model the dynamical behavior of the system [508]. Further math-
ematical mining tools are also being investigated to infer valuable information
from these data-sets, e.g. SVD analysis [568, 252, 87, 632, 607, 530, 8, 9, 104].
Even with these constraints, this approach has been successfully used to inves-
tigate several disease states, e.g. B cell lymphoma [5], breast tumors [426, 419].
An intermediate yet extremely challenging sub-area of work is that of multiscale
modeling involving extrapolation of the molecular signaling events to tissue-
2
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Identifying Ensembles of Signal Transduction Models using
Pareto Optimal Ensemble Techniques (POETs)
Sang Ok Song, Anirikh Chakrabarti, and Jeffrey D. Varner*
School of Chemical and Biomolecular Engineering, Cornell University, Ithaca NY 14853
Abstract
Mathematical modeling of complex gene expression programs is an emerging tool for
understanding disease mechanisms. However, identification of large models sometimes requires
training using qualitative, conflicting or even contradictory data sets. One strategy to address this
challenge is to estimate experimentally constrained model ensembles using multiobjective
optimization. In this study, we used Pareto Optimal Ensemble Techniques (POETs) to identify a
family of proof-of-concept signal transduction models. POETs integrate Simulated Annealing
(SA) with Pareto optimality to identify models near the optimal tradeoff surface between
competing training objectives. We modeled a prototypical-signaling network using mass action
kinetics within an ordinary differential equation (ODE) framework (64-ODEs in total). The true
model was used to generate synthetic immunoblots from which the POET algorithm identified the
117 unknown model parameters. POET generated an ensemble of signaling models, which
collectively exhibited population-like behavior. For example, scaled gene expression levels were
approximately normally distributed over the ensemble following the addition of extracellular
ligand. Also, the ensemble recovered robust and fragile features of the true model, despite
significant parameter uncertainty. Taken together, these results suggest that experimentally
constrained model ensembles could capture qualitatively important network features without exact
parameter information.
Keywords
Systems biology; mathematical modeling; robustness and fragility
Introduction
Mathematical modeling of signal transduction and gene expression programs is an emerging
tool for understanding disease mechanisms. Kitano suggested that analysis of molecular
networks using predictive computer models will play an increasingly important role in
biomedical research [1]. However, conventional wisdom suggests that the data requirement
to identify and validate complex mechanistic models is too large. Molecular network models
often exhibit complex behavior [2]. Typically, it is not possible to uniquely identify model
parameters, even with extensive training data and perfect models [3]. Thus, despite
identification standards [4] and the integration of model identification with experimental
design [5], parameter estimation remains challenging even with structurally complete
models. This reality has brought into the foreground a number of interesting questions. For
example, do we actually need exact parameter knowledge to predict qualitatively important
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Figure 1.1: Schematic of the strategies explored in the current study: A
combination of bottom-up analysis (signaling networks based
analysis) and a top-down analysis (using microarray/high
throughput experimental data) was used to investigate stress
responses in eukaryotes. Using steps S1-S4 we can explain
complex behaviors in biological systems. Using steps S1-S8,
we can explore and identify fragile/robust features of complex
signaling networks and identify therapeutically relevant tar-
gets. Using S9-S11, we can mine high throughput data (e.g.,
microarray data) for functional relationships and new insights
into cellular functioning.
3
level/organ-level phenotypes. While cellular networks provide deductive ca-
pabilities in investigating biological mechanisms, there is a need to inductively
extrapolate the consequences of cell signaling to tissue/organ function. This
presents an emerging need of models taking both signaling networks and dif-
ferent biochemical and biophysical contexts into account [11, 310, 326, 434, 578].
Computational multiscale modeling approaches are poised to address these
growing needs [578].
In my research, I have used a combination of bottom-up analysis (signal-
ing networks based analysis) and a top-down analysis (using microarray/high
throughput experimental data) to investigate stress responses in eukaryotes.
This form of research is by nature interdisciplinary and involved the participa-
tion of experimentalists and fellow researchers from a wide range of academic
disciplines (please see acknowledgements). Broadly, I shall classify my work
into the three strategical bins as discussed below.
1.1 Bottom up analysis of large complex cellular programs:
Modeling signaling networks.
Generally computational models used to investigate cellular signaling networks
are those with biochemical/biophysical mechanistic detail [256, 600, 59, 286,
285, 425, 272, 18, 526, 320, 319, 369]. This bottom-up approach makes use of laws
of mass action and/or Michaelis - Menten enzyme kinetics to mechanistically
represent individual biochemical reactions in a signaling network. These mod-
els are definitely viable/useful in mining/elucidating relationships between the
participating components [4]. The primary assumption here is that the individ-
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ual biochemical reactions represented are sufficient to describe the overall sig-
naling network dynamics. However, predictions/analysis based on this form of
modeling is usually sensitive to missing/incorrect species, interactions or both
[526, 320, 319, 369]. Additionally these models require a large number of pa-
rameters (rate constants, initial conditions) to be appropriately constrained. It
is typically impossible to identify uniquely model parameters, even with ex-
tensive training data and perfect models [148]. These bring forward the devel-
opment of parameter estimation and ensemble routes of analysis of such sys-
tems [26, 280, 54, 401, 505]. It also highlights the utility and relatively open area
of parameter independent routes of development and analysis of such mod-
els [463, 186, 589, 57, 158, 406, 404, 415, 253]. Even with these limitations, the
detailed yet simplified representation of the biochemical and biophysical mech-
anisms enables the ease of model generation using softwares [487, 44, 561, 79]
and to perform predictive computational experiments, which can later be vali-
dated experimentally.
Bhalla and Iyengar pioneered the use of large scale signaling network mod-
els, integrating several signaling pathways to study neurons [39]. The authors
demonstrated how crosstalk between signaling pathways could give rise to
emergent behaviors such as signal integration across time scales, bistability, and
feedback. This form of investigation has made immense progress over the years
leading to several prominent studies [600, 59, 286, 285, 425, 272, 18, 526, 320, 319,
369]. Mechanistic models are also useful for understanding the fundamental de-
sign principles underlying biological networks. Alon and colleagues combined
modeling and experimental studies to demonstrate how common network mo-
tifs found in signaling networks can give rise to a diverse spectrum of systems
properties such as network robustness, signaling acceleration/deceleration, and
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memory [7, 353]. Taken together, biochemically and biophysically mechanistic
models of cell signaling are useful for understanding the mechanisms for cell
signaling regulation and the relationships between cell signaling networks and
the functions they regulate.
By enabling the identification of robust/fragile parts of signaling networks,
computational modeling has led to new ways of rationally designing multi-
target or multi-component therapies. With this idea in mind, we assembled
a series of molecular modules describing different aspects of the cellular re-
sponse to stress. Some of these modules included the Unfolded Protein Re-
sponse (UPR), Hypoxic Response (HR) and Tumor Angiogenesis, Epithelial to
Mesenchymal Transition (EMT), Insulin mediated Translation Initiation and Re-
nal Allograft Failure. These modules were modeled using mass action kinetics
with an Ordinary Differential Equation (ODE) based framework to investigate
the internal regulatory cores. For example, in UPR we identified the differential
negative feedback of ATF4 as the key in the adaptation phase via regulation of
BiP (details in Chapter 3). Similarly in HR, we identified the role of AP1 in me-
diating the autocrine response via VEGF and IL8 signaling modules (details in
Chapter 6). Model generation was done using UNIVERSAL, an in house soft-
ware freely available at google code. We addressed issues pertaining to uncer-
tainties within these models by developing POETs, a multi-objective optimizing
algorithm which allowed us to train our models with experimental data from
the literature [504]. POETs presented us with an advantage by generating an
ensemble of models consistent with experimental data. The diversity within
these ensembles were used to study different operational paradigms within
these modules. For example, in EMT we identified the differential modes of
crosstalk between MAPK and SMADs in mediating the cellular transformation
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(details in Chapter 5). These different modes of operation suggest insights into
different diseases and irregularities in cellular adaptation. We subsequently an-
alyzed these models using parameter independent structural analysis tools like
extreme pathways and parameter dependent tools like fragility and robustness
to identify targets relevant to therapeutic interventions. These configurations
represent experimentally testable hypothesis and potentially new strategies to
manipulate the cellular responses.
1.2 Modeling integration of intracellular signaling to tis-
sue/organ level behavior: Multiscale modeling.
At the molecular level, signaling networks implicated in several disease states
exhibit considerable complexity in size and connectivity. The intrinsic complex-
ity of these networks complicates the interpretation of experimental findings.
Added to this is the dynamical interactions between the cells and their sur-
rounding microenvironmental changes. Extrapolating the molecular signaling
events to tissue-level/organ-level phenotypes adds another layer of complexity
across spatio-temporal and functional scales. While cellular networks provide
deductive capabilities in investigating biological mechanisms, there is a need
to inductively extrapolate the consequences of cell signaling to tissue/organ
function. This presents an emerging opportunity and the need for models tak-
ing both signaling networks and different biochemical and biophysical contexts
into account [11, 310, 326, 434, 578]. Computational multiscale modeling ap-
proaches are poised to address these growing needs [578]. Multiscale models
have been used extensively in several disease states e.g. in cardiac physiol-
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ogy [600], epidermal wound healing [514], renal physiology [112] to identify
biological mechanisms, infer multiscale consequences to cell signaling activi-
ties. Multiscale modeling as such is modular in nature and involves integrating
common linkages (species/components) across individual computational mod-
els of different length scales. For example, Cortassa et. al. developed an inte-
grated model of the guinea pig cardiomyocyte, linking cell electrophysiology,
force generation, and mitochondrial energy generation to investigate phenom-
ena such as oxidative-stress induced action potential shortening [84].
Disease states like cancer are heterogeneous cellular entities involving dy-
namical interactions between genetically altered cells and their surrounding
microenvironmental changes. These forms of disease states present an emerg-
ing importance and need of models taking both signaling networks and dif-
ferent biochemical and biophysical contexts into account. For example, factors
like vascular endothelial growth factor (VEGF) and/or interleukin-8 (IL8) have
been implicated in multiple studies in the regulation of some tumor growth as
well as in the activation and chemotactic guidance of capillary sprouting and
growth. Detailed computational models of such complex phenomena using in-
tricate cellular signaling mechanisms, nutrient/growth factor transport, move-
ment/interactions between normal and tumor cells is critical in identifying the
key regulators of such a system. We have created a signaling assisted multiscale
modeling approach (SAMM) to study systems across multiple length scales.
Key highlights of SAMM include use of detailed cellular models to regulate cel-
lular decisions, use of an ensemble of models to incorporate differences between
cells, coupling intracellular markers and probabilistic rules to monitor cellular
fate and cellular motility and a hybrid approach to improve speed of solving
of external and internal mass-balances. SAMM allows us the flexibility to in-
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clude multiple cell types, freedom of seeding cells with specific internal cellular
machinery within complex geometries, regulate multiple cellular decisions us-
ing internal and secreted cellular markers, ease of computation and improved
solving speed.
We demonstrated using SAMM the ability to capture and identify spatio-
temporal effects upon growth, ability to model and monitor effects of internal
variations in the cells e.g., species knockouts (KO’s) and ultimately ability to
monitor effects of coupling probabilistic rules to internal marker levels and its
effects on growth morphology and growth dynamics. For this study we used a
tumor/endothelial cell model which has been used earlier to study eukaryotic
hypoxic response [70]. Both VEGF and IL8 have been shown to regulate, in an
autocrine signaling based mechanism, the ability of the tumor to grow. While
this was used to investigate tumor growth, a similar set-up with different cell-
types could be used to study other phenomenon e.g. angiogenesis, transplant
failure. There are however several open areas of development in this form of
modeling, e.g. using further detailed/comprehensive cellular models, efficient
ways of solving extracellular/intracellular mass balances, incorporating stress
and extracellular matrix properties, improved models of cellular fate/decisions
based on combination of internal and external species/conditions, cell size vari-
ations, flow and other considerations.
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1.3 Top down analysis: High-throughput data coupled with
physiochemical model based assessment of biomarker im-
portance.
Recent advancements in high-throughput methods for characterizing genomic,
transcriptomic, proteomic, and metabolomic states allow one to view the global
consequences of molecular perturbations rather than just the usual suspects [508].
However, this wealth of high-throughput data creates new challenges in data in-
terpretation, because most of the measurements lack a biological context for in-
terpreting the biological relevance to the experimental perturbation. These mea-
surements give a snapshot of activity at various levels at the time of isolation
[508, 606, 166]. While this has successfully provided a detailed view in several
disease states, e.g. B cell lymphoma [5], breast tumors [426, 419]; it lacks provid-
ing us with the understanding of relationships within gene networks [606, 166].
Interactions between gene products are extremely complex and are not the
only determinant of cellular behavior [508]. To address the area of inferring
connectivity from such high-throughput data, several groups are working to set
up tools [136, 52, 51, 96, 95, 503, 594, 528, 169]. Researchers use clustering or
correlation based techniques to infer information about the topology of the con-
nections extensively [528, 169, 303, 594, 24, 293]. These techniques help reduce
the complexity of these data sets by identifying clusters of signaling species
that may either be co-regulated or that can similarly regulate other species in a
signaling network. However these techniques are insufficient to determine the
kinetic or dynamic parameters required to model the dynamical behavior of the
system [508]. Another strategy in extracting potential gene relationships from
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such high-throughput data is by using singular value decomposition (SVD)
[568, 252, 87, 632, 607, 530, 8, 9, 104]. These approaches draw on the use of
computational tools to identify features in the data that may globally represent
the entire data set (e.g., principal components). These approaches inherently
make few/no assumptions about the data and have the capability to provide
unbiased identification of unexpected correlations. These correlations might
not explain the causality between correlated components, however they can be
useful for identifying nonintuitive patterns in the data and help guide future
experiments.
In the current study, using a top down strategy, we used these extensive data-
sets to investigate cellular signaling, identify malfunctions, create predictive
models to infer patient outcome. Specifically we employed this strategy in case
of hypoxia induced tumor growth and angiogenesis. We created an in house
platform to analyze microarray data and overlay the quantitative information
on pre-curated pathways to identify malfunctions within the cells. We coupled
this to mathematical analysis techniques such as singular value decomposition
(SVD) to identify key mediators of the response. Using these strategies, we
identified differential regulators of the cellular behavior in 2D versus 3D exper-
imental protocols. We also identified differential behaviors and involvement of
key signaling pathways in mediating the hypoxic response. While this form of
analysis provided key insights in the experimental directions, which are being
pursued by our collaborators, we specifically used this insight to create proof-
of-concept physiochemical models to further the process of modeling these dis-
ease states. This strategy has immense scope of development, from identifying
key regulators to forming proof-of-concept physiochemical models.
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CHAPTER 2
A REVIEW OF THE MAMMALIAN UNFOLDED PROTEIN RESPONSE
Authors - Chakrabarti A, Chen AW, Varner JD.
Published in - Biotechnol Bioeng. 2011 Dec; 108(12):2777-93.
2.1 Abstract
Proteins requiring post-translational modifications such as N-linked glycosyla-
tion are processed in the endoplasmic reticulum (ER). A diverse array of cellular
stresses can lead to dysfunction of the ER and ultimately to an imbalance be-
tween protein-folding capacity and protein-folding load. Cells monitor protein
folding by an inbuilt quality control system involving both the ER and the Golgi
apparatus. Unfolded or misfolded proteins are tagged for degradation via ER
associated degradation (ERAD) or sent back through the folding cycle. Contin-
ued accumulation of incorrectly folded proteins can also trigger the Unfolded
Protein Response (UPR). In mammalian cells, UPR is a complex signaling pro-
gram mediated by three ER transmembrane receptors: activating transcription
factor 6 (ATF6), inositol requiring kinase 1 (IRE1) and double-stranded RNA-
activated protein kinase (PKR)-like endoplasmic reticulum kinase (PERK). UPR
performs three functions, adaptation, alarm and apoptosis. During adaptation,
the UPR tries to reestablish folding homeostasis by inducing the expression of
chaperones that enhance protein folding. Simultaneously, global translation is
attenuated to reduce the ER folding load while the degradation rate of unfolded
proteins is increased. If these steps fail, the UPR induces a cellular alarm and mi-
tochondrial mediated apoptosis program. UPR malfunctions have been associ-
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ated with a wide range of disease states including tumor progression, diabetes,
as well as immune and inflammatory disorders. This review describes recent
advances in understanding the molecular structure of UPR in mammalian cells,
its functional role in cellular stress, and its pathophysiology.
2.2 Introduction
Protein folding is strategically important to cellular function. Secreted,
membrane-bound and organelle-targeted proteins are typically processed and
folded in the endoplasmic reticulum (ER) in eukaryotes [363, 456, 245]. Intracel-
lular perturbations caused by a variety of stressors disturb the specialized envi-
ronment of the ER leading to the accumulation of unfolded proteins [117, 134].
Glucose deprivation, aberrant calcium regulation, viral infection and hypoxia
can all alter protein folding and induce ER stress [456, 245]. Physiological pro-
cesses such as aging can also influence protein folding [363]. Normally, cells en-
sure that proteins are correctly folded using a combination of molecular chap-
erones, foldases and lectins [363]. However, when proper folding can not be
restored, incorrectly folded proteins are targeted to ER Associated Degradation
(ERAD) pathways for processing [245]. If unfolded or misfolded proteins con-
tinue to accumulate, eukaryotes induce the unfolded protein response (UPR).
In mammalian cells, UPR is a complex signaling program mediated by three
ER transmembrane receptors: activating transcription factor 6 (ATF6), inositol
requiring kinase 1 (IRE1) and double-stranded RNA-activated protein kinase
(PKR)-like endoplasmic reticulum kinase (PERK). UPR performs three func-
tions, adaptation, alarm and apoptosis. During adaptation, the UPR tries to
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reestablish folding homeostasis by inducing the expression of chaperones that
enhance protein folding. Simultaneously, translation is globally attenuated to
reduce the ER folding load while the degradation of unfolded proteins is in-
creased. If these steps fail, the UPR induces a cellular alarm and apoptosis pro-
gram. The alarm phase involves several signal transduction events, ultimately
leading to the removal of the translational block and the down-regulation of the
expression and activity of pro-survival factors such as the B-cell lymphoma 2
(Bcl2) protein. After the alarm phase, cells can undergo apoptosis, although ER
stress can also initiate autophagy [386, 609, 36, 240, 218, 270, 146]. Thus, ER fold-
ing homeostasis strongly influences physiology [134]. Aberrant protein folding
and UPR have been implicated in a number of pathologies. For example, the
onset of diabetes [478] as well as myocardial ischaemia, cardiac hypertrophy,
atherosclerosis and heart failure [164] have all been linked with aberrant fold-
ing or UPR signaling. This review describes the molecular basis of UPR in mam-
malian cells, and its functional role in cellular stress induced pathophysiology.
First, we explore the regulation and activity of the IRE1, ATF6 and PERK stress
receptors. Next, we review the role of aberrant UPR and ER-stress in a variety of
diseases, including cancer and neurodegenerative disorders. Lastly, we present
recent strategies to manipulate UPR which have been shown to enhance protein
titers in mammalian hosts.
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2.2.1 The folding cycle, quality control and ER associated
degradation (ERAD).
Newly synthesized polypeptide chains enter the ER through a peptide translo-
con in the ER membrane composed of four proteins, Sec61α,β,γ and TRAM
[340]. Upon entering the ER, these nascent chains begin to fold, often as they are
being co-translationally modified [124]. In the cytosol, protein folding is largely
driven by the collapse of hydrophobic side chains which ultimately form the
core of the folded protein. Another key factor, the burial of electrostatic inter-
actions, e.g., salt brides or hydrogen bonds in the hydrophobic core, constrains
possible folding choices in a very complex free energy landscape. The forces
that govern cytosolic folding are also active in the ER. However, protein folding
in the ER is more complex because of post-translational modifications such as
disulfide bond formation or N-linked glycosylation. Interestingly, the folding
landscape in the ER can sometimes be traversed quickly; small proteins like the
Semliki Forest virus capsid protein can fold in approximately 50ms [470]. How-
ever, for more complex proteins, e.g., the human coagulation factors V and VIII,
folding can take several minutes to hours to complete [424].
The folding quality of proteins in the ER is maintained by an in-built qual-
ity control (QC) system (Fig. 2.1) which ensures proteins are in their native
folded state before exiting the ER [114, 117]. A protein is correctly folded if
it has attained its native conformation after required co- or post-translational
modifications. On the other hand, exposed hydrophobic regions, unpaired cys-
teine residues, or aggregation are all markers of an unfolded or misfolded con-
formation [114]. The best characterized QC system in the ER is the so-called
glycan-code [195]. Most polypeptides entering the ER are modified by adding
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Figure 2.1: The calnexin/calreticulin protein folding cycle. Yellow circles
denote glucose groups and while blue circles denote mannose
groups. After entering the ER lumen, glucosidase I and II re-
move two glucose groups. The monoglucosylated glycoprotein
then interacts with calnexin/calreticulin. These chaperones in-
teract with the thiol-disulphide oxidoreductase ERp57. Cleav-
age of the last glucose residue by glucosidase II leads to the re-
lease of the chaperones. At this time, the protein could have ei-
ther folded and left the ER or it could have attained an incorrect
state. The incorrectly folded proteins are then the substrates
of UDP glucose:glycoprotein glucosyltransferase, which puts a
glucose residue back to the incorrectly folded protein. This en-
ables the protein to spend some more time in folding in the
ER. If the protein fails to fold in a repeated number of cy-
cles, the mannose residue is removed by α-1,2-mannosidase I.
This enables the protein to be recognized by ER-degradation-
enhancing 1,2-mannosidase-like protein (EDEM). This targets
the unfolded proteins for ER-associated degradation (ERAD).
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preassembled oligosaccharides to asparagine side chains appearing in ASN-X-
SER/THR motifs [199]. Once attached, these oligosaccharide groups can be
sequentially modified by glucosidases I and II to form mono-glucosylated in-
termediates that are recognized by the ER lectins calnexin and calreticulin [180]
and the associated oxidoreductase ERp57 [393, 392, 579, 313, 192]. Calnexin is a
type I membrane protein with a β-sandwich carbohydrate binding domain and
a hairpin, called the P-domain, extending away from the carbohydrate bind-
ing domain [480]. Calrecticulin is the soluble paralog of calnexin with only
minor structural differences in the P-domain [480, 116, 115]. Calnexin and cal-
recticulin binding increases the efficiency of glycoprotein folding by protecting
against aggregation [193] and ensures that misfolded proteins are retained in
the ER [436]. These ER glycoprotein chaperones also promote disulfide bond
formation through their interaction with ERp57; ERp57 binds the P-domain of
both calnexin and calrecticulin thereby promoting disulfide bond formation at
specific glycoprotein locations [393, 392, 142]. Glycoproteins are released from
calnexin and calrecticulin by further glucose cleavage by glucosidases II. Once
released, these proteins can fold into their native conformation, they can be re-
glucosylated and re-processed by the calnexin/calreticulin cycle, or they can
be targeted for ER-associated degradation (ERAD) (recently reviewed in Maat-
tanen et. al. [325]). Interestingly, while calnexin and calrecticulin ultimately
promote folding, they do not recognize misfolded proteins. Misfolded proteins
can be targeted (or re-targeted) to the calnexin/calrecticulin cycle by glucosy-
lation with UDP-glucose; the C-terminal domain of glycoprotein glucosyltrans-
ferase (GT) glucosylates near-native conformations by using its N-terminal pro-
tein sensor to locate exposed hydrophobic residues [507, 545, 63, 88]. In this
way, GT acts as an adapter allowing attachment of calnexin/calreticulin and re-
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processing in the calnexin/calreticulin cycle [411]. Repeated glycosylation and
deglycosylation cycles ensure misfolded glycoproteins spend sufficient time in
the ER to correctly fold. Exit from the calnexin/calreticulin cycle can also lead to
ERAD. In this case, terminal mannose residues are removed from the attached
oligosaccharides by ER α-mannosidase I, which leads to interaction with mem-
brane localized ER degradation enhancing α-mannosidase like proteins (EDEM
and EDEM2) [217, 391] and subsequent retro-translocation to the cytosol. The
retro-translocon responsible for transporting unfolded or misfolded proteins
out of the ER is uncertain [546]; several ER membrane proteins have been pro-
posed including Sec61 components, Derlin family members and E3-ubiquitin
ligases (reviewed in [194]). Mannose removal decreases the likelihood that a
unfolded protein will be processed in the calnexin/calreticulin cycle [114], thus,
increasing the probability of terminal mannose cleavage and retro-translocation.
Once in the cytosol, these unfolded or misfolded proteins are degraded by the
ubiquitin proteasome system [205].
Hydrophobic unfolded or misfolded proteins are recognized in the ER by
molecular chaperones which bind these proteins and increase the probability of
correct folding [138, 198, 200]. Similar to calnexin and calrecticulin, hydropho-
bic chaperone binding increases the residence time of unfolded proteins in the
ER lumen, giving these proteins a chance to fold (Fig. 2.2A). For example, the
HSP70 family of chaperones recognize, in an ATP-dependent manner, exposed
hydrophobic patches on a broad spectrum of unfolded or misfolded proteins
[245]. Repeated binding and release of HSP70 chaperones ensures that incor-
rectly folded proteins do not exit the ER [245]. One critical member of the
HSP70 family is BiP or GRP78. BiP consists of an N-terminal ATPase domain
and a C-terminal peptide binding domain [157]. When bound to ATP, BiP binds
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unfolded hydrophobic stretches with low-affinity. However, unfolded or mis-
folded protein binding stimulates the N-terminal ATPase activity of BiP result-
ing in an ADP-bound form with much higher affinity for hydrophobic motifs
[157]. Interestingly, the affinity of BiP (and other HSP70 family members) for
ADP is approximately six-fold greater than for ATP. Thus, nucleotide exchange
factors (NEFs) such as BiP associated protein (BAP), Sil1/S1s1p or GrpE-like
proteins are required to catalyze the ADP/ATP exchange needed for the disso-
ciation of BiP from unfolded proteins [547]. In addition to its role as a folding
chaperone, BiP also functions as an ER stress regulator by buffering Ca2+ lev-
els [447]. BiP interacts with ER-localized caspase-7 [447] and prevents the ac-
tivation of pro-apoptotic Bcl2 family members such as Bax [437, 144]. Beyond
these activities, BiP also regulates the activation of the three transmembrane
ER stress transducers: PERK, ATF6 and IRE1. Normally, BiP is bound to these
ER receptors, blocking their activation. However, in the presence of exposed hy-
drophobic residues BiP disassociates, allowing PERK, ATF6 and IRE1 activation
(Fig. 2.2B). Overexpression of BiP leads to reduced activation of IRE1 and PERK
[38, 262]. The PERK and ATF6 branches are thought to be activated before IRE1
[515]; this ordering is consistent with the signals that each branch transduces.
The PERK and ATF6 pathways largely promote ER adaptation to misfolding,
while IRE1 has a dual role, transmitting both survival and pro-apoptotic sig-
nals.
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2.2.2 Double-stranded RNA-activated protein kinase (PKR)-
like endoplasmic reticulum kinase (PERK) pathway:
The PERK branch of UPR transduces both pro-survival as well as pro-apoptotic
signals following the accumulation of unfolded or misfolded protein in the ER.
However, its main function is to modulate translation. PERK is a type I trans-
membrane protein, composed of a ER luminal stress sensor and a cytosolic pro-
tein kinase domain. Dissociation of BiP from the N-terminus of PERK initiates
dimerization and autophosphorylation of the kinase domain at T981 [246]. The
C-terminal kinase domain shares homology with the eukaryotic translation ini-
tiation factor 2α (eIF2α) and the kinases, protein kinase R (PKR), heme-regulated
inhibitor (HRI) kinase, and the gene control non-derepressible-2 (GCN2) kinase
[184, 494, 493]. The eIF2α protein, which is composed of three subunits, is criti-
cal to translation initiation in eukaryotes, including GTP-dependent start-site
recognition [351]. Phosphorylation of the α subunit of eIF2α blocks the ex-
change of GDP bound to eIF2α; hence, eIF2α remains bound to partner initi-
ation factors (eIF2B) and translation initiation is blocked [156]. Activated PERK
can phosphorylate eIF2α at S51 [184, 444], which leads to three downstream ef-
fects. First, phosphorylated eIF2α globally attenuates translation initiation. De-
creased translation reduces the influx of protein into the ER, hence diminishing
the folding load. Translation attenuation is followed by increased clearance of
the accumulated proteins from the ER by ERAD and expression of pro-survival
genes. For example, PERK activation induces of the expression of cellular in-
hibitor of apoptosis (cIAP) [179]. Interestingly, decreased protein translation is
not universal; genes with internal ribosome entry site (IRES) sequences in the 5′
untranslated regions bypass the eIF2α translational block [481]. One of the most
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well-studied of these, ATF4, encodes a cAMP response element-binding tran-
scription factor (C/EBP) [318] ATF4 that drives the expression of pro-survival
functions such as amino acid transport and synthesis, redox reactions and pro-
tein secretion [185]. Taken together, these effects seem to be largely pro-survival.
However, ATF4 can also induce the expression of pro-apoptotic factors. For ex-
ample, ATF4 induces the expression of the transcription factor C/EBP homol-
ogous protein (CHOP), which is associated with apoptotic cell-death. CHOP
(also known as GADD153) is 29 kDa protein composed of an N-terminal tran-
scriptional activation domain and a C-terminal basic-leucine zipper (bZIP) do-
main that is normally present at low levels in mammalian cells [455]. The tran-
scriptional activator domain is positively regulated by phosphorylation at S78
and S81 by p38 MAPK family members [574, 344] while the bZIP domain plays
a key role in the homodimerization of the protein [341, 344]. CHOP activity
promotes apoptosis primarily by repression of Bcl2 expression and the sensiti-
zation of cells to ER-stress inducing agents [167, 345]. For example, Matsumoto
et al. showed that ectopic expression of CHOP in M1 myeloblastic leukemia
cells reduced Bcl2 protein concentrations, while Bax levels remained constant
[341]. They further established a link between CHOP expression and apoptosis
in these cells. However, while CHOP expression is negatively correlated with
Bcl2 levels, there is no CHOP binding site in the bcl2 promoter [345]. McCul-
lough et al. have suggested that the bZIP domain of CHOP could act with other
bZIP transcription factors to regulate bcl2 expression [345]. Thus, it’s likely that
the connection between CHOP expression and apoptosis is more complex than
simple down-regulation of Bcl2 expression.
Given its central role in translation attenuation, cells have evolved multiple
axes to regulate PERK activity. First, the cytosolic kinase domain of PERK can be
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Figure 2.2: In response to the folding imbalance, cells initiate the cytopro-
tective unfolded protein response (UPR). A: The problem of
unfolded or misfolded proteins in the ER is addressed by in-
creasing the folding capacity through the up-regulation of the
expression of chaperone proteins, attenuating translation by
regulating eIF2α, and promoting the degradation of misfolded
proteins through ER-associated degradation (ERAD). If UPR is
unable to restore the folding balance, ER stress will eventually
lead to apoptotic cell-death. B: The three signal transduction
pathways mediating the unfolded protein response in higher
eukaryotes. First, the PRKR-like ER kinase (PERK) pathway is
initiated after BiP dissociation from PERK. While PERK trans-
duces both pro- and anti-apoptotic signals, its main function is
translation attenuation through the phosphorylation of eIF2α.
Next, the activating transcription factor 6 (ATF6) pathway is
activated following BiP dissociation. ATF6 induces the expres-
sion of chaperones e.g., BiP as well as apoptosis effectors such
as CHOP. Lastly, the inositol-requiring kinase 1 (IRE1) pathway
is activated following BiP dissociation from IRE1. Activated
IRE1 has both an endoribonuclease and a serine-threonine ki-
nase activity that drive can pro-apoptotic signals.
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inhibited by the action of the DNAJ family member P58IPK . P58IPK was initially
discovered as an inhibitor of the eIF2α protein kinase PKR [292]. P58IPK , whose
expression is induced following ATF6 activation, binds to the cytosolic kinase
domain of PERK, inhibiting its activity [599, 558]. Inhibition of PERK kinase ac-
tivity relieves eIF2α phosphorylation, thereby removing the translational block.
Interestingly, P58IPK expression occurs several hours after PERK activation and
eIF2α phosphorylation. Thus, P58IPK induction may mark the end of UPR adap-
tation, and the beginning of the alarm/apoptosis phase of the response [515].
In addition to its direct interaction with PERK, P58IPK is also involved in co-
translational protein degradation [398]. In this role, P58IPK is thought to recruit
Hsp70 to the cytosolic opening of the ER translocon in an effort to extract stalled
nascent proteins. Interestingly, P58IPK has also been identified as an ER-luminal
co-chaperone acting in conjunction with BiP, although BiP-independent associ-
ation between P58IPK and a mutant vesicular stomatitis virus envelope glyco-
protein (VSV-Gts045) was also observed [422]. The activity of P58IPK appears
to be regulated; recently, Ni et al. reported a novel UPR-inducible cytosolic
BiP isoform (GRP78va), generated by alternative splicing and IRES mediated
translation, that antagonizes cytosolic P58IPK in several human and mouse cell-
lines [375]. Second, PERK induces a negative feedback loop, through its down-
stream effector CHOP, involving the direct de-phosphorylation of eIF2α. CHOP
induces the expression of GADD34 which, in conjunction with protein phos-
phatase 1 (PP1), assembles into a phosphatase which dephosphorylates the S51
residue of eIF2α [384]. GADD34 is a member of the GADD family of genes
which are induced by DNA damage and a variety of other cellular stresses
[621]. The GADD34 binding partner in this complex appears to be responsible
for PP1α recognition and targeting of the phosphatase complex to the ER. As-
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sociation between GADD34 and PP1 is encoded by a C-terminal canonical PP1
binding motif, KVRF, while approximately 180 residues, near the N-terminus of
GADD34, appear to be responsible for ER localization [56].
2.2.3 Activating transcription factor 6 (ATF6) pathway:
ATF6 activation involves a complex series of translocation and irreversible
proteolytic processing steps, ultimately leading to the up-regulation of a pro-
survival transcriptional program, in the presence of unfolded or misfolded pro-
teins. First, ATF6 is translocated from the ER to the golgi apparatus following
BiP dissociation. Once resident in the golgi, ATF6 is proteolytically processed,
after which it drives its transcriptional program. ATF6 is a 90 kDa ER transmem-
brane protein with two homologs: ATF6α [191, 178] and ATF6β [354, 249, 190].
The ATF6α homolog is thought to be primarily responsible for transcriptional
regulation of pro-survival genes following ER stress, however, ATF6β may also
play a role [190, 598, 537]. Similar to IRE1 and PERK, ER stress leads to the
dissociation of BIP from the N-terminus of ATF6, followed by translocation and
activation. However, the mechanism of BiP interaction with ATF6 and the fac-
tors controlling ATF6 translocation to the golgi remain uncertain. N-terminal
golgi localization sequences (GLS1 and GLS2) seem to be involved with BiP
regulation of ATF6. BiP binding to the N-terminal GLS1 promotes the retention
of ATF6 in the ER [489]. On the other hand, the GLS2 domain was required
to target ATF6 to the golgi body following BiP dissociation from GLS1 [489].
The lectin CRT might also have a role in keeping the ATF6 in the ER [215].
Unlike the previous two kinase pathways, ATF6 activation does not involve
phosphorylation of a C-terminal kinase domain. Rather, after translocated to
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the golgi, ATF6 undergoes regulated intramembrane proteolysis (RIP); the lu-
minal domain is first cleaved by serine protease site-1 protease (S1P) followed
by metalloprotease site-2 protease (S2P) cleavage [191, 605, 75, 490]. Cleavage
at the juxtamembrane site allows the 50 kDa transcriptional domain of ATF6 to
be translocated to the nucleus where it regulates the expression of genes with
ATF/cAMP response elements (CREs) [575] and ER stress response elements
(ERSE) in their promoters [610, 263]. Cleaved ATF6 induces a gene expression
program, in conjunction with other bZIP transcription factors and required co-
regulators, such as nuclear factor Y (NF-Y) [263, 612], that increases chaperone
activity as well as the degradation of unfolded proteins [598, 590]. For example,
ATF6 upregulates BiP, protein disulfide isomerase (PDI) and ER degradation-
enhancing alpha-mannosidase-like protein 1 (EDEM1) expression. Addition-
ally, ATF6 induces the expression of the X box-binding protein 1 (XBP1) which,
after processing by activated IRE1α, induces the expression of chaperones as
well as control elements such as P58INK [611]. The ATF6-induced gene expres-
sion program is also cytoprotective. For example, ATF6 induces regulator of cal-
cineurin 1 (RCAN1) expression [32]. RCAN1 sequesters calcineurin [32], a cal-
cium activated protein-phosphotase B, that dephosphorylates Bcl2-antagonist
of cell death (BAD) at S75 or S99 [571]. This leads to sequestering of Bcl2 by Bad,
which inhibits its downstream anti-apoptotic activity [571]. Recently, a number
of ATF6 homologs have been identified, e.g., OASIS, CREBH, LUMAN/CREB3,
CREB4 and BBF2H7 that are processed in a similar way as ATF6, yet their func-
tion remains unknown [457]. Thus, ER-stress induced ATF6 signaling may be
responsible for additional undiscovered functionality.
Currently, little is known about deactivation of ATF6. Recently, XBP1u, the
unspliced form of XBP1, has been implicated as a negative regulator for ATF6
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[615]. Following, the induction of ER stress, two versions of XBP1 exist: XBP1u
and sXBP1 [615]. In the recovery phase following ER stress, high levels of XBP1u
may play a dual role. First, XBP1u binds sXBP1, promoting complex degrada-
tion [614, 541]. Second, XBP1u can bind ATF6α rendering it more prone to pro-
teasomal degradation [615]. Taken together, these two steps may slow the tran-
scription of ER chaperones and ERAD components during the recovery phase
following ER stress.
2.2.4 Inositol-requiring kinase 1 (IRE1) pathway:
IRE1 is the most evolutionarily conserved branch of UPR and its interactome
has recently been reviewed by Hetz and Glimcher [208]. IRE1 initiates a pro-
gram with both pro-survival and pro-apoptotic components in the presence of
misfolded or unfolded proteins. IRE1 is a 100 kDa type I ER transmembrane
protein with both an endoribonuclease and a serine-threonine kinase domain
[245]. IRE1 has two homologs, IRE1α and IRE1β; IRE1α is expressed in a variety
of tissues [540] while IRE1β is found only in the intestinal epithelia [540, 573].
The N-terminus of IRE1, located in the ER lumen, senses unfolded or misfolded
proteins through its interaction with BiP [85, 486, 499]. There has been some con-
troversy surrounding the mechanism of unfolding-induced BiP dissociation and
the role of possible direct interaction of unfolded proteins with IRE1. Normally
BiP is bound to the N-terminus of IRE1 [38, 389, 309]. However, in the presence
of unfolding cues BiP dissociates and is sequestered by the unfolded or mis-
folded proteins [255]. IRE1 may also sense unfolded cues in a BiP independent
manner through a N-terminal peptide binding domain [309, 308]. Interaction of
this domain with unfolded or misfolded proteins has been suggested as a pre-
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cursor to BiP dissociation. Current studies in yeast have suggested that BiP first
dissociates, allowing IRE1 dimerization. This step is then followed by direct
sensing of unfolded motifs which work to orient IRE1 into an active signaling
cluster [254]. In either case, BiP dissociation allows IRE1 activation. IRE1 is
activated by homooligomerization followed by autophosphorylation of the C-
terminal kinase domain at S724 [486, 584, 583, 403]. IRE1 activation enables both
its kinase and endoribonuclease activities to transduce signals simultaneously
through two distinct signaling axes. The endoribonuclease activity cleaves a
26-nucleotide intron from the XBP1-mRNA [491, 611, 291] which generates a 41
kDa frameshift variant (sXBP1) that acts as a potent transcription factor. sXBP1
homodimers, along with co-regulators such as nuclear factor Y (NF-Y), regulate
the expression of a variety of ER chaperones and protein degradation related
genes [330, 439]. sXBP1 also upregulates the expression of P58IPK ; as discussed
previously, P58IPK is a member of the DNAJ protien family that negatively reg-
ulates PERK activity, forming one of the many modes of crosstalk between the
UPR branches [599].
The cytosolic domains of activated IRE1α transduce late-phase UPR sig-
nals. Cytosolic IRE1α dimers interact with adaptors such as tumor necrosis
factor receptor-associated factor 2 (TRAF2) to drive signal-regulating kinase
(ASK1) activation and then subsequently cJUN NH2-terminal kinase (JNK) and
p38MAPK activation [554]. IRE1α also modulates the activation of other kinases
such as extracellular signal-regulated kinases (ERKs) as well as nuclear factor κB
(NF-κB) pathways [374, 219]. However, the role of these additional effectors in
UPR is not well understood. ASK1 activity is regulated by phosphorylation/de-
phosphorylation at several sites as well as by physical interaction with other
proteins. The current model for ASK1 activation, at least for TNF-mediated
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activation, involves release of ASK1 from inhibitory proteins such as 14-3-3
[377], TRAF-dependent homodimerization [168] and autophosphorylation at
T845 [542]. Phosphorylation of ASK1 at S83 by Akt/PKB (protein kinase B)
[250] and dephosphorylation at S845 by protein phosphatase 5 (PP5) [359] both
decrease ASK1 activity. More recently, the kinase PIM1 has also been shown
to phosphorylate ASK1 at S83 [172]. Interaction with CDC25A and 14-3-3 pro-
teins have also been shown to decrease ASK1 activity [637, 630]. ASK1 phos-
phorylates and activates two downstream kinases, MMK4 and MMK3 which
in turn activate JNK and p38 MAP kinase, respectively. JNK is activated by
dual phosphorylation at T183 and Y185 by MMK4 [102]. Once activated, JNK
performs a number of functions including activation of the pro-apoptotic Bim
protein [294, 430] and the inhibition of Bcl2 [596]. Activated JNK activates the
proapoptotic Bcl-2 family member Bim by phosphorylation at S65 [294, 430].
Bim is normally sequestered by motor complexes interacting with the cytoskele-
ton [431]. Following JNK-mediated phosphorylation, Bim translocates to the
mitochondrial outer membrane, where it promotes cytochrome c release and
caspase activation [431, 73]. Interestingly, a positive feedback loop exists be-
tween Bim and caspase 3 activation; phosphorylated Bim is a caspase 3 target,
that once cleaved, is a more potent inducer of cytochrome c release [73, 82].
Recent ER stress studies in MCF-7 breast carcinoma-derived cells using thapsi-
gargin (Tg) suggested that Bim expression was regulated by CHOP; following
Tg treatment, a two-fold increase in Bim mRNA and a five-fold increase in Bim
proteins were observed [432]. JNK activation also regulates the activity of anti-
apoptotic protein Bcl2 [596, 582]. Active JNK1 inhibits Bcl2 via phosphorylation
at sites T69, S70 and S87 [582]. In contrast, other stress induced proteins like p38
family members phosphorylate Bcl2 at S87 and T56 only [94]. Ultimately, inhibi-
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tion of Bcl2 and the activation of Bim leads to BAX/BAK dependent apoptosis.
Thus, signals initiated from the cytosolic kinase domain of IRE1α are largely
pro-apoptotic.
IRE1α activity is regulated by several proteins, including tyrosine phos-
phatase 1B (PTP-1B), ASK1-interactive protein 1 (AIP1) and members of the
Bcl2 protein family. PTP-1B has been implicated in a number of IRE1α signal-
ing events. The absence of PTP-1B reduced IRE1α dependent JNK activation,
XBP1 splicing and EDEM transcription in immortalized and primary mouse
embryonic fibroblasts [171]. However, no physical interaction between IRE1α
and PTP-1B was established. On the other hand, AIP1 physically interacts with
both TRAF2 and IRE1α, suggesting a model in which AIP1 facilitates IRE1α
dimerization and activation [321]. The C-terminal period-like domain (PER) of
AIF1 binds the N-terminal RING finger domain of TRAF2, followed by ASK1-
JNK signaling [623]. Thus, based on these findings, Luo et al. postulated that
AIF1 may be directly involved in the IRE1α-TRAF2 complex and its activation
of the ASK1-JNK signaling axis [321]. This hypothesis was validated in AIP1-
KO mouse studies; AIP1-knockout mouse embryonic fibroblasts and vascular
endothelial cells showed significant reductions in ER-stress induced ASK1-JNK
activation that was rescued in AIP1 knock-in cells [321]. IRE1α has also been
shown to directly interact with Bcl-2 family members Bax and Bak. Hetz et al.
showed that Bax and Bak complex with the cytosolic domain of IRE1α and mod-
ulate IRE1α signaling [207]. Bax and Bak double knockout mice failed to signal
through the IRE1α UPR branch following tunicamycin-induced ER stress; how-
ever, PERK signaling markers, e.g., eIF2α phosphorylation, responded normally
[207]. This pro-activation role of Bak and Bax may be modulated by one of the
few negative regulators of IRE1α activity, Bax inhibitor 1 (BI-1). BI-1 is an anti-
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apoptotic protein that enhances cell survival following several intrinsic death
stimuli [593]. Bailly-Maitre et al. were the first to suggest that BI-1 may down-
regulate IRE1α and possibly ATF6 activity [21]. BI-1 deficient mice displayed
increased XBP1s and enhanced JNK activity in the liver and kidney, while eIF2α
phosphorylation remained normal under ER-stress conditions [21]. Lisbona et
al. later showed that BI-1 directly interacts with the cytosolic domain of IRE1α,
inhibiting its endoribonuclease activity [307]. Interestingly, BI-1 interacts with
several members of the Bcl2 protein family e.g., Bcl2 and Bcl-XL, even though
it has no homology [593]. Members of the HSP family of proteins have also
been shown to regulate IRE1α. For example, HSP90 interacts with the cytosolic
domain of IRE1α, potentially protecting it from degradation by the proteasome
[332]. HSP72 interaction with the cytosolic IRE1α domain has also recently been
shown to enhance IRE1α endoribonuclease activity [175]. Taken together, these
modes of IRE1α regulation with the exception of B1-1, largely promote or en-
hance IRE1α signaling.
2.2.5 ER stress-induced autophagy and apoptosis:
Ultimately, if UPR fails to restore ER homeostasis, cells initiate terminal pro-
grams such as autophagy or apoptosis. Several recent studies indicate that ER
stress can trigger autophagy [386, 609, 36, 240, 218, 270, 146, 582]. Autophagy is
an evolutionarily conserved cellular pathway, in which a cell recycles its macro-
molecules and organelles [295]. Autophagy is initiated by the formation of an
autophagosome, composed of part of the cytosol or cellular organelles, encased
in a double membrane [295, 276, 78]. Autophagosomes then bind endolysoso-
mal vesicles, leading to the creation of the autolysosome. The autolysosome is
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then degraded, completing the autophagy cycle. The key regulatory proteins
involved in the nucleation and formation of the autophagosomal membrane
are class III phospha-tidylinositol 3-kinase (PI3K), p150 myristylated protein ki-
nase and Beclin-1 [295]. On the other hand, the ER-stress sensors PERK, IRE1
and cytosolic Ca2+ all act as effectors initiating autophagy in ER stressed cells
[386, 218, 270, 146]. JNK1 mediated phosphorylation of Bcl2 at T69, S70 and S87
may also be important; phosphorylation at these sites leads to the dissociation of
Bcl2 from Beclin-1, and the activation of autophagy [582]. Association of Beclin-
1 with PI3K and other proteins promotes the localization of other autophagy
related proteins to the preautophagosomal membrane [296]. Autophagy can be
inhibited in eukaryotic cells by several factors, including the mammalian target
of rapamycin complex 1 (mTORC1) protein complex [380, 348].
The autophagy program is a cellular reboot mechanism while apoptosis is a
terminal death program. Apoptosis is characterized by nuclear and cytoplasmic
condensation, blebbing of the plasma membrane and DNA fragmentation [247].
The dying cell eventually disintegrates into membrane-enclosed apoptotic bod-
ies which are quickly destroyed by phagocytes or neighboring cells. A common
biomarker of apoptosis is the activation of aspartate-specific proteases, collec-
tively known as caspases [6]. Caspases rapidly dismantle cell cycle, cytoskeletal
and organelle proteins by proteolytic cleavage. There are two pathways that
result in caspase activation in response to apoptotic signals; the death-receptor
and the stress mediated pathways. The death-receptor pathway is marked by
ligand-mediated activation of death receptors on the plasma membrane. The
alternative pathway for caspase activation is mediated by cellular stress e.g., ER
stress. Caspases are activated from their zymogens (procaspases), in response
to various death cues. First, the initiator caspases, caspase-8 and caspase-9, are
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activated in response to death cues [360]. This is followed by the activation
of executioner caspases, such as caspase-3, caspase-6 and caspase-7. Activated
executioner caspases proteolytically process several substrates, facilitating cell
death. They also activate initiator caspases, forming a positive feedback loop.
Activation of both the PERK and IRE1 pathways modulate stress-induced
apoptosis through their regulation of Bcl2 expression and activity. Overall,
stress induced apoptosis can occur through both mitochondrial-dependent and
independent pathways. Stress signals cause oligomerization of pro-apoptotic
proteins, such as Bax and Bak. These proteins are normally sequestered at
the mitochondrial outer membrane by the survival protein Bcl2, under non-
apoptotic conditions [581]. Once Bax and Bak oligomerize, they insert into the
mitochondrial membrane and breach membrane integrity [370]. This results
in a net efflux of cytochrome-c from the mitochondria to the cytosol and the
initiation of the well-studied Apaf-1 mediated caspase-9 activation pathway.
Recently, crosstalk between the ER and mitochondria during apoptosis, which
might initiate mitochondrial apoptotic events, has also been explored [101]. This
crosstalk may be facilitated via the release of Ca2+ ions from the ER into the cy-
tosol, in response to ER stress. Mitochondrial uptake of Ca2+ initiates membrane
fission and caspase activation via an uncertain mechanism. However, a few key
drivers of ER Ca2+ release in response to stress signals have been identified [376].
Fas-mediated caspase-8 activation leads to cleavage of the membrane-bound ER
protein, Bap31. Although Bap31 is membrane-bound, its caspase-recognition
sequence is cytosolic, thus it is accessible by caspase-8. The truncated prod-
uct, Bap20, is believed to promote the release of ER Ca2+ [108, 536, 101]. In-
terestingly, Bcl2 is also localized to the ER-membrane, but its role is uncertain
[2]. Once in the mitochondria, Ca2+ modulates the permeability transition (PT)
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pore (PTP) thereby increasing the efflux of cytochrome-c [99, 37]. Stress induced
mitochondrial-independent apoptotic pathways are not well understood. Cur-
rently, caspase 12 has been suggested as a possible apoptotic mediator in mice
[515, 608, 364]. However, caspase 12 is not expressed in human cells. Moreover,
there is considerable debate about its role in stress-induced apoptotic cell-death
[464].
2.3 The pathophysiology of ER-stress and aberrant UPR.
ER stress plays an important role in a spectrum of diseases ranging from neu-
rodegeneration, cardiac diseases, cancer, diabetes to muscle degeneration (Ta-
ble 2.3). Understanding ER-stress mechanisms in the context of these diseases
presents a unique opportunity for drug discovery. Current therapeutic efforts
have largely focused on amplifying the adaptive, pro-survival components of
the UPR signal, for example, by inducing chaperone expression, which works
to restore ER homeostasis. However, in the context of cancer, the opposite out-
come is sought; in this case a number of strategies have focused on inhibiting
proteasome function (Table 2.3.3).
2.3.1 Diabetes:
In the context of diseases such as diabetes, pancreatic β-cells depend on efficient
UPR signaling to meet the demands for constantly varying levels of insulin syn-
thesis. Type 1 diabetes is marked by excessive loss of pancreatic β-cells, while
type 2 diabetes is marked by pancreatic β-cell dysfunction. The large biosyn-
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Table 2.1: Relevance of ER stress in human disease states
Disease
state
Role of ER-Stress and UPR Key proteins Reference
Alzheimer’s
disease
(AD)
AD-induced Presenilin 1 regulates BiP. Presenilin 1,
PERK, eIF2α,
BiP
[553, 242, 532,
352, 379]
Parkinson’s
disease
(PD)
Suppressed ER-stress-induced apoptosis and aggre-
gation of α-synuclein.
Parkin, α-
synuclein
[92, 518, 224,
423, 461]
Amyotrophic
lateral scle-
rosis (ALS)
Altered ERAD machinery and activation of ASK1. SOD, ASK1 and
Derlin-1
[378]
Bipolar Dis-
order
Current medications target induction of UPR. XBP1 [239, 77, 238]
Stroke CHOP and UPR mediates neuronal response in Is-
chemia.
PERK-eIF2α ,
ASK1, CHOP
[524, 281, 412,
516]
Heart Dis-
ease
Degeneration of cardiac myocytes, transaortic con-
striction. Myocardial infarction induces UPR.
IRE1, PERK-
eIF2α, ASK1
[165, 388, 538,
496, 402, 567]
Atheroscler-
osis
Regulates inflammatory genes in vascular cells. IRE1, JNK,
TRAF2, XBP1
[152, 622, 289,
183]
Type 1 dia-
betes
Regulators in normal conditions and triggers β cell
dysfunction and apoptosis in ER Stress.
PERK-eIF2α,
JNK and Cal-
cium
[475, 13, 135,
595, 227, 396,
397]
Type 2 dia-
betes
ER stress is a key aspect of type 2 diabetes. XBP1, JNK [399]
Cancer Cytoprotective branches of UPR vital to survival and
progression of tumors.
BiP, XBP1,
ATF6, PERK
[498, 145, 230,
454, 40]
Autoimmune
disease
Development of plasma cells and dendritic cells. XBP1, GRP78,
HLA-B27
[543, 43, 83]
Acute kid-
ney injury
Upregulation of BiP, CHOP and down-regulation of
Bcl-2 in primary glomerular diseases.
BiP, CHOP, Bcl2 [334, 22]
thetic load placed on the ER because of insulin production in response to food
uptake (glucose) can overwhelm the folding capacity of the ER, resulting in ER
stress. This leads to subsequent PERK activation and reduction of protein syn-
thesis. In PERK -/- cells, protein synthesis is unresponsive to the stress and
leads to accumulation of unfolded proteins (e.g. proinsulin) and ultimately cell
death. It has been shown that PERK deficient mice are more prone to diabetes
and progressive hyperglycemia [183]. In type II diabetes, ER stress leads to
JNK-mediated phosphorylation of insulin receptor substrate 1 (IRS1) at S307
[399]. IRS1 is a substrate of Insulin receptor. Phosphorylation of IRS1 therefore
inhibits insulin action. Nitric oxide (NO), is also a key player in β-cell death
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in type-1 diabetes and vascular complications in type-2 diabetes. NO depletes
ER Ca2+ leading to ER stress and ultimately apoptosis. Pancreatic β-cells have
shown that NO-induced apoptosis is CHOP dependent [396]. Thus, ER stress
is a critical feature of both type-I and type-II diabetes at the molecular, cellular
and organismal level.
2.3.2 Role of UPR in hypoxia and cancers:
The ER not only acts as the center for maturation of proteins, but also as a crit-
ical node for oxygen sensing and signaling. In rapidly growing tumors, cells
face stressors like hypoxia and nutrient deprivation both of which can lead to
ER stress and ultimately UPR. For example, oxygen deprivation has recently
been shown to be an initiator of UPR [269]. Interestingly, the connection be-
tween hypoxia and UPR is through hypoxia inducible factor (HIF) independent
pathways. Hypoxia leads to PERK activation and the transient phosphoryla-
tion of eIF2α [268, 324, 265]. This effect occurs on a time scale of minutes in
the case of anoxia, and is slower for moderate (pO2 ≤ 1%) hypoxic conditions
[265]. Because of their ability to transduce pro-apoptotic signals, the modu-
lation of PERK and IRE1 activity has been explored as a potential anti-cancer
strategy. Versipelostatin, a repressor of BiP expression, has been shown to pro-
duce anti-tumor activity in MKN-74 xenograft mouse models [410]. Enhanced
apoptosis has also been observed in BiP-deficient fibrosarcoma cells, and XBP1-
and PERK-deficient mouse fibroblasts [230, 454, 40]. Another related anti-cancer
strategy is the induction of ER-stress using proteasome or protein trafficking in-
hibitors. Bortezomib, a selective inhibitor of the 26S proteasome, is used for the
treatment of relapsed multiple myeloma, a plasma cell neoplasia [372]. Anti-
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tumor activity was also observed with Bortezomib in preclinical pancreatic can-
cer studies using the L3.6pl cell-line [366]. Addition of Bortezomib to splenic
and bone marrow plasma cells led to a 40-fold increase in CHOP expression,
and a subsequent decrease in Bcl2 levels [372]. HIV type 1 (HIV-1) protease in-
hibitors (PI) like Nelfavir and Atazanavir are also currently being studied for the
treatment of malignant gliomas [433]. Studies in glioblastoma cells suggested
that Nelfavir or Atazanavir led to inhibition of proteasome activity and subse-
quently CHOP-induced cell death [433]. Thus, although no mechanistic link
between proteasome inhibitors and UPR has been established, anecdotal evi-
dence, such as CHOP induction, suggests these inhibitors are at least partially
inducing ER-stress and subsequent UPR-mediated cell death. Recently, stud-
ies targeting intracellular trafficking of proteins have also been explored as an
anti-cancer strategy. Brefeldin A treated chronic lymphocytic leukemia (CLL)
cells showed induction of ER stress, caused by inhibition of protein trafficking,
ultimately resulting in Golgi collapse and cell death [64]. Inhibition of protein
trafficking from the ER can also lead to ER swelling and p53-independent apop-
tosis [64].
2.3.3 Neurodegenerative disorders:
Neurodegenerative diseases like Parkinsons or Alzheimers are often associ-
ated with the accumulation of unfolded or misfolded proteins. Incorrect pro-
tein folding alters neuronal connectivity, neuronal death and ERAD function
[304, 506, 33, 243] (Table 1). Alzheimers disease (AD) is characterized by the
progressive decline of cognitive function. This decline has been associated with
the formation of protein aggregates involving several proteins including amy-
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Table 2.2: Therapeutic interventions targeting ER stress.
Compound Pathway Function Reference
Valporate (VPA),
lithium
ER chaperones
(BiP, GRP94,
Calreticulin)
Remove ER Stress; ER chaperone induc-
tion in Neuro-protection in Bipolar Dis-
orders.
[48, 210, 488]
BiP inducer X (BIX) ER chaperones
(BiP)
Remove ER Stress; Small-molecule in-
ducer of BiP in Celebral ischemia; stroke
resulting in reduced cell death.
[279]
Salubrinal eIF2α, Bcl2 Phosphatase inhibitor; PERK-eIF2α
pathway agonist in Parkinson’s disease;
anti-stroke; regulator of Bcl2.
[475, 49, 449,
281, 183, 13,
248]
p38 MAPK antagonists p38 MAPK
(CHOP activ-
ity)
Apoptosis up; p38 dependent CHOP
phosphorylation regulator in stroke, di-
abetes.
[613, 574, 352,
412, 516]
Versipelostatin (VST) BiP Apoptosis up; Alters BiP production in
glucose-deprived solid tumors.
[410]
Bortezomib, Nelfavir,
Atazanavir
Proteasome,
XBP1
Apoptosis up; Inhibition of HIV-1 pro-
teasome activity. CHOP mediated cell
death.
[288, 433, 160,
372]
Brefeldin A CHOP, BiP Apoptosis up; Inhibition of protein traf-
ficking, ER swelling.
[64]
loid b-peptide (Ab) [483]. Mutations in the Ab precursor protein (APP) and
Presenillins (PS1 and PS2), which mediate APP cleavage, are associated with
the early onset of AD [587, 483, 242]. Mutant PS1 increased Ab production and
ER stress mediated apoptosis in human neuroblastoma cells [564, 342, 282]. In
these studies, the mutant PS1 suppressed IRE1 phosphorylation and ultimately
down-regulated BiP expression [243]. However, there is contradictory evidence
about the role of UPR in AD. For example, increased levels of BiP and PERK
have been found in AD human brain specimens [216]. Thus, the central issue of
whether UPR is initiated for neuro-protection or neuronal death, has yet to be
determined.
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2.3.4 Immune and Inflammatory disorders:
Unfolded or misfolded protein accumulation and UPR-induction is observed in
autoimmune diseases like rheumatoid arthritis, inflammatory bowel diseases
and multiple sclerosis. UPR and the inflammatory response are connected
through several modalities including increased reactive oxygen species (ROS),
increased calcium release from the ER, activation of JNK and the activation of
NF-κB [628]. NF-κB plays a central role in inflammation [451]. In unstressed
cells, NF-κB is inactive, sequestered by the inhibitor of NF-κB (IκB). UPR induc-
tion leads to phosphorylation and subsequent degradation of IκB and the ex-
pression of inflammatory genes [517, 451]. UPR also plays a key role in autoim-
mune diseases. CREBH, an ATF6 homolog, translocates to the golgi and under-
goes cleavage by S1p and S2p proteases in the presence of ER stress. Proteolytic
processing releases an N-terminal fragment that migrates to the nucleus and
induces C-reactive protein and serum amyloid P-component expression [629].
Both of these genes are associated with the activation of the acute inflamma-
tory response [629]. CREBH can also induce pro-inflammatory cytokines such
as IL-6 and IL-1β [629].
2.3.5 The role of UPR in biologics production.
Biologics can be produced in a variety of hosts ranging from bacteria to mam-
malian cells [29]. Mammalian hosts, such as Chinese Hamster Ovary (CHO)
cells, have been used for therapeutic protein production since as early as 1986
[592, 356]. Several current biologics are secreted, for example, the monoclonal
antibodies (MAb) interferon-γ (IFNγ) or erythropoeitin (EPO) [278]. Thus, ER
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processing and the unfolded protein response are critical to the production of
these and many other therapeutic proteins. Interestingly, overexpression of ER
chaperones like BiP and PDI typically have not significantly increased protein
titers [47, 91, 260]. Instead, overexpression of other UPR proteins, such as X-Box
binding protein 1 (XBP1), which is a key regulator of the secretory pathway,
have had more pronounced effects on production [278, 539]. For example, over-
expression of XBP1s increased by 2.5-fold MAb titers in CHO and NS0 cell lines
which exhibit secretory bottlenecks [278]. Another strategy to enhance produc-
tion is to modulate the translation block imposed by eIF2α phosphorylation. For
example, GADD34 overexpression increased the de-phosphorylation of eIF2α,
leading to an approximately 40% increase in the production of the glycopro-
tein Antithrombin III (ATIII) in CHO cells [394]. ATF4 overexpression has also
been shown to increase ATIII production [387]. Thus, engineering mammalian
hosts with optimal protein production capacity involves manipulating multiple
unfolded protein response components, not just chaperones such as BiP.
2.4 Summary and Conclusions
Protein folding is strategically important to cellular function. Perturbations
to the unique folding environment of the endoplasmic reticulum (ER) lead to
the accumulation of unfolded or misfolded proteins. Higher eukaryotes have
evolved a complex three-pronged response to correct aberrant folding, known
as the unfolded protein response. The unfolded protein response acts to restore
ER homeostasis. However, following prolonged or severe ER stress, cells initi-
ate an alarm phase ultimately leading to apoptotic cell death. Malfunctions in
the folding state of critical proteins have been linked with cancer, diabetes and
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other diseases. Thus, the ability of UPR to regulate cell fate, has made it a pri-
mary area of study for pathophysiology and a potential therapeutic axis for the
treatment of a diverse array of diseases.
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3.1 Abstract
Cellular stressors routinely lead to malfunctions in the folding state of criti-
cal proteins, thereby playing a vital role in disease states like cancer, diabetes
and cardiovascular ailments. Newly synthesized proteins must fold and assem-
ble into unique three-dimensional structures, in order to become functionally
active. Cells monitor protein folding by an inbuilt quality-control system in-
volving both the Endoplasmic Reticulum (ER) and the Golgi apparatus. Incor-
rectly folded proteins are tagged for degradation via ER associated degradation
(ERAD) or sent back through a refolding cycle. However, accumulation of in-
correctly folded proteins can trigger a cascade of events, termed the Unfolded
Protein Response (UPR). UPR leads to re-establishing the cellular homeostasis.
In this study, we developed a family of mechanistic models of eukaryotic UPR,
which was composed of a system of ordinary differential equations. The ob-
jective of this study was to assemble a series of molecular modules describing
different aspects of UPR and subsequently analyze these models for fragility
and robustness. Kinetic parameters for these models were estimated by com-
paring simulations with experimental data. Using POETs and a cross-validation
scheme, we developed an ensemble of models, consistent with literature data.
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Model analysis highlighted the presence of a sequential order for firing of the ER
stress transducers in UPR. The counteracting effects of the ER stress transduc-
ers converge at feedback regulation of the molecular chaperone BiP. The three
main regulators of feedback, ATF4, cleaved ATF6 and XBP1s share the load en-
suring the phased response of UPR. However these regulators add on to the
overall fragility of the system and allow scope for manipulation of UPR as seen
by sensitivity/robustness analysis. Downstream effects of UPR include a bal-
ance between cell survival and cell death based on the magnitude of the stress.
Model analysis suggested that the cell-death axis was relatively robust owing
to redundant routes e.g., APAF-1 dependent and APAF-1 independent routes of
apoptosis. However the cell-survival axis was relatively susceptible to pertur-
bations owing to multiple levels of regulation, thereby highlighting importance
of key proteins like CHOP.
3.2 Introduction
Protein folding is strategically important to cellular function in all organisms. In
eukaryotes, secreted, membrane-bound and organelle-targeted proteins are typ-
ically processed and folded in the endoplasmic reticulum (ER) [363, 456, 245].
Intracellular perturbations caused by a variety of stressors disturb the special-
ized environment of the ER leading to the accumulation of misfolded or un-
folded proteins [117, 134]. Shifts in folding capacity have been associated with
diseases such as cancer, diabetes and cardiovascular disorders [117]. Physiolog-
ical processes such as aging can also influence protein folding [363]. Normally,
cells ensure proper protein folding using a combination of molecular chaper-
ones, foldases and lectins [363]. However, when proper folding can not be re-
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stored, unfolded or misfolded proteins are targeted to ER Associated Degra-
dation (ERAD) pathways for processing [245]. If unfolded or misfolded pro-
teins continue to accumulate, eukaryotes induce the unfolded protein response
(UPR). In mammalian cells, UPR is a complex signaling program mediated by
three ER transmembrane receptors: activating transcription factor 6 (ATF6), in-
ositol requiring kinase 1 (IRE1) and double-stranded RNA-activated protein
kinase (PKR)-like endoplasmic reticulum kinase (PERK). UPR performs three
functions, adaptation, alarm and apoptosis. During adaptation, the UPR tries to
reestablish folding homeostasis by inducing the expression of chaperones that
enhance protein folding. Simultaneously, translation is globally attenuated to
reduce the ER folding load while the degradation of unfolded proteins is in-
creased. If these steps fail, the UPR induces a cellular alarm and apoptosis pro-
gram. The alarm phase involves several signal transduction events, ultimately
leading to the removal of the translational block and the down-regulation of
the expression and activity of pro-survival factors such as the B-cell lymphoma
2 (Bcl2) protein. After the alarm phase, cells can undergo apoptosis, although
ER stress can also initiate autophagy [386, 609, 36, 240, 218, 270, 146]. Thus, ER
folding homeostasis strongly influences mammalian physiology [134].
In this study we used physiochemical computer modeling as a tool to study
the mammalian unfolded protein response. Physiochemical models which de-
scribe system-level responses can prioritize experimental directions, generate
testable hypothesis and perhaps identify and validate potential therapeutic tar-
gets [256]. For mammalian UPR, physiochemical modeling might tell us the
critical components of each branch, and ultimately what must be manipulated
to get a desired network response, for example, enhanced death or survival.
However, there are critical limitations with physiochemical models. Foremost
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amongst these is the large number of unknown model parameters and uncer-
tainty in the model structure. It is typically impossible to uniquely identify
model parameters, even with extensive training data and perfect models [148].
Alternatively, ensemble approaches, which use uncertain model families, have
emerged as a promising strategy in systems biology and other fields like climate
prediction [26, 280, 54, 401, 505]. Their central value has been the ability to quan-
tify simulation uncertainty and to experimentally constrain model predictions.
For example, Gutenkunst et al. showed that predictions were possible using sig-
nal transduction model ensembles, despite sometimes only order of magnitude
parameter estimates [176]. More recently, Luan et al. predicted patient response
to therapeutic intervention using an ensemble of human coagulation models
where approximately 40% of the model parameters had a coefficient of varia-
tion (CV) greater than 0.5 [319]. Model ensembles have also been used with
parameter dependent analysis techniques, e.g., sensitivity analysis to robustly
estimate important signaling network features. For example, Tasseff et al. char-
acterized emergent behavior between androgen and growth factor signaling in
prostate cancer cell-lines using an ensemble of models and sensitivity analysis
[526]. Thus, despite uncertainty, ensembles of physiochemical models can be
used to understand qualitative properties of complex biochemical networks.
We developed a population of physiochemical models describing the adap-
tation, alarm and apoptosis phases of mammalian UPR. Traditionally, it has
been hypothesized that there is a sequential order for firing of the ER stress
transducers in UPR. The PERK and ATF6 branches are thought to be activated
before IRE1 [515] and largely promote ER adaptation to misfolding, while IRE1
is the last one to fire as it has a dual role, transmitting both survival and pro-
apoptotic signals. However our modeling analysis suggests that these three
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branches fire simultaneously with varying rates and the state of the cell in terms
of adaptation, alarm or apoptosis is a result of counteracting effects of these
three prongs of UPR signaling. The counteracting effects is further substanti-
ated by simulated knockout studies, where in knockout of one ER stress trans-
ducer lead to enhancement of the other branches of UPR, e.g, if we want more
protein production even with ER stress, PERK KO might suggest as a viable
route as that shall lead to no translational block. However the IRE1 branch shall
amplify and so will the ATF6 branch and ultimately still lead to death (less com-
pared to WT). So a viable strategy could be to regulate CHOP, as it shall lead to
reduced death by regulation of Bcl2. One common playground for the three ER
stress transducers is the feedback regulation of BiP expression. Model analysis
substantiated the significance of BiP feedback in the overall robustness of the
system. Removal of any one branch of BiP feedback lead to increased sensitiv-
ity of the other branches. So there was load/responsibility sharing within the
system. Interestingly, removal of all nodes of BiP feedback increased the overall
robustness of the system. So while BiP feedback is crucial in terms of the cell
to adapt to small perturbations, at the same time this makes the system more
fragile and susceptible to manipulations. Model analysis further highlighted
the presence of redundant routes of regulation of apoptosis such as APAF-1
dependent/independent strategies. While manipulation of pro-death axis of
the system (cleaved caspases) was relatively robust to perturbations, manipu-
lation of the pro-survival axis (Bcl2) was relatively feasible via CHOP depen-
dent/independent strategies. Overall UPR was seen to be robust to pertur-
bations (simulated knockout/overexpression studies), thereby highlighting the
redundancy and crosstalk within the three branches of UPR. However, BiP reg-
ulation at the transcriptional level via intermediates of the ER-stress transducer
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signaling cascades (e.g. ATF4, XBP1s) was seen to be the key in the regulation
of UPR. The EUPR model is available in SBML in the supplemental materials.
3.3 Results
3.3.1 Formulation of the UPR network architecture.
The UPR network described the ER folding cycle, ER-associated degradation
(ERAD), ER-stress transducer (PERK, IRE1 and ATF6) signaling cascades and
stress-induced caspase activation (Fig. 3.1). The network consisted of 636 pro-
tein or mRNA species interconnected by 1090 interactions (Fig. 3.1 Inset). Con-
nectivity was formulated from a comprehensive review of the primary litera-
ture [363, 456, 245, 117, 134, 481, 167, 345, 32, 208, 554, 515], and from on-line
databases; String-8 [233], NetworKIN [305] and TRANSFAC. Model connectiv-
ity was not specific to a single cell-line. Rather, it was a canonical representation
of the pathways involved in monitoring and controlling the folding capacity
of a generic well-mixed ER compartment. UPR induction was modeled as the
release of BiP from the ER stress transducers, PERK, IRE1α and ATF6 leading
initially to adaptation of the folding cycle and then subsequently to alarm and
apoptosis. The adaption phase of UPR was marked by general translation atten-
uation, selective transcriptional programs for key species like bZIP transcription
factor ATF4 [318], cellular inhibitor of apoptosis (cIAP) [179], molecular chaper-
ones e.g., BiP [185] and enhanced clearance of accumulated proteins via ERAD.
The alarm and apoptosis phases were mediated by the induction of CHOP [455],
regulation of Bcl2, Bcl2-antagonist of cell death (BAD) [571] and (TNF) receptor
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associated factor 2 (TRAF2) [294, 430, 596, 515] activation (Fig. 3.1). Model con-
nectivity is available in SBML format from the supplemental materials.
3.3.2 Estimating a population of canonical UPR models using
POETs.
Despite a significant identifiability challenge, the multiobjective POETs algo-
rithm generated a predictive UPR model population. The three phases of UPR
were modeled using mass action kinetics within an ordinary differential equa-
tion (ODE) framework. While ODEs and mass-action kinetics are common
methods of modeling biological pathways [479, 74, 203], this modeling strat-
egy resulted in a large number of unknown model parameters. These param-
eters were not uniquely identifiable (data not shown). Instead, we estimated
an experimentally constrained population of parameters using multiobjective
optimization. A population of the 1726 unknown model parameters (1090 ki-
netic parameters and 636 initial conditions) was estimated from 33 dynamic
and steady state data-sets taken from literature (Table 3.1). The residual between
model simulations and each of the experimental constraints was simultaneously
minimized using the multiobjective POETs algorithm [504]. A leave-eight-out
cross-validation strategy was used to independently estimate the training and
prediction error over the 33 data sets; we estimated four different model fami-
lies, where eight of the 33 objectives were reserved for validation and 25 were
used model training each family. Thus, each model family was trained and
validated on different experimental data. Starting from an initial best-fit initial
parameter set (nominal set), more than 25,000 probable models were estimated
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Figure 3.1: An array of cellular stressors can perturb the folding environ-
ment in the endoplasmic reticulum (ER) leading to unfolded or
misfolded protein. In response to the folding imbalance, cells
initiate the cytoprotective unfolded protein response (UPR).
The problem of unfolded or misfolded proteins in the ER is
addressed by increasing the folding capacity through the up-
regulation of the expression of chaperone proteins, attenuating
translation by regulating eIF2α, and promoting the degrada-
tion of misfolded proteins through ER-associated degradation
(ERAD). If UPR is unable to restore the folding balance, ER
stress will eventually lead to apoptotic cell-death. The three
signal transduction pathways mediating the unfolded protein
response in higher eukaryotes. First, the PRKR-like ER kinase
(PERK) pathway is initiated after BiP dissociation from PERK.
While PERK transduces both pro- and anti-apoptotic signals,
its main function is translation attenuation through the phos-
phorylation of eIF2α. Next, the activating transcription factor 6
(ATF6) pathway is activated following BiP dissociation. ATF6
induces the expression of chaperones e.g., BiP as well as apop-
tosis effectors such as CHOP. Lastly, the inositol-requiring ki-
nase 1 (IRE1) pathway is activated following BiP dissociation
from IRE1. Activated IRE1 has both an endoribonuclease and
a serine-threonine kinase activity that drive can pro-apoptotic
signals. Inset: The UPR network consisted of 636 protein or
mRNA species interconnected by 1090 interactions.
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by POETs from which we selected N = 100 models (25 from each training fam-
ily) with a Pareto rank of one or less (from approximately 1200 possible choices)
for further study. For each objective, the nominal, training (75 models) and pre-
diction (25 models) error was calculated for each objective (Table 3.1). Models
used for prediction error calculations for a particular objective were not trained
on that objective. The prediction likelihood was statistically significantly better
for 31 of the 33 objective functions at a 95% confidence level, compared with
random parameter sets generated from the nominal set (Table 3.1). Thus, PO-
ETs generated model families that predicted approximately 94% of the objective
functions with a significantly higher likelihood than a random control. How-
ever, the specific value of any given parameter was likely not well described.
The coefficient of variation (CV) for the model parameters ranged from 0.5 - 1.6,
where approximately 65% of the parameters were constrained with a CV ≤ 1.0
(Fig. 3.2). The most constrained parameters involved a wide-array of functions
e.g., regulation of PERK, eIF2α, ATF4, Calcineurin, BiP, CHOP and ATF6 sig-
naling. However, the least constrained parameters involved JNK and apoptosis
interactions.
POETs identified Pareto fronts between several objectives, e.g., O13×O14,
O25×O29, O11×O29 and O27×O2 in the training data (Fig. 3.3). Strong Pareto
fronts suggested an inability to simultaneously model different aspects of the
training data. However, fronts could also result from experimental artifacts,
e.g., variation between cell-lines, time-scale differences or from functional rela-
tionships in the data. Globally, adaptation and alarm phase training constraints
conflicted with those involving apoptosis. For example, objectives involving
caspase-7 or caspase-9 activity conflicted with phosphorylated eIF2α levels.
Phosphorylation of eIF2α by activated PERK attenuates translation, which de-
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Table 3.1: Objective function list along with species, cell-type, nominal error,
training error, prediction error, random error with a randomly generated pa-
rameter set and the corresponding literature reference.
Obj# species cell type nominal training prediction random source
O1 ATF6 free HEK293 0.25 0.25 ± 0.04 0.26 ± 0.08 0.49 ± 0.05 [301]
O2 peIF2α HEK293 0.14 0.23 ± 0.08 0.25 ± 0.11 0.51 ± 0.11 [301]
O3 BiP mRNA HEK293 0.24 0.43 ± 0.17 0.49 ± 0.15 0.72 ± 0.13 [301]
O4 CHOP mRNA HEK293 0.55 0.56 ± 0.07 0.57 ± 0.06 0.68 ± 0.20 [301]
O5 Cleaved PARP HEK293 0.24 0.23 ± 0.14 0.23 ± 0.17 0.50 ± 0.19 [302]
O6 pIRE1α AR42J 0.37 0.36 ± 0.05 0.35 ± 0.07 0.63 ± 0.09 [38]
O7 PERK AR42J 0.19 0.36 ± 0.27 0.38 ± 0.29 0.46 ± 0.20 [38]
O8 pPERK AR42J 0.10 0.14 ± 0.09 0.15 ± 0.15 0.28 ± 0.08 [38]
O9 BIP mRNA MEF 0.19 0.30 ± 0.14 0.26 ± 0.07 0.66 ± 0.24 [597]
O10 BIP Protein P19 EC 0.42 0.34 ± 0.15 0.35 ± 0.11 0.68 ± 0.15 [236]
O11 CHOP Protein P19 EC 0.24 0.42 ± 0.20 0.38 ± 0.18 0.59 ± 0.20 [236]
O12 sXBP1 protein MEF 0.34 0.29 ± 0.08 0.30 ± 0.06 0.40 ± 0.11 [60]
O13 CHOP Protein MEF 0.46 0.43 ± 0.12 0.45 ± 0.13 0.56 ± 0.18 [60]
O14 XBP1 mRNA MEF 0.57 0.48 ± 0.13 0.49 ± 0.13 0.47 ± 0.05 [60]
O15 peIF2α MEF 0.38 0.37 ± 0.08 0.38 ± 0.03 0.44 ± 0.11 [598]
O16 ATF4 nuclear MEF 0.63 0.67 ± 0.06 0.67 ± 0.07 0.68 ± 0.16 [598]
O17 CHOP Protein MEF 0.52 0.51 ± 0.12 0.53 ± 0.08 0.64 ± 0.19 [598]
O18 BIP Protein MEF 0.18 0.34 ± 0.18 0.34 ± 0.23 0.55 ± 0.16 [598]
O19 Spliced XBP1 MEF 0.49 0.49 ± 0.04 0.48 ± 0.04 0.50 ± 0.10 [291]
O20 Cleaved ATF6 MEF 0.45 0.44 ± 0.06 0.44 ± 0.05 0.49 ± 0.11 [291]
O21 cIAP Protein NIH 3T3 0.36 0.25 ± 0.15 0.30 ± 0.10 0.52 ± 0.15 [179]
O22 Caspase 12 Protein Transfected
HEK 293T
0.44 0.57 ± 0.11 0.52 ± 0.11 0.75 ± 0.11 [438]
O23 Phospho eIF2α Liver of
Mice
0.50 0.51 ± 0.07 0.51 ± 0.04 0.50 ± 0.12 [206]
O24 Procaspase 12 SAK2 0.28 0.46 ± 0.28 0.38 ± 0.26 0.78 ± 0.14 [440]
O25 Caspase 12 SAK2 0.12 0.22 ± 0.12 0.25 ± 0.13 0.73 ± 0.07 [440]
O26 Procaspase 9 SAK2 0.14 0.28 ± 0.22 0.33 ± 0.26 0.78 ± 0.13 [440]
O27 Caspase 9 SAK2 0.03 0.19 ± 0.16 0.24 ± 0.18 0.68 ± 0.14 [440]
O28 Procaspase 7 SAK2 0.31 0.44 ± 0.24 0.43 ± 0.23 0.74 ± 0.14 [440]
O29 Caspase 7 SAK2 0.64 0.61 ± 0.07 0.58 ± 0.11 0.75 ± 0.07 [440]
O30 Procaspase 3 SAK2 0.34 0.46 ± 0.19 0.46 ± 0.21 0.82 ± 0.13 [440]
O31 Caspase 3 SAK2 0.34 0.39 ± 0.09 0.42 ± 0.13 0.74 ± 0.10 [440]
O32 PARP Protein SAK2 0.37 0.51 ± 0.17 0.51 ± 0.14 0.85 ± 0.13 [440]
O33 Cleaved PARP SAK2 0.11 0.21 ± 0.17 0.31 ± 0.21 0.67 ± 0.15 [440]
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Figure 3.2: POETs generated an ensemble of models that predicted ap-
proximately 94% of the objective functions with a significantly
higher likelihood than a random control. (A) The coefficient of
variation (CV) for the model parameters ranged from 0.5 - 1.6,
where approximately 65% of the parameters were constrained
with a CV ≤ 1.0 (black dots). (B) We selected five parameter sets
(red dots in A) for further analysis based on CV and distance
from the nominal parameter set (based on second norm).
creases the ER folding load. Thus, eIF2α phosphorylation is a key early adaptive
event in UPR. On the other hand, caspase-9 is a stress-induced death marker
activated only after UPR has failed to restore folding homeostasis. Conflicts
between these early and late phase markers suggested the UPR time-scale was
perhaps cell-line or perturbation dependent. Similarly, negative feedback may
lead to conflicting objectives. For example, XBP1 mRNA measurements (O14)
conflicted with CHOP protein measurements (O13), even though these data-sets
were taken from the same study and were collected in the same cell-line. XBP1
splicing increased BiP levels, which in turn reduced CHOP protein levels, hence
the trade-off. Lastly, in addition to fronts, we also observed strong correlation
between objectives. For example, models that performed well for the CHOP
protein (O11), also performed well against Procaspase-12 (O22) measurements,
even though these were not in the same cell-line or from the same study. Both
CHOP and Procaspase-12 are downstream of IRE1/TRAF2/JNK signaling cas-
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Figure 3.3: Objective function plot for selected training constrains
(O1,O2,. . .O33) for the UPR model population generated using
POETs. Points denote separate models in the population. Sev-
eral objectives exhibit clear Pareto fronts, e.g., O29 × O25. This
suggests an inability to model both training constraints simul-
taneously or conflicts in the training data.
cade, so these errors were directly correlated.
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3.3.3 The population of UPR models recapitulated adaptation,
alarm and apoptotic events across multiple cell-lines and
timescales.
We trained the UPR ensemble using data from UPR initiation events (e.g., PERK
activation) and the downstream activation of proteins involved in apoptosis
(BiP, caspase-3 and caspase-7). ER stress induced by exposure to thapsigargin
(Tg), a non-competitive inhibitor of SERCA Ca2+ transporters, leads to the disso-
ciation of BiP from the ER-stress transducers. For theses initial proof-of-concept
simulations, we assumed that the action of Tg and other stress-inducing agents
such as dithiothreitol (DTT) was identical, i.e., induction of BiP dissociation.
Within 20 min after Tg exposure, PERK was activated and transmitting adap-
tation signals downstream. The population of UPR models recapitulated the
timescale of PERK phosphorylation (Fig. 3.4A) as well as its downstream signal-
ing activity, for example, the phosphorylation of eIF2α (Fig. 3.4H). The nuclear
fraction of ATF4 increased from approximately zero (untreated cells) to a max-
imum value 4 hrs after Tg exposure. While the model ensemble generally pre-
dicted the correct trend, there was significant error in the early time points for
ATF4 (Fig. 3.4G). The phosphorylation of eIF2α by PERK is required for ATF4
activation. Interestingly, when we compared model simulations of p-eIF2α lev-
els following Tg (1µM) exposure in MEFs with measurements (O15 [598]), the
model correctly captured the appropriate behavior. To test the functioning of
the ATF6 branch of UPR model, we compared simulations with measurements
of cleaved ATF6 in tunicamycin-treated MEFs [291]. ER stress leads to the re-
lease of the BiP from ATF6. Cleaved ATF6 is then translocated to the nucleus
where it up-regulates gene expression [191, 178]. Simulations of cleaved ATF6
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levels following UPR initiation were consistent with measurements (Fig. 3.4C).
The formation of p-PERK or p-IRE1 initiates a complex series of events that op-
erate on both short and long time-scales. Signals from the ER stress transducers
converge downstream to regulate BiP transcription [330, 439, 263, 612]. Model
ensemble recapitulated correct trends of BiP mRNA with maximum levels ∼ 8
hrs, similar to what was seen in experiments done on HEK293 cells (Fig. 3.4D)
[301]. One of the long-term outcomes of PERK/IRE1 activation is apoptotic cell
death. In the proof-of-concept ER-model the link between UPR and apoptosis
occurred through the action of eIF2α, the dual role of the ATF4 transcription
factor and caspase-12 activation by IRE1-TRAF2 signaling axis. We constrained
model parameters associated with the activation of the cell-death program us-
ing measurements of pro/caspase-7 levels, pro/caspase-9 levels, pro/caspase-3
levels, pro/caspase-12 levels and PARP cleavage mediated by executioner cas-
pases following treatment with 0.5µM Tg [440]. These experiments were per-
formed in Sak2 cells that lack Apaf-1 protein expression [440]. Thus, these data
allowed us to include a non-Apaf-1 mediated stress-induced caspase activation
pathway into the model. The population of models recapitulated caspase-3 (Fig.
3.4K), caspase-9 (Fig. 3.4J) as well as cleaved Parp levels (Fig. 3.4L) following ex-
posure to ER stress-inducers. Interestingly, while PERK activation occurred on
the timescale of minutes, initiator and executioner caspase activation occurred
over 36 hrs. Thus, the population of UPR models captured complex signaling
events occurring across multiple timescales.
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55
3.3.4 Signal flow analysis of UPR highlighted modes of
crosstalk and redundancy in BiP and Bcl2 regulation.
Traditionally, it has been hypothesized that there is a sequential order for firing
of the ER stress transducers in UPR. The PERK and ATF6 branches are thought
to be activated before IRE1 [515] and largely promote ER adaptation to misfold-
ing, while IRE1 is the last one to fire as it has a dual role, transmitting both
survival and pro-apoptotic signals. However our modeling analysis suggests
that these three branches fire simultaneously with varying rates and the state of
the cell in terms of adaptation, alarm or apoptosis is a result of counteracting
effects of these three prongs of UPR signaling (Fig. 3.5 and Fig. 3.6).
The counteracting effects is further substantiated in simulated knockout
studies, where in knockout of one ER stress transducer leads to enhancement
of the other branches of UPR (Fig. 3.6A-C). UPR induction in the model was
controlled by manipulation of the generation rate of unfolded or misfolded pro-
tein (qP) in the ER compartment. Upon UPR induction, initially (≤ 1hr) the
response is damped marking the adaptation phase of UPR. This is followed by
an increase in the activity of the IRE1α, PERK and ATF6 cascades at ∼ 1 hr mark-
ing the onset of the alarm phase, which leads to a final steady state ∼ 8-10 hrs
marking the onset of the commitment or apoptosis phase of UPR (Fig. 3.5). This
time frame was consistent with the maximum levels of BiP mRNA upon UPR
induction [301]. This analysis was substantiated further by looking at the fluxes
at different phases of UPR induction. As compared to P1 (No-UPR Steady State
Fig. 3.5), we saw that early on at 1 hr after unfolded protein dose there was a
marked increase in ATF4 and CHOP regulation, ATF6 signaling along with un-
folded protein sensing and degradation. These are hallmarks of the adaptation-
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Figure 3.5: Proof of concept simulation unfolded protein response activa-
tion. A:UPR induction was controlled by manipulating the
generation rate of unfolded or misfolded protein (qP) in the ER
compartment. A step-change in qP from qP = 0.1 to qP = 100
was issued at approximately t = 0.1 hrs and then adjusted back
to qP = 0.1 at t = 20 hrs. B:Flux through the PERK, ATF6 and
IRE1 stress sensing branches as a function of time following
a step change in misfolded protein generation. C:Simulated
expression profile for the 59 genes in the model. The symbol
UPROT denotes the level of unfolded protein.
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Figure 3.6: Signal flow analysis using simulated knockout (KO) of key pro-
teins on the UPR system: Simulation results suggest that the
three branches in UPR fire simultaneously with varying rates
and the state of the cell in terms of adaptation, alarm or apop-
tosis is a result of counteracting effects of these three prongs of
UPR signaling. (A-C) The counteracting effects is seen when
knockout of one ER stress transducer leads to enhancement
of the other branches of UPR. (D) ATF4, cleaved ATF6 and
XBP1s act as integrators of the signals coming from all the three
branches of UPR and furthermore leads to regulation of BiP,
thereby leading to a negative feedback or control of UPR sig-
nal. PERK and ATF4 KO studies revealed a slower and lower
amount of BiP production (∼ 50%) as compared to WT. How-
ever, ATF6 or IRE1 KO did not affect BiP regulation as com-
pared to WT. (E) Regulation of BiP was the critical regulator
of spliced XBP1 (XBP1s), which in turn acts as a key marker
of progression through different stages of UPR. (F) PERK and
ATF4 KO lead to delay in the onset of apoptosis (marked by
slower and lower reduction of Bcl2 levels. This effect could be
attributed to the lack of CHOP mediated branch of Bcl2 regu-
lation. On the other hand, IRE1 and CHOP KO leads to drastic
reduction in apoptosis (marked by little or no change of Bcl2
levels). CHOP KO, implicated the importance of CHOP in the
down-regulation of Bcl2. IRE1 KO implicated the critical role
of IRE1-TRAF2 mediated route of apoptosis. Overall flux anal-
ysis highlighted the extensive amount of crosstalk within the
three branches of the UPR network.
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alarm phase of the UPR response (Fig. 3.7D). The apoptosis phase (≥ 8-10 hrs
P2), was marked by increased BiP regulation, enhanced ATF4 transcriptional
activity, increased mitochondrial membrane permeability and increased apop-
totic fluxes. So the cell has committed itself to apoptosis mediated cell death. We
compared the ability of the system to recuperate upon reversal of unfolded pro-
tein loads from the alarm phase (P4, Fig. 3.5 ) and the apoptosis phase (P2, Fig.
3.5 ). If we reduced the protein load after the cell was committed to apoptosis
(as in P3), we found that the cell continued to function similar to the UPR state
even upon protein load reduction after 25 hrs (Fig. 3.7C). Certain modules were
seen to reduce like IRE1-TRAF2 signaling, ASK1 activation. However not much
difference was seen in terms of apoptotic fluxes, denoting the commitment of
the cell to death and to a point of no return. On the contrary if we reduced the
load of proteins in the adaptation-alarm phase (P4), we saw that the cell could
recuperate using its ERAD machinery and the regulation of BiP (Fig. 3.7E-F).
We further investigated the effect of simulated knockout (KO) and overex-
pression (OX) of key proteins on the UPR system. Interestingly, PERK and ATF4
KO studies revealed a slower and lower amount of BiP production (∼ 50%) as
compared to WT. However, ATF6 or IRE1 KO did not affect BiP regulation as
compared to WT. This highlighted the dominant role of ATF4 in regulation of
BiP, which is consistent with experimental evidence [324]. Regulation of BiP was
the critical regulator of spliced XBP1 (XBP1s), which in turn acts as a key marker
of progression through different stages of UPR (Fig. 3.6E). ATF4, cleaved ATF6
and XBP1s act as integrators of the signals coming from all the three branches
of UPR and furthermore leads to regulation of BiP, thereby leading to a negative
feedback or control of UPR signal. Another interesting note was the regulation
of pro-apoptosis phenotype via regulation of Bcl2. PERK and ATF4 KO lead to
59
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Figure 3.7: Cross plot of the fluxes at P1-P5 as denoted in Fig. 3.5: We tried
to see is how the system behaves and how the system can re-
cuperate from UPR dose when it is in the adaptation phase as
compared to the apoptosis phase. (D) As compared to P1 (No-
UPR Steady State), we see that early on at 1 hr after UPR dose
there is a marked increase in ATF4 and CHOP regulation, ATF6
signaling along with unfolded protein sensing and degrada-
tion. These are hallmarks of the adaptation-alarm phase of the
UPR response. (A) If we continue with the dose of UPR till
around 25 hrs, we see the fluxes reach a steady state. This state
is marked by increased BiP regulation, enhanced ATF4 tran-
scriptional activity, increased mitochondrial membrane perme-
ability and increased apoptotic fluxes. This state is similar to
the Apoptotic phase of UPR, where in the cell has committed
itself to apoptosis mediated cell death. (B) and (C) If we reduce
the UPR load after the cell has committed to apoptosis (as in
P3), we find that the cell continues to function similar to the
UPR state even upon UPR load reduction after 25 hrs. There
are certain aspects which are seen to reduce like IRE1-TRAF2
signaling, ASK1 activation. However not much difference is
seen in terms of apoptotic fluxes, denoting the cell has commit-
ted itself to death and is in a point of no return. (E)-(F) On the
contrary if we reduce the load of UPR in the adaptation-alarm
phase (P4), we see that the cell can recuperate using its ERAD
machinery and the regulation of BiP.
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delay in the onset of apoptosis (marked by slower and lower reduction of Bcl2
levels, Fig. 3.6F). This effect could be attributed to the lack of CHOP mediated
branch of Bcl2 regulation. On the other hand, IRE1 and CHOP KO leads to dras-
tic reduction in apoptosis (marked by little or no change of Bcl2 levels, Fig. 3.6F).
CHOP KO, implicated the importance of CHOP in the down-regulation of Bcl2.
IRE1 KO implicated the critical role of IRE1-TRAF2 mediated route of apopto-
sis. Overall signal flow analysis highlighted the extensive amount of crosstalk
within the three branches of the UPR network. Taken together, the population
of EUPR models recapitulated both short- and long timescale behavior follow-
ing overload of unfolded proteins in a variety of cell types. It also captured
the integration between multiple pathways and generated specific and testable
hypothesis about the role of network components in signal propagation.
3.3.5 Sensitivity analysis stratified locally and globally impor-
tant components of the UPR architecture.
First-order sensitivity coefficients were computed, time-averaged (over approx-
imately 8 hrs of simulated time following ER stress) and rank-ordered for the
1090 models parameters and 636 species under normal and UPR induced con-
ditions. Five parameter sets were selected from the parent ensemble based on
rightful representation of the diversity for the sensitivity calculations (further
details in the materials and methods). We selected only a few parameter sets
for the sensitivity analysis, because of the computational cost of computing all
1090 coefficients over several hours of simulated time. However, we did select
diverse sets as shown by the scatter in the CV values (Fig. 3.2).
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Figure 3.8: Plot of species sensitivity at earlier (0-2 hrs) versus later (6-8
hrs) time points: Sensitivity analysis was conducted over dis-
crete two hour time windows thereby revealing the time evo-
lution of the importance of UPR network modules. We found
that signal integration via the transcriptional activity of ATF6,
ATF4 and XBP1s along with RCAN1 and cIAP role in apopto-
sis were significantly more important at 6-8 hrs as compared
to 0-2 hrs time window. This is consistent with the dominant
role of the negative feedback via the transcriptional regulation
of BiP in UPR. Interestingly, the majority of species rankings
were similar as seen in the cluster in the grey box.
Infrastructure parameters e.g. nuclear transport, RNA polymerase or ribo-
some binding were globally critical, independent of stress (black points, Fig.
3.9). Additionally, apoptotic species and parameters were also important, both
in the presence and absence of UPR (yellow points, Fig. 3.9). Thus, as expected,
components such as RNA polymerase or caspase activation were globally im-
portant irrespective of the folding state of the ER. More interesting however
were coefficients that shifted above or below the 45o-line in the presence of
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UPR. These points denote differentially important network components. While
the majority of parameters and species became more important in the presence
of stress, we found a band of parameters (Fig. 3.9 Inset) that were differen-
tially important under stress. For example, the rank-ordering of the sensor and
stress-transducer modules clearly increased in the presence of UPR. Approxi-
mately, 172 or 15% of the parameters were significantly more important in the
presence of UPR. These parameters were largely associated with adaptation and
processing of unfolded or misfolded proteins, e.g., unfolded protein degrada-
tion, cleaved ATF6-induced gene expression, IRE1-TRAF2 mediated apoptosis
regulation and RCAN1 regulation. Likewise, 75 or 12% of the species were sig-
nificantly more important in UPR compared with normal protein loads (data
not shown).
Sensitivity analysis conducted over discrete two hour time windows re-
vealed the time evolution of the importance of UPR network modules (Fig. 3.9).
Comparison of the 0 - 2 hrs time window with itself (top panel, first column
of Fig. 3.9), supported the earlier results that infrastructure components were
globally critical followed by ERAD species. These species remained important
in all time windows. On the other hand, during the initial 0 - 2 hrs window,
ER stress transduction pathway components were robust. Comparison of the
0 - 2 hrs time window with later time points (working down the first column,
Fig. 3.9), showed the increasing importance of different modules as a function
of time. For example, components of the PERK and IRE1 modules were more
important in the 2 - 4 hrs window compared to the earlier time points, while
alarm and apoptotic phase species were more important in the 6 - 8 hrs win-
dow compared to the earlier time points. Specifically, signal integration via the
transcriptional activity of ATF6, ATF4 and XBP1s along with RCAN1 and cIAP
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Figure 3.9: Rank-ordering of species sensitivities in the presence of UPR as
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role in apoptosis were significantly more important at 6-8 hrs as compared to
0-2 hrs time window. This is consistent with the dominant role of the negative
feedback via the transcriptional regulation of BiP in UPR. Interestingly, the ma-
jority of species rankings were similar after 6 hrs (bottom row, Fig. 3.9 and Fig.
3.8). This analysis supports the structural analysis results, wherein the signal
integrators like XBP1s and transcriptional regulation of BiP via ATF6 and ATF4
are the key regulators of the phased response of UPR.
To further investigate the role of positive BiP regulation via ATF6, ATF4
and XBP1s, we conducted sensitivity analysis upon knocking out the feedback
branches of BiP for the nominal parameter set (Fig. 3.10). Interestingly, upon
knockout of any individual feedback branch like that of ATF4, ATF6 and XBP1s,
the system overall remains equally robust. However the sensitivity of the alter-
nate feedback components increases. This was most evident upon ATF4 feed-
back KO. We distinctly saw increase in sensitivity of feedback components as-
sociated with XBP1s and ATF6 (Fig. 3.10). Upon ATF6 and XBP1s feedback KO,
there wasn’t much change in terms of sensitivity of the system. This further
attests the key regulatory effect of ATF4 in mediating the positive BiP feedback
which is an essential component of the adaptation phase of UPR. Another in-
teresting observation was that when we completely knockout all the feedback
branches of BiP in the adaptation phase, the system overall becomes relatively
more robust (Fig. 3.10). We distinctly saw a major shift of sensitivity of BiP
upon removal of positive feedback. Overall ∼ 54 % of the parameters were dif-
ferentially less sensitive upon removal of BiP feedback as compared to WT. This
brings to light how the presence of BiP feedback makes the system more suscep-
tible/sensitive to perturbations. This highlights the essential role and relevance
of targeting the BiP feedback in manipulating UPR and specific importance of
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Figure 3.10: Plot of parameter sensitivity with APAF-1 feedback KO and
all BiP feedback KO: Upon knockout of any individual feed-
back branch like that of ATF4, ATF6 and XBP1s, the system
overall remains equally robust. However the sensitivity of
the alternate feedback components increases. This was most
evident upon ATF4 feedback KO. (A) We saw increase in sen-
sitivity of feedback components associated with XBP1s and
ATF6. Upon ATF6 and XBP1s feedback KO, there wasn’t
much change in terms of sensitivity of the system (data not
shown). This further attests the key regulatory effect of ATF4
in mediating the positive BiP feedback which is an essential
component of the adaptation phase of UPR. (B) When we
completely knockout all the feedback branches of BiP in the
adaptation phase, the system overall becomes relatively more
robust. We distinctly saw a major shift of sensitivity of BiP
upon removal of positive feedback. Overall ∼ 54 % of the
parameters were differentially less sensitive upon removal of
BiP feedback as compared to WT. This brings to light how
the presence of BiP feedback makes the system more suscep-
tible/sensitive to perturbations.
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ATF4 amongst the three feedback branches.
3.3.6 Robustness analysis predicted the phenotypic conse-
quence of structural perturbations to the UPR network.
We calculated the direction of unfolded protein load induced concentration
shifts for 636 markers following single parameter knockouts (Edge KO), sin-
gle gene knockouts (GKO) and single gene overexpression (GOX) to the UPR
network for the nominal parameter set (Fig. 3.11). Robustness coefficients were
used to quantify the effect of structural perturbations on network markers. Co-
efficients with values > 1 (< 1) indicated a marker increased (decreased) com-
pared to the basal state, while a value ∼ 1 indicated approximately no change
following a perturbation. Phenotypic behavior of the UPR models were an-
alyzed as a result of perturbation, using downstream markers like Caspase 3
(marker for cell death), Bcl2 (marker for cell-survival) and other key signal inte-
grators of the signals from ER stress transducers e.g., XBP1s, CHOP and ATF4.
Overall, we found that in the survival-death phenotypic plane, the pro-death
phenotype (marked by robustness coefficients > 1 for Caspase 3) was seen to be
relatively robust to structural (both GKO, GOX and Edge KO) perturbations.
Few perturbations lead to increased Caspase 3 levels, e.g., overexpression of
Procaspases 9/3 (Fig 3.11 A, Table 3.2). This robustness of the apoptotic marker
caspase 3, can be attributed to the redundant sources of cell death (e.g., APAF-1
dependent and APAF-1 independent strategies). To confirm this we ran sim-
ulated APAF-1 KOs over the entire ensemble (Fig. 3.13). We found that there
were two populations of cells in the ensemble: population 1 where APAF-1 was
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Figure 3.11: Robustness analysis of the UPR network: A-B Phenotypic
phase plane analysis for the the UPR model following struc-
tural perturbations. Coupling coefficients (area under the
curve from the simulation with species removed dived by the
wild-type simulation) for all 636 model species were calcu-
lated for the nominal parameter set following gene overex-
pression/knockout (A) and deletion of single network edges
(B). Coupling coefficients of one indicate no change in a
marker level following a perturbation, while values less
(greater) than one denote decreased (increases) marker lev-
els. C Structural distinguishability analysis: We computed
the dendrogram of the coupling coefficients for single GKO
of model species. Individual coupling coefficients were clus-
tered, where the euclidean norm was used as the distance
metric and the linkage function was the inner square product
(variance minimization algorithm). Each additional cluster
was chosen to reduce the overall variance (y-axis). A general
description of the biological function of the clusters were indi-
cated by each group. Insets: Distinguishability as the magni-
tude of the orthogonal components for all knockout species.
Species were ordered from largest to smallest magnitudes.
Red markers indicate species which were statistically signif-
icant.
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the dominant regulator of cell-death (marked by enhanced reduction in caspase
3 upon APAF-1 KO) and population 2 where APAF-1 is not the most dominant
regulator (marked by reduced effect on Caspase 3 upon APAF-1 KO) (Fig. 3.13).
This behavior is consistent based on the training data from Sak2 cells (APAF-1
−ve cells) [440]. Interestingly, manipulation of the pro-survival axis via regula-
tion of Bcl2 was possible (Fig 3.11A, Table 3.2). For example, KO of PERK/ATF4
signaling components lead to increased Bcl2 marker levels (Fig 3.11A). This be-
havior is attributed to the dominant role of PERK-ATF4 mediated regulation of
CHOP which downstream leads to down-regulation of Bcl2 levels (seen earlier
in signal analysis results). To further investigate the extent of CHOP mediated
down-regulation of Bcl2, we simulated CHOP KOs over the entire ensemble
(Fig. 3.13). We identified two distinct populations within the ensembles. One
with a strong effect of CHOP mediated down-regulation of Bcl2 (marked by
∼ 10 fold increase in Bcl2 levels) and the other with very little effect of CHOP
on Bcl2 levels. This behavior could be attributed to other conflicting means of
regulation of Bcl2 levels. Other schemes of regulating Bcl2 levels include per-
turbations involving eIF2α, BiP, JNK, cIAP and RCAN1 (Fig 3.11A, Table 3.2).
Robustness analysis allowed us to investigate complex network properties
like redundancy and crosstalk. For example, the direct correlation between
ATF4 and CHOP was further noted in the ATF4-CHOP phenotypic plane. Any
perturbations affecting ATF4 affected CHOP levels in the same manner (reduc-
tion in ATF4 levels lead to reduced levels of CHOP) (Fig. 3.11A-B). However,
owing to redundant sources of CHOP regulation (e.g., via XBP1s), effect on
CHOP is damped as compared to significant changes in ATF4 levels. In the
XBP1s-CHOP plane, we see at lower levels of XBP1s and CHOP, there is a di-
rect relation between XBP1s levels and CHOP levels. However, there exists very
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Figure 3.12: Simulations with translation attenuation built in the model:
One of the key aspects which was not included in the current
model was translation attenuation. So we simulated that to
identify that there isnt much of a change overall in the system
except for the tad bit delay in the onset of the responses.
few strategies of having both high XBP1s levels and CHOP levels indicating that
higher XBP1s doesn’t necessarily mean higher CHOP levels. To further investi-
gate the implications of the feedback regulation of BiP via ATF4/ATF6/XBP1s,
we simulated KOs of these components over the entire ensemble (Fig. 3.14).
KO of ATF6 and XBP1s mediated feedback of BiP was seen to have little effect
(as marked by robustness coefficients for BiP, Fig. 3.14). However, ATF4 me-
diated feedback KO led to significant amount of reduction in BiP levels (Fig.
3.14) thereby highlighting the significance of ATF4 in BiP feedback. Upon KO
of all branches of BiP feedback, we found overall reductions of BiP levels. How-
ever, there were two distinct populations. One with a ∼ 10 fold reduction in BiP
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Figure 3.13: Survival-death phenotypic plane for APAF-1 and CHOP KOs
over the entire ensemble: (A) With APAF-1 KO, we found that
there were two populations of cells in the ensemble: popula-
tion 1 where APAF-1 was the dominant regulator of cell-death
(marked by enhanced reduction in caspase 3 upon APAF-1
KO) and population 2 where APAF-1 is not the most domi-
nant regulator (marked by reduced effect on Caspase 3 upon
APAF-1 KO). (B) Upon CHOP KO, we identified two distinct
populations within the ensembles. One with a strong effect
of CHOP mediated down-regulation of Bcl2 (marked by ∼ 10
fold increase in Bcl2 levels) and the other with very little effect
of CHOP on Bcl2 levels. This behavior could be attributed to
other conflicting means of regulation of Bcl2 levels.
levels while the other had ∼ 1000 fold reduction in BiP levels. These two pop-
ulations could resemble two distinct operational paradigms within UPR. In the
first mode of operation feedback regulation of BiP is really strong so when we
knockout BiP feedback we have drastic reductions in BiP levels and ultimately
a stronger and faster UPR response.
Global analysis of the gene knockout robustness coefficients by clustering to
minimize the variance, provides a systems-level insight into the UPR network.
As in Fig. 3.11C, dendrogram of the single GKOs revealed clusters with inherent
functional relationships. For example, the most distinct separation was between
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Figure 3.14: To further investigate the implications of the feedback regu-
lation of BiP via ATF4/ATF6/XBP1s, we simulated KOs of
these components over the entire ensemble. (A) Upon KO of
all branches of BiP feedback, we found overall reductions of
BiP levels. However, there were two distinct sub-populations.
One with a ∼ 10 fold reduction in BiP levels while the other
had ∼ 1000 fold reduction in BiP levels. These two pop-
ulations could resemble two distinct operational paradigms
within UPR. In the first mode of operation feedback regula-
tion of BiP is really strong so when we knockout BiP feed-
back we have drastic reductions in BiP levels and ultimately
a stronger and faster UPR response. (B) ATF4 mediated feed-
back KO led to significant amount of reduction in BiP levels
thereby highlighting the significance of ATF4 in BiP feedback.
(C-D) However, KO of ATF6 and XBP1s mediated feedback
of BiP was seen to have little effect (as marked by robustness
coefficients for BiP).
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Table 3.2: Phenotypic response of simulated Gene knockout/overexpression.
(G.O.S - Gene Overexpression Studies, G.K.S - Gene Knockout Studies)
Increased
marker levels
Phenotype G.O.S
(% of
cases)
Example genes G.K.S (% of
cases)
Example genes
BCL2 Cell Sur-
vival
16 PERK, ATF4, cIAP, Bcl2,
ATF6, RCAN1, Bad, UB
24 HSP40, BiP, PERK,
eIF2α, ATF4, NFY,
JNK, Bad, CHOP,
CREB, Procaspase 8
CHOP – 5 eIF2α, CHOP 3.5 CEBP, CREB
Caspase 3 Cell Death 9 Procaspase 9/8/3/6/7 0 –
XBP1 – 12 BiP, cIAP, XBP1, RCAN1 3.5 NFY, TRAF2
BiP – 12 PERK, IRE1, NFY, ATF6,
CEBP, CREB, UB
12 HSP40, BiP, eIF2α,
ATF4, NFY, S1P, S2P
PARP DNA dam-
age
3.5 Procaspase 9, PARP 0 –
ATF4 – 20 HSP40, PERK, BiP,
eIF2α, ATF4, IRE1,
BAK, TRAF2, ASK1,
JNK, p38MAPK, Calcin-
uerin, CHOP, CREB
5 NFY, CEBP, CREB
unfolded protein sensing and IRE1/PERK signal initiation from the rest of the
knockouts. PERK/ATF4 branch as seen earlier, plays a dominant role in the
regulation of BiP and CHOP upon the onset of UPR. Similarly, IRE1/TRAF2
signaling axis is valuable to the apoptosis module. Another interesting func-
tional module was that of CHOP, involving p38MAPK which leads to down-
regulation of Bcl2 levels which considerably affects the apoptosis module. We
computed the magnitude of the orthogonal components of the single GKO coef-
ficients (Fig. 3.11C Inset). The orthogonal component was used to establish the
uniqueness of the knockout. All the single GKOs were found to have orthogonal
components greater than one with a 95% confidence. KO of BiP, Procaspase 9,
IRE1, PERK and TRAF2 were some of the knockouts which produced the most
unique effects. This is in accord to the critical role of BiP in initiating and fur-
ther regulating the time scale of progression and the ultimate result of the UPR
response. So PERK via ATF4 plays a key role in regulation of BiP, is rightly seen
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to have a major effect as compared to other GKOs. Similarly, regulation of the
apoptosis branch via IRE1-TRAF2 and Procaspase 9 rightly were seen to have
the most effect as compared to other GKOs.
3.4 Discussion
Proteins requiring post-translational modifications such as N-linked glycosyla-
tion or disulfide bond formation are processed in the endoplasmic reticulum
(ER). A diverse array of cellular stresses can lead to dysfunction of the ER,
and ultimately to an imbalance between protein-folding capacity and protein-
folding load. Unfolded or misfolded proteins are tagged for degradation via ER
associated degradation (ERAD) or sent back through the folding cycle. Contin-
ued accumulation of incorrectly folded proteins can also trigger the Unfolded
Protein Response (UPR). In this study, we formulated a mechanistic model of
the cellular response to stress (protein overload) and studied the core regula-
tory aspects and downstream effects of UPR induction. PRKR-like ER kinase
(PERK), inositol-requiring kinase 1 (IRE1) and activating transcription factor 6
(ATF6) were modeled as the key UPR initiators. While UPR has been exten-
sively studied [363, 456, 245, 117, 134, 481, 167, 345, 32, 208, 554, 515], a de-
tailed mathematical model to investigate the complexities involved is lacking.
The UPR network architecture is based on extensive review of the literature
[363, 456, 245, 117, 134, 481, 167, 345, 32, 208, 554, 515]. Mass balance equa-
tions describing 636 species interconnected by 1090 interactions were formu-
lated using mass-action kinetics within an ordinary differential equation (ODE)
framework. Four model populations were estimated using multi-objective op-
timization (33 objective functions) in conjunction with a leave-eight out cross-
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validation strategy using POETs [504]. These model populations were then an-
alyzed using population-based sensitivity and robustness analysis. Overall we
identified sources of network crosstalk and redundancy within the UPR module
which could be the reason for emergent properties and be the links for aberra-
tions in cellular adaptation to stress.
A key finding of our study was that the overall outcome of UPR was as a
result of simultaneous firing and competition between signaling mediated by
the three ER-stress transducers: PERK, IRE1 and ATF6. This is in contrast to
the traditional belief that PERK and ATF6 branches are activated before IRE1
[515]. So what we hypothesize is that instead of a sequential ordering of these
branches, the state of the cell in terms of adaptation, alarm or apoptosis is a
result of counteracting effects of these three prongs of UPR signaling. The coun-
teracting/competing effects was further substantiated in simulated knockout
studies, where in knockout of one ER stress transducer lead to enhancement of
the other branches of UPR. Signal transduction architectures frequently contain
redundancy, feedback and crosstalk. These topological features ensure signal
propagation is adaptable, efficient and robust. However, they also make repro-
gramming signal flow challenging. This was highlighted remarkably in case
of UPR. Signals from the three ER-stress transducers converged at the level of
up-regulation of BiP. This is the key junction which regulates the three stages
(onset and time) of adaptation/alarm and apoptosis. In this regard, regulators
of this feedback cleaved ATF6, ATF4 and XBP1s were seen as highly sensitive
components of UPR. Interestingly these components put-together increased the
overall fragility of the system and presenting more scope of manipulation of the
UPR response. This was substantiated by sensitivity analysis upon KO of the
feedback loops, where we saw increased stability of the UPR module. When
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these feedback components were knocked out individually, the system over-
all remained stable thanks to increased activity and load sharing via the other
feedback branches. Amongst the three components of feedback, we identified
ATF4 as the key load bearer/regulator. This was substantiated by signal flow,
robustness and sensitivity analysis. This is really interesting as ATF4 protein
has shown to be present greater levels in cancer compared to normal tissue,
and it is up-regulated by signals of the tumor microenvironment such as hy-
poxia/anoxia, oxidative stress, and ER stress [10]. So any aberrations in regula-
tion of ATF4 could potentially serve as a specific target in cancer therapy. As a
target ATF4 is attractive because it is also potentially involved in angiogenesis
and adaptation of cancer cells to hypoxia/anoxia, which are major problems in
cancer progression [10].
Downstream effects of UPR ranges from cellular adaptation/survival (low
stress) to the cell committing to apoptosis mediated death (high stress). Our
modeling analysis suggested that the cell-death phenotype (marked by in-
creased levels of Caspase 3 as compared to WT) was relatively robust. This
robustness could be attributed to redundant routes of APAF-1 dependent and
APAF-1 independent routes of apoptosis. This claim is supported by experi-
mental evidence in Sak2 cells [440] and as seen by our simulated knockout stud-
ies where we identified two distinct populations representing clear distinctions
in APAF-1 dependent and independent routes of apoptosis. Interestingly, ma-
nipulation of the pro-survival phenotype (marked by increased levels of Bcl2 as
compared to WT) was feasible. The most effective route was via manipulation
of PERK/ATF4/CHOP branch. This was substantiated by simulated CHOP KO
experiments over the entire ensemble, wherein we identified two distinct pop-
ulations within the ensembles. One with a strong effect of CHOP mediated
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down-regulation of Bcl2 (marked by ∼ 10 fold increase in Bcl2 levels) and the
other with very little effect of CHOP on Bcl2 levels. This complex network be-
havior could be attributed to other conflicting means of regulation of Bcl2 lev-
els. Rightfully so, induction of CHOP is involved in the development of various
diseases and several therapeutic interventions [395]. For instance, suppression
of CHOP by RNA interference, decoy oligodeoxynucleotides or drug inhibitors
have a significant therapeutic potential to modulate type I diabetes and brain
ischemia. On the other hand, overexpression of CHOP may represent a new
class of anticancer therapy. Since induction of BiP has been observed in a vari-
ety of tumor cells, overexpression of CHOP directed by the BiP promoter may
be used as a highly specific therapy for cancer [395]. Model analysis also high-
lighted the essential role of RCAN1 and IRE1-TRAF2 routes of apoptosis. ATF6
induces regulator of calcineurin 1 (RCAN1) expression [32]. RCAN1 sequesters
calcineurin [32], a calcium activated protein-phosphotase B, that dephospho-
rylates Bcl2-antagonist of cell death (BAD) at S75 or S99 [571]. This leads to
sequestering of Bcl2 by Bad, which inhibits its downstream anti-apoptotic ac-
tivity [571]. Recently, a number of ATF6 homologs have been identified, e.g.,
OASIS, CREBH, LUMAN/CREB3, CREB4 and BBF2H7 that are processed in
a similar way as ATF6, yet their function remains unknown [457]. Thus, ER-
stress induced ATF6 signaling may be responsible for additional undiscovered
functionality.
Given the structural and parametric uncertainty associated with the current
version of the UPR model, we were still able to extract interesting insight into
the complex inner workings and present falsifiable hypothesis regarding ma-
nipulating the UPR program. While we did an extensive search of the liter-
ature to formulate the model, we were missing certain key structural aspects
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of UPR which could provide a more comprehensive analysis for further gen-
erations of the model. One key missing aspect is the negative regulation of
the three ER-stress transducers. Given PERK’s central role in translation atten-
uation, cells have evolved multiple axes to regulate PERK activity. First, the
cytosolic kinase domain of PERK can be inhibited by the action of the DNAJ
family member P58IPK . P58IPK was initially discovered as an inhibitor of the
eIF2α protein kinase PKR [292]. P58IPK , whose expression is induced following
ATF6 activation, binds to the cytosolic kinase domain of PERK, inhibiting its ac-
tivity [599, 558]. Inhibition of PERK kinase activity relieves eIF2α phosphoryla-
tion, thereby removing the translational block. Interestingly, P58IPK expression
occurs several hours after PERK activation and eIF2α phosphorylation. Thus,
P58IPK induction may mark the end of UPR adaptation, and the beginning of
the alarm/apoptosis phase of the response [515]. Second, PERK induces a neg-
ative feedback loop, through its downstream effector CHOP, involving the di-
rect de-phosphorylation of eIF2α. CHOP induces the expression of GADD34
which, in conjunction with protein phosphatase 1 (PP1), assembles into a phos-
phatase which dephosphorylates the S51 residue of eIF2α [384]. GADD34 is
a member of the GADD family of genes which are induced by DNA damage
and a variety of other cellular stresses [621]. The GADD34 binding partner in
this complex appears to be responsible for PP1α recognition and targeting of
the phosphatase complex to the ER. Association between GADD34 and PP1 is
encoded by a C-terminal canonical PP1 binding motif, KVRF, while approxi-
mately 180 residues, near the N-terminus of GADD34, appear to be responsible
for ER localization [56]. Currently, little is known about deactivation of ATF6.
Recently, XBP1u, the unspliced form of XBP1, has been implicated as a negative
regulator for ATF6 [615]. Following, the induction of ER stress, two versions of
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XBP1 exist: XBP1u and sXBP1 [615]. In the recovery phase following ER stress,
high levels of XBP1u may play a dual role. First, XBP1u binds sXBP1, promot-
ing complex degradation [614, 541]. Second, XBP1u can bind ATF6α rendering
it more prone to proteasomal degradation [615]. Taken together, these two steps
may slow the transcription of ER chaperones and ERAD components during
the recovery phase following ER stress. IRE1α activity is regulated by several
proteins, including tyrosine phosphatase 1B (PTP-1B), ASK1-interactive protein
1 (AIP1) and members of the Bcl2 protein family. PTP-1B has been implicated
in a number of IRE1α signaling events. The absence of PTP-1B reduced IRE1α
dependent JNK activation, XBP1 splicing and EDEM transcription in immor-
talized and primary mouse embryonic fibroblasts [171]. However, no physical
interaction between IRE1α and PTP-1B was established. On the other hand,
AIP1 physically interacts with both TRAF2 and IRE1α, suggesting a model in
which AIP1 facilitates IRE1α dimerization and activation [321]. The C-terminal
period-like domain (PER) of AIF1 binds the N-terminal RING finger domain of
TRAF2, followed by ASK1-JNK signaling [623]. Thus, based on these findings,
Luo et al. postulated that AIF1 may be directly involved in the IRE1α-TRAF2
complex and its activation of the ASK1-JNK signaling axis [321]. This hypothe-
sis was validated in AIP1-KO mouse studies; AIP1-knockout mouse embryonic
fibroblasts and vascular endothelial cells showed significant reductions in ER-
stress induced ASK1-JNK activation that was rescued in AIP1 knock-in cells
[321]. IRE1α has also been shown to directly interact with Bcl-2 family mem-
bers Bax and Bak. Hetz et al. showed that Bax and Bak complex with the
cytosolic domain of IRE1α and modulate IRE1α signaling [207]. Bax and Bak
double knockout mice failed to signal through the IRE1α UPR branch following
tunicamycin-induced ER stress; however, PERK signaling markers, e.g., eIF2α
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phosphorylation, responded normally [207]. This pro-activation role of Bak and
Bax may be modulated by one of the few negative regulators of IRE1α activity,
Bax inhibitor 1 (BI-1). BI-1 is an anti-apoptotic protein that enhances cell sur-
vival following several intrinsic death stimuli [593]. Bailly-Maitre et al. were the
first to suggest that BI-1 may downregulate IRE1α and possibly ATF6 activity
[21]. BI-1 deficient mice displayed increased XBP1s and enhanced JNK activity
in the liver and kidney, while eIF2α phosphorylation remained normal under
ER-stress conditions [21]. Lisbona et al. later showed that BI-1 directly inter-
acts with the cytosolic domain of IRE1α, inhibiting its endoribonuclease activity
[307]. Interestingly, BI-1 interacts with several members of the Bcl2 protein fam-
ily e.g., Bcl2 and Bcl-XL, even though it has no homology [593]. Members of
the HSP family of proteins have also been shown to regulate IRE1α. For exam-
ple, HSP90 interacts with the cytosolic domain of IRE1α, potentially protecting
it from degradation by the proteasome [332]. HSP72 interaction with the cy-
tosolic IRE1α domain has also recently been shown to enhance IRE1α endori-
bonuclease activity [175]. Taken together, these modes of IRE1α regulation with
the exception of B1-1, largely promote or enhance IRE1α signaling. Given the
importance of CHOP in regulation of Bcl2, it is vital to establish the exact con-
nectivity. However, while CHOP expression is negatively correlated with Bcl2
levels, there is no CHOP binding site in the bcl2 promoter [345]. McCullough
et al. have suggested that the bZIP domain of CHOP could act with other bZIP
transcription factors to regulate bcl2 expression [345]. Thus, it’s likely that the
connection between CHOP expression and apoptosis is more complex than sim-
ple down-regulation of Bcl2 expression. These missing structural connections
shall allow us to establish a detailed model and extract more relevant insights
into manipulating UPR.
80
3.5 Materials and Methods
3.5.1 Formulation and solution of the model equations.
The unfolded protein response model was formulated as a set of coupled ordi-
nary differential equations (ODEs):
dx
dt
= S · r (x,p) x (to) = xo (3.1)
The symbol S denotes the stoichiometric matrix (636 × 1090). The quantity x
denotes the concentration vector of proteins or protein complexes (636× 1). The
term r (x,p) denotes the vector of reaction rates (1090 × 1). Each row in S de-
scribed a protein or protein-protein complex, while each column described the
stoichiometry of network interactions. Thus, the (i, j) element of S, denoted by
σi j, described how protein i was involved in rate j. If σi j < 0, then protein i was
consumed in r j. Conversely, if σi j > 0, protein i was produced by r j. Lastly, if
σi j = 0, there was no protein i in rate j. All of these interactions were obtained
from the literature.
We assumed mass-action kinetics for each interaction in the network. The
rate expression for interaction q was given by:
rq
(
x, kq
)
= kq
∏
j∈{Rq}
x−σ jqj (3.2)
The set
{
Rq
}
denotes reactants for reaction q while σ jq denotes the stoichio-
metric coefficient (element of the matrix S) governing species j in reaction q.
All reversible interactions were split into two irreversible steps. The mass-
action formulation, while expanding the dimension of the UPR model, regu-
larized the mathematical structure; this allowed automatic generation of the
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model code using UNIVERSAL and regularized the unknown model parame-
ters (parameters were one of only three types, association, dissociation or cat-
alytic rate constants). UNIVERSAL, an open source Java code generator, gen-
erates multiple code types from text and SBML inputs. UNIVERSAL is freely
available as a Google Code project (http://code.google.com/p/universal-code-
generator/). Thus, although mass-action kinetics increased the number of pa-
rameters and species, they reduced the complexity of model analysis. In this
study, we considered well-mixed nuclear, cytosolic and extracellular compart-
ments. The model equations were solved using the LSODE routine in OCTAVE
(v 3.1.0; www.octave.org) on an Apple workstation (Apple, Cupertino, CA; OS
X v10.6.4).
Unfolded protein response conditions were simulated by running the model
to steady state and then providing a dose of proteins. The steady-state was es-
timated numerically by repeatedly solving the model equations and estimating
the difference between subsequent time points:
‖x (t + ∆t) − x (t) ‖2 ≤ γ (3.3)
The quantities x (t) and x (t + ∆t) denote the simulated concentration vector at
time t and t + ∆t, respectively. The L2 vector-norm was used as the distance
metric. We used ∆t = 1 s and γ = 0.001 for all simulations.
3.5.2 Estimation and cross-validation of a population of models
using Pareto Optimal Ensemble Techniques (POETs).
POETs is a multiobjective optimization strategy which integrates several local
search strategies e.g., Simulated Annealing (SA) or Pattern Search (PS) with a
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Pareto-rank-based fitness assignment [504]. Denote a candidate parameter set
at iteration i + 1 as ki+1. The squared error for ki+1 for training set j was defined
as:
E j(k) =
T j∑
i=1
(
Mˆi j − yˆi j(k)
)2
(3.4)
The symbol Mˆi j denotes scaled experimental observations (from training set j)
while the symbol yˆi j denotes the scaled simulation output (from training set j).
The quantity i denotes the sampled time-index and T j denotes the number of
time points for experiment j. The read-out from the training immunoblots was
band intensity where we assumed intensity was only loosely proportional to
concentration. Suppose we have the intensity for species x at time i = {t1, t2, .., tn}
in condition j. The scaled measurement would then be given by:
Mˆi j = Mi j −miniMi jmaxiMi j −miniMi j (3.5)
Under this scaling, the lowest intensity band equaled zero while the highest
intensity band equaled one. A similar scaling was defined for the simulation
output.
We computed the Pareto rank of ki+1 by comparing the simulation error at it-
eration i+1 against the simulation archive Ki. We used the Fonseca and Fleming
ranking scheme [133]:
rank (ki+1 | Ki) = p (3.6)
where p denotes the number of parameter sets that dominate parameter set ki+1.
Parameter sets on or near the optimal trade-off surface have small rank. Sets
with increasing rank are progressively further away from the optimal trade-
off surface. The parameter set ki+1 was accepted or rejected by the SA with
probability P (ki+1):
P(ki+1) ≡ exp {−rank (ki+1 | Ki) /T } (3.7)
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where T is the computational annealing temperature. The initial temperature
To = n/log(2), where n is user defined (n = 4 for this study). The final temper-
ature was T f = 0.1. The annealing temperature was discretized into 10 quanta
between To and T f and adjusted according to the schedule Tk = βkT0 where β
was defined as:
β =
(
T f
To
)1/10
(3.8)
The epoch-counter k was incremented after the addition of 100 members to the
ensemble. Thus, as the ensemble grew, the likelihood of accepting parameter
sets with a large Pareto rank decreased. To generate parameter diversity, we
randomly perturbed each parameter by ≤ ±25%. We performed a local pattern-
search every q steps to minimize the residual for a single randomly selected
objective. The local pattern-search algorithm has been described previously
[149, 560]. The parameter ensemble used in the simulation and sensitivity stud-
ies was generated from the low-rank parameter sets in Ki.
We simultaneously calculated training and prediction error during the pa-
rameter estimation procedure using leave-eight-out cross-validation [261]. The
complete set of training data (33 objectives) was subdivided into four bins; in
each bin 25 data sets were reserved for training while eight were reserved for
prediction. In the first bin DS1 . . .DS8 were used for validation while DS9 . . .DS33
were used for training. In the second bin DS9 . . .DS16 were used for validation
while DS1 . . .DS8 DS17 . . .DS33 were used for training, etc. Thus, we formulated
four ensembles from which we evenly selected parameter sets for the parent en-
semble (Fig. 3.2). While cross-validation required that we generate additional
model populations, we trained and tested against all the data sets.
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3.5.3 Sensitivity and robustness analysis of the population of
UPR models.
Sensitivity coefficients were calculated as shown previously [504] using five
models selected from the ensemble (red points, Fig. 3.2). The resulting sensi-
tivity coefficients were scaled and time-averaged (Trapezoid rule):
Ni j ≡ 1T
∫ T
0
dt · |αi j (t) si j(t)| (3.9)
where T denotes the final simulation time and αi j = 1. The time-averaged sensi-
tivity coefficients were then organized into an array for each ensemble member:
N () =

N ()11 N ()12 . . . N ()1 j . . . N ()1P
N ()21 N ()22 . . . N ()2 j . . . N ()2P
...
...
...
...
N ()M1 N ()M2 . . . N ()M j . . . N ()MP

 = 1, 2, . . . ,N (3.10)
where  denotes the index of the ensemble member, P denotes the number of pa-
rameters, N denotes the number of ensemble samples and M denotes the num-
ber of model species. To estimate the relative fragility or robustness of species
and reactions in the network, we decomposed the N () matrix using Singular
Value Decomposition (SVD):
N () = U()Σ()VT,() (3.11)
Coefficients of the left (right) singular vectors corresponding to largest β sin-
gular values of N () were rank-ordered to estimate important species (reaction)
combinations. Only coefficients with magnitude greater than a threshold (δ =
0.1) were considered. The fraction of the β vectors in which a reaction or species
index occurred was used to rank its importance.
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Robustness coefficients of the form:
α
(
i, j, to, t f
)
=
(∫ t f
to
xi (t) dt
)−1 (∫ t f
to
x( j)i (t) dt
)
(3.12)
were calculated to understand the robustness of the network. The robustness
coefficient α
(
i, j, to, t f
)
is the ratio of the integrated concentration of a network
marker in the presence (numerator) and absence (denominator) of structural
or operational perturbation. The quantities t0 and t f denote the initial and final
simulation time respectively, while i and j denote the indices for the marker and
the perturbation respectively. If α
(
i, j, to, t f
)
> 1, then the perturbation increased
the marker concentration. Conversely, if α
(
i, j, to, t f
)
 1 the perturbation de-
creased the marker concentration. Lastly, if α
(
i, j, to, t f
)
∼ 1 the perturbation did
not influence the marker concentration.
3.5.4 Species clustering and dendrogram.
A dendrogram was derived by considering each of the knockouts(over-
expressions) as variables and the average log of robustness coefficient (LRC)
for each of the species as observations. We used the Euclidean norm in LRC
space as the distance metric. The linkage function (objective function for iden-
tifying variable clusters) was the inner squared distance (minimum variance al-
gorithm). The Statistical Toolbox of Matlab (The Mathworks, Natick, MA) was
used to generate the distances, linkages and the final dendrogram.
86
3.5.5 Identification of distinguishable species.
Robustness coefficients were used to rank-order knockout(overexpression) ex-
periments in terms of the greatest unique responses and identify species which
were linearly distinguishable. The response of the knockout(overexpression)
was measured in terms of the robustness coefficients. The LRC had desirable
linear properties, such that no response (no change in trajectories from wild-
type) returns a value of zero and similar negative and positive responses have
different directions but similar magnitudes. We considered the unique compo-
nent of the response to be the orthogonal component in LRC space and the mag-
nitude of the response to be the Euclidean norm. The orthogonal components
and there magnitude were identified for each parameter set in the ensemble
by first choosing the knockout(overexpression) with the greatest magnitude, x1
and placing it in the empty setV. The knockout(overexpression) x1 defines the
orthogonal directions in the LRC space. We then calculated the orthogonal com-
ponents for all remaining knockouts(overexpressions) relative to x1, and added
the knockout(overexpression) species with the greatest orthogonal magnitude
to setV. In general the components of all remaining xi orthogonal to setVwere
calculated and the largest was moved into set V. This process was continued
until all knockout(overexpression) species, xi were added to set V. Mathemat-
ically two species were considered distinguishable if and only if they were lin-
early independent (the orthogonal components were non-zero). We considered
a threshold value of one or five and performed a student t-test (Matlab Statistical
Toolbox, The Mathworks, Natick, MA) to identify which species had orthogonal
components above the threshold with a 95% confidence over the ensemble.
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4.1 Abstract
Insulin, the primary hormone regulating the level of glucose in the bloodstream,
modulates a variety of cellular and enzymatic processes in normal and diseased
cells. Insulin signals are processed by a complex network of biochemical inter-
actions which ultimately induce gene expression programs or other processes
such as translation initiation. Surprisingly, despite the wealth of literature on in-
sulin signaling, the relative importance of the components linking insulin with
translation initiation remains unclear. We addressed this question by develop-
ing and interrogating a family of mathematical models of insulin induced trans-
lation initiation. The insulin network was modeled using mass-action kinetics
within an ordinary differential equation (ODE) framework. A family of model
parameters was estimated, starting from an initial best fit parameter set, using
24 experimental data sets taken from literature. The residual between model
simulations and each of the experimental constraints was simultaneously min-
imized using multiobjective optimization. Interrogation of the model popula-
tion, using sensitivity and robustness analysis, identified an insulin-dependent
switch that controlled translation initiation. Our analysis suggested that with-
out insulin, a balance between the pro-initiation activity of the GTP-binding
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protein Rheb and anti-initiation activity of PTEN controlled basal initiation. On
the other hand, in the presence of insulin a combination of PI3K and Rheb activ-
ity controlled inducible initiation, where PI3K was only critical in the presence
of insulin. Other well known regulatory mechanisms governing insulin action,
for example IRS-1 negative feedback, modulated the relative importance of PI3K
and Rheb, but did not fundamentally change the signal flow.
4.2 Introduction
Insulin, the primary hormone regulating the level of glucose in the bloodstream,
modulates a variety of cellular and enzymatic processes in normal and dis-
eased cells [636, 358, 89, 462, 477, 619, 118]. The regulation of cellular func-
tion by insulin and insulin-like growth factors I/II (IGF-I/II) is a highly com-
plex process [413, 128, 525, 467, 466, 450, 322]. Insulin and IGF-I/II interact
with insulin receptors (IR), and type I/II IGF receptors (IGF-IR/IIR) in addi-
tion to other transmembrane receptors [525]. These interactions ultimately in-
duce gene expression programs or other processes such as translation initia-
tion. Translation rates of many cell cycle and survival proteins are modulated
by growth factor, hormone or other mitogenic signals [34]. Insulin induces
the activation of class I Phosphoinositide 3-kinases (PI3Ks), which in turn ac-
tivate the serine/threonine protein kinase Akt and the mammalian target of ra-
pamycin (mTOR). The PI3K/Akt/mTOR signaling axis is important to a variety
of cellular programs, including apoptosis [602], cell size control [150] and trans-
lation initiation. Among other functions, activation of the PI3K/Akt/mTOR
axis results in the phosphorylation of eukaryotic translation initiation factor
4E-binding protein (4E-BPx) family members [161]. Phosphorylation of 4E-BPx
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causes the release of the eukaryotic translation initiation factor 4E (eIF4E), which
is critical to directing ribosomes to the 7-methyl-guanosine cap of eukaryotic
mRNAs. Previously, the availability of eIF4E has been shown to be rate limit-
ing for translation initiation in many eukaryotic cell-lines [635, 34]. Given its
central role in cell biology, evolutionarily optimized infrastructure like transla-
tion might be expected to be robust or highly redundant. Surprisingly, dereg-
ulated translation, especially involving growth-factor or insulin induced initia-
tion mechanisms, has been implicated in a spectrum of cancers [42].
Despite the wealth of literature on insulin signaling, the relative importance
of the components linking insulin with translation initiation remains unclear.
Many investigators have explored this question using both experimental and
computational tools. For example, Caron et al. recently published a compre-
hensive map of the mTOR signaling network, including a detailed portrait of
insulin induced mTOR activation and its downstream role in translation initi-
ation [68]. Taniguchi et al. proposed three criteria to identify the critical nodes
of insulin signaling: network divergence, degree of regulation and potential
crosstalk [525]. Using these criteria, they identified insulin-receptor (IR), PI3K
and Akt as the critical nodes of insulin action. Several insightful mathematical
models of insulin-signaling have also been published [122, 107, 46, 223]. While
these models vary in their focus and biological scope, none has exclusively fo-
cused on how insulin stimulates translation initiation. This particular question
was addressed by Nayak et al., who analyzed a family of detailed mathematical
models of growth factor and insulin induced translation initiation [368]. Like
the Taniguchi et al. hypothesis, their study suggested that Akt/mTOR were
structurally fragile, and likely the key elements integrating growth factor sig-
naling with translation. However, the Nayak et al. model neglected several
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key features of insulin processing, e.g., negative feedback of IR resulting from
mTOR activity.
The objective of this study was to rank-order the importance of components
of insulin-induced translation initiation using computational tools. Toward this
objective, we analyzed an ensemble of mechanistic mathematical models of in-
sulin induced translation initiation that was a significant extension of our previ-
ous work [368]. First, we expanded the original model connectivity to include a
detailed description of the regulation and activity of insulin, insulin-like growth
factor and platelet-derived growth factor (PDGF) receptor family members (in-
cluding negative feedback). Second, we refined the description of the phospho-
rylation state of Akt and its downstream role in the activation of the mTORC1
and mTORC2 complexes. Lastly, we used new model estimation and interroga-
tion techniques to generate and analyze an uncorrelated population of initiation
models that were simultaneously consistent with 24 qualitative and quantitative
data sets. Interrogation of this model population, using sensitivity and robust-
ness analysis, identified an insulin-dependent switch that controlled translation
initiation. Without insulin, a balance between the pro-initiation activity of the
GTP-binding protein Rheb and anti-initiation activity of PTEN controlled basal
initiation. Rheb knockdown simulations confirmed decreased initiation in the
majority of the model population, while translation initiation increased for all
models in the population following a PTEN deletion. On the other hand, a com-
bination of PI3K and Rheb activity controlled insulin inducible initiation. PI3K
deletion in the presence of insulin removed the ability of the network to pro-
cess insulin signals, but did not remove initiation altogether. PI3K deletion re-
duced initiation to approximately 60% of its maximum level. Interestingly, the
relative contribution of PI3K versus Rheb to the overall initiation level could
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be tuned by controlling IRS-1 feedback. In the absence of feedback, PI3K was
more important than Rheb to signal propagation, while the opposite was true
in the presence of feedback. Taken together, our modeling study supported the
Taniguchi et al. hypothesis that PI3K was a critical node in the insulin-induced
initiation network. However, we also found that the role of PI3K was nuanced;
PI3K in combination with Rheb controlled initiation in the presence of insulin,
while the combination of PTEN and Rheb controlled basal initiation.
4.3 Results
4.3.1 Translation initiation model connectivity.
The translation initiation model consisted of 250 protein, lipid or mRNA species
interconnected by 573 interactions (Fig. 4.1). The model described the inte-
gration of insulin and growth-factor signaling with 80S assembly. While other
eukaryotic translation initiation mechanisms exist, we focused only on cap-
mediated translation as the dominant translation mechanism [333]. The model
interactome was taken from literature (SBML file available in the supplemental
materials); the connectivity of insulin- and growth-factor induced translation
initiation has been extensively studied [322, 228]. The model interactome was
not specific to a single cell line. Rather, it was a canonical representation of
the pathways involved in insulin and growth-factor induced initiation. Using a
canonical network allowed us to explore general features of insulin or growth-
factor induced translation initiation without cell line specific artifacts. Binding
of insulin or IGF-I/II with IR or IGF-I/IIR promotes the autophosphorylation
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of the cytosolic domains of these receptors at tyrosine residues. Receptor au-
tophosphorylation promotes the formation of adaptor complexes, which are an-
chored in place by insulin receptor substrate (IRSx) family members; IRSx are re-
quired for the assembly of adaptor complexes involving the SHC-transforming
protein 1 (Shc), Son of Sevenless (SoS), growth factor receptor-bound protein 2
(Grb2) and Ras proteins [502, 501, 452]. In the model we considered only the
IRS-1 protein and neglected other IRSx family members. Adaptor complex for-
mation ultimately culminates in the activation of the catalytic subunit of PI3K.
Among their many roles, PI3Ks catalyze the phosphorylation of the phospho-
lipid PIP2 to PIP3 [619]. PIP3 is critical to the localization of 3-phosphoinositide-
dependent kinase 1 (PDK1) to the membrane, where it phosphorylates the mas-
ter kinase Akt at Thr308 [357]. Akt is further phosphorylated at Ser473 by the
rictor-mammalian target of rapamycin (mTORC2) protein [472]. Once phospho-
rylated, Akt promotes translation initiation by directly or indirectly activating
the mTORC1 protein [636]. Akt directly activates mTORC1 through a novel
binding partner known as PRAS40 [469, 177]. However, mTORC1 can also
be activated by the GTP bound form of the Ras homologue enriched in brain
(Rheb) protein. Without insulin, Rheb is regulated by the tuberous sclerosis
complex TSC1/2, which has GTPase activating protein (GAP) activity. Akt di-
rectly phosphorylates TSC1/2 which inhibits its GAP activity and allows Rheb-
mediated activation of mTORC1 [225, 331]. Activated mTORC1 plays two key
roles in translation initiation; first, it activates ribosomal protein S6 kinase beta-1
(S6K1) and second it phosphorylates eukaryotic translation initiation factor 4E-
binding protein (4E-BPx) family members [189]. In this study, we included only
4E-BP1 and modeled a single deactivating phosphorylation site. Phosphory-
lated 4E-BP1 releases eIF4E which, along with other initiation factors, is critical
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Figure 4.1: Schematic of the translation initiation signaling network.
Growth factors trigger receptor dimerization and the formation
of adaptor complexes which activate PI3K. PI3K then signals
through PIP2/3 to activate Akt. Activated Akt can then acti-
vate mTORC1 either directly or by phosphorylating TSC1/2,
an inhibitor of Rheb. Activated mTORC1 can phosphorylate
4EBP1 and activate S6K1, two necessary checkpoints for trans-
lation initiation. mTORC1 can also phosphorylate IRS-1, a neg-
ative feedback which inhibits formation of the adaptor com-
plex and attenuates insulin signaling.
to directing ribosomes to the 7-methyl-guanosine cap structure of eukaryotic
mRNAs [228].
Several mechanisms attenuate insulin and growth-factor induced transla-
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tion initiation. First, insulin signal propagation can be controlled by disrupting
adaptor complex formation. For example, we included tyrosine phosphatases
and competitive inhibitors such as protein-tyrosine phosphatase 1B (PTP1B), src
homology phosphotyrosyl phosphatase 2 (SHP2), growth factor receptor-bound
protein 10 (Grb10) and suppressor of cytokine signaling 1/3 (SOCS1/3) which
interfere with adaptor complex formation and activity [525, 113, 361, 549]. Sec-
ond, several mechanisms control PIP3 formation, PDK1 recruitment and Akt
phosphorylation [525]. In the model, we included the phosphatase and tensin
homolog (PTEN) protein, which dephosphorylates PIP3 [513], as well as the
SH2 (Src homology 2)-containing inositol phosphatase-1 (SHIP1) protein which
hydrolyses the 5′-phosphates from PIP3 [306]. Lastly, S6K1 inhibits IRS-1 activ-
ity by phosphorylation at Ser318 [173]. S6K1/IRS-1 feedback has been shown to
be important in insulin resistance and cancer [322, 551, 550, 111].
4.3.2 Estimating an ensemble of translation initiation models
using POETs.
Translation initiation was modeled using mass-action kinetics within an ordi-
nary differential equation (ODE) framework. ODEs and mass-action kinetics
are common methods of modeling biological pathways [479, 74, 203]. How-
ever, ODEs have several important limitations that could be addressed with
other model formulations e.g., Partial Differential Equation (PDE) based mod-
els. PDEs naturally describe spatially distributed intracellular processes or can
be used to model population dynamics using population balance methods [497].
However, the computational burden associated with solving and analyzing sys-
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tems of PDEs, especially at the scale of the current study, would be substantial.
Alternatively, we have addressed both of these ODE shortcomings (without re-
sorting to a PDE formulation) by including well-mixed compartments to ac-
count for spatially localized species and processes and have considered an en-
semble of models in our analysis to coarse-grain population phenomena. Irre-
gardless of whether we have an ODE or PDE model formulation, both classes of
model typically require the identification of a large number of unknown model
parameters. The initiation model had 823 unknown parameters (573 kinetic pa-
rameters and 250 initial conditions), which were not uniquely identifiable (data
not shown). We estimated an experimentally constrained population of parame-
ters using multiobjective optimization. Model parameters were estimated, start-
ing from an initial best fit parameter set, using 24 in vitro and in vivo data sets
taken from literature (Table 4.1). These training data were taken from multi-
ple independent studies (in different cell lines) exploring insulin and IGF-I/II
signaling or in-vitro translation initiation. These data were largely western blot
measurements of the total or phospho-specific abundance of proteins following
the addition of a stimulus or inhibitor. While the use of multiple cell-lines was
not ideal, it did allow us to capture a consensus picture of insulin or IGF-I/II
initiated signaling (which was useful in understanding the general operational
principles of the network). However, one should be careful when applying con-
sensus models to specific cell lines or tissues, as these generally may behave
qualitatively differently.
The residual between model simulations and each of the experimental con-
straints was simultaneously minimized using the multiobjective POETs algo-
rithm [504]. We used a leave-three-out cross validation strategy to indepen-
dently estimate prediction and training error during parameter identification
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Figure 4.2: The scaled simulation error (SSE) for selected objective func-
tion pairs for N = 5818 rank zero initiation models. The SSEs
for objective functions chosen by cross-validation for predic-
tion was set to zero and disregarded when ranking other sets.
The red point denotes the performance of the nominal param-
eter set.
(Table 4.1). Additionally, a random control (100 random parameter sets) was
run to check the training/prediction fitness above random (Table 4.1). The train-
ing error for 23 of the 24 objectives was statistically significantly better than the
random control at a 95% confidence level. Additionally, for 20 of the 24 objec-
tives, the model prediction error was also significantly better than the random
control (p≤0.05). Of the four remaining objectives (O4,O5,O12 and O13), three
involved phosphorylated Akt (O4 and O12) or IRS-1 (O13), each of which had
redundant measurements in the objective set that were significant. While the re-
maining objective, which involved IRS-1 levels (O5), was not significantly better
than the random control, the absolute error was small.
The ensemble of translation models recapitulated diverse training data
across multiple cell lines. POETs generated 18,886 probable models with Pareto
rank ≤ 4. Model parameters had coefficients of variation (CV) ranging from
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0.65 to 1.10. Further, 89% (512 of 573) of the model parameters were constrained
with a CV < 1. The performance of 5,818 rank-zero models is shown in Fig. 4.2.
The majority of objective functions were uncorrelated e.g., O4×O13 or O12×O13
or directly proportional e.g., O3×O11 or O9×O15. Uncorrelated or proportional
objectives suggested the model population simultaneously described each train-
ing constraint. However, several other objectives were inversely proportional
e.g., O12×O14. For these pairs, the model was unable to simultaneously fit
both training data sets. Surprisingly, these objectives were the same protein
pAkt(Thr308) O9×O12 and pS6K1(Thr389) O3×O14, taken from either different
cell lines or different labs.
This suggested conflicts in the data e.g., cell line variation or differences in
specific laboratory protocols, rather than structural inaccuracies in the model,
were responsible for the inverse relationship. The key indicators of eukary-
otic translation initiation are the phosphorylation of S6K1 and 4E-BP1 [189].
Both Tzatos et al. and Villalonga et al. performed insightful studies exploring
the dynamics of S6K1 and 4E-BP1 phosphorylation in L6 Myotubes and RhoE
3T3 cells [548, 566]. The ensemble recapitulated these observations with error
distributions that were statistically significantly better than random parameters
(train = 0.27±0.33, rand = 2.95±0.51; train = 0.57±0.33, rand = 1.76±0.43) (Fig. 4.3A
and 4.3B, Table 4.1). The model population also recapitulated IGF1 induced Akt
and S6K1 phosphorylation (train = 0.12±0.13, rand = 0.69±0.11; train = 0.18±0.07,
rand = 0.69 ± 0.11) (Fig. 4.3E and 4.3F, Table 4.1). Lorsh et al. studied riboso-
mal assembly dynamics in rabbit reticulocytes, suggesting the formation of the
eIF2:GTP:Met-tRNA tertiary complex was rate limiting in 80S formation [316].
Our model captured 80S assembly dynamics, including the crucial lag phase in
the first two minutes of stimulation (train = 0.42 ± 0.46, rand = 1.24 ± 0.71) (Fig.
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Table 4.1: Objective function list along with species, cell type, cellular compart-
ment, nominal error, training error, prediction error, random error with a ran-
domly generated parameter set and the corresponding literature reference.
O# Species Cell Type Nominal Training Prediction Random Source
O1 PI3K Activ-
ity
3T3-L1 cells 0.01 0.01 ± 0.00 0.01 ± 0.00 0.67 ± 0.20 [298]
O2 PIP3 3T3-L1 cells 0.00 0.00 ± 0.00 0.00 ± 0.00 0.84 ± 0.08 [298]
O3 pS6K1
(T389)
3T3-L1 cells 0.39 0.17 ± 0.15 0.27 ± 0.24 1.55 ± 0.49 [177]
O4 pAkt (S473) 3T3-L1 cells 0.38 0.30 ± 0.23 0.53 ± 0.29 0.50 ± 0.38 [177]
O5 IRS1 3T3-L1 cells 0.43 0.47 ± 0.62 1.37 ± 0.71 0.56 ± 0.58 [177]
O6 pAkt (S473) 393T cells 0.06 0.28 ± 0.32 0.43 ± 0.35 1.10 ± 0.31 [177]
O7 pAkt (S473) C2C12 myotubes 0.05 0.12 ± 0.13 0.12 ± 0.13 0.69 ± 0.11 [283]
O8 pS6K1
(T421/S424)
C2C12 myotubes 0.20 0.18 ± 0.07 0.20 ± 0.10 0.47 ± 0.22 [283]
O9 pAkt (T308) HUVEC cells 1.21 0.78 ± 0.38 0.94 ± 0.36 1.20 ± 0.79 [204]
O10 IRS-1P
(S636/639)
L6 Myotubes 1.34 1.17 ± 0.37 1.13 ± 0.35 1.28 ± 0.38 [548]
O11 pS6K1(T389) L6 Myotubes 0.98 0.27 ± 0.33 0.55 ± 0.64 2.95 ± 0.51 [548]
O12 pAkt (T308) L6 Myotubes 0.93 0.62 ± 0.36 0.71 ± 0.34 0.84 ± 0.48 [548]
O13 IRS-1P
(S636/639)
L6 Myotubes 1.24 1.07 ± 0.38 1.29 ± 0.31 1.35 ± 0.36 [548]
O14 pS6K1
(T389)
L6 Myotubes 2.36 2.02 ± 0.43 2.26 ± 0.24 1.95 ± 0.38 [548]
O15 pAkt (T308) L6 Myotubes 0.97 0.39 ± 0.35 0.48 ± 0.33 0.87 ± 0.82 [548]
O16 pS6K1(T389) RhoE 3T3 cells 1.33 0.28 ± 0.33 0.21 ± 0.25 2.94 ± 0.54 [566]
O17 c4EBP-
P (S65,
T37/46)
RhoE 3T3 cells 0.37 0.57 ± 0.33 0.85 ± 0.38 1.76 ± 0.43 [566]
O18 Cap-Met-
Puro
rabbit reticulocytes 0.46 0.42 ± 0.46 0.86 ± 0.73 1.24 ± 0.71 [316]
O19 43S-mRNA rabbit reticulocytes 0.19 0.37 ± 0.39 0.57 ± 0.47 1.14 ± 0.64 [316]
O20 pAkt (S473) A14 NIH 3T3 cells 1.12 0.98 ± 0.23 0.99 ± 0.23 1.16 ± 0.15 [151]
O21 pS6K1(T389) A14 NIH 3T3 cells 1.20 0.57 ± 0.29 0.57 ± 0.23 0.69 ± 0.21 [151]
O22 Rheb HeLa cells 0.00 0.15 ± 0.83 0.10 ± 0.71 1.99 ± 0.09 [151]
O23 pS6K1(T389) HeLa cells 0.13 0.14 ± 0.11 0.24 ± 0.23 0.77 ± 0.58 [151]
O24 c4EBP1-P
(T70)
HEK293 cells 0.25 0.34 ± 0.26 0.62 ± 0.41 0.90 ± 0.22 [151]
4.3C, Table 4.1). Inhibitor data was also used for model training. Without in-
sulin, PI3K was not activated and pAkt (Ser473) levels remained low (Fig 4.3D,
lane 1). Following insulin stimulation, PI3K activation resulted in increased
pAkt(Ser473) levels (Fig 4.3D, lane 2). Wortmannin, a PI3K inhibitor, signifi-
cantly decreased pAkt(Ser473) (Fig 4.3D, lane 3). While our model population
qualitatively captured this decrease, the levels of pAkt(Ser473) were higher than
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those observed experimentally. The model was not trained using mTORC1/2
measurements, however species immediately upstream and downstream of
mTORC1/2, namely pAkt(Ser473) or S6K1 were used in model training. With-
out insulin, pAkt(Ser473) and S6K1(Thr421/Ser424) levels were low (Fig 4.3E/F,
lanes 1). Addition of insulin increased pAkt(Ser473) and S6K1(Thr421/Ser424).
Upon rapamycin addition, mTORC1 was inhibited and the levels of phospho-
rylated S6K1 decreased (Fig. 4.3E, lane 3). However, because of its position
upstream of mTORC1, pAkt(Set473) levels were unchanged (Fig. 4.3E, lane 3).
The model was validated by comparing simulations with in vivo and in vitro
data sets not used for training or cross-validation (Table 4.2). For four of the five
prediction data sets, the model demonstrated errors statistically significantly
better than a random control (p≤0.05). However, the remaining prediction case
(P3), while not significantly different than random, has a small error relative to
the other objectives. Data from Lorsh et al. was used to validate the dynamics
of intermediate ribosomal complexes [316]. The level of 43S mRNA was quan-
tified using both GTP and a non-degradable GTP-like homologue GMP-PNP
(Fig. 4.4A). Data involving GMP-PNP was used for training while data involv-
ing GTP was used only for validation (pred = 0.52 ± 0.40, rand = 0.82 ± 0.51).
Garami et al. explored insulin-induced Rheb activation and the role of TSC1/2
in the presence and absence of wortmannin and rapamycin [151]. We first com-
pared measured versus simulated Rheb-GTP levels, with and without insulin,
in the absence of inhibitors.
While we captured the qualitative trends, we over-predicted the percentage
of GTP bound Rheb (pred = 0.22 ± 0.11, rand = 0.42 ± 0.01) (Fig. 4.4B). The
model also failed to predict sustained Rheb-GTP levels in the presence of ra-
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Figure 4.3: Ensemble performance against selected training objectives (N
= 400). Dotted lines represent the simulation mean of the en-
semble, while the shaded region denotes the 99.9% confidence
estimate for the mean. The solid dots represent the scaled
experimental data. A. Time course data for p70S6K1 phos-
phorylation in response to insulin stimulation (L6 Myotubes).
B. Time course data for c4EBP1 phosphorylation in response
to FBS (RhoE 3T3 cells). C. In vitro time course of the 80S
complex measured by puromycin assay (rabbit reticulocyte).
D. pAkt(Ser473) levels at 20 minutes in the presence and ab-
sence of insulin and wortmannin (393T cells). E,F. pAkt(Set473)
and activated p70S6K1 levels at 15 minutes in the presence
and absence of insulin-like growth factor (IGF) and rapamycin
(C2C12 myotubes).
pamycin. This suggested that sustained pAkt(Ser473) levels (observed in Fig.
4.3E) were not correlated with increased Rheb-GTP activity. Garami et al. also
measured the levels of GTP bound Rheb in both wild-type and TSC2 knockout
cells. Because of TSC2’s regulatory role, a TSC2 knockout significantly increased
Rheb-GTP levels (pred = 0.10 ± 0.03, rand = 0.09 ± 0.06) (Fig. 4.4C). Lastly, the
model predicted the levels of 4E-BP1 bound eIF4E in response to heat shock
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Table 4.2: Blind Prediction (P#) list along with species, cell type, prediction error,
random error with a randomly generated parameter set and the corresponding
literature reference.
P# Species Cell Type Compartment Prediction Random Source
P1 43S-mRNA (GTP) rabbit retic-
ulocytes
in vitro 0.52 ± 0.40 0.82 ± 0.51 [316]
P2 Rheb-GTP A14 NIH
3T3 cells
Total lysate 0.22 ± 0.11 0.42 ± 0.01 [151]
P3 Rheb-GTP A14 NIH
3T3 cells
Total lysate 0.10 ± 0.03 0.09 ± 0.06 [151]
P4 eIF4E:4EBP1 CHO K1
cells
Total lysate 0.51 ± 0.33 1.67 ± 1.17 [570]
P5 pAkt(Ser473) HEK293
cells
Total lysate 0.27 ± 0.09 0.72 ± 0.09 [151]
(pred = 0.51 ± 0.33, rand = 1.67 ± 1.17) (Fig. 4.4D) [570]. Because the model was
not trained on stress-induced translation inhibition, this result further demon-
strated the predictive power of the model population.
4.3.3 Sensitivity analysis identified robust and fragile features
of the initiation architecture.
Sensitivity analysis generated falsifiable predictions about the fragility or ro-
bustness of structural features of the initiation architecture. First order sensitiv-
ity coefficients were computed for 40 parameter sets selected from the ensemble
(materials and methods), time-averaged and rank-ordered for the 250 species
in the model, in the presence and absence of insulin and IRS-1 feedback. The
sensitive components of insulin signaling shifted from Rheb in the absence of
insulin to a combination of Rheb and PI3K in the presence of insulin. Sensitivity
coefficients (si j) were calculated with and without insulin over the complete 100
min response (Fig. 4.5A). Globally, processes involved with 80S formation were
consistently ranked among the most sensitive, irrespective of insulin. However,
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the sensitivity of other signal processing components changed with insulin sta-
tus. For example, without insulin, Rheb/Rheb-GDP were highly fragile (rank
≥ 0.25), while PI3K, PIP2, PIP3 and PTEN were highly robust (rank ∼ 0.0). Sur-
prisingly, the relative sensitivity of these network components changed in the
presence of insulin. While the fragility of Rheb/Rheb-GDP shifted modestly
upward with insulin, the sensitivity of PI3K and its downstream complexes
increased dramatically (rank ≥ 0.45) following insulin stimulation. This sug-
gested that the combination of PI3K and Rheb activity was critical to insulin
action over the full 100 min time window. However, it was unclear whether
PI3K was always important, or if there was a temporal window in which PI3K
became important following insulin stimulation. To explore this question, we
time-averaged the sensitivity coefficients over early- and late-phase time peri-
ods following insulin stimulation (Fig. 4.5B). The 0-5 minute time period cap-
tured the initial network dynamics, while the 30-100 minute time period cap-
tured the network at a quasi-steady state. Generally, network components were
more sensitive under dynamic operation (species beneath the 45o line), com-
pared with steady state. However, there were exceptions to this trend. For
example, PI3K, PTEN and TSC1/2 were equally sensitive in both time frames,
suggesting these species played important roles in both dynamic and steady
state signaling. On the other hand, the Rheb rank decreased from 0.6 to 0.25 as
the network moved toward steady state. Taken together, the sensitivity results
suggested that Rheb activity controlled the background level of translation ini-
tiation while the PI3K axis in combination with Rheb regulated insulin-induced
initiation. Moreover, the transition between PTEN and PI3K control occurred
directly after the addition of insulin, giving rise to switch like behavior.
IRS-1 phosphorylation, a well known negative feedback mechanism [322,
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551, 550, 111], attenuated PI3K sensitivity. We explored the role of IRS-1 feed-
back by comparing sensitivity coefficients under insulin stimulation in the pres-
ence and absence of IRS-1 feedback (Fig. 4.5C). The most significant change
without feedback was the sensitivity of the IR:IRS-1 and adaptor complexes
(Fig. 4.5C, black fill); IR:IRS-1, which anchors the adaptor complex to the ac-
tivated receptor and is immediately upstream of PI3K activation, changed from
NSS rank ' 0.04 to 0.32. The sensitivity of the PI3K/Akt signaling axis also
increased in the absence of feedback (Fig. 4.5C, grey fill). Surprisingly, the sen-
sitivity of Rheb and many ribosomal components decreased in the absence of
feedback. Similar results were observed when sensitivity coefficients were time
averaged over the 0 to 5 min time window (Fig. 4.5D). These sensitivity calcu-
lations suggest that IRS-1 feedback plays a significant role in insulin signaling
by modulating the relative importance of PI3K versus Rheb. Thus, IRS-1 feed-
back though not directly identified as a fragile regulatory motif, has significant
effects on network function.
Lastly, the architectural features of the initiation network identified by sen-
sitivity analysis, as either fragile or robust, were likely parameter independent.
While first-order sensitivity coefficients are local, we sampled a family of uncor-
related parameter sets (mean correlation of approximately 0.6) to generate a set
of consensus conclusions. By sampling over many uncorrelated sets, we calcu-
lated how our conclusions changed with different unrelated parameter sets. The
distribution of ranking (standard-error shown in Fig. 4.5) suggested that despite
parametric uncertainty, sensitivity analysis over an uncorrelated model popu-
lation produced a consensus estimate of the strongly fragile or robust elements
of the insulin signaling network. Previously, we (and others) have shown that
monte-carlo parameter set sampling produced similar results in several studies
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across many signaling networks [510, 320, 74, 527].
4.3.4 Robustness analysis identified key regulators of transla-
tion initiation
Knockdown simulations were conducted for 92 proteins to estimate the func-
tional connectedness of the initiation network. The effects of the perturbations
were quantified by calculating the relative change (α) in translational activity
(80S formation) for each simulated knockout in the presence (Fig. 4.6A) and ab-
sence (Fig. 4.6B) of insulin. Knockdown simulations were conducted using 400
models selected from the ensemble based on error and correlation (materials
and methods). Proteins were classified based on their impact on translational
activity: little or no effect (α ≈ 1, white fill), moderate decrease (α ≈ 0.6, dark
grey), critical (α ≈ 0, light grey) and increase (α > 1, black). Generally, knock-
downs in the presence of insulin were more likely to decrease initiation (Fig.
4.6A). Knockdown analysis identified 24 proteins (or 26% of the network) that
were critical to translation initiation irrespective of insulin status; these critical
components included mTORC1, S6K1, several initiation factors and other ribo-
somal components. Sensitivity analysis suggested basal translation was gov-
erned by Rheb, while insulin-induced initiation was governed by PI3K. Robust-
ness analysis showed that perturbations in PI3K signaling, in the presence of
insulin, restored initiation control to Rheb. Initiation was reduced by 40% by
disrupting species immediately upstream or downstream of PI3K; a moderate
reduction in the presence of insulin demonstrated that initiation was governed
by both PI3K and Rheb. Lastly, deletion of TSC1/2 (negative regulator of Rheb)
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or 4E-BP1 (sequesters the cap-binding protein eIF4E), increased initiation in the
presence of insulin. Interestingly, for several proteins the direction or magni-
tude of change in initiation activity depended upon the presence or absence of
insulin. For example, PTEN deletion significantly increased initiation (α  1) in
the absence of insulin, but had no effect when insulin was present. On the other
hand, PI3K deletion had a moderate reduction on 80S formation in the presence
of insulin, but only a small effect in the absence of insulin (Fig. 4.6B). These re-
sults suggested that PI3K and PTEN were conditionally fragile proteins; in the
presence of insulin, PI3K is a critical signal processing node, while PTEN acts to
restrain inadvertent basal initiation.
Paradoxically, Rheb and mTORC2 subunit (sin1, rictor) knockdowns in-
creased initiation. Our expectation from sensitivity analysis was that a Rheb
knockdown would reduce initiation, irrespective of insulin status. However,
this was not universally true; some members of the model population showed
increased initiation (Fig. 4.6C). Following the deletion of PTEN, approximately
80% (or 323 of the 400 models sampled) had increased initiation in the absence
of insulin. Of these models, 16% (or 51 of 323) had at least a two fold increase
in translational activity. This result was expected; deletion of a protein species
resulted in a qualitatively similar change in initiation across the ensemble of
models. However, for Rheb knockdowns, members of the ensemble demon-
strated qualitatively different behavior. For 84% (or 334 of 400) of the mod-
els sampled, Rheb knockdowns significantly down-regulated initiation. Thus,
the vast majority of models behaved as expected. Interestingly, 20 models (or
5% of the models sampled) had increased translation initiation in the presence
of a Rheb knockdown, with 15 models demonstrating greater than a two-fold
change (Fig. 4.6C). Thus, the model population estimated by POETs contained
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Figure 4.6: Species knockdown simulations for a population of translation
initiation models (N = 400). Simulated knockdowns were per-
formed by removing nodes from the stoichiometric matrix. The
relative change in 80S formation resulting from the removal of
a species was used to quantify the impact of the knockdown.
A. Species knockdowns in the presence of insulin. Simulated
knockdowns resulted in increased (black), constant (white),
moderately decreased (dark grey) or severely decreased (light
grey) translational levels. B. Species knockouts in the ab-
sence of insulin. Simulated knockdowns resulted in increased
(black), constant (white), or decreased (grey) translational lev-
els. C. Histogram of translation levels across each member of
parameter ensemble. Asterisk index indicates parameter sets
that were selected for further analysis. D. Alternative modes
of network operation. For a subset of the ensemble, initiation
increased following Rheb or mTORC2 disruption. Asterisk in-
dicates rate-limiting step.
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models with qualitatively different behavior. Histograms of sin1 and rictor
knockdowns showed a similar trend (results not shown). We explored the flux
vectors of these outlying parameter sets to better understand the mechanistic
effect of Rheb and rictor/sin1 knockouts. All of the outlying models were in
regions of parameter space where the association between Rheb and GTP was
very high. Strong Rheb/GTP binding resulted in abnormally high signal flux
to mTORC1 despite the inhibitory effects of TSC1/2 (Fig. 4.6D, top-left). Con-
sequently, less GTP was available for the energy-dependent steps of translation
initiation (i.e. formation of eIF2-GTP-met-tRNA tertiary complex). Addition-
ally, strong association between Rheb and GTP resulted in high levels of acti-
vated mTORC1 and S6K1. However, despite the high levels of mTORC1, GTP-
dependent pre-initiation reactions were rate limiting (Fig. 4.6D, labeled*). Thus,
Rheb knockdown released the network from its GTP limitation and shifted the
predominant signaling mode to mTORC2. This shift in signaling, while lower-
ing the activated mTORC1/S6K1 level, ultimately resulted in higher levels of
initiation (Fig. 4.6 bottom-left). On the other hand, the rictor/sin1 knockdown
behaved differently. The rate-limiting step for the rictor/sin1 knockdowns was
mTORC1 activation: more Rheb-GTP was present than there was mTORC1 to be
activated (Fig. 4.6D top-right). Thus, knockdown of rictor/sin1 prevented the
assembly of mTORC2 and freed the mTOR subunit to be used for mTORC1 as-
sembly. This shift toward mTORC1 assembly and activation relieved the Rheb-
GTP/mTORC1 bottleneck, resulting in increased initiation.
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4.4 Discussion
In this study, we developed and analyzed a population of insulin and growth
factor induced translation initiation models. These models described the in-
tegration of insulin and growth-factor signals with 80S assembly. A family of
model parameters was estimated from 24 transient and steady state data sets us-
ing multiobjective optimization. In addition to the training data, the model fam-
ily also predicted novel data sets not used during model training. The popula-
tion of initiation models was analyzed using sensitivity and robustness analysis
to identify the key components of insulin-induced translation initiation. With-
out insulin, a balance between the pro-initiation activity of the GTP-binding
protein Rheb and anti-initiation activity of PTEN controlled basal initiation.
Rheb knockdown simulations confirmed decreased initiation in the majority of
the model population. Surprisingly, we also identified a model subpopulation
in which deletion of Rheb or mTORC2 components increased initiation. In these
cases, removal of Rheb or mTORC2 components relieved a rate-limiting bottle-
neck e.g., constrained levels of GTP, leading to increased initiation. On the other
hand, in the absence of insulin, translation initiation increased for all models in
the population following a PTEN deletion. In the presence of insulin, Rheb and
PTEN were no longer the dominant arbiters of initiation; a combination of PI3K
and Rheb activity controlled inducible initiation, where PI3K was only critical
in the presence of insulin. PI3K deletion in the presence of insulin removed
the ability of the network to process insulin signals, but did not remove initi-
ation altogether. PI3K deletion reduced initiation to approximately 60% of its
maximum level. Interestingly, the relative contribution of PI3K versus Rheb to
the overall initiation level could be tuned by IRS-1 feedback. In the absence of
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feedback, PI3K was more important than Rheb to signal propagation, while the
opposite was true in the presence of feedback.
PI3K and PTEN in combination with Rheb are components of a switch that
regulates inducible and basal translation initiation. In the absence of insulin,
a balance between the pro-initiation activity of Rheb and the anti-initiation ac-
tivity of PTEN regulated basal initiation. On the other hand, in the presence
of insulin, control shifted to a combination of Rheb and PI3K, where PI3K ac-
tivity regulated the inducible fraction of initiation. Thus, deletion of PTEN,
constitutive activation of PI3K or constitutively active Rheb could all induce
aberrant translation initiation without an insulin or growth factor signal. Yuan
and Cantley noted that every major species in the PI3K pathway is mutated or
over-expressed in a wide variety of solid tumors [619]. For example, activating
mutations in PIK3CA, the gene encoding the catalytic subunit of PI3K, induces
oncogene signaling in colon, brain and gastric cancers [468]. On the other hand,
PTEN mutations have long been implicated in a spectrum of cancer types [465].
Both PIK3CA and PTEN mutations induce a pro-initiation operational mode
in the absence of growth factor. Likewise, constitutive Rheb activity induces a
variety of pleiotropic traits involving translation. For example, Saucedo et al.
showed that Rheb over-expression in Drosophila melanogaster increased cell size,
wing area and G1/S cell cycle progression [473]. Rheb and TSC1/2 mutations
are also frequently observed in cancer [235, 311]. Taken together, our study
supports the supposition of Taniguchi et al. that PI3K is a critical arbiter of
insulin-induced translation initiation [525]. However, we have also shown that
initiation control and particularly the role of PI3K was more nuanced; while
insulin or growth-factor inducible initiation was controlled by PI3K, basal initi-
ation was controlled by Rheb. Moreover, in the absence of insulin, PTEN was
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the critical upstream initiation regulator, not PI3K. This suggested that the rela-
tive level of the phosphorylated phospholipids PIP2 and PIP3 was actually the
key mediator of initiation. Lastly, Taniguchi et al. suggested that Akt was also a
key node involved in insulin action. Our previous model directly supports this,
however, the current model does not. Rather, our analysis suggested that Rheb
was the downstream controller of initiation. These two points of view are not
contradictory however, as Rheb activation is driven by phosphorylated Akt.
The initiation model connectivity was assembled from an extensive litera-
ture review, however, several potentially important signaling mechanisms were
not included. First, we should revisit the role of PRAS40. Currently, PRAS40
acts as a cofactor that aids in pAkt(Ser473)-mediated activation of mTORC1.
Sancak et al suggested that PRAS40 sequesters mTORC1, and only after phos-
phorylation by Akt does it releases from mTORC1 [469]. Other groups have
also shown that mTORC1 can phosphorylate and inhibit PRAS40, thus pro-
viding a positive feedback mechanism for Akt-mediated mTORC1 activation
[132, 572]. A more complete description of PRAS40 will enhance our ability
to interrogate Akt dependent mTORC1 activation. Second, we need to refine
the description of IRS-1 feedback. Currently, we assume a single deactivating
phosphorylation event at Ser308. However, several studies have shown that
IRS-1 can be phosphorylated at multiple serine sites, which are both activating
and deactivating [414, 173]. Additionally, PTEN is known to dephosphorylate
activated PDGF receptors and attenuate their activity, a feature not included
currently [519]. A more complete description of IRS-1 phosphorylation could
help define how, and under what conditions, IRS-1 regulation attenuates PI3K
activation. Third, we modeled the regulation of 4E-BPx as a single phospho-
rylation event where phosphorylated 4E-BPx was unable to bind to eIF4E. In
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reality, 4E-BPx family members, such as 4E-BP1, have several phosphorylation
sites [442] and the release of eIF4E is driven only after multiple conserved phos-
phorylation events [162]. Additionally, eIF4E can itself be phosphorylated at
Ser209; while there is agreement that the phosphorylation of eIF4E does have a
regulatory significance, the data is contradictory as to whether it is positive or
negative [474]. Fourth, signaling downstream of mTORC1 has also been shown
to mediate translation modes beyond those included in our model. eIF3 has
been identified as a scaffolding protein that recruits mTORC1 to untranslated
mRNA and facilitates S6K1 and 4E-BP1 phosphorylation [214]. S6K1 can also
activate eIF4B, a protein that helps eIF4A to unwind the secondary structure
of untranslated mRNA [443]. Further, a recently discovered scaffold protein,
SKAR, has been shown to assist S6K1 recruitment to mRNA [323]. Lastly, be-
cause of mTORC1’s unique cellular role, it would be interesting to explore how
other aspects of metabolism interact with insulin signaling to mediate decisions
between translation, lipid synthesis or proliferation. In these studies, one could
imagine constructing in-vivo mouse models to explore the physiological role of
mTORC1 signaling in important diseases such as diabetes or cancer.
4.5 Materials and Methods
4.5.1 Formulation and solution of the model equations.
The translation initiation model was formulated as a set of coupled non-linear
ordinary differential equations (ODEs):
dx
dt
= S · r (x,p) x (to) = xo (4.1)
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The symbol S denotes the stoichiometric matrix (250 × 573). The quantity x
denotes the concentration vector of proteins (250 × 1). The term r (x,p) denotes
the vector of reaction rates (573 × 1). The (i, j) element of the matrix S, denoted
by σi j, described how protein i was involved in rate j. If σi j < 0, then protein i
was consumed in r j. Conversely, if σi j > 0, protein i was produced by r j. Lastly,
if σi j = 0, then protein i was not involved in rate j. We assumed mass-action
kinetics for each interaction in the network. The rate expression for interaction
q was given by:
rq
(
x, kq
)
= kq
∏
j∈{Rq}
x−σ jqj (4.2)
The set
{
Rq
}
denotes reactants for reaction q while σ jq denotes the stoichiometric
coefficient (element of the matrix S) governing species j in reaction q. The quan-
tity kq denotes the rate constant governing reaction q. All reversible interactions
were split into two irreversible steps. Model equations were generated using
UNIVERSAL from an SBML input file (available in the supplemental materials).
UNIVERSAL is an open source Objective-C/Java code generator, which is freely
available as a Google Code project (http://code.google.com/p/universal-code-
generator/). The model equations were solved using the LSODE routine in OC-
TAVE (v 3.0.5; www.octave.org) on an Apple workstation (Apple, Cupertino,
CA; OS X v10.6.4).
When calculating the response of the model to the addition of insulin or
other growth factors, we first ran to steady state and then issued the pertur-
bation. The steady state was estimated numerically by repeatedly solving the
model equations and estimating the difference between subsequent time points:
‖x (t + ∆t) − x (t) ‖2 ≤ γ (4.3)
The quantities x (t) and x (t + ∆t) denote the simulated concentration vector at
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time t and t + ∆t, respectively. The L2 vector-norm was used as the distance
metric, where ∆t = 1 s and γ = 0.001 for all simulations.
4.5.2 Estimation and cross-validation of a population of models
using Pareto Optimal Ensemble Techniques (POETs).
We used multiobjective optimization in combination with cross-validation to
estimate an ensemble of initiation models. Multiobjective optimization in com-
bination with cross-validation allowed us to address qualitative conflicts in the
training data, and to protect against model over-training. While computation-
ally more complex than single-objective formulations, multiobjective optimiza-
tion is an important tool to address qualitative conflicts in training data that
arise from experimental error or cell-line artifacts [182]. Multiobjective opti-
mization balances these conflicts allowing us to identify a consensus model pop-
ulation. In this study we used the Pareto Optimal Ensemble Technique (POETs)
to perform the optimization. POETs integrates standard search strategies e.g.,
Simulated Annealing (SA) or Pattern Search (PS) with a Pareto-rank fitness as-
signment [504]. Denote a candidate parameter set at iteration i + 1 as ki+1. The
squared error for ki+1 for training set j was defined as:
E j(k) =
T j∑
i=1
(
Mˆi j − yˆi j(k)
)2
(4.4)
The symbol Mˆi j denotes scaled experimental observations (from training set j)
while yˆi j denotes the scaled simulation output (from training set j). The quantity
i denotes the sampled time-index and T j denotes the number of time points for
experiment j. In this study, the experimental data used for model training was
typically the band intensity from immunoblots, where intensity was estimated
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using the ImageJ software package [1]. The scaled measurement for species x at
time i = {t1, t2, .., tn} in condition j is given by:
Mˆi j = Mi j −miniMi jmaxiMi j −miniMi j (4.5)
Under this scaling, the lowest intensity band equaled zero while the highest
intensity band equaled one. A similar scaling was defined for the simulation
output. By doing this scaling, we trained the model on the relative change in
blot intensity, over conditions or time (depending upon the experiment). Thus,
when using multiple data sets (possibly from different sources) that were quali-
tatively similar but quantitatively different e.g., slightly different blot intensities
over time or condition, we captured the underlying trends in the scaled data.
We computed the Pareto rank of ki+1 by comparing the simulation error at it-
eration i+1 against the simulation archive Ki. We used the Fonseca and Fleming
ranking scheme [133] to estimate the number of parameter sets that dominate
ki+1. Parameter sets with increasing rank are progressively further away from
the optimal trade-off surface. The parameter set ki+1 was accepted or rejected by
POETs with probability P (ki+1):
P(ki+1) ≡ exp {−rank (ki+1 | Ki) /T } (4.6)
where T is the annealing temperature and rank (ki+1 | Ki) denotes the Pareto rank
for ki+1. The annealing temperature was discretized into 10 quanta between To
and T f and adjusted according to the schedule Tk = βkT0 where β was defined
as
(
T f /To
)1/10
. The initial temperature was given by To = n/log(2), where n = 4
was used in this study and the final temperature was T f = 0.1. The epoch-
counter k was incremented after the addition of 100 members to the ensemble.
Thus, as the ensemble grew, the likelihood of accepting parameter sets with
a large Pareto rank decreased. To generate parameter diversity, we randomly
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perturbed each parameter by ≤ ±25%. We performed a local pattern search
every q steps to minimize the residual for a single randomly selected objective.
The local pattern-search algorithm has been described previously [149].
A leave-three-out cross-validation strategy was used to simultaneously cal-
culate the training and prediction error during the parameter estimation pro-
cedure [261]. The 24 training data sets were partitioned into eight subsets,
each containing 21 data sets for training and three data sets for validation. The
leave-three-out scheme generated 18,886 probable models. From the approxi-
mately 6000 rank zero models, we iteratively selected 50 random models from
each cross-validation trial with the lowest correlation and shortest Euclidian
distance to the origin (minimum error). This selection technique produced sub-
ensembles with low set-to-set correlation (≤ 0.50) and minimum training error.
4.5.3 Sensitivity and robustness analysis of the initiation
model population.
Sensitivity coefficients were calculated for 40 models selected from the ensemble
(rank-zero, low-correlation, minimum error selection). First-order sensitivity
coefficients at time tq:
si j
(
tq
)
=
∂xi
∂k j
∣∣∣∣∣∣
tq
(4.7)
were computed by solving the kinetic-sensitivity equations [105]:dx/dtds j/dt
 =
 S · r (x,k)A (t) s j + b j (t)
 j = 1, 2, . . . , P (4.8)
subject to the initial condition s j(t0) = 0. The quantity j denotes the param-
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eter index, P denotes the number of parameters in the model, A denotes the
Jacobian matrix, and b j denotes the jth column of the matrix of first-derivatives
of the mass balances with respect to the parameters. Sensitivity coefficients
were calculated by repeatedly solving the extended kinetic-sensitivity system
for forty parameters sets selected from the final 400 member ensemble. These
sets were chosen to be comparable to the final 400 member ensemble on the
basis of parametric coefficient of variation (CV); the sets selected for sensitivity
analysis had a mean CV of 0.85 ± 0.5 and a mean correlation of approximately
0.6. Thus, there were diverse and uncorrelated. The JacobianA and the b j vector
were calculated at each time step using their analytical expressions generated by
UNIVERSAL.
The resulting sensitivity coefficients were scaled and time-averaged (Trape-
zoid rule):
Ni j ≡ 1T
∫ T
0
dt · |si j(t)| (4.9)
where T denotes the final simulation time. The time-averaged sensitivity coef-
ficients were then organized into an array for each ensemble member:
N () =

N ()11 N ()12 . . . N ()1 j . . . N ()1P
N ()21 N ()22 . . . N ()2 j . . . N ()2P
...
...
...
...
N ()M1 N ()M2 . . . N ()M j . . . N ()MP

 = 1, 2, . . . ,N (4.10)
where  denotes the index of the ensemble member, P denotes the number of pa-
rameters, N denotes the number of ensemble samples and M denotes the num-
ber of model species. To estimate the relative fragility or robustness of species
and reactions in the network, we decomposed the N () matrix using Singular
Value Decomposition (SVD):
N () = U()Σ()VT,() (4.11)
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Coefficients of the left (right) singular vectors corresponding to largest θ ≤ 15
singular values of N () were rank-ordered to estimate important species (reac-
tion) combinations. Only coefficients with magnitude greater than a threshold
(δ = 0.001) were considered. The fraction of the θ vectors in which a reaction or
species index occurred was used to determine its importance (sensitivity rank-
ing). The sensitivity ranking was compared between different conditions to un-
derstand how control in the network shifted as a function of perturbation or
time (Fig. 4.5).
Robustness coefficients were calculated as shown previously [527]. Robust-
ness coefficients (denoted by α
(
i, j, to, t f
)
) are the ratio of the integrated concen-
tration of a network marker in the presence (numerator) and absence (denom-
inator) of a structural or operational perturbation. The quantities t0 and t f de-
note the initial and final simulation time, respectively, while i and j denote the
indices for the marker and the perturbation respectively. If α
(
i, j, to, t f
)
> 1, then
the perturbation increased the marker concentration. Conversely, if α
(
i, j, to, t f
)
<
1 the perturbation decreased the marker concentration. Lastly, if α
(
i, j, to, t f
)
∼ 1
the perturbation did not influence the marker concentration. Robustness coeffi-
cients were calculated over 400 models selected from the ensemble (rank-zero,
low-correlation, minimum error selection). Convergence analysis suggested
that the qualitative conclusions drawn from the robustness analysis would not
change if more than N = 400 parameter sets were sampled (Fig. 4.7).
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Figure 4.7: Effect of the ensemble size on the knockdown simulations.
Fold change of the translational activity was calculated for en-
semble sizes of N = 50 (white fill), N = 100 (light grey), N = 200
(dark grey) and N= 400 (black) randomly selected parameter
sets in the presence and absence of insulin. For the majority of
the perturbations, the robustness coefficients converged for as
few as 50 parameter sets. In a small number of other cases, the
robustness coefficients varied significantly up to 200 parameter
sets. Between 200 - 400 sets the robustness coefficients largely
converged to qualitatively and quantitatively similar answers.
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CHAPTER 5
ANALYSIS OF THE CORE ARCHITECTURE REGULATING TGFβ
INDUCED EMT
Authors - Gould R, Chakrabarti A, Butcher JB and Varner JD.
Submitted to - Mol. Sys. Biol.
5.1 Abstract
Transforming growth factor β (TGFβ) has been shown as a potent inducer of
epithelial to mesenchymal transition (EMT) in both embryonic and pathologi-
cal conditions. The complexity of TGFβ signaling is overwhelming due to the
large numbers of interacting protein complexes, complicated feedback mecha-
nisms, and cross-talk between multiple signaling pathways. As a result, even
understanding the fundamental regulation of cell specific markers remains diffi-
cult. Systems biology has been suggested as an essential tool for understanding
the orchestration of EMT and omission of such a critical contributor may lead
to an inaccurate understanding. Thus, we modeled the molecular interactions
of TGFβ induced EMT using mass action kinetics within an ordinary differen-
tial equation (ODE) based framework. 2695 unknown model parameters (1700
kinetic constants and 995 non-zero initial conditions) were estimated using 41
steady-state experimental data sets taken from literature sources. Using POETs
we implemented a population based approach to identify different operational
paradigms within EMT. Using signal flow, sensitivity, and robustness analysis,
our model suggested three important levels of regulation. The differential role
of AP1/SP1, selective de-phosphorylation of the MAPK/ERK cascade, and the
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availability of LEF1. These results provide insight into the core molecular ar-
chitecture of TGFβ induced EMT and reveal possible transformational aspects
between cellular phenotype.
5.2 Introduction
Epithelial to mesenchymal transition (EMT) is an important phenomenon ini-
tiating the development of tissues and other morphogenetic events. This pro-
cess is associated with a loss of epithelial traits, such as E-cadherin, and the
acquisition of mesenchymal characteristics, such as Vimentin, and Fibronectin
[520, 521]. TGFβ has been shown an important inducer of this process as seen
by the initiating the formation of endocardial cushions in the atrioventricular
valves and mediating palate fusion of medial epithelial cells [620]. In this con-
text, EMT terminates and has been suggested as a highly controlled process
[290]. While being an integral process during development, EMT is also re-
capitulated under pathological conditions, prominently in fibrosis and in in-
vasion and metastasis of carcinomas [533]. The complexity of TGFβ signaling
is overwhelming due to the large numbers of interacting protein complexes,
complicated feedback mechanisms, and cross-talk between multiple signaling
pathways [534]. As a result, even understanding the regulation of cell specific
markers remains difficult.
Systems biology has been suggested as an essential tool for understanding
the dynamic integration of such complex pathways and omission of such a criti-
cal contributor may lead to inaccurate understanding of EMT [3]. Current com-
putation models investigating TGFβ signaling have proven insightful. For ex-
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ample, Chung et al. constructed an ordinary differential equation model using
mass action kinetics to investigate the mechanisms associated with receptor ac-
tivation and Smad signaling. Their model suggested that a reduction in the level
of functional TGFβ receptors in cancer cells may lead to attenuated and slower
TGFβ stimulated signaling responses via Smad2 [76]. Similar work by Vilar et
al. suggested specific changes in receptor trafficking patterns that can lead to
phenotypes that favor tumor progression [565]. Although these models have
provided useful information about receptor dynamics, they are limited in com-
plexity, and understanding global phenomenons such as TGFβ induced EMT
cannot be considered.
Investigating large scale networks have proven to be difficult. This is due to
the structural/parametric uncertainty associated with all deterministic models
and lack of computational approaches capable of handling such vast systems.
Recent methods to minimize parametric uncertainty have suggested a popula-
tion based approach rather than a single best-fit but uncertain model. While,
ensembles often constrain individual parameter values poorly, they can still ro-
bustly capture model predictions [176]. Tasseff et al. used this approach to
effectively capture which signaling systems were important in the loss of an-
drogen dependence [526]. Furthermore, the application of advanced sampling
techniques have demonstrated the capability to investigate extensive parame-
ter space. For example, multi-objective optimization ensemble techniques can
be used to balance conflicts in the training data [505].
Recent work by Medici et al. has revealed key molecular pathways through
which sequential activation of TGFβ isoforms induces EMT. This framework
culminates decades of work within the EMT field and has provided a structural
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basis through which systems biology can now be applied. Our objective was
to develop a computational model which can quantitatively investigate the in-
duction of EMT through MAPK and Smad dependent pathways. Model infras-
tructure components included TGFβ2 ligand binding, TGFβRI,II,III transmem-
brane growth factor receptor phosphorylation, activation of the Ras/MAPK
pathways, autocrine response of the TGFβ3 ligand, activation of the Smad path-
ways, cytosolic release of β-catenin from E-cadherin, and complex cross-talk
between the MAPK/Smad signaling pathways. We modeled the molecular in-
teractions using mass action kinetics (describe the rate of each molecular inter-
action) within an ordinary differential equation (ODE) framework. Thus, 2695
unknown model parameters (1700 kinetic constants and 995 non-zero initial
conditions) were estimated using 41 steady-state training sets taken from lit-
erature sources. Model parameters were estimated using experimental values
conducted with DLD1 colon carcinoma, MDCKII, and A375 melanoma cells and
taken from literature sources [347]. We implemented a population approach to
estimate a family or ensemble of parameters that was consistent with the train-
ing data [346]. Using POETs, we extensively investigated parameter space to
determine the best possible ensemble and cross-validate through a leave one
out technique.
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5.3 Results
5.3.1 Biological Background - EMT
TGFβ induced EMT is a complex process involving both the canonical MAPK
and Smad pathways (Fig. 5.1). TGFβ2 signals through the RAS-RAF-MEK-ERK-
AP1 pathway to up-regulate snail and slug expression [346]. Snail, a known
repressor of junctional proteins, inhibits the expression of E-cadherin [61]. This
initial repression of E-cadherin leads to a release of β-catenin from cell mem-
brane. Cystolic β-catenin can then translocate to the nucleus and form transcrip-
tional complexes with TCF-4 to drive TGFβ3 expression [347]. TGFβ3 signals
to the cells interior by binding to type II receptors, which form heterodimers
with type I receptors (ALK5, ALK2) [103]. This activates the receptors ser-
ine/threonine kinase activity to phosphorylate and activate the receptor Smads
2/3 [339]. To increase ligand affinity, β-glycan (TGFβR3) can also interact with
TGFβRI,II which has been shown in both development and adult conditions
[155]. Phosphorylated Smads 2/3 (pSmad2/3) then form heterodimers with
partner Smad4 and translocate to the nucleus. pSmads complexes then up-
regulate other transcription factors, such as LEF1 [347]. The pSmad2/4/LEF1
has been shown to directly repress the E-cadherin gene [367]. LEF1 also binds
with β-catenin to upregulate mesenchymal proteins and further promote the
mesenchymal to epithelial transition [347]. The MAPK and Smad pathways
involve redundant feedback mechanisms involving both inhibitory and syner-
gistic effects at the cytosolic and nuclear level [337]. In response to the MAPK
pathway, Smad2/3 are phosphorylated by ERK at multiple MAP kinase sites in
the linker region that negatively affect Smad function [338]. Downstream com-
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ponents of MAP kinase signaling pathways, especially transcription factors of
the AP1/SP1 family, interact with the R-Smad/ Smad4 complex, providing an
additional level of crosstalk between these pathways [231].
5.3.2 Estimating the ensemble of TGFβ induced EMT models
using POETs
EMT has been described as a complex process orchestrated by multiple sig-
naling pathways, with numerous redundant feedback systems. Applying an
ODE model to such a vast system makes it difficult to identify model parame-
ters, even with extensive training data. However, population of model based
approaches have been promising due to their ability to constrain model be-
havior despite uncertainty (structural and parametric). In this study, an en-
semble of plausible model parameters was estimated for TGFβ induced cancer
cell lines. Model connectivity (human) was assembled from literature and on-
line databases; String-8 [233], NetworKIN [305] and TRANSFAC. The 2695 un-
known model parameters (1700 kinetic constants and 995 non-zero initial con-
ditions) were estimated using 41 steady-state training sets taken from litera-
ture sources [347]. Kinetic parameters and unspecified initial conditions were
estimated using the POETs multiobjective optimization algorithm [504]. Addi-
tionally, we used cross-validation to independently estimate both the prediction
and training error during the parameter estimation (Table 5.2). We used a leave-
one-out strategy where one of the eleven objectives was reserved for validation
while the remaining ten were used for model training. Thus, eleven different
model families, trained and validated on different experimental data sets were
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Figure 5.1: Schematic overview of the interaction network used in model-
ing the TGFβ induced EMT phenomenon. The model describes
activation of the MAPK cascade through TGFβ2 followed by
and autocrine response of TGFβ3 stimulating the Smad cas-
cade. Cross-talk between MAPK and Smads has been shown
at both the cytosolic and nuclear levels.
128
generated. POETs generated more than 15,000 probable models. We selected
models with pareto rank one or less (N = 1091) for further study. The coeffi-
cient of variation (CV) for the parameters in the model ensemble ranged from
0.9 - 2.8. Approximately 50% of the model parameters were constrained with
a CV ≤ 1.6. The most tightly constrained parameters governed LEF1 expres-
sion, transcription of Snail, and TGFβ3 regulation, while the least constrained
parameters involved crosstalk between MAPK and transcriptional factor acti-
vation, e.g., ERK mediated AP1 activation. POETs was successful in identify-
ing conflicts/relationships between the objective functions which were used for
training/predictions.
Pareto fronts developed between several objectives, e.g., O3×O5, O7×O8,
and O5×O8 (Fig. 5.3). These fronts indicated conflicts in the training data
and/or an inability of the model to simultaneously capture different aspects of
the training data. For example, O3 and O5 were measurements of the expression
levels of TGFβ3 and the β-catenin/TCF4 complex through snail/slug induction.
A front between these objectives suggested that overexpression of E-cadherin in
O5 was conflicting with snail repression and therefore, not able to dissolve the
β-catenin/TCF4 complex. On the other hand, a linear relationship developed
between several objective functions, e.g., O2×O9 and O8×O11. These fronts in-
dicated strong relationships between the training data and was effectively cap-
tured by the model. For example, O2 and O9 were measurements based upon
the expression levels of Vimentin and E-cadherin through snail/slug and TGFβ3
induction (Fig. 5.3). The strong correlation between objectives suggested that
the knockout of LEF1 was critical for maintaining E-cadherin expression in both
cases.
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OBJ-1
Snail 0.00 1.00 0.00 Snail 0.00 0.09 0.00 Snail 0.00 1.00 0.00 Snail 0.00 0.16 0.00
Slug 0.00 0.00 1.00 Slug 0.00 0.00 0.19 Slug 0.00 0.00 1.00 Slug 0.00 0.00 0.19
LEF1 0.00 0.73 1.00 LEF1 0.00 0.22 0.37 LEF1 0.00 0.66 1.00 LEF1 0.00 0.18 0.32
Snail - - + Snail - - + Snail - - + Snail - - +
Slug - + - Slug - + - Slug - + - Slug - + -
OBJ-2
E-cad 0.92 0.00 0.00 1.00 0.81 E-cad 0.19 0.00 0.00 0.10 0.14 E-cad 1.00 0.00 0.00 0.06 0.06 E-cad 0.25 0.00 0.00 0.01 0.02
VIM 0.00 0.96 1.00 0.00 0.00 VIM 0.00 0.11 0.11 0.00 0.00 VIM 0.00 1.00 0.95 0.00 0.00 VIM 0.00 0.15 0.14 0.00 0.00
Snail - + - + - Snail - + - + - Snail - + - + - Snail - + - + -
Slug - - + - + Slug - - + - + Slug - - + - + Slug - - + - +
DN LEF1 - - - + + DN LEF1 - - - + + DN LEF1 - - - + + DN LEF1 - - - + +
OBJ-3
TGFB3 0.00 1.00 0.95 LEF1 0.00 0.13 0.12 LEF1 0.00 0.77 1.00 LEF1 0.00 0.22 0.20
Snail - - + Snail - - + Snail - - + Snail - - +
Slug - + - Slug - + - Slug - + - Slug - + -
OBJ-4
LEF1 0.00 0.98 1.00 0.03 0.02 LEF1 0.00 0.10 0.11 0.01 0.01 LEF1 0.00 0.95 1.00 0.00 0.00 LEF1 0.00 0.10 0.10 0.00 0.00
E-cad 1.00 0.00 0.00 0.54 0.35 E-cad 0.20 0.00 0.00 0.16 0.12 E-cad 1.00 0.34 0.37 0.00 0.37 E-cad 0.26 0.13 0.14 0.00 0.06
VIM 0.00 1.00 0.94 0.00 0.00 VIM 0.00 0.13 0.12 0.00 0.00 VIM 0.00 0.72 1.00 0.00 0.00 VIM 0.00 0.15 0.15 0.00 0.00
Snail - + - + - Snail - + - + - Snail - + - + - Snail - + - + -
Slug - - + - + Slug - - + - + Slug - - + - + Slug - - + - +
TGFB3-Ab - - - + + DN LEF1 - - - + + DN LEF1 - - - + + DN LEF1 - - - + +
OBJ-5
B-catenin 0.01 0.99 1.00 0.00 0.25 LEF1 0.01 0.99 1.00 0.00 0.25 LEF1 0.00 0.00 0.00 0.02 1.00 LEF1 0.00 0.00 0.00 0.02 0.65
TCF4 0.87 0.23 0.00 0.77 1.00 E-cad 0.87 0.23 0.00 0.77 1.00 E-cad 1.00 0.04 0.00 0.95 1.00 E-cad 0.93 0.12 0.00 1.00 0.95
Snail - + - + - Snail - + - + - Snail - + - + - Snail - + - + -
Slug - - + - + Slug - - + - + Slug - - + - + Slug - - + - +
E-cad - - - + + DN LEF1 - - - + + DN LEF1 - - - + + DN LEF1 - - - + +
OBJ-6
TGFB3 0.00 0.89 1.00 0.49 0.60 LEF1 0.00 0.14 0.12 0.09 0.09 LEF1 0.00 0.71 1.00 0.31 0.48 LEF1 0.00 0.12 0.16 0.08 0.11
E-cad 0.90 0.00 0.00 1.00 0.71 0.18 0.00 0.00 0.15 0.12 0.52 0.00 0.00 0.92 1.00 0.06 0.00 0.00 0.16 0.17
VIM 0.00 0.97 1.00 0.51 0.66 E-cad 0.00 0.10 0.10 0.05 0.07 E-cad 0.00 1.00 0.94 0.40 0.39 E-cad 0.00 0.15 0.15 0.06 0.06
Snail - + - + - Snail - + - + - Snail - + - + - Snail - + - + -
Slug - - + - + Slug - - + - + Slug - - + - + Slug - - + - +
E-cad - - - + + DN LEF1 - - - + + DN LEF1 - - - + + DN LEF1 - - - + +
OBJ-7
Snail 0.00 0.00 Snail 0.00 0.00 Snail 0.00 0.00 Snail 0.00 0.00
Slug 0.00 0.00 Slug 0.00 0.00 Slug 0.00 0.00 Slug 0.00 0.00
TGFB3 - + Snail - + Snail - + Snail - +
OBJ-8
LEF1 0.05 1.00 0.00 LEF1 0.02 0.14 0.00 LEF1 0.02 1.00 0.00 LEF1 0.01 0.25 0.00
TGFB3 - - + Snail - - + Snail - - + Snail - - +
DN Smad4 - + - Slug - + - Slug - + - Slug - + -
OBJ-9
E-cad 0.96 0.00 0.96 1.00 LEF1 0.20 0.00 0.20 0.17 LEF1 0.86 0.00 0.86 1.00 LEF1 0.19 0.00 0.19 0.22
VIM 0.00 1.00 0.00 0.00 E-cad 0.00 0.11 0.00 0.00 E-cad 0.00 1.00 0.00 0.00 E-cad 0.00 0.24 0.00 0.00
TGFB3 - + - + Snail - + - + Snail - + - + Snail - + - +
DN Smad4 - - + - Slug - - + - Slug - - + - Slug - - + -
DN LEF1 - - - + DN LEF1 - - - + DN LEF1 - - - + DN LEF1 - - - +
OBJ-10
Snail 0.00 1.00 0.00 Slug 0.00 0.19 0.00 Slug 0.00 1.00 0.00 Slug 0.00 0.18 0.00
Slug 0.00 1.00 0.00 LEF1 0.00 0.20 0.00 LEF1 0.00 1.00 0.00 LEF1 0.00 0.12 0.00
TGFB2 - + + Snail - + + Snail - + + Snail - + +
DN MEK - - + Slug - - + Slug - - + Slug - - +
OBJ-11
LEF1 0.05 1.00 0.00 LEF1 0.02 0.15 0.00 LEF1 0.02 1.00 0.00 LEF1 0.01 0.25 0.00
TGFB2 - + + Snail - + + Snail - + + Snail - + +
DN MEK - - + Slug - - + Slug - - + Slug - - +
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Mean Trained S.E. Trained Mean Predicted S.E. Predicted
Figure 5.2: Eleven different objective functions used to train our model.
Our model was able to effectively predict the simulated ex-
periments 85 percent of the time. The high predictability can
be contributed to the leave-one-out cross validation scheme,
objective functions with overlapping data, and multi-objective
optimization (POETs) algorithm.
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Figure 5.3: Selected objective value plot for the ensemble of EMT mod-
els: POETs generated more than 15,000 probable models. We
selected models with pareto rank one or less (N = 1091)
for further study. POETs was successful in identifying con-
flicts/relationships between the objective functions which
were used for training/predictions. Pareto fronts developed
between several objectives, e.g., O3×O5, O7×O8, and O5×O8.
These fronts indicated conflicts in the training data and/or an
inability of the model to simultaneously capture different as-
pects of the training data. On the other hand, a linear rela-
tionship developed between several objective functions, e.g.,
O2×O9 and O8×O11. These fronts indicated strong relation-
ships between the training data and was effectively captured
by the model .
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5.3.3 Signal flow study within EMT model reveals temporal
shifts in TGFβ Induced EMT
To investigate temporal shifts for key species dominating the EMT response,
we calculated the scaled branch fluxes through the system using steady state
vectors. Three modes of operation were simulated to clarify distinct behavioral
differences: (a) no dose of TGFβ2 (steady state), (b) TGFβ2 stimulation, and
(c) TGFβ2 stimulation while blocking the autocrine response of TGFβ3. Upon
TGFβ2 stimulation, MAPK signals through the MEK cascade to activate down-
stream transcription factors AP1 and SP1. Phosphorylation of these complexes
occurs in a sequential order, starting at 1 hr and increases through 48 hrs. When
blocking TGFβ3, phosphorylation of these complexes is still maintained (Fig.
5.4A). AP1/SP1 stimulates Snail/Slug repression of the E-cadherin complex to
reduce substrate affinity β-catenin and accumulation of free cytosolic β-catenin
ensues(Fig. 5.4B). On the contrary, blocking TGFβ3, membrane bound β-catenin
increased after 10 hrs, while low levels of free cytosolic β-catenin accumulated
between 1-10 hrs (Fig. 5.4C). Accumulation of free β-catenin is critical for com-
plexing with TCF4 to rapidly produce the autocrine response of TGFβ3 between
1-10 hrs. During the autocrine response of TGFβ3, formation and spatial loca-
tion of the Smad complexes occurs in a time dependent manner. Smad2 phos-
phorylation occurs within 1 hr, the complex pSmad2/4 forms within 5 hrs, and
nuclear localization of the complex dramatically increases after 10 hours(Fig.
5.4D). At steady state, scale branch flux the E-cadherin complex was maintained
at a basal epithelial level with no expression of Vimentin. During TGFβ2 stimu-
lation, both MAPK and Smad act synergistically to repress the E-cadherin com-
plex within 1hr. This is followed by increase of Vimentin at 1hr, while expo-
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nentially increasing 10 hrs. Both species elevate within 1 hr, however the com-
plex does not significantly form until 10 hrs (Fig. 5.4E). Upon blocking TGFβ3,
Snail/Slug downregulates the E-cadherin complex between 5-10 hrs followed
by an overwhelming response of TF1 to reverse expression of E-cadherin at 10hr
(Fig. 5.4F).
5.3.4 The ensemble of TGFβ Induced EMT models recapit-
ulated the distinct signaling pathways associated with
TGFβ isoforms
Our ensemble of parameter sets recapitulates the core signaling pathways asso-
ciated with TGFβ induced EMT (Fig. 5.5) (Table. 5.2). The literature values used
for training purposes were conducted in DLD1 colon carcinoma, MDCKII, and
A375 melanoma cells [347]. TGFβ2 signals through the MAPK pathway to up-
regulate expression of snail and slug and downstream effectors, such as LEF1.
This was captured through a (10 a.u.) stimulation of TGFβ2 and inhibition of the
MEK complex (Fig. 5.5A-B). To define the role of snail and slug, simulated over-
expression studies were conducted(Fig. 5.5C-F). These simulations constrained
the effects of snail and slug to indirectly upregulate the autocrine response of
TGFβ3 through the β-catenin-TCF4 complex. Overexpression of the E-cadherin
complex was able to inhibit the epithelial transformation by sequestering avail-
able cytosolic β block EMT. TGFβ3 signals through the Smad pathway to upreg-
ulate expression of LEF1 and downstream effectors. This was captured through
a (10 a.u.) stimulation of TGFβ3 and inhibitory studies using the DN-Smad4 and
DN-LEF1 complex (Fig. 5.5G-I). Expression of both Vimentin and E-cadherin
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Figure 5.4: Signal flow analysis of key species at steady state, TGFβ2 stim-
ulation, and blocking the TGFβ3 autocrine response. (A) TGFβ2
stimulates the MAPK pathway to activate transcription fac-
tor AP1 (5-10hr). (B) The MAPK cascade is directly respon-
sible for rapid expression of snail and slug and downstream
TGFβ3 formation (1hr). (C) TGFβ2 reduces membrane affin-
ity for b-catenin, allowing rapid free-cytosolic b-catenin to ac-
cumulate (1hr). Blocking TGFβ3 increases membrane bound
b-catenin (10hr). (D) TGFβ3 activates the Smad cascade. Nu-
clear localization of the pSmad2/4 complex (10hr) is depen-
dent upon both the phosphorylation of Smad2 (1hr) and com-
plexing with Smad4 (5hr). (E) TGFβ2 rapidly reduces the E-
cadherin complex, while upregulating Vimentin (5-10 hours).
Blocking TGFβ3 increases E-cadherin (10hr) and Vimentin is
significantly reduced. (F) Expression of the E-cadherin com-
plex (10hr) is positively regulated by the TF-1 transcription fac-
tor.
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were shown dependent upon these complexes. Although these sets do not en-
compass the full set of trained data, they provide a core sample of the molecular
mechanism driving TGFβ induced EMT. Further sets are included in the sup-
plement. In whole, our model was able to effectively predict the simulated ex-
periments 85 percent of the time. The high predictability can be contributed to
the leave-one-out cross validation scheme, objective functions with overlapping
data, and multi-objective optimization (POETs) algorithm. The model was also
compared against temporal data using MDCKII cells, to measure the effective-
ness as a pure prediction [346]. E-cadherin expression reduced exponentially
over a 72 hours and was captured within one standard error of our prediction.
pSmad2 production increased exponentially over a 72 hours and was also cap-
tured within one standard error of our prediction. LEF1 production increased
exponentially over a 72 hours, but could only be observed effectively after the
48hr time point(Fig. 5.5J-L).
5.3.5 Population sensitivity analysis revealed globally and
temporally important network components
Sensitivity analysis has been widely used to understand fragility within net-
works [176]. First order sensitivity coefficients were computed for two cases:
(a) TGFβ2 stimulation, and (b) TGFβ2 stimulation while knocking down the
autocrine response of TGFβ3 using 55 parameter sets selected from the parent
ensemble. These 55 parameter sets were chosen based on diversity from the
nominal parameter set, its coefficient of variation, and low correlation (Fig. 5.6).
The coefficients were time-averaged (from 0-48 hrs or in pre-selected time
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Figure 5.5: Using POETs and cross-validation, our ensemble of parameter
sets recapitulates the core signaling pathways associated with
TGFβ induced EMT. (A-B) TGFβ2 (10 a.u.) signals through the
MAPK pathway to upregulate expression of snail and slug and
downstream effectors, such as LEF1. (C-F) Overexpression of
snail and slug indirectly upregulated the autocrine response
of TGFβ3 through the β-catenin-TCF4 complex. In contrast,
overexpression of the E-cadherin complex was able to inhibit
the epithelial transformation by sequestering available cytoso-
lic β block EMT. Likewise, DN-LEF1 and TGFβ3-Ab inhibited
the epithelial transformation. (G-I) TGFβ3 signals through the
Smad pathway to upregulate expression of LEF1 and down-
stream effectors. This was captured through a (10 a.u.) stim-
ulation of TGFβ3 and inhibitory studies using the DN-Smad4
and DN-LEF1 complex. Expression of both Vimentin and E-
cadherin were shown dependent upon these complexes. (J-
L) The model was also compared against untrained temporal
data, to measure the effectiveness as a pure prediction. E-
cadherin expression reduced exponentially over 72 hours, pS-
MAD2 production increased linearly over a 72 hours and, LEF1
production increased over a 72 hours, but could only be cap-
tured after effectively after the 48hr time point.
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Figure 5.6: Using POETs we generated N=1091. (A) The coefficient of vari-
ation (CV) for the parameters in the model ensemble ranged
from 0.9 - 2.8 (black dots). 55 parameter sets were chosen for
subsequent analysis (purple dots). (B-D) The 55 parameter sets
were chosen based on diversity from the nominal parameter
set (as seen by the histogram of the second norm in C-D). Ap-
proximately % of parameter sets its coefficient of variation, and
low correlation.
bands) to form the N array and decomposed using SVD (materials and meth-
ods). The magnitude of the coefficients of the left (right) singular vectors corre-
sponding to largest singular values ofN was used to rank-order the importance
of the nodes (edges) in the model. Given the phased behavior of TGFβ isoforms
involved in the system, we analyzed the temporal changes in the specie sensitiv-
ity within four separate time bins (0-2, 2-5, 5-10, and 10-48 hrs). Deviation from
the 45 was used to see qualitative differences in terms of importance (species).
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In terms of species for the TGFβ2 perturbed case, mRNA expression levels of
E-cadherin were seen to be more important at early (0-2 hrs) compared to later
times (10-24 hrs) (Fig. 5.7A). This was expected as snail was rapidly induced
early on to repress the E-cadherin gene. However, the actual E-cadherin pro-
tein complexes were not affected until later time periods (5-10 hrs). Phospho-
rylated Smads and inhibited Smads were also seen important later (10-48 hrs)
compared to early times (0-2 hrs). In particular pSmad2/4/LEF1 complex and
pSmad3/4 were the most important at later times (10-48 hrs). This can partially
be attributed to delayed response of nuclear localization of Smad complexes as
shown through the flux analysis. Interestingly, AP1 and SP1 complexes were
also seen to be important at later times (10-24 hrs). This possibly suggests that
sustained activation of the MAPK pathway is needed in conjunction with the
Smad pathway to fully induce EMT.
In the case of the blocked response to TGFβ3 autocrine signaling, TF1 mRNA
and E-cadherin mRNA levels were seen at early (0-2 hrs) times followed by the
formation of the E-cadherin complex (5-10hrs). At later time frames (10-48 hr),
activated ERK, SP1, and AP1 were shown to be important (Fig. 5.7B). Inter-
estingly, β-catenin/TCF4 complexes are similar to the TGFβ2 perturbed case.
This suggests that snail/slug repression of E-cadherin is important for reducing
substrate affinity for β-catenin and accumulation of cytosolic β-catenin. How-
ever, full repression of the E-cadherin complex does not occur without the com-
bined effect of the pSmad2/4/LEF1 complex. This highlights the sequential
role of both snail/slug and pSmad2/4/LEF1 repression complexes to inhibit
E-cadherin formation.
Overall time-averaged sensitivity was conducted to identify the globally im-
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Figure 5.7: First order sensitivity coefficients were computed for the
temporal response of TGFβ2 stimulation, and blocking the
TGFβ3 autocrine response. (A) During TGFβ2 stimulation pS-
mad2/4/LEF1 complex and pSmad3/4 were the most impor-
tant at later times (10-48 hrs) followed by the AP1 and SP1
complexes. (B) When blocking the TGFβ3 autocrine response
mRNA expression levels of E-cadherin were seen at early (0-
2 hrs) times, however, at later time frames (10-48 hr), acti-
vated ERK, SP1, and AP1 were shown to be important. Degra-
dation of pSmad2/3 and expression of TF1mRNAs also tran-
spire. (C) Overall time-averaged sensitivity revealed differen-
tial regulation of key complexes. pSmad2/Smad4/LEF1 was
most important in the TGFβ2 perturbed case. In both cases,
the transcription factor SMAD3 was ranked among the high-
est followed by membrane bound β-catenin, YREG1, RasGTP,
and MAPK phosphatases. This suggests the importance of
sustained activation of the both MAPK/Smad pathways, po-
tential negative feedback through the ERK cascade, and pS-
MAD2/4/LEF1 as a critical complex within the TGFβ2 per-
turbed case.
portant species in each condition (Fig. 5.7C). In whole, we distinctly see species
which are important in +TGFβ2 +TGFβ3 case as compared to +TGFβ2 -TGFβ3.
These include components like the pSmad2/4/LEF1 and pSmad3/4 complexes.
Less sensitive but also important components include the Smad3/SP1 complex,
which has been shown to regulate TGFβR3. In both cases, the cytosolic Smad3
was ranked among the highest followed by membrane bound β-catenin, YREG1,
and Ras-GTP. Interestingly, MAPK phosphatases were also important in both
cases, suggesting a feedback mechanism to regulate high activated levels of the
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ERK cascade.
5.3.6 Robustness analysis revealed hypothetical schemes in
regulating phenotypic shifts in TGFβ induced EMT
TGFβ signal transduction networks are notorious for its overwhelming large
numbers of interacting species, redundant signaling modules, and crosstalk be-
tween modules. These topological features often lead to complex synergistic
behaviors as well as robustness [510]. However, networks which are highly
optimized for specific tasks may also contain hidden fragility [65]. Here, we
generated falsifiable predictions about the fragility or robustness of the EMT
network using robustness analysis. Robustness coefficients were used to quan-
tify the effect of structural perturbations (node deletions and over-expressions)
on 995 species in the EMT model. Robustness coefficients with values > 1 (<
1) indicated a marker increased (decreased) compared to a base state, while a
value of 1 indicated approximately no change following a perturbation.
Gene knockdowns with TGFβ2 perturbation for the 88 elemental species
were computed using 55 parameter sets from the ensemble (Fig. 5.8A). These
parameters were identical to the sensitivity analysis and selected based on di-
versity from the nominal parameter set (further details in supplemental mate-
rials). Phenotypic behavior of the ensemble was captured using downstream
markers Vimentin (mesenchymal) and E-cadherin (epithelial) at 48 hours. This
was used to identify the role of individual gene components and understand
population average behavior. Overall, the 88 elemental knockouts shifted the
population towards an epithelial phenotype. As seen earlier in the sensitivity
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Figure 5.8: Analysis on all 88 elemental genes revealed a key species in-
volved in shifting cellular phenotype. (A) Gene knockdowns
with TGFβ2 perturbation for the 88 elemental species were
computed using 55 parameter sets from the ensemble. Phe-
notypic behavior of the population was analyzed using down-
stream markers Vimentin (mesenchymal) and E-cadherin (ep-
ithelial). YREG1, AP1, SP1, and TGFβ3 were just a few of the
important species for regulating phenotype. (B) A dendrogram
of the single gene knockouts was used to reveal clusters with
inherent functional relationships. The most distinct separation
was between the receptor components of the MAPK pathway
and TGFβ3 signal induction through β-catenin/LEF1.
analysis, key species such as LEF1, TGFβ3 and Smad4 were differentially more
important in the presence of TGFβ3 and prevented the shift towards the mes-
enchymal phenotype. These findings are consistent with the observations in the
training data. Other species such as TGFβR3, AP1, SP1, and Smad3/4 were also
shown to be important for regulating phenotype. Interestingly, a few knockouts
even resulted to increase mesenchymal phenotype, e.g., YREG1.
We further investigated functional classifications within these knockouts. A
dendrogram revealed clusters of inherent functional relationships (Fig. 5.8B).
The most distinct separation was between the receptor components of the
MAPK pathway and TGFβ3 signal induction through β-catenin/LEF1. These
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clusters represent the sets of knockouts capable of producing qualitatively sim-
ilar perturbations in the system. Further clustering revealed similarities be-
tween bothTGFβ2 and TGFβ3 knockouts. In particular, Smad2/3, SP1/AP1,
TF1, Snail/Slug, and YREG1. The uniqueness of the 88 gene knockouts was gen-
erated through orthogonality. We see that 37.5% of the knockouts did not pro-
duce any unique result. At the same time, species like RAF-pase (phosphatase
for RAF), β-catenin, LEF1, Smad2, and TGFβR3 produced the most unique re-
sult. This suggests that knockouts of these components are potentially impor-
tant for phenotypic shift and provide a basis for further investigation.
5.3.7 Computational analysis identified hypothetical schemes
in regulating phenotypic shifts in TGFβ induced EMT
Using signal flow, sensitivity, and robustness analysis, we identified three im-
portant areas of regulation. First, AP1/SP1 have near binding sites to the
promoter of the snail/slug region and directly regulate expression in MDCK
cells. To maintain an epithelial phenotype at steady state, we incorporated a
transcription factor-1 (TF1) which positively expresses E-cadherin and is regu-
lated through the MAPK pathway. As shown through our flux analysis, TGFβ2
induces the Ras/MAPK pathway to activate the AP1/SP1 transcription com-
plexes. Rapid expression of Snail/Slug (<1hr) competes with TF1 for regu-
lating the E-cadherin gene. When knocking down TGFβ3, TF1 overwhelms
Snail/Slug and dominates E-cadherin expression (>5hr). Thus, the early phase
of epithelial transformation is directly related to the regulation (magnitude and
binding affinity) of Snail/Slug/TF1 expression. Using robustness analysis, AP1
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knockouts revealed distinct subpopulations of parameter sets capable of shift-
ing towards a mesenchymal phenotype. This was shown through negative ex-
pression of the E-cadherin complex. Similarly, SP1 knockdowns revealed dis-
tinct subpopulations that were capable of positively expressing Vimentin (Fig.
5.9B). Taken together, these results suggested the differential role of AP1/SP1
throughout the ensemble of parameter sets and may prove as an important
transformational aspect between cellular phenotype.
Second, over-expression of all 88 elemental species revealed an interesting
behavior of the ERK phosphatase. As one would expect, over-expression should
reduce the phosphorylated levels of the MAPK cascade and mesenchymal phe-
notype. It is well known that MPKs provide negative feedback mechanism for
MAP kinase activity and experimental over-expression studies have confirmed
reductions within the oncogenic-Ras cell lines. However, our model has iden-
tified a sub-population of parameter sets that was shown capable of exacerbat-
ing the mesenchymal phenotype (Fig. 5.9C). After further investigation, it was
revealed that the negative feedback induced by ERK on Smad regulation was
the contributing factor. During the over-expression of the ERK phosphatase, a
reduction of phosphorylated ERK lead to a larger decline of inhibited Smads
compared to MAPK activity. Therefore, within this sub-population of param-
eter sets, an increase of phosphorylated pSmad2 was shown (Fig. 5.10A). To
confirm that the increase of pSmad2 was a function of reduced ERK inhibition
and not from another source, we found that the total levels of inhibited pSmad2
through targeted ERK was also less (Fig. 5.10B). As a positive control, we double
over-expressed ERK and MEK phosphatase which lead to complete inhibition
of the MAPK cascade and mesenchymal phenotype (Fig. 5.10C). In whole, a bal-
ance between the ERK cascade and inhibition of Smads is clearly seen. Selected
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Figure 5.9: Using signal flow, sensitivity, and robustness analysis, we iden-
tified three important areas of regulation. (A) The differential
role of AP1/SP1 throughout the ensemble of parameter sets
may prove as an important transformation aspect between nor-
mal and cancerous cells. Both AP1/SP1 knockouts revealed
distinct subpopulations of parameter sets capable of shifting
towards a mesenchymal phenotype. (B) A balance between
the ERK cascade and inhibition of Smads plays an important
role in a positive feedback of the TGFβ3 autocrine response.
Over-expression of ERK phosphatase lead to a decline of inhib-
ited Smads potentially through a selective dephosphorylation
of MAPK/ERK cascade targeting Smad proteins. (C) The avail-
ability of LEF1 limits the induction of EMT and takes prece-
dent in forming the Psmad2/LEF1 complex over other com-
plexes. YREG1 knockdowns revealed distinct subpopulations
of parameter sets capable of shifting towards a mesenchymal
phenotype through expression of Vimentin.
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Figure 5.10: Selected phosphorylation through MAPK phosphatases may
plan an important role in facilitating a positive feedback
mechanism. (A) Sub-population of parameter sets lead to an
increase to phosphorylated pSmad2. (B) To confirm that the
increase of pSmad2 was a function of reduced ERK inhibition
and not from another source, we found that the total levels
of inhibited pSmad2 through targeted ERK was less. (C) As
a positive control, we double over-expressed ERK and MEK
phosphatase which shutdown of the MAPK cascade and thus,
mesenchymal shift.
phosphorylation through MAPK phosphatases may play an important role in
facilitating a positive feedback mechanism through which the maximum effect
of theTGFβ3 autocrine response can occur.
Third, TGFβ 3 knockdowns have revealed a large distribution of parameter
sets capable of shifting phenotypic markers. This suggests that production or
sensitivity of TGFβ3 may play a role in regulating magnitude of EMT induction.
According to our trained data and sensitivity analysis, LEF1 has been shown as
an important component downstream of the TGFβ3 autocrine response. Upon
TGFβ2 stimulation, DN-LEF1 was capable of inhibiting EMT. Recent work by
Arce et al. has shown a complex role of (Amino terminal Enhancer of Split) AES
and Groucho/TLE on suppressing LEF1 activity. AES opposes LEF1 transcrip-
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tional activation while Groucho/TLE binds with LEF1 for a histone deacetylase
repression. In addition, β-catenin directly displaces Groucho/TLE repressors
from TCF/LEF1 in Wnt-mediated transcription activation [14]. Although we
did not implement the direct structure of this complex feedback, we introduced
the hypothetical protein YREG1 which directly represses LEF1. YREG1 knock-
down and over-expression studies revealed distinct subpopulations of parame-
ter sets capable of shifting towards a mesenchymal phenotype. This was shown
through positive expression of the Vimentin complex. Surprisingly, minimal
changes occurred within the E-cadherin complex (Fig. 5.9D). Thus, transcrip-
tional complexes such as the the β -catenin/LEF1 complex, which drives Vi-
mentin expression, are much more effected by YREG1. On the contrary, the
pSmad2/4/LEF1 complex, which binds to E-cadherin, is minimally effected by
YREG1. This suggested that the availability of LEF1 takes precedent in forming
the pSmad2/LEF1 complex over other complexes such as β-catenin/LEF1.
5.4 Discussion
Systems insight into complex cellular responses like EMT holds promise in un-
raveling the molecular components and logic underlying dynamic integration
of signals leading to diverse responses. Previous studies in modeling TGFβ,
while limited in scope, provided an insightful analysis for the role of recep-
tor dynamics and Smads. In the current study, we formulated and analyzed a
family of mechanistic models (1700 kinetic constants and 995 initial conditions)
using a detailed molecular framework which described the global induction of
EMT through TGFβ isoforms. The models were identified using 45 different
experimental data sets taken from literature from DLD1 colon carcinoma, MD-
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CKII, and A375 melanoma cell lines [347]. To address parametric uncertainty
in ODE based deterministic models, we implemented an ensemble approach
using POETs. The ensemble of parameter sets allowed us to identify different
operational paradigms within EMT (sub-populations), which provide insightful
information into the possible transformational aspects between cellular pheno-
type. Using model analysis tools like signal flow, sensitivity and robustness
analysis, we were able to identify a few key regulatory modes within TGFβ in-
duced EMT.
The ERK-MAPK pathway has been shown to modify TGFβ signaling at mul-
tiple levels. One such way is that the activated Ras pathway inhibits the TGFβ-
induced nuclear accumulation of Smad2/3, as seen in epithelial cells [633]. ERK
kinases have been shown to phosphorylate Smad2 and Smad3 at specific sites
in the region linking the MH1 and MH2 domains. These sites are separate from
the TGFβ receptor phosphorylation sites which activate Smad nuclear translo-
cation [338]. The effect of interaction between ERKs and Smads is the subject
of some controversy, with data suggesting that such an interaction either en-
hances or inhibits downstream events. A hyperactive Ras pathway has been
shown to effectively counteract the antiproliferative activity of TGFβ through
attenuation of Smad accumulation in the nucleus [275]. In contrast, Ras signals
strongly cooperated with Smads for invasion of human carcinoma cells [385].
The regulation of MPKs (MAPK phosphatases) are highly specific and tightly
controlled through dual specificity. Four unique sub-groups have been shown
to regulate specific complexes within ERK,JNK, and p38 cascades. It has been
suggested that the role of an additional N-terminal domain within the type III
subgroup could be to provide a cross-talk between MAPK and other signaling
pathways[123]. Interestingly, our model suggests that upon TGFβ stimulation,
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high levels of MAPK induces the autocrine response of TGFβ3 and inhibition of
pSmads is limited. A possibility is through selective dephosphorylation of the
MAPK/ERK complexes targeting pSmads.
The role of mechanistic mathematical modeling in understanding global
molecular phenomenons (such as EMT) remains unclear. Structural and para-
metric uncertainty associated with this form of modeling study is of critical con-
cern. In this study, a molecular framework was implemented from numerous
experimental resources to mimic the canonical signaling pathways associated
with TGFβ induced EMT. However, in the current version of the model we
lack certain modules of signaling within EMT. In particular, the regulation of
β-catenin through the GSK3β complex is a widely studied and intricate compo-
nent of the EMT process. TGFβ 3 signals through PI3K to activate AKT. AKT
can then phosphorylate and inactivate the GSK3β complex. GSK3β is an impor-
tant target of both Snail and β-catenin for degradation through the ubiquitin-
proteasome pathway. Thus, it provides a critical negative feedback mechanism
which would should be incorporated in further models. Specifically to our
model, expression of Snail increases through 72 hours. In contrast, experimental
data has shown that activity of Snail peaks at 24 hours. This is possibly through
the regulation of GSK3β and should be included in future models. Addressing
missing structural components like that of GSK3β could allow us to get a more
comprehensive insight into TGFβ signaling. Given the scope of the problem
and limitations imposed by structural/parametric uncertainties, we were able
to investigate into the mechanistic workings of EMT and present falsifiable hy-
pothesis relevant to manipulating EMT. While this study was limited to EMT,
a similar framework could be used to understand and investigate other similar
operational modes relevant to biology.
148
5.5 Materials and Methods
5.5.1 Formulation and solution of the model equations
The EMT model was formulated as a set of coupled ordinary differential equa-
tions (ODEs):
dx
dt
= S · r (x,p) x (to) = xo (5.1)
The symbol S denotes the stoichiometric matrix (995 × 1700). The quantity x
denotes the concentration vector of proteins or protein complexes (995× 1). The
term r (x,p) denotes the vector of reaction rates (1700 × 1). Each row in S de-
scribed a protein or protein-protein complex, while each column described the
stoichiometry of network interactions. Thus, the (i, j) element of S, denoted by
σi j, described how protein i was involved in rate j. If σi j < 0, then protein i was
consumed in r j. Conversely, if σi j > 0, protein i was produced by r j. Lastly, if
σi j = 0, there was no protein i in rate j. All of these interactions were obtained
from the literature.
We assumed mass-action kinetics for each interaction in the network. The
rate expression for interaction q was given by:
rq
(
x, kq
)
= kq
∏
j∈{Rq}
x−σ jqj (5.2)
The set
{
Rq
}
denotes reactants for reaction q while σ jq denotes the stoichio-
metric coefficient (element of the matrix S) governing species j in reaction q.
All reversible interactions were split into two irreversible steps. The mass-
action formulation, while expanding the dimension of the EMT model, regu-
larized the mathematical structure; this allowed automatic generation of the
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model code using UNIVERSAL and regularized the unknown model parame-
ters (parameters were one of only three types, association, dissociation or cat-
alytic rate constants). UNIVERSAL, an open source Java code generator, gen-
erates multiple code types from text and SBML inputs. UNIVERSAL is freely
available as a Google Code project (http://code.google.com/p/universal-code-
generator/). Thus, although mass-action kinetics increased the number of pa-
rameters and species, they reduced the complexity of model analysis. In this
study, we considered well-mixed nuclear, cytosolic and extracellular compart-
ments. The model equations were solved using the LSODE routine in OCTAVE
(v 3.1.0; www.octave.org) on an Apple workstation (Apple, Cupertino, CA; OS
X v10.6.4).
5.5.2 Estimation and cross-validation of a population of models
using Pareto Optimal Ensemble Techniques (POETs)
POETs is a multiobjective optimization strategy which integrates several local
search strategies e.g., Simulated Annealing (SA) or Pattern Search (PS) with a
Pareto-rank-based fitness assignment [504]. POETs has been described previ-
ously [504]. The local pattern-search algorithm has been described previously
[149, 560]. The parameter ensemble used in the simulation and sensitivity stud-
ies was generated from the low-rank parameter sets (Rank ≤ 4) in Ki. We simul-
taneously calculated training and prediction error during the parameter estima-
tion procedure using leave-one-out cross-validation [261]. The complete set of
training data (11 objectives) was subdivided into 11 bins; in each bin 10 data sets
were reserved for training while one were reserved for prediction. In the first
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bin DS1 was used for validation while DS2 . . .DS11 were used for training, etc.
Thus, we formulated 11 ensembles from which we evenly selected parameter
sets for the parent ensemble (supplementary materials). While cross-validation
required that we generate additional model populations, we trained and tested
against all the data sets.
5.5.3 Sensitivity and robustness analysis of the population of
EMT models
Sensitivity coefficients were calculated as shown previously [505, 504, 526] us-
ing 55 models selected from the ensemble (supplementary materials). The re-
sulting sensitivity coefficients were scaled and time-averaged (Trapezoid rule)
as discussed previously [504]. To estimate the relative fragility or robustness
of species and reactions in the network, we decomposed the N () matrix us-
ing Singular Value Decomposition (SVD). Coefficients of the left (right) singular
vectors corresponding to largest β singular values of N () were rank-ordered
to estimate important species (reaction) combinations. Only coefficients with
magnitude greater than a threshold (δ = 0.1) were considered. The fraction of
the β vectors in which a reaction or species index occurred was used to rank its
importance.
5.5.4 Robustness Analysis of the population of EMT models
Robustness coefficients were calculated to understand the robustness of the net-
work as discussed previously [526]. If the robustness coefficient α > 1, then the
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perturbation increased the marker concentration. Conversely, if α  1 the per-
turbation decreased the marker concentration. Lastly, if α ∼ 1 the perturbation
did not influence the marker concentration.
5.5.5 Identification of distinguishable knockouts(overexpression)
and clustering
Robustness coefficients were used to rank-order knockout(overexpression) ex-
periments in terms of the greatest unique responses and identify species which
were linearly distinguishable. The response of the knockout(overexpression)
was measured in terms of the robustness coefficients. A dendrogram was de-
rived by considering each of the knockouts(overexpressions) as variables and
the average log of robustness coefficient (LRC) for each of the species as obser-
vations. The Statistical Toolbox of Matlab (The Mathworks, Natick, MA) was
used to generate the distances, linkages and the final dendrogram.
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CHAPTER 6
ANALYSIS OF THE EUKARYOTIC HYPOXIC RESPONSE REVEALED
HIF-1, AP-1 AND NF-κβ MEDIATED CROSSTALK BETWEEN IL-8 AND
VEGF SIGNALING CASCADES
Authors - Chakrabarti A, Lequieu JP, Kumarga AN, Manzi B, Stojiljkovic M, Chen
M, Guros NB, Dromms RA, Tasseff RA, Verbridge SS, Stroock A, Fischbach-Teschl C
and Varner JD.
Submitted to - Bio Phys J.
6.1 Abstract
Eukaryotes initiate a complex program in response to low levels of extracellu-
lar oxygen. The hypoxic response, which is mediated in part by the action of
the HIF1α transcription factor and reactive oxygen species (ROS), involves the
integration of several intracellular signaling axes. While the hypoxic response
is vital to normal physiology and development, it is also a prevalent feature of
angiogenesis. In this study, we developed a family of mechanistic mathematical
models of the signaling pathways involved in the eukaryotic hypoxic response.
We cataloged the molecular modules mediating different aspects and branches
of the hypoxic response and integrated these modules into a single compre-
hensive model. The integrated hypoxia model (548 molecular species intercon-
nected by 920 interactions), was analyzed to determine critical points of network
failure and possible sources of crosstalk and redundancy. Model parameters
were estimated by comparing simulations with experimental data. We identi-
fied a population of models, consistent with data, using a novel multi-objective
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optimization framework combined with cross-validation. EHR model analysis
revealed a two-phased response within EHR. Initial activity of NF-κβ and AP-1
mediated by VEGF and IL-8 signaling cascades lead to autocrine mediated sig-
nal amplification (∼ 24-48 hrs) in both VEGF (less significant) and IL-8 (more sig-
nificant) signals. This phased behavior was validated with experimental studies
on MDA-MB231 cells. Structural analysis using extreme pathways identified
modes of crosstalk within VEGF and IL-8 signaling e.g., via p38MAPK, MAPK
and PKC, and modes of redundancy e.g., divergent sources of transcription fac-
tor (NF-κβ, AP-1) activation. On the other hand, sensitivity analysis suggested
that regulators of HIF-1α stability e.g., PHD and FIH along with NF-κβ and
AP-1 activation were critical components of the hypoxia program. Computa-
tional gene knockdown(overexpression) studies identified network configura-
tions that either amplified or destroyed the hypoxic response and modulated
the levels of phenotypic markers. Ultimately, analysis of the model population
suggested that interdiction of both NF-κβ and AP-1 regulatory blocks within
EHR was required to disrupt the hypoxic program. These configurations rep-
resent experimentally testable hypothesis and potentially new strategies to ma-
nipulate the hypoxia program.
6.2 Introduction
Tumors, like healthy tissue, require oxygen and other nutrients to grow [66].
However, for tumors beyond a limiting size, oxygen can not be sufficiently sup-
plied to support continued growth. The eukaryotic hypoxia response (EHR),
induced by reduced extracellular oxygen, plays a prominent role in angiogen-
esis [349, 50]. Angiogenesis is a developmental program important in a vari-
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ety of normal physiological contexts [66]. However, in cancer the activation
of the angiogenic switch is a critical event in the vascularization of primary
and metastatic tumors. The underlying mechanisms controlling angiogenesis
are still emerging. Oxygen in the microenvironment is sensed by hypoxia in-
ducible factor 1 α (HIF1α) and the generation of reactive oxygen species (ROS)
[300, 355]. HIF1α mediates the initial phase of the angiogenic program by form-
ing a transcriptionally active complex with HIF1β and co-activators such as
p300. The stability of the HIF1α subunit is oxygen dependent [429]. In nor-
moxic conditions, hydroxylation at two prolyl residues (P402 and P564) by PHD
proteins promotes the association of HIF1α with the Von Hippel-Lindau (VHL)
E3 ubiquitin ligase and subsequently leads to degradation. An additional hy-
droxylation site at N803 near the C-terminus of HIF1α is regulated by the as-
paraginyl hydroxylase FIH. Hydroxylation at N803 does not influence stability;
rather, it blocks the interaction of the HIF1α C-terminal domain with transcrip-
tional co-activators such as p300. Activated HIF1 up-regulates the expression
of many factors including VEGF and Interleukin-8 (IL-8) [580]. On the other
hand, the second oxygen dependent signaling axis, ROS, promotes nuclear fac-
tor κB (NF-κβ) activation [355]. NF-κβ also regulates both VEGF and IL-8 ex-
pression [355, 580]. The exact relationship between ROS and NF-κβ activation
is unclear. However, ROS has been hypothesized to activate a serine kinase
which in-turn phopshorylates the N-terminal serine residues (S32/S36) on IKK;
potential mechanisms reviewed in [131]. Secreted VEGF and IL-8 signals can
then amplify the hypoxic response and induce proliferative signals via both
autocrine or paracrine signaling mechanisms through the VEGFR and CXCR
receptor families.
Physiochemical models which describe system-level responses can priori-
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tize experimental directions, generate testable hypothesis and perhaps identify
and validate potential therapeutic targets [59, 16, 259, 256]. However, it is typ-
ically impossible to uniquely identify model parameters, even with extensive
training data and perfect models [148]. Alternatively, ensemble approaches,
which use uncertain model families, have emerged as a promising strategy to
deal with model uncertainty in systems biology and other fields like climate
prediction [505, 26, 280, 54, 401]. Their central value has been the ability to
quantify simulation uncertainty and to experimentally constrain model predic-
tions. For example, Gutenkunst et al. showed that predictions were possible
using ensembles of signal transduction models despite sometimes only order
of magnitude parameter estimates [176]. More recently, Luan et al. predicted
patient response to therapeutic intervention using an ensemble of human co-
agulation models [319]. Model ensembles have been used with parameter de-
pendent analysis techniques to robustly estimate important signaling network
features. For example, Tasseff et al. characterized emergent behavior between
androgen and growth factor signaling in prostate cancer using an ensemble of
models and sensitivity analysis [526]. Parameter independent techniques such
as extreme pathway analysis have also been used to extract qualitatively impor-
tant features of signaling architectures [406]. Extreme pathways have been used
to characterize the structural basis of emergent properties such as crosstalk in
signaling architectures [405].
In this study, we developed and analyzed a population of mathematical
models of the eukaryotic hypoxic response. The ensemble of EHR models
was identified and tested using experimental data from both mouse and hu-
man cell lines [601, 267, 336, 343, 264, 312, 241, 170, 454]. Thus, the model
described the canonical response of different cell types to oxygen deprivation
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and re-oxygenation studies. Model predictions were independently validated
by ELISA measurements of secreted VEGFA and IL-8 in MDA-MB231 cells, un-
der hypoxic (1% pO2) and normoxic (17% pO2) conditions. Parameter depen-
dent and independent model interrogation techniques identified key aspects
and components of EHR signal propagation. Flux-based analysis revealed a
two-phased response within EHR. Initial activity of NF-κβ and AP-1 mediated
by VEGF and IL-8 signaling cascades lead to autocrine mediated signal am-
plification in both VEGF (less significant) and IL-8 (more significant) signals.
This phased behavior was validated with experimental studies on MDA-MB231
cells. Structural analysis of EHR using extreme pathway analysis identified
modes of crosstalk and redundancy. For example, the highest frequency com-
ponent involved in crosstalk was RAS-GTP which was involved in the feedback
regulation of VEGF and IL-8 cascades via MAPK, while transcription factor ac-
tivation was highly redundant given the convergent sources of transcription
factor controls from both VEGF and IL-8 cascades. On the other hand, sensi-
tivity analysis suggested that regulators of HIF-1α stability e.g., PHD and FIH
along with NF-κβ and AP-1 activation were critical components of the hypoxia
program. Computational gene knockdown(overexpression) studies identified
network configurations that modulated the levels of phenotypic markers and
revealed the basis for emergent properties such as positive and negative syn-
ergy. For example, crosstalk between the VEGFA and IL-8 signaling axes was
predicted to be mediated by MAPK, PKC and p38MAPK. To successfully ma-
nipulate the hypoxic response, it is therefore vital to regulate both NF-κβ and
AP-1 regulatory blocks within EHR. The current EHR model, with inherent
structural and parametric uncertainties, identified falsifiable strategies in ma-
nipulating the hypoxic response. The EHR model is available in SBML in the
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supplemental materials.
6.3 Results
6.3.1 EHR model connectivity.
Model connectivity (human) was assembled from literature and on-line
databases; String-8 [233], NetworKIN [305] and TRANSFAC. The EHR model
described 548 protein or mRNA species interconnected by 920 interactions (Fig.
6.1). The EHR was modeled using mass action kinetics within an ordinary dif-
ferential equation (ODE) framework. ODEs and mass-action kinetics are com-
mon methods of modeling biological pathways [147, 479, 510, 297, 512, 320, 505,
74, 203].
The model described the integration between extracellular O2 levels and
VEGFA, IL-8 autocrine induced intracellular gene expression, proliferation and
death programs. EHR was induced by increased reactive oxygen species (ROS)
and increased stability of hypoxia inducible factor-1α (HIF-1α). ROS induction
was assumed to be inversely proportional to intracellular oxygen concentra-
tion. For HIF-1α, we modeled oxygen-dependent PHD/VHL-induced HIF-1α
degradation and FIH-induced inhibition. In addition to HIF-1α, we modeled
the expression and regulation of four other transcription factors: AP-1, ATF2,
MEF2 and NF-κβ. AP-1 expression was dependent upon both ATF2 and MEF2.
Both ATF2 and MEF2 were constitutively expressed and regulated by phos-
phorylation at T69/T71/T73 for ATF2 and T312/T319 for MEF2 by p38MAPK
family members. We modeled a single activating phosphorylation site on AP-
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Figure 6.1: The Eukaryotic Hypoxic Response: Low cellular oxygen marks
the increased stability of HIF1α and ROS production. Via the
role of transcription factors like AP1, NF-κβ and HIF1, VEGF
and IL8 signaling cascades lead to the critical balance medi-
ating tumor (regular cell) growth and angiogenic signaling.
Nomenclature: HIF1 - Hypoxia Inducible Factor 1, VEGFa
- Vascular Endothelial Growth Factor A, VEGFR2 - Vascular
Endothelial Growth Factor Receptor 2, IL8 - Interleukin -8,
CXCR1 - IL-8 (or CXCL8) chemokine receptors, PKC - Pro-
tein Kinase C, PI3K - Phosphoinositide 3-kinase, p38MAPK -
p38 Mitogen-Activated Protein Kinases, p50 p65 - Nuclear Fac-
tor κ -light-chain-enhancer of activated B cells. Species (pro-
teins and protein-protein complexes) and corresponding inter-
actions making up the Eukaryotic Hypoxic Response (EHR)
model (Top Left).
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1 (S63/S73), which was regulated by ppERK (phosphorylated ERK) which is
formed downstream of both IL-8 and VEGFA signaling cascades. NF-κβ regula-
tion was more complex; NF-κβwas assumed to be sequestered by a lumped pool
of IκB family members. The regulation of this pool occurred by phosphoryla-
tion at S32/S36 and Y42 on IκB; S32/S36 was phosphorylated by PKC while Y42
was regulated by an unknown ROS-dependent kinase. Lastly, protein markers
downstream of these transcription factors were used to characterize prolifer-
ation, survival and death phenotypes. AP-1 dependent Cyclin D expression
was used as a marker of proliferation. NF-κβ dependent Bcl2 expression was
used to characterize cell survival while HIF-1α dependent BNIP3 expression
was used as a cell death marker. In addition to these markers, the expression of
VEGFA, IL-8 and their respective surface receptors VEGFR2 and CXCR1/2 was
also modeled. These receptors were connected to transcription factor activation
through the activity of the MAPK, p38MAPK and PKC kinases. Complete de-
tails of the interactions in the model are enlisted in the supplementary materials.
6.3.2 Estimating a population of EHR models using POETs.
Model parameters were estimated using 20 experimental data sets taken from
literature (Table 6.1). In total, 1468 unknown parameters (920 kinetic parameters
and 548 initial conditions) were present in the EHR model. Both kinetic param-
eters and unspecified initial conditions were estimated using the POETs multi-
objective optimization algorithm [504]. Additionally, we used cross-validation
to independently estimate both the prediction and training error during the pa-
rameter estimation (Table 6.1). We used a leave-five-out strategy; five of the
twenty objectives were reserved for validation while the remaining 15 were
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Figure 6.2: Selected objective value plot for the ensemble of EHR models:
The grid is a compilation of 2-dimensional plots of the objective
values obtained using POETs [504]. Multi-objective optimiza-
tion scheme allowed us to obtain trade-offs between diverse
data sets as seen in O18-O19, O12-O13 and O13-O14. Inset:
O18-O19 plot states how we obtain a trade-off between objec-
tive functions for BNIP3 in MCF-7 cells and HEK293 cells. This
allows us to address qualitative differences in the behavior of
BNIP3 in the two cell lines. This figure suggests how POETs
was successful in addressing conflicts (due to cell type, exper-
imental protocols etc.) in the data-sets while searching the pa-
rameter space.
used for model training. Thus, we estimated four different model families each
of which was trained and validated on different experimental data. POETs gen-
erated more than 40,000 probable models.
We selected models with Pareto rank one or less (N = 3233) for further
study. The coefficient of variation (CV) for the parameters in the model ensem-
ble ranged from 0.8 - 1.8 (supplemental materials). Approximately, 20% of the
model parameters were constrained with a CV ≤ 1 while 65% of the model pa-
rameter sets had a correlation coefficient of less than 80% (supplemental materi-
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als). This suggested that we generated a diverse population of EHR models. The
most tightly constrained parameters governed oxygen uptake, transcription fac-
tor regulation and HIF1α degradation. On the other hand, the least constrained
involved the MAPK module and the downstream interactions of BNIP3. Pareto
fronts developed between several objectives, e.g., O5×O13, O12×O13, O13×O14
and O18×O19. These fronts indicated conflicts in the training data or an in-
ability of the model to simultaneously capture different aspects of the training
data (Fig. 6.2). For example, O18 and O19 were BNIP3 protein measurements
taken from MCF-7 and HEK293 cells. A front between these objectives sug-
gested that hypoxia-induced BNIP3 expression varied between these cell-lines.
On the other hand, conflicts between CXCR1 expression (O13) and other net-
work components were perhaps rooted in the network topology, e.g., VEGFR
and CXCR1/2 mediated competing integration pathways.
The ensemble of EHR models recapitulated diverse training data across mul-
tiple cell-lines (Table 6.1). Training data for the EHR model were chosen based
upon species connectivity as well as structural analysis of the EHR network.
Hypoxic, re-oxygenation and IL-8 induction studies were all used for model
training. Approximately, 55% of the models in the ensemble performed better
in training versus validation. When compared to the initial best fit model, we
lost resolution for ∼50% of the objective functions (Table 6.1). The most signif-
icant loss was for Bcl2 mRNA (O6) and extracellular IL-8 measurements (O11).
On the other hand, we saw improvements for BNIP3 (O19) and NF-κβ (O12)
objective functions.
On average, we predicted VEGFA signaling events better (average predic-
tion error of 0.32) compared to IL-8 (average prediction error of 0.41). A sam-
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Figure 6.3: Average model performance against data for selected species in
the model: Average model performance with one standard er-
ror is shown for four key species in the network ((A) HIF-1 data
and (B) CXCR1 data used from studies performed by Maxwell
et. al. on hypoxic PC3 cells [343], (C) VEGFa data used from
studies performed by Romero-Ramirez et. al. on MEFs [454], (D)
VEGFa data used from IL-8 induced studies done by Martin
et. al. on SVEC cells [336]). Overall the model recapitulated the
behavior of species (both upstream and downstream) across di-
verse data sets [601, 267, 336, 343, 264, 312, 241, 170, 454].
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Table 6.1: Objective function list along with species, cell-type, cellular compart-
ment, nominal error (nom), training error, prediction error, random error with
a randomly generated parameter set and the corresponding literature reference
(ref).
Obj# species type cells compartment nom training prediction random ref
O1 IL-8 mRNA PC3 Total RNA 0.32 0.45 ± 0.11 0.44 ± 0.13 0.68 ± 0.09 [343]
O2 IL-8 Protein PC3 Total lysate 0.52 0.50 ± 0.09 0.48 ± 0.08 0.70 ± 0.05 [343]
O3 CXCR1 mRNA PC3 Total RNA 0.46 0.40 ± 0.11 0.44 ± 0.13 0.73 ± 0.20 [343]
O4 CXCR1 Protein PC3 Total lysate 0.25 0.30 ± 0.12 0.33 ± 0.11 0.52 ± 0.19 [343]
O5 HIF-1α Protein PC3 Total RNA 0.34 0.34 ± 0.13 0.38 ± 0.15 0.66 ± 0.14 [343]
O6 Bcl2 mRNA PC3 Total lysate 0.09 0.36 ± 0.15 0.37 ± 0.16 0.74 ± 0.06 [343]
O7 PLGF mRNA MEF Total RNA 0.27 0.32 ± 0.12 0.29 ± 0.10 0.75 ± 0.16 [170]
O8 VEGF mRNA MEF Total RNA 0.29 0.28 ± 0.16 0.25 ± 0.15 0.68 ± 0.28 [170]
O9 VEGF mRNA MEF Total RNA 0.42 0.38 ± 0.13 0.31 ± 0.16 0.69 ± 0.09 [454]
O10 HIF1α Protein GES Total lysate 0.25 0.28 ± 0.14 0.25 ± 0.08 0.51 ± 0.23 [312]
O11 IL8
(free)
Protein HUVEC Supernatant 0.08 0.33 ± 0.24 0.40 ± 0.27 0.42 ± 0.24 [241]
O12 NF-κB Protein Jurkat T Total lysate 0.72 0.44 ± 0.22 0.42 ± 0.22 0.53 ± 0.18 [264]
O13 CXCR1 mRNA PC3 Total RNA 0.25 0.39 ± 0.16 0.37 ± 0.17 0.76 ± 0.09 [343]
O14 VEGFa mRNA SVEC Total RNA 0.55 0.43 ± 0.16 0.42 ± 0.19 0.76 ± 0.18 [336]
O15 VEGFa Protein SVEC Total lysate 0.15 0.24 ± 0.23 0.18 ± 0.18 0.58 ± 0.29 [336]
O16 VEGFR2 Protein SVEC Total lysate 0.21 0.26 ± 0.19 0.32 ± 0.24 0.57 ± 0.23 [336]
O17 VEGFa Protein SVEC Supernatant 0.19 0.28 ± 0.24 0.35 ± 0.27 0.56 ± 0.30 [336]
O18 BNIP3 Protein MCF-7 Total lysate 0.34 0.34 ± 0.12 0.33 ± 0.12 0.64 ± 0.12 [267]
O19 BNIP3 Protein HEK293 Total lysate 0.52 0.26 ± 0.16 0.24 ± 0.13 0.46 ± 0.26 [267]
O20 AP1 Protein HT29 Total ex-
tracts
0.08 0.14 ± 0.11 0.16 ± 0.10 0.81 ± 0.22 [601]
ple of the model performance for key species is shown in Fig. 6.3. The model
population captured the enhanced stability of HIF1α following the shift from
normoxia to hypoxia (≤ 2% pO2) in PC3 cells (Fig. 6.3A). The enhanced stability
occurred over a short timescale (approximately four hours). After transloca-
tion, nuclear HIF1α was then free to complex with HIF1β and p300 to drive
the initial hypoxia-induced expression program. This second phase occurs on a
longer timescale, 24 48 hrs after the shift to hypoxic environment (≤ 2% pO2).
The model also captured the long timescale behavior e.g., CXCR1 (Fig. 6.3B)
and VEGFA (Fig. 6.3C) expression. VEGFA and CXCR1 expression was regu-
lated by both HIF1α and NF-κβ. Thus, both VEGFA and CXCR1/2 expression
is partially driven by positive feedback by VEGF and IL-8 mediated autocrine
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signaling. Another example of crosstalk was the connection between exoge-
nous IL-8 and VEGFA expression (Fig. 6.3D). The model recapitulated IL-8 (100
ng/ml) induced VEGFA expression in SVEC cells in a normoxic environment.
It suggested this integration occurred following the phosphorylation of IκB at
S32/S36 in a PKC-dependent manner, leading to NF-κβ activation.
We analyzed the dynamics within the EHR network by looking at the flux
distributions over time, upon induction of hypoxia (≤ 2% pO2) and upon recov-
ery from hypoxia by inducing normoxic conditions (≥ 17% pO2) (Fig. 6.4A). At
hypoxic conditions, we found that there was a two-phased response demarcat-
ing the onset of a later autocrine mediated signal amplification. We found that
VEGF signaling branch was the first to respond, mediated by the activity of HIF-
1 and ROS mediated NF-κβ activation. Around 24 hours into hypoxia, we saw
a second increment in VEGF and IL-8 signaling. This late phase behavior was
a result of the positive feedback mediated by the activation of AP-1 and NF-κβ
downstream of both VEGF and IL-8 signaling cascades. Simulated KO studies
of AP-1 and NF-κβ supports their role in signal amplification (supplementary
materials Fig. 2).
Comparatively, the dominant increase in the IL-8 signaling branch was more
in the second phase of the response (consistent with experimental data as dis-
cussed later). However upon induction of normoxic conditions, we did not see a
difference in terms of recovery time between VEGF and IL-8 signaling cascades.
HIF-1 and NF-κβ activity dropped down within a few hours of induction of
normoxic conditions. On the contrary VEGF and IL-8 took around 10-15 hrs to
recover. Steady state flux comparisons (P1 and P2 in Fig. 6.4A-B) revealed that
in the ∼1% O2 conditions, flux through the MAPK module is higher compared
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Figure 6.4: Flux analysis of EHR: (A) Plot of the scaled flux (0-1) of HIF-
1/NF-κβ transcription factors and secreted VEGFA/IL8 over
time. At hypoxic conditions, there was a two-phased response
demarcating the onset of a later autocrine mediated signal am-
plification. VEGF signaling branch was the first to respond,
mediated by the activity of HIF-1 and ROS mediated NF-κβ
activation. Around 24 hours into hypoxia, we saw a second
increment in VEGF and IL-8 signaling. However upon induc-
tion of normoxic (∼17% O2) conditions, we did not see a dif-
ference in terms of time of recovery between VEGF and IL-8
signaling cascades. HIF-1 and NF-κβ activity dropped down
within a few hours of induction of normoxic conditions. On
the contrary VEGF and IL-8 took around 10-15 hrs to recover.
(B-D) Fluxes at P1 (∼10% O2) when compared to P2 (∼1% O2 af-
ter 60 hrs) show increased VEGF and IL8 signaling leading to
enhanced MAPK activity along with increased NF-κβ activity
both via ROS and downstream of receptor signaling cascades.
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to ∼10% O2 conditions (Fig. 6.4B). This was owing to the convergent MAPK
activation downstream of both VEGF and IL-8 signaling. Relatively, there was
a hundred fold increase in Cyclin-D regulation in hypoxia (∼1% O2), mediated
by activation of AP-1 signaling. Steady state flux comparisons (P2 and P3 in
Fig. 6.4A-D) revealed that there was a switch like behavior in the EHR. This
switch characteristic was exhibited via the oxygen mediated increased stability
of HIF-1α via PHD and ROS activity. For example, components above the 45
in Fig. 6.4D, indicate the dominant mode of operation in normoxic (∼17% O2)
conditions. These include PHD and ROS regulation via oxygen, which induces
low amount of VEGF and IL-8 signaling. On the contrary, components below
the 45 in Fig. 6.4D, indicate the dominant mode of operation in hypoxic (∼1%
O2) conditions. These include the VEGF and IL-8 mediated signal integration.
Taken together, the population of EHR models recapitulated both short- and
long timescale behavior following hypoxia or exposure to exogenous IL-8 in a
variety of cell types. It also captured the integration between multiple path-
ways and generated specific and testable hypothesis about the role of network
components in signal propagation.
6.3.3 Model Prediction against 1% and 17% O2 experimental
data in MDA-MB231 cells.
Micro-fabricated 3-D tumor models offer the potential to recreate cell-
microenvironment interactions that recapitulate human tumor behavior [563].
Recently, they have been used to investigate the individual contributions of O2
concentration, culture dimensionality, cellECM interactions, and the coupling
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of these effects on tumor angiogenesis [563]. In this study, we measured VEGF
and IL-8 secretions of MDA-MB231 cells in alginate hydrogels under hypoxic
(1% O2) and normoxic (17% O2) conditions at days 1, 3 and 5 (details in materi-
als and methods) and compared it to simulation predictions (Fig. 6.5).
At hypoxic (1% O2) conditions, we found that secreted VEGF levels almost
reach steady state values by day 1 as compared to day 3 and 5 (Fig. 6.5A), which
was consistent with model predictions. This behavior indicated that the major
fold change in the VEGF signaling occurred in the first phase of the hypoxic
response as predicted by the model simulations. However at normoxic (17% O2)
conditions, we saw a decrease in VEGF levels at day 3 and 5 as compared to day
1. We found that the delay in the response of the system to normoxic conditions
was of the order of a day, after which the levels dropped down to ∼ 50% of the
actual values. This behavior could be a result of the reduced levels of HIF-1
and ROS mediated VEGF and IL-8 signal activation. In case of IL-8, at hypoxic
conditions we found experimentally that secreted IL-8 levels rose slowly and
reached steady state values around day 3 to day 5 (Fig. 6.5B). However model
predictions showed a faster rate for IL-8 production. This discrepancy could
be due to the lack of important structural information. For example, recently
it was shown that HIF-1 induction attenuated Nrf-2 dependent IL-8 expression
in HUVECs [315]. Lack of this negative control on IL-8 expression via HIF-1,
could be one of the many reasons for the high predicted rate of IL-8 secretion
in the model. Interestingly, it was observed both experimentally and predicted
by the model that under normoxic conditions secreted IL-8 levels increased with
time. One potential explanation is that, normoxic conditions leads to even lower
amount of basal HIF-1 activation and subsequently more Nrf-2 mediated IL-8
expression. However the model lacked this connectivity, yet it recapitulated this
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Figure 6.5: Comparison of experimental data (ELISA measurements) ver-
sus simulation predictions for secreted VEGF and IL-8 in 1%
and 17% O2 samples in MDA-MB231 cells: At hypoxic (1% O2)
conditions, secreted VEGF levels almost reach steady state val-
ues by day 1 as compared to day 3 and 5, indicating that the
major fold change in the VEGF signaling occurs in the first
phase of the hypoxic response consistent with the prediction
by the model simulations. However at normoxic (∼17% O2)
conditions, we see a decrease in VEGF levels at day 3 and 5
as compared to day 1, which is a result of reduced levels of
HIF-1 and ROS mediated VEGF activation. In case of IL-8, at
hypoxic conditions we found experimentally that secreted IL-
8 levels rose slowly and reached steady state values around
day 3 to day 5. However model predictions showed a faster
rate for IL-8 production. Interestingly, it was observed both ex-
perimentally and predicted by the model that under normoxic
conditions secreted IL-8 levels increased with time.
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behavior. This was a result of lower amount of CXCR1/2 production leading to
higher amount of free extracellular IL-8 levels. Taken together, the population
of EHR models with inherent structural and parametric uncertainty provided
valid predictions for hypoxic and normoxic experiments.
6.3.4 Parameter independent topological analysis identified
the structural basis of EHR crosstalk and redundancy.
Signal transduction architectures frequently contain redundancy, feedback and
crosstalk. These topological features ensure signal propagation is adaptable,
efficient and robust. However, they also make reprogramming signal flow chal-
lenging. To understand the structural basis of crosstalk and redundancy in EHR,
we calculated the extreme pathways (EPs) of the EHR network. Extreme path-
ways (EPs) are systemic pathway vectors which describe steady-state flux dis-
tributions through molecular networks. While EPs tell us nothing about net-
work dynamics, the convex combination of these vectors provides a means of
understanding possible steady-state phenotypes. Thus, extreme pathways and
elementary modes [482] have been used previously to understand the qualita-
tive features of metabolic and signaling networks [511, 406, 405].
To calculate EPs, we used a flux based cut-off (Flux (AU/gdw hr) > 0.1)
to select which interactions were participating at steady state for 10%, 1% and
17% O2 conditions (points P1, P2 and P3 in Fig. 6.4A). The EPs (2515 for 10%
O2, 2332 for 1% O2 and 2556 for 17% O2) of the EHR network were calculated
using ExPA [31] and the Octave programming environment (www.octave.org).
The structural importance of any interaction was measured on the basis of its
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participation in the EPs at any state. In case of 10% O2, HIF-1β regulation had
the most participation number in EPs (∼300 EPs) (Fig. 6.6A-B).
VEGFR1 signaling was seen to be more significant in 10% O2 conditions as
compared to 1% O2 conditions, giving importance to the decoy signaling role
of VEGFR1. While in case of 1% O2, MAPK regulation mediated by MEK-
Pase (phosphatase for MEK) and VEGFR2-mediated signaling was seen to be
the most important in terms of participation in EPs (∼300 EPs). In case of 17%
O2, HIF-1α regulation via O2 was the set of reactions with the most participation
(∼170 EPs) (Fig. 6.6A-C). Overall, VEGF signaling elements were structurally
most important in both 10% and 1% O2 conditions. This corroborated with the
dominant modes of operation (as seen by flux based studies) at different O2 lev-
els.
Singular value decomposition (SVD) of the stoichiometric [121] and EP ma-
trices [428] both generated a singular value spectrum where the largest mode
had a fractional weight of only 2%. Compared to other biological networks e.g.,
genome scale E.coli and S.cerevisiae metabolic networks [448, 137], or the human
coagulation network [319], the EHR network was less organized around a single
dominant mode. However, the EHR network did contain significant crosstalk
and redundancy. Crosstalk and redundancy amongst the EHR network EPs (for
1%, 10% and 17% O2 conditions) was calculated according to the scheme of Pa-
pin and Palsson [406] (Fig. 6.6D). For both 1% and 10% O2 conditions, we found
that ∼60% of the EPs had a disjoint output sets and a similar/same input sets,
suggesting a divergent nature of the network. For example, oxygen sensing lead
to HIF-1 and ROS mediated activation of VEGF and IL-8 signals, subsequently
leading to multiple outputs like active PI3K, active MAPK components, active
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Figure 6.6: Structural analysis of the EHR model: EHR model was ana-
lyzed by the Extreme pathway analysis (Details in Materials
and methods) to identify the critical structural components.
(A-C) Extreme pathway analysis revealed the VEGF module as
structurally most important followed by the transcription fac-
tor (AP1 and NF-κβ) module. (D) Analysis of the EP’s of the
EHR network showed presence of significant crosstalk and re-
dundancy. For both 1% and 10% O2 conditions, we found that
∼60% of the EPs had a disjoint output sets and a similar/same
input sets, suggesting a divergent nature of the network. For
example, oxygen sensing lead to HIF-1 and ROS mediated acti-
vation of VEGF and IL-8 signals, subsequently leading to mul-
tiple outputs like active PI3K, active MAPK components, active
transcription factors e.g. NF-κβ, AP-1. We found that ∼5% of
the EPs exhibit redundancy. This exhibited redundant routes
within the EHR, for example: VEGF could lead to AP-1 activa-
tion either directly via MAPK or via p38MAPK. The crosstalk
and redundancy observed in the EPs could be the structural ba-
sis of complex behaviors such as synergy. On the other hand,
the redundant EPs identified the structural basis of EHR ro-
bustness, i.e., which interactions could be removed while si-
multaneously maintaining network function.
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transcription factors e.g. NF-κβ, AP-1. We found that ∼5% of the EPs exhibit re-
dundancy. This exhibited redundant routes within the EHR, for example: VEGF
could lead to AP-1 activation either directly via MAPK or via p38MAPK. Under
17% O2 conditions, we found that ∼50% of the EPs exhibited a divergent nature.
At any mode of operation >50% of the EPs encoded network crosstalk, i.e., the
same or similar inputs produced variable outputs (Fig. 6.6D). Taken together,
the crosstalk and redundancy observed in the EPs could be the structural ba-
sis of complex behaviors such as synergy. On the other hand, the redundant
EPs identified the structural basis of EHR robustness, i.e., which interactions
could be removed while simultaneously maintaining network function. The EP
matrix is available in the supplemental materials.
6.3.5 Population sensitivity analysis revealed globally and
temporally important network components.
Sensitivity analysis has been used previously in several studies to estimate crit-
ical features of networks important to human health, see e.g., [74]. First order
sensitivity coefficients were computed for both 10% O2 and 1% O2 conditions
using parameter sets selected based on CV (supplementary materials). These
coefficients were then time-averaged (from 0-30 hrs or in 6 hr time steps) to
form the N array and decomposed using SVD (materials and methods). The
magnitude of the coefficients of the left (right) singular vectors corresponding
to largest β singular values of N were used to rank-order the importance of the
nodes (edges) in the model (Fig. 6.7 and supplementary materials).
Given the phased behavior involved in the system, we analyzed the tempo-
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Figure 6.7: Ranked NSS index for species and parameters in the EHR mod-
els: Temporal changes in the rank of the species is plotted for
5 time bands (0-6, 6-12, 12-18, 18-24 and 24-30 hrs) in hypoxic
(∼1% O2) case. In terms of species in the case of 1% O2, MAPK
components were seen to be more important at later (24-30 hrs)
time band as compared to earlier (0-6 hrs) times of EHR. MAPK
is a critical regulator of AP-1 activation, which in turn plays an
important role at later times (> 24 hrs) leading to autocrine me-
diated IL-8 signal amplification. AP-1 and NF-κβ regulatory
module was the second group of species which was relatively
more important at later time points. Inset - Ranks of the param-
eters are plotted with one standard deviation for ∼1% against
∼10% O2 case. In terms of parameters, infrastructure parame-
ters e.g. nuclear transport, RNA polymerase or Ribosome bind-
ing were globally critical components. Interactions governing
the regulation of VEGFR2 and VEGFA were the most fragile in
both 1% and 10% O2 conditions. Regulation of the expression
and activation of transcription factors like AP-1, HIF-1 and NF-
κβ was in the top 25 fragile species and parameters. In terms of
a modular comparison, the transcription factor module was the
most fragile, closely followed by the HIF1, VEGF and IL8 mod-
ules. Comparatively, the MAPK module was relatively robust.
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ral changes in the sensitivities of the species(parameters) in five time bands (0-6,
6-12, 12-18, 18-24 and 24-30 hrs) (Fig. 6.7 and supplementary materials). Devia-
tion from the 45 was used to see qualitative differences in terms of importance
in species(parameters). In terms of species in the case of 1% O2, MAPK compo-
nents were seen to be more important at later (24-30 hrs) time band as compared
to earlier (0-6 hrs) times of EHR (Fig. 6.7). MAPK is a critical regulator of AP-1
activation, which in turn plays an important role at later times (> 24 hrs) lead-
ing to autocrine mediated IL-8 signal amplification. AP-1 and NF-κβ regulatory
module was the second group of species which was relatively more important at
later time points. This could be attributed to the regulatory role played by AP-1
and NF-κβ in influencing the positive feedback downstream of both VEGF and
IL-8 signaling cascades. Interestingly, both VEGF and IL-8 signaling modules
are relatively equally fragile(robust) throughout EHR. In terms of parameters,
infrastructure parameters e.g. nuclear transport, RNA polymerase or Ribosome
binding were globally critical components. Interactions governing the regula-
tion of VEGFR2 and VEGFA were the most fragile in both 1% and 10% O2 con-
ditions. This supports the structural importance of VEGF signaling seen by the
extreme pathway analysis and the dominant role played by these interactions as
evidenced by the Flux analysis. Regulation of the expression and activation of
transcription factors like AP-1, HIF-1 and NF-κβwas in the top 10 fragile species
and parameters (Fig. 6.7 Inset and supplementary materials). This result can be
attributed to critical nature of AP-1 and NF-κβ mediated crosstalk in the EHR
model via regulation of the VEGF and IL-8 signaling cascades. So the feedback
and signal amplification mediated by AP-1 and NF-κβ was the most critical as-
pect of the EHR. Other key components identified by sensitivity analysis were
related to HIF-1α, IL8 expression, regulation of PI3K and MAPK. Sensitivity
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analysis also revealed the fragility of the downstream regulation of Cyclin D
and Bcl2. A modular comparison of importance of the interactions revealed
the transcription factor (AP-1 and NF-κβ regulation) module as the most fragile
while the MAPK module was relatively robust (Fig. 6.7 Inset). Taken together,
sensitivity analysis revealed that while overall MAPK module was relatively
robust in the system, at later (>24 hrs) into hypoxia MAPK components are
relatively fragile. Overall VEGF signal integration, AP-1/NF-κβ/HIF-1α regu-
lation was seen as the most fragile aspect of EHR. Comparatively IL-8 signaling
module was relatively robust.
6.3.6 Robustness analysis presented NF-κβ and AP-1 as the key
regulatory nodes in manipulating the EHR.
Signal transduction architectures frequently contain redundancy, feedback and
crosstalk. For example, nearly 70% of the EPs of the EHR network involved
crosstalk or redundancy. These topological features often lead to complex syn-
ergistic behaviors as well as robustness. However, networks which are highly
optimized for specific tasks, may also contain hidden fragility [65]. Here, we
generated falsifiable predictions about the fragility or robustness of the EHR
network using robustness analysis. Robustness coefficients were used to quan-
tify the effect of structural perturbations (edge/node deletions and overexpres-
sion) on network markers. Coefficients with values > 1 (< 1) indicated a marker
increased (decreased) compared to a base state, while a value of ∼ 1 indicated
approximately no change following a perturbation. For each type of perturba-
tion, we calculated the robustness coefficients using the nominal parameter set.
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We calculated the direction of O2-induced concentration shifts for 548 mark-
ers following single parameter knockouts (SPK), dual parameter knockouts
(DPK) and multiple parameter knockouts (MPK) to the EHR network. In the
SPK study, we found that on average 200 parameters led to increased marker
levels, while around 350 parameters led to decreased marker levels. Deletion of
interactions involved with PHD formation, HIF-1α degradation, the regulation
of decoy receptors for VEGFA and the sequestering of VEGFA and IL-8 signals
resulted in the most pronounced effects. This result supports the claim of the
structural analysis that VEGF and IL-8 signal integration and HIF-1α regula-
tion in hypoxia are the most critical aspects of EHR. SPK analysis also high-
lighted the importance of AP-1, p38MAPK and PKC. This result is in accord
with the positive feedback mediated by these species on the EHR, so any alter-
ations in the regulation of AP-1, p38MAPK and PKC have a reduction in the
marker levels. Phenotypic behavior of the EHR models were analyzed as a re-
sult of parameter knockout, using downstream markers like BNIP3 (marker for
cell death), Bcl2 (marker for cell survival) and Cyclin D (marker for cell growth)
(supplementary materials Fig. A.4). We identified 35% of SPK cases which had
a pro-death phenotype marked by increased (robustness coefficient > 1) marker
levels of BNIP3 and decreased (robustness coefficient < 1) marker levels of Bcl2
(supplementary materials). Around 20% of SPK cases had a pro-growth pheno-
type marked by increased (robustness coefficient > 1) marker levels of Cyclin D
as compared to pro-death phenotype (supplementary materials). Results clearly
shows the +ve correlation between cell growth and cell survival phenotypic be-
havior. It is interesting to note the feasibility of regulating the phenotypic be-
havior by altering one or more interactions. This highlights the importance of a
structurally complete model in order to analyze the overall behavior.
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Figure 6.8: Robustness Analysis of EHR models: (A) Dendrogram of the
single gene knockouts revealed clusters with inherent func-
tional relationships. For example, the most distinct separation
was between the MAPK, PKC and VEGF signal initiation seg-
ment from the rest of the knockouts. MAPK and PKC are one
of the few pillars mediating the crosstalk between VEGF and
IL-8 signaling and also regulating signal amplification. On the
other hand, functional groups like regulation of NF-κβ, regula-
tion of AP-1, HIF-1 regulation and IL-8 signal initiation were
all rightly classified as having similar grouped responses. In-
set - A: Plot of the orthogonal components of each knockout so
as to identify the uniqueness of the knockout. All the single
gene knockouts were found to have orthogonal components
greater than one with a 95% confidence. Knockout of HIF-1α,
p38MAPK, p65, PLCγ and VEGFA were some of the knockouts
which produced the most unique knockouts. (B) Phenotypic
analysis (pro-death as elevated BNIP3 levels or pro-survival as
elevated Bcl2 levels) of dual gene knockouts using three cases:
case 1 - CXCR1 & PHD KO, case 2 - VEGFR1 & PI3K KO and
case 3 - RAFPase & p65 KO. In case 1, there was a diverse dis-
tribution of response in terms of pro-death phenotype (marked
by log of robustness coefficients of BNIP3 both > and < 1). We
found two populations, one set of ensembles (∼25%) revealed a
pro-death phenotype marked by a ten-fold increment in BNIP3
levels. On the other hand, there was a population of the en-
semble (∼50%) which did not have much effect over the BNIP3
levels. This attested the fact that we have a diversity in terms of
cellular behavior in the ensemble of our EHR models. In case 3,
RAFPase and p65 KO lead to a dominant pro-death phenotype.
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Single gene knockdown and over-expression studies are common in the
experimental literature. However, large-scale single or combinatorial knock-
down experiments similar to, for example the Keio collection in E. coli [20],
are not tractable in human or mouse hosts. Comprehensive knockout and
over-expression simulations, using validated mechanistic models, are perhaps
an alternative means to generate testable hypotheses and therapeutic insights.
We looked at 548 markers following the deletion or overexpression of the 49-
regulated genes from the model (supplementary material Fig. A.5). Gene
knockout studies revealed the critical players involved in increase of marker
levels as components of the HIF-1α degradation machinery (e.g., PHD) and
HIF-1α regulation (e.g., FIH), decoy receptors for the VEGFA (e.g., VEGFR1)
and regulatory elements of the MAPK cascades (e.g., ERKPase) (supplemen-
tary materials Fig. A.5). However, the predominant effect of gene knockouts
was that of reduced marker levels. Early stage markers of the EHR signaling
cascade like HIF-1α, HIF-1β, VEGFA, VEGFR2, PKC, p38MAPK, NF-κβ and AP-
1 were clearly seen to have an enhanced down-regulatory effect (Fig. A.5A).
Global analysis of the gene knockout robustness coefficients by clustering to
minimize the variance, provides a systems-level insight into EHR. As in Fig.
??A, dendrogram of the single gene knockouts revealed clusters with inherent
functional relationships. For example, the most distinct separation was between
the MAPK, PKC and VEGF signal initiation segment from the rest of the knock-
outs. MAPK and PKC are one of the few pillars mediating the crosstalk between
VEGF and IL-8 signaling and also regulating signal amplification. On the other
hand, functional groups like regulation of NF-κβ, regulation of AP-1, HIF-1 reg-
ulation and IL-8 signal initiation were all rightly classified as having similar
grouped responses. We computed the magnitude of the orthogonal components
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of the single gene knockout coefficients (Fig. 6.8A Inset). The orthogonal com-
ponent was used to establish the uniqueness of the knockout. All the single
gene knockouts were found to have orthogonal components greater than one
with a 95% confidence. Knockout of HIF-1α, p38MAPK, p65, PLCγ and VEGFA
were some of the knockouts which produced the most unique knockouts. In-
terestingly, knockouts implicating or regulating the transcription factors are the
most influential knockouts. Gene overexpression results were complementary
to the knockout studies, revealing the key role of regulation of HIF-1α signal ini-
tiation, regular and decoy VEGFA signaling and components of MAPK (MEK,
ERK) (Fig. A.5B). Complementary to normal intuitions, increase in HIF-1α or
IL-8 alone did not lead to up-regulation of the EHR due to crosstalk mediated
by NF-κβ and AP-1 in regulating VEGF and IL-8 signaling cascades. However,
overexpression of CXCR1, VEGFA, VEGFR2, ERK and MEK lead to increased
marker levels and enhanced EHR (Fig. A.5B). Dendrogram of the clusters of
overexpression studies revealed that IL-8, AP-1 regulation and HIF-1 regula-
tion had the most distinct separation from the rest of the overexpression studies
(Fig. A.7). Around 96% of the single gene overexpression studies were found to
have orthogonal components greater than one with a 95% confidence (Fig. A.7
Inset).
Using combinatorial gene knockouts (1176 exclusive combinations of two
genes), we explored the phenotypic behavior exhibited by the EHR model (Fig.
A.6). Combinatorial gene knockouts identified unique phenotypes as com-
pared to the phenotypic behavior obtained by SPK-DPK analysis. We identi-
fied sub-populations that had a pro-survival (15%), pro-growth (15%) and pro-
death (65%) phenotype. The positive correlation between pro-growth and pro-
survival phenotypes could be attributed to the transcriptional role of AP-1 and
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NF-κβ. The dominant phenotype of pro-death could be attributed to the HIF-1
dependent regulation of BNIP3 and NF-κβ dependent regulation of Bcl2. How-
ever the dominant phenotype in tumors and cancer is that of pro-growth and
pro-survival. It was interesting to note populations that were both pro-death
and pro-survival. Synergistic effects in combinatorial gene knockouts were due
to the crosstalk of VEGF and IL-8 signaling cascades mediated by the role of
NF-κβ and AP-1.
We isolated three cases to investigate the dual gene knockouts further: case
1 - CXCR1 & PHD KO, case 2 - VEGFR1 & PI3K KO and case 3 - RAFPase & p65
KO and analyzed their effect over the entire ensemble (Fig. 6.8B). We analyzed
the effects of these KOs in the pro-growth and pro-death phenotypic plane. In
case 1, there was a diverse distribution of response in terms of pro-death phe-
notype (marked by log of robustness coefficients of BNIP3 both > and < 1) (Fig.
6.8B Inset). We found two populations, one set of ensembles (∼25%) revealed a
pro-death phenotype marked by a ten-fold increment in BNIP3 levels. On the
other hand, there was a population of the ensemble (∼50%) which did not have
much effect over the BNIP3 levels. This attested the fact that we have a diver-
sity in terms of cellular behavior in the ensemble of our EHR models. BNIP3
activity is regulated both at transcriptional level via HIF-1 and at the protein
level via binding to Bcl2. PHD knockout, leads to stronger HIF-1 signal so at
the transcriptional level we have more BNIP3 production. However, the role
of Bcl2 is regulated via NF-κβ which is regulated by both HIF-1 dependent and
HIF-1 independent cascades. So the difference in the BNIP3 levels in the popu-
lation, could be attributed to the differential regulation of NF-κβ in the ensem-
ble. In case 2, we did not find much effect of the KO over the ensemble. This
was attributed to the lack of structural connectivity between active PI3K and
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the other components of the model. Active PI3K was a downstream component
in the current EHR model and was only connected to Paxillin. VEGFR1 in the
model only acts as a decoy receptor for VEGFA, so knockout of VEGFR1 only
leads to amplification of the hypoxic signal in the VEGF branch. However in
recent experiments it was shown that VEGFR1 signals through the eNOS path-
way leading to implications in the VEGF signaling pathway [535], which has
not been currently included in the model. In case 3, RAFPase and p65 KO lead
to a dominant pro-death phenotype. This behavior was captured by the model
by the lack of NF-κβ activity leading to no Bcl2 production and enhanced BNIP3
activity. This observation was consistent with the literature, where in RelA or
p65 KO lead to embryonic lethality and liver degeneration in mice [30]. To suc-
cessfully manipulate the hypoxic response, it is therefore vital to regulate both
NF-κβ and AP-1 regulatory signaling blocks of EHR. The current EHR model,
even with inherent structural and parametric uncertainty, identifies falsifiable
strategies in manipulating the hypoxic response.
6.4 Discussion
Eukaryotic hypoxic response (EHR) blankets a diverse set of responses medi-
ated by a single physiological stimulus i.e. lack of sufficient oxygen. EHR glob-
ally leads to altered cellular functioning, stimulation of erythropoiesis, angio-
genesis, vascular tone regulation, altered cell viability and proliferation [12].
The activation of the angiogenic switch represents a critical event in the vascu-
larization of primary and metastatic tumors and thus in the progression of the
pathology. The underlying cellular and molecular mechanisms controlling the
angiogenic switch are still emerging. However, what is generally accepted is
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that changes in the tumor microenvironment e.g., extracellular oxygen concen-
tration, induce a multifaceted program involving both autocrine and paracrine
signaling amongst an array of cell types. Specifically, the role of EHR in angio-
genesis has become an area of interest because of its potential as a therapeutic
locus [349, 50]. In this study, we formulated a family of canonical EHR mod-
els describing events in the initial phase of the angiogenic switch. Mass bal-
ance equations describing 548 species interconnected by 920 interactions were
formulated using mass-action kinetics within an ordinary differential equation
(ODE) framework. Four model populations were estimated using multiobjec-
tive optimization (20 objective functions) in conjunction with a leave-five-out
cross-validation strategy. We compared the average performance of the mod-
els in the population, by comparing training and prediction likelihood. The
multiobjective optimization scheme (POETs) improved the training and predic-
tion likelihood for 70% of the objective functions, relative to an initial best-fit
parameter set. POETs also identified Pareto fronts between a subset of the train-
ing objectives. These fronts indicated conflicts in the training data e.g., cell-
line to cell-line variation or an inability to simultaneously model different as-
pects of the training data. POETs generated a population of 40,000 probable
models, from which we selected a diverse sub-family with Pareto rank one or
less for further study. To identify critical nodes, the EHR network and model
populated were analyzed using parameter dependent and independent analy-
sis techniques. Model analysis based on the flux allowed a temporal analysis
of EHR. Parameter-dependent sensitivity and robustness analysis were used to
rank-order the importance of nodes and edges in the EHR network. We also
analyzed the topological features of the EHR network using extreme pathway
decomposition, in particular identifying the structural basis of crosstalk and re-
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dundancy.
EHR model analysis revealed that there is a temporal progression within
EHR, which has its implications in terms of parameter(species) robust-
ness(sensitivity) and correspondingly affects complex network properties like
crosstalk and redundancy within EHR. Under hypoxic conditions (∼ 1% O2),
we found that there was a two-phased response demarcating the onset of a later
autocrine mediated signal amplification. While initially both HIF-1 and ROS
mediated activation of VEGF and IL-8 signaling cascades took place, there was
a late phase amplification of VEGF and IL-8 consistent with autocrine mediated
signal amplification due to AP-1. This result was validated by independent
ELISA measurements of secreted VEGF and IL-8 in MDA-MB231 cells at days
1,3 and 5. In phase I, VEGF signaling branch was the first to respond, medi-
ated by the activity of HIF-1 and ROS mediated NF-κβ activation. However,
VEGF levels reached steady state by 24 hrs (seen both by simulation and exper-
imental study). Phase II of the response was marked by a small increment of
VEGF and 3-5 fold increment in IL-8 signaling. This late phase behavior was
a result of the positive feedback mediated by the activation of AP-1 and NF-
κβ downstream of both VEGF and IL-8 signaling cascades. This phenomenon
is consistent with previous studies in OSCC-3 cells in both in-vivo and in-vitro
studies [129]. However, the time scales of the signal amplification was different
between model prediction (∼ 24 hrs) and as seen in the experiments (∼ 48 hrs).
This difference could be attributed to the negative feedback mediated by HIF-1
induction which leads to attenuated Nrf-2 dependent IL-8 expression as seen in
HUVECs [315]. Lack of this negative control on IL-8 expression via HIF-1, could
be one of the many reasons for the high predicted rate of IL-8 secretion in the
model. Interestingly, it was observed both experimentally and predicted by the
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model that under normoxic conditions secreted IL-8 levels increased with time.
One potential explanation could be that, normoxic conditions lead to even lower
amount of basal HIF-1 activation and subsequently more Nrf-2 mediated IL-8
expression. Overall, the population of EHR models recapitulated both short-
and long timescale behavior following hypoxia or exposure to exogenous IL-
8 in a variety of cell types (training and prediction studies). It also captured
the integration between multiple pathways and generated specific and testable
hypothesis about the role of network components in signal propagation.
Consistent with the key regulatory role of AP-1 and NF-κβ in EHR, we iden-
tified that in case of 1% O2 (hypoxia), MAPK regulation mediated by MEKPase
(phosphatase for MEK) and VEGFR2-mediated signaling was the most impor-
tant in terms of participation in EPs (∼300 EPs). On the contrary, in case of 17%
O2 (normoxia), HIF-1α regulation via O2 was the set of reactions with the most
participation (∼170 EPs). In case of complex biological networks like EHR, in-
teractions between specific or shared species between multiple pathways gives
rise to intricate complexities within the network. These complexities critically
affect the dynamics and properties of the system. Currently research techniques
aim at identification of global network properties [234, 459, 277]. Signal trans-
duction architectures however, frequently contain redundancy, feedback and
crosstalk. These topological features ensure signal propagation is adaptable,
efficient and robust. However, they also make reprogramming signal flow chal-
lenging. Extreme pathway decomposition (and the closely related elementary
mode decomposition) systematically decompose large networks into indepen-
dent mass-balanced pathways [482, 406]. Thus, instead of a relying on arbitrary
pathway definitions found in the literature, EPs could be used to systematically
decompose complex networks. EPs can also be used to identify the structural
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basis of complex network properties such as crosstalk and redundancy. In this
study, EPs for EHR provided a structural significance of key components in any
mode of functioning of EHR. The structural analysis corroborated the structural
relevance of MAPK in hypoxic conditions. Using EPs, we found that in case of
hypoxia ∼60% of the EPs exhibited crosstalk, while ∼5% of the EPs exhibited
redundancy. Overall, EP analysis of EHR suggested a divergent nature of the
EHR. This suggests that, oxygen sensing lead to HIF-1 and ROS mediated acti-
vation of VEGF and IL-8 signals, subsequently leading to multiple outputs like
active PI3K, active MAPK components, active transcription factors e.g. NF-κβ,
AP-1 which have the capability to communicate with other signaling modules
in the cell. The redundancy within EHR, reiterates multiple routes of activation
and feedback of key transcription factors like AP-1, NF-κβ.
Consistent with the later time importance of AP-1, regulators of AP-1 i.e.
p38MAPK and MAPK were seen as fragile aspects at ∼ 24-30 hrs into Hypoxia
as compared to earlier time points in the sensitivity analysis. Sensitivity anal-
ysis is an enabling tool for the investigation of fragility in molecular networks.
It has been used earlier to identify fragile interactions in cell-cycle models [369]
and in human coagulation cascades [319] as well in other systems [274]. It has
been suggested that sensitivity analysis of experimentally constrained model
ensembles could in fact generate a reasonable estimate of what was impor-
tant in a network [504]. In terms of species sensitivity in the case of 1% O2,
MAPK components were seen to be more important at later (24-30 hrs) time
band as compared to earlier (0-6 hrs) times of EHR. This highlights the criti-
cal role of MAPK as a critical regulator of AP-1 activation in autocrine medi-
ated signal amplification. Both parameter and species sensitivities suggested
that AP-1 and NF-κβ regulatory module gained importance as time progressed
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into EHR. This emphasizes the regulatory role played by AP-1 and NF-κβ in
influencing the positive feedback downstream of both VEGF and IL-8 signal-
ing cascades. Interestingly, both VEGF and IL-8 signaling modules were rela-
tively equally fragile(robust) throughout EHR. While sensitivity analysis iden-
tifies the critical elements in the EHR network, it does not elucidate the effect of
a specific perturbation on the other components in the system. In this regard,
simulated gene-knockout (single/combinatorial) and gene over-expression ex-
periments for the EHR model using robustness analysis, allowed us to identify
critical components to manipulate the hypoxic response. Robustness analysis
has been used previously in molecular networks for androgen dependent and
independent prostate cancer models to identify fragile and robust subsystems
[526]. This simulation scheme bears resemblance to current experimental pro-
tocols, where we regulate the hypoxic programs are via gene knockouts or gene
over-expression. Up-regulation of the hypoxic program has been used success-
fully in studies related to transplantation, wherein angiogenesis is a desired and
critical aspect for survival of cells [400, 604]. On the contrary, in cancer therapy
down-regulation of hypoxic response is a much sought after target [349]. Gene
knockout and two-fold overexpression studies revealed the critical players as
components of the HIF-1α degradation machinery (e.g., PHD) and HIF-1α reg-
ulation (e.g., FIH), decoy receptors for the VEGFA (e.g., VEGFR1) and regula-
tory elements of the MAPK cascades (e.g., ERKPase). In the phenotypic space
as a result of single/combinatorial gene knockout/overexpression simulations,
we identified sub-populations that had distinct pro-survival, pro-growth and
pro-death phenotypes. Behavioral shifts in the phenotypic space (like positive
correlation between pro-growth and pro-survival phenotypes) were due to the
role of AP-1 and NF-κβ. The dominant phenotype of pro-death could be at-
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tributed to the HIF-1 dependent regulation of BNIP3 and NF-κβ dependent reg-
ulation of Bcl2. Synergistic effects controlled by crosstalk and redundancy in
the EHR network thereby controls the phenotypic behavior of the EHR models
upon manipulation. In order to successfully manipulate the hypoxic response,
it is therefore vital to regulate both NF-κβ and AP-1. This highlights the im-
portance of regulating both HIF-1 and ROS mediated signaling blocks. Recent
experimental studies have shown combination strategies aimed at maximizing
the clinical potential of HIF-1 inhibition, to be highly effective [441].
Overall, model analysis suggested relationships between structure, function
and regulation within the EHR network and provide testable hypothesis which
can be validated experimentally. Key aspects of the EHR model were centered
around regulation and manipulation of HIF-1α, AP-1 and NF-κβ. Importance
of HIF-1α regulation highlighted by the structural and robustness analysis is
supported by the evidence in literature wherein inhibition of HIF-1α is used as
a strategy in tumor therapy [552, 484]. However we are lacking some details
in regulation of HIF-1α, which taken into account might reveal a clearer pic-
ture [25]. In the current EHR model, HIF-1α was regulated only at the protein
level. We only have the constitutive expression of HIF-1α and HIF-1β. In order
to get a complete picture of regulation of HIF-1α, we should include the neg-
ative regulation of HIF-1α via the regulation of PHD2 protein. PHD2 mRNA
and protein have been reported to be upregulated in case of hypoxia, leading to
negative feedback [25]. Transcriptional role of HIF-1 is mediated via binding to
p300 protein. CITED2/4 proteins (increased expression in hypoxia) have been
identified which competitively binds to p300 thereby operating in a negative
feedback loop to down-regulate HIF-1 mediated transactivation [25]. p53 has
been seen to promote Mdm2-mediated ubiquitination and proteasomal degra-
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dation of HIF-1α [445]. Furthermore there exists a positive feedback to HIF-1α
signaling mediated by growth factor and cytokines via Ras/Raf/MAPK and
PI3-K/Akt/PKB cascades [25]. These pathways also play a role in regulating
the HIF-1 signaling cascades in Normoxia. Given the role of VEGF and IL-8
signaling pathways in angiogenesis, it has rightly been targeted in several ef-
forts in regulating tumors [591, 271, 126]. Regulation of VEGF by the human-
ized monoclonal antibody bevacizumab, is currently used successfully for the
treatment of cancer [127]. In the current model, VEGF mediated signal initia-
tion has been modeled via VEGFA, VEGFR1/2/3, heparin sulfate proteoglycans
(hspg) and neuropilins. Given the importance of VEGF signaling, we might get
a clearer and more specific picture upon inclusion of specific details regard-
ing variants of VEGFA (VEGF-206, VEGF-165 and VEGF-183), other ligands
like VEGFB/C/D/E and the specific role of Neuropilin-1 [458]. Neuropilin-1
mRNA and protein have been seen to be overexpressed in case of human colon
growth and progression [409]. Downstream effects of VEGF signaling cascade
mediated by PI3K-AKT module have also not been taken into account in the
current EHR model [562, 69]. Both structurally and functionally relevant, role
of AP-1 and NF-κβ has been identified by the model analysis to be of high impor-
tance. Rightfully so, regulation of NF-κβ has been seen to be critically involved
in cancer development and progression, as well as in resistance to chemother-
apy and radiotherapy [27]. Thereby, the therapeutic potential and benefit of
targeting NF-κβ and ROS in cancer holds great promise [27, 555]. Currently,
a narrow account of NF-κβ regulation has been taken into account in the EHR
model. It shall be interesting to incorporate the detailed complexity associated
with regulation of NF-κβ and then analyze the critical aspects of the EHR model
[86]. In terms of NF-kB, we have not taken into account the regulation of IKK
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via PKC. IKK traditionally leads to Ser32 and Ser36 phosphorylation of IKBα,
thereby targeting it for proteosomal degradation [86]. However in case of hy-
poxia another alternate route of IKBα phosphorylation not including proteoso-
mal degradation also plays a key part [86]. In the current EHR model, we have
AP-1 regulation via p38MAPK and ROS. We have not taken into account the
individual dimer components, namely cFOS and cJUN. To get a comprehensive
insight into the role of AP-1, we should include specific details like ERK2 me-
diated phosphorylation of cFOS at T232 to establish the link between ERK and
AP-1 [23]. MAP kinases ERK, JNK and p38 phosphorylate and activate Elk-1 re-
sulting in enhanced SRE-dependent cFOS expression [586]. JNK and p38 MAP
kinases lead to activation and enhanced expression of cJUN [586]. Given struc-
tural and parametric uncertainty in the given scheme of model generation, the
EHR models were successful in identifying the critical components of EHR and
present valuable insight in regulating the hypoxic program. Structural analy-
sis coupled with concurrent developments in systems biology provides a scope
for a functional and mechanistic basis for design of simulated experiments and
prediction of critical targets in large-scale complex biological models.
6.5 Materials and Methods
6.5.1 Formulation and solution of the model equations.
The eukaryotic hypoxic response model was formulated as a set of coupled or-
dinary differential equations (ODEs):
dx
dt
= S · r (x,p) x (to) = xo (6.1)
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The symbol S denotes the stoichiometric matrix (548 × 920). The quantity x de-
notes the concentration vector of proteins or protein complexes (548 × 1). The
term r (x,p) denotes the vector of reaction rates (920 × 1). Each row in S de-
scribed a protein or protein-protein complex, while each column described the
stoichiometry of network interactions. Thus, the (i, j) element of S, denoted by
σi j, described how protein i was involved in rate j. If σi j < 0, then protein i was
consumed in r j. Conversely, if σi j > 0, protein i was produced by r j. Lastly, if
σi j = 0, there was no protein i in rate j. All of these interactions were obtained
from the literature.
We assumed mass-action kinetics for each interaction in the network. The
rate expression for interaction q was given by:
rq
(
x, kq
)
= kq
∏
j∈{Rq}
x−σ jqj (6.2)
The set
{
Rq
}
denotes reactants for reaction q while σ jq denotes the stoichio-
metric coefficient (element of the matrix S) governing species j in reaction q.
All reversible interactions were split into two irreversible steps. The mass-
action formulation, while expanding the dimension of the EHR model, regu-
larized the mathematical structure; this allowed automatic generation of the
model code using UNIVERSAL and regularized the unknown model parame-
ters (parameters were one of only three types, association, dissociation or cat-
alytic rate constants). UNIVERSAL, an open source Java code generator, gen-
erates multiple code types from text and SBML inputs. UNIVERSAL is freely
available as a Google Code project (http://code.google.com/p/universal-code-
generator/). Thus, although mass-action kinetics increased the number of pa-
rameters and species, they reduced the complexity of model analysis. In this
study, we considered well-mixed nuclear, cytosolic and extracellular compart-
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ments. The model equations were solved using the LSODE routine in OCTAVE
(v 3.1.0; www.octave.org) on an Apple workstation (Apple, Cupertino, CA; OS
X v10.6.4).
Hypoxic conditions were simulated by running the model to steady state
and then reducing the oxygen input. The steady-state was estimated numeri-
cally by repeatedly solving the model equations and estimating the difference
between subsequent time points:
‖x (t + ∆t) − x (t) ‖2 ≤ γ (6.3)
The quantities x (t) and x (t + ∆t) denote the simulated concentration vector at
time t and t + ∆t, respectively. The L2 vector-norm was used as the distance
metric. We used ∆t = 1 s and γ = 0.001 for all simulations.
6.5.2 Estimation and cross-validation of a population of models
using Pareto Optimal Ensemble Techniques (POETs).
POETs is a multiobjective optimization strategy which integrates several local
search strategies e.g., Simulated Annealing (SA) or Pattern Search (PS) with a
Pareto-rank-based fitness assignment [504]. Denote a candidate parameter set
at iteration i + 1 as ki+1. The squared error for ki+1 for training set j was defined
as:
E j(k) =
T j∑
i=1
(
Mˆi j − yˆi j(k)
)2
(6.4)
The symbol Mˆi j denotes scaled experimental observations (from training set j)
while the symbol yˆi j denotes the scaled simulation output (from training set j).
The quantity i denotes the sampled time-index and T j denotes the number of
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time points for experiment j. The read-out from the training immunoblots was
band intensity where we assumed intensity was only loosely proportional to
concentration. Suppose we have the intensity for species x at time i = {t1, t2, .., tn}
in condition j. The scaled measurement would then be given by:
Mˆi j = Mi j −miniMi jmaxiMi j −miniMi j (6.5)
Under this scaling, the lowest intensity band equaled zero while the highest
intensity band equaled one. A similar scaling was defined for the simulation
output.
We computed the Pareto rank of ki+1 by comparing the simulation error at it-
eration i+1 against the simulation archive Ki. We used the Fonseca and Fleming
ranking scheme [133]:
rank (ki+1 | Ki) = p (6.6)
where p denotes the number of parameter sets that dominate parameter set ki+1.
Parameter sets on or near the optimal trade-off surface have small rank. Sets
with increasing rank are progressively further away from the optimal trade-
off surface. The parameter set ki+1 was accepted or rejected by the SA with
probability P (ki+1):
P(ki+1) ≡ exp {−rank (ki+1 | Ki) /T } (6.7)
where T is the computational annealing temperature. The initial temperature
To = n/log(2), where n is user defined (n = 4 for this study). The final temper-
ature was T f = 0.1. The annealing temperature was discretized into 10 quanta
between To and T f and adjusted according to the schedule Tk = βkT0 where β
was defined as:
β =
(
T f
To
)1/10
(6.8)
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The epoch-counter k was incremented after the addition of 100 members to the
ensemble. Thus, as the ensemble grew, the likelihood of accepting parameter
sets with a large Pareto rank decreased. To generate parameter diversity, we
randomly perturbed each parameter by ≤ ±25%. We performed a local pattern-
search every q steps to minimize the residual for a single randomly selected
objective. The local pattern-search algorithm has been described previously
[149, 560]. The parameter ensemble used in the simulation and sensitivity stud-
ies was generated from the low-rank parameter sets in Ki.
We simultaneously calculated training and prediction error during the pa-
rameter estimation procedure using leave-five-out cross-validation [261]. The
complete set of training data (20 objectives) was subdivided into four bins; in
each bin 15 data sets were reserved for training while five were reserved for
prediction. In the first bin DS1 . . .DS5 were used for validation while DS6 . . .DS20
were used for training. In the second bin DS6 . . .DS10 were used for validation
while DS1 . . .DS5 DS11 . . .DS20 were used for training, etc. Thus, we formulated
four ensembles from which we evenly selected parameter sets for the parent en-
semble (Fig. A.1). While cross-validation required that we generate additional
model populations, we trained and tested against all the data sets.
6.5.3 Sensitivity and robustness analysis of the population of
EHR models.
Sensitivity coefficients were calculated as shown previously [505, 504, 526] us-
ing 40 models selected from the ensemble (red points, supplementary materials
Fig. A.1). The resulting sensitivity coefficients were scaled and time-averaged
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(Trapezoid rule):
Ni j ≡ 1T
∫ T
0
dt · |αi j (t) si j(t)| (6.9)
where T denotes the final simulation time and αi j = 1. The time-averaged sensi-
tivity coefficients were then organized into an array for each ensemble member:
N () =

N ()11 N ()12 . . . N ()1 j . . . N ()1P
N ()21 N ()22 . . . N ()2 j . . . N ()2P
...
...
...
...
N ()M1 N ()M2 . . . N ()M j . . . N ()MP

 = 1, 2, . . . ,N (6.10)
where  denotes the index of the ensemble member, P denotes the number of pa-
rameters, N denotes the number of ensemble samples and M denotes the num-
ber of model species. To estimate the relative fragility or robustness of species
and reactions in the network, we decomposed the N () matrix using Singular
Value Decomposition (SVD):
N () = U()Σ()VT,() (6.11)
Coefficients of the left (right) singular vectors corresponding to largest β sin-
gular values of N () were rank-ordered to estimate important species (reaction)
combinations. Only coefficients with magnitude greater than a threshold (δ =
0.1) were considered. The fraction of the β vectors in which a reaction or species
index occurred was used to rank its importance.
Robustness coefficients of the form:
α
(
i, j, to, t f
)
=
(∫ t f
to
xi (t) dt
)−1 (∫ t f
to
x( j)i (t) dt
)
(6.12)
were calculated to understand the robustness of the network. The robustness
coefficient α
(
i, j, to, t f
)
is the ratio of the integrated concentration of a network
marker in the presence (numerator) and absence (denominator) of structural
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or operational perturbation. The quantities t0 and t f denote the initial and final
simulation time respectively, while i and j denote the indices for the marker and
the perturbation respectively. If α
(
i, j, to, t f
)
> 1, then the perturbation increased
the marker concentration. Conversely, if α
(
i, j, to, t f
)
 1 the perturbation de-
creased the marker concentration. Lastly, if α
(
i, j, to, t f
)
∼ 1 the perturbation did
not influence the marker concentration.
In this study, we simulated single and double edge knockouts along with
protein deletion and overexpression. For multiple simultaneous perturbations,
combinatorial effects were evaluated by calculating synergy coefficients. The
synergy coefficient for a marker k following a combinatorial perturbation j, de-
noted by Si j, was
Si, jk =
α
(i, j)
k
αik + α
j
k
i, j =
(
1, 2, . . . ,Npk
)
(6.13)
defined as the robustness coefficients for marker i in the presence of multiple
simultaneous perturbations (set j) normalized by the sum of the individual ro-
bustness coefficients of each single perturbation in set j.
6.5.4 Species clustering and dendrogram.
A dendrogram was derived by considering each of the knockouts(overexpressions)
as variables and the average log of robustness coefficient (LRC) for each of the
species as observations. We used the Euclidean norm in LRC space as the dis-
tance metric. The linkage function (objective function for identifying variable
clusters) was the inner squared distance (minimum variance algorithm). The
Statistical Toolbox of Matlab (The Mathworks, Natick, MA) was used to gener-
ate the distances, linkages and the final dendrogram.
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6.5.5 Identification of distinguishable species.
Robustness coefficients were used to rank-order knockout(overexpression) ex-
periments in terms of the greatest unique responses and identify species which
were linearly distinguishable. The response of the knockout(overexpression)
was measured in terms of the robustness coefficients. The LRC had desirable
linear properties, such that no response (no change in trajectories from wild-
type) returns a value of zero and similar negative and positive responses have
different directions but similar magnitudes. We considered the unique compo-
nent of the response to be the orthogonal component in LRC space and the mag-
nitude of the response to be the Euclidean norm. The orthogonal components
and there magnitude were identified for each parameter set in the ensemble
by first choosing the knockout(overexpression) with the greatest magnitude, x1
and placing it in the empty setV. The knockout(overexpression) x1 defines the
orthogonal directions in the LRC space. We then calculated the orthogonal com-
ponents for all remaining knockouts(overexpressions) relative to x1, and added
the knockout(overexpression) species with the greatest orthogonal magnitude
to setV. In general the components of all remaining xi orthogonal to setVwere
calculated and the largest was moved into set V. This process was continued
until all knockout(overexpression) species, xi were added to set V. Mathemat-
ically two species were considered distinguishable if and only if they were lin-
early independent (the orthogonal components were non-zero). We considered
a threshold value of one or five and performed a student t-test (Matlab Statistical
Toolbox, The Mathworks, Natick, MA) to identify which species had orthogonal
components above the threshold with a 95% confidence over the ensemble.
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6.5.6 3-D Alginate Tumor Models
Alginate hydrogels (3% [w/v]) were used as 3-D cell scaffolds. Alginate
(Protanal LF; FMC Biopolymer, Philadelphia, PA) was dissolved in serum-free
DMEM, and MDA-MB231 cells (ATCC) were suspended in this dissolved algi-
nate at a density of 20 × 106 cell/mL. Cell-seeded alginate gels were cast into 4
mm diameter, 200 µm thick cylinders using a plexiglass mold, and cross-linked
with 100 mM CaCl2 for 15 min. Discs were then cultured in 24-well plates,
with a single disc and 500 µL culture media (DMEM + 10% FBS + 1% peni-
cillin/streptomycin) per well. Cells were cultured at 37◦C, 5% CO2 and either 1
or 17% O2 in controlled atmosphere incubators (Thermo Fisher Scientific, Inc.,
Waltham, MA). Media was changed daily.
6.5.7 Analysis of Angiogenic Factor Secretion
Media and discs were collected 24 hrs after the previous media change, at days
1, 3 and 5. VEGF and IL-8 concentration in media were analyzed by ELISA
(R&D Systems, Minneapolis, MN) and normalized to total DNA content to cor-
rect for cell number variations. To measure DNA content, discs were dissolved
in 50 mM EDTA and released and rinsed cells lysed in Carons´ buffer. DNA
concentration was then measured using Quant-iT PicoGreen dsDNA reagent
(Invitrogen Co.).
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7.1 Abstract
Several disease states like cancer are heterogeneous cellular entities involving
dynamical interactions between genetically altered cells and their surrounding
microenvironmental changes. These forms of disease states present an emerg-
ing importance and need of models taking both signaling networks and dif-
ferent biochemical and biophysical contexts into account. For example, fac-
tors like vascular endothelial growth factor (VEGF) and/or interleukin-8 (IL-8)
have been implicated in multiple studies in the regulation of breast cancer as
well as in the activation and chemotactic guidance of capillary sprouting and
growth. Detailed computational models of such complex phenomena using in-
tricate cellular signaling mechanisms, nutrient/growth factor transport, move-
ment/interactions between normal and tumor cells is critical in identifying the
key regulators of such a system. We have created a protein signaling assisted
multi-scale modeling approach (SAMM) to study such systems. Key highlights
of SAMM include use of pre-established detailed cellular models to regulate
cellular decisions, use of an ensemble of models to incorporate differences be-
tween cells, coupling intracellular markers and probabilistic rules to monitor
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cellular fate and cellular motility and a hybrid approach to improve speed of
solving of external and internal mass-balances. SAMM allows us the flexibil-
ity to include multiple cell types, freedom of seeding cells with specific internal
cellular machinery within complex geometries, regulate multiple cellular deci-
sions using internal and secreted cellular markers and improved solving speed.
In the current study, we demonstrated using SAMM and a tumor/endothelial
cell model the ability to capture and identify spatio-temporal effects upon GF
(VEGF and/or IL-8) induced growth, ability to model and monitor effects of
internal variations in the cells e.g., species KO’s and ultimately ability to moni-
tor effects of coupling probabilistic rules to internal marker levels and its effects
on growth morphology and growth dynamics. While this was used currently
to investigate tumor growth and angiogenesis, a similar set-up with different
cell-types could be used to study other multiscale phenomenon.
7.2 Introduction
Breast cancer is one of the prevailing cancers diagnosed among women today
as well as the second leading cause of cancer death in women [232]. At the
molecular level, signaling networks implicated in breast cancer exhibit consid-
erable complexity in size and connectivity [390, 106, 603, 529, 222]. The intrin-
sic complexity of these networks complicates the interpretation of experimental
findings [603]. Added to this is the dynamical interactions between the cells
and their surrounding microenvironmental changes. Extrapolating the molecu-
lar signaling events to tissue-level/organ-level phenotypes adds another layer
of complexity across spatio-temporal and functional scales [600]. While cellu-
lar networks provide deductive capabilities in investigating biological mecha-
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nisms, there is a need to inductively extrapolate the consequences of cell signal-
ing to tissue/organ function. This presents an emerging importance and need of
models taking both signaling networks and different biochemical and biophysi-
cal contexts into account [11, 310, 326, 434, 578]. Computational multiscale mod-
eling approaches are poised to address these growing needs [578]. Multiscale
models have been used extensively in several disease states e.g. in cardiac phys-
iology [600], epidermal wound healing [514], renal physiology [112] to identify
biological mechanisms, infer multiscale consequences to cell signaling activities.
At the molecular level, human epidermal growth factor receptor 2 (HER2 or
ErbB-2) and the associated epidermal growth factor receptor (EGFR) signaling
is implicated widely in human breast cancer [585, 624, 213, 335]. Several stud-
ies have further implicated a connection between HER2 signaling and vascular
endothelial growth factor (VEGF) [421, 416, 317, 72, 446] and interleukin 8 (IL-
8) [446, 72] signaling (Fig. 7.1). VEGF signaling plays a role in endothelial cell
proliferation, migration as well as alteration of the extracellular environment
[130, 125], thereby affecting the survival and invasiveness of breast cancer cells
[427, 187]. At the same time, IL-8 signaling promotes growth and metastasis
of tumors and angiogenesis [140, 35, 585]. Several studies have reported ele-
vated expression of these pro-angiogenic cytokines in case of aggressive tumor
growth and decreased survival of patients with breast cancer [72, 446] high-
lighting the key role of angiogenesis. Modeling signaling networks involved in
breast cancer has come a long way over the years (recently reviewed in Lazzara
et. al.) [287]. Across a multiscale level, several recent advances have been made
in modeling breast cancer [531, 310, 326, 435, 434, 509, 314, 495]. While some
studies focused on identifying the role of point-mutations in EGFR signaling in
the onset of oncogenic transformations [314, 495], others used this integrative
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Figure 7.1: (A) Signaling networks implicated in Breast Cancer: EGFR
Signaling, VEGF Signaling and IL8 Signaling. These signal-
ing cascades independently or in combination leads to activa-
tion of kinases which further downstream leads to activation
of transcription factors. These active transcription factors lead
to transcriptional regulation of genes in the nucleus. Arrows
indicate direction of signal flow. A representative transcrip-
tion factor is shown to demonstrate transcription. (B) Cancer
is a complex process bridging spatial and temporal scales in-
volving many different cell types and processes. The inter-
play of these cells, extracellular environment and other cues
orchestrate cancer growth and progression. Multiscale model-
ing incorporating multiple processes over wide range of scales
in a quantitative manner holds great promise in unraveling the
mysteries in case of cancer.
method along with pharmacokinetic measurements to predict resistance based
on specific tumor properties and thus improve treatment outcome [143].
We have created a signaling assisted multiscale modeling approach (SAMM)
to study systems across multiple length scales. Key highlights of SAMM include
use of detailed cellular models to regulate cellular decisions, use of an ensemble
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of models to incorporate differences between cells, coupling intracellular mark-
ers and probabilistic rules to monitor cellular fate and cellular motility and a
hybrid approach to improve speed of solving of external and internal mass-
balances. SAMM allows us the flexibility to include multiple cell types, free-
dom of seeding cells with specific internal cellular machinery within complex
geometries, regulate multiple cellular decisions using internal and secreted cel-
lular markers, ease of computation and improved solving speed. In the current
study, we demonstrated using SAMM the ability to capture and identify spatio-
temporal effects upon growth, ability to model and monitor effects of internal
variations in the cells e.g., species KO’s and ultimately ability to monitor effects
of coupling probabilistic rules to internal marker levels and its effects on growth
morphology and growth dynamics. For this study we used a tumor/endothelial
cell model which has been used earlier to study eukaryotic hypoxic response
[70]. Both VEGF and IL8 have been shown to regulate, in an autocrine signal-
ing based mechanism, the ability of the tumor to grow. While this was used
currently to investigate tumor growth and angiogenesis, a similar set-up with
different cell-types could be used to study other multiscale phenomenon.
7.3 Modeling Breast Cancer across Multiple Length Scales
Across multiple length scales, several recent advances have been made in mod-
eling breast cancer [531, 310, 435, 434, 509, 314, 495]. While some studies focused
on identifying the role of point-mutations in EGFR signaling in the onset of
oncogenic transformations [314, 495], others used this integrative method along
with pharmacokinetic measurements to predict resistance based on specific tu-
mor properties and thus improve treatment outcome [143]. Efforts in this front
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however have faced several challenges ranging from modeling complex intra-
cellular signaling events to spatio-temporal and functional complexities at the
tissue-level/organ-levels and crosstalk between the same.
At the molecular level, the number of signaling components involved in the
regulation and progression of breast cancer is just immense [222, 197, 350, 209,
106]. However, the key signaling components implicated so far revolve around
the role of EGFR, VEGF and IL8 signaling [585, 624, 213, 335, 421, 416, 317, 72,
446, 72]. Malfunctions in EGFR signaling has been highly implicated in several
forms of cancer [585, 365, 97, 98, 381, 383, 382]. HER2 (ErbB-2 or c-neu) is the
most potent oncoprotein in the family and overexpression of HER2 (HER2+) is
seen in about 20-30% of breast cancer cases and has been associated with worse
prognosis, large tumor size, higher metastatic potential, and decreased survival
[476, 624, 213, 335, 616]. Growth and progression of tumors is mediated by
the delicate balance of proangiogenic and antiangiogenic factors which regulate
angiogenesis [585, 181]. VEGF is one of most potent proangiogenic factors stim-
ulating endothelial cell proliferation and migration and regulating invasiveness
of breast cancer cells [125, 427, 187]. A tight relationship between HER2 and
VEGF signaling cascades has been seen in preclinical studies on cancer cell lines
[421, 416, 317]. It is suggested that these pathways are functionally linked, lead-
ing to the hypothesis that VEGF might have a role in the acquired resistance
to anti-ErbB drugs when these receptors are pharmacologically blocked [544].
However, regulation of VEGF signaling cascades in breast cancer remain con-
troversial [585]. Another key regulator of angiogenesis is IL-8 [446, 72]. Several
studies have reported elevated expression of these pro-angiogenic cytokines in
case of aggressive tumor growth and decreased survival of patients with breast
cancer [72, 446]. Besides the direct signaling connections, hypoxia in solid tu-
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mors (marked by reduced oxygen levels) also stimulates the expression of both
IL-8 and VEGF, and VEGF can further enhance IL-8 expression [453]. Model-
ing signaling networks involved in breast cancer has come a long way over the
years (recently reviewed in Lazzara et. al.) [287].
At the microscopic scale, coupling internal cellular signaling to dynamical
interactions between cells and their surrounding microenvironmental changes
and extrapolating this to tissue-level/organ-level phenotypes has seen a lot of
activity in the recent years [531, 310, 326, 435, 434, 509, 314, 495]. While some
focussed on a holistic picture of cancer modeling several focused on smaller sub
issues. Given the central role of EGFR signaling in cancer, Athale et. al. studied
the effects of EGFR density on tumor growth dynamics, both on the sub- and the
multi-cellular levels [17]. They used this to identify links between EGFR density
and increase in phenotypic switching activity between proliferative and migra-
tory traits. Using an EGFR gene-protein interaction network module, Zhang
et. al. investigated the proliferation-to-migration switch during tumor growth in
case of brain cancer using multiscale approaches [631]. Macklin et. al. used an
agent based multiscale modeling approach to investigate ductal carcinoma in
situ (DCIS) of the breast [328]. They used patient-specific molecular and cellular
measurements to calibrate their model as well. Frieboes et. al. used multiscale
modeling techniques to identify specific functional relationships linking tumor
growth and regression to the underlying phenotype under drug response [143].
However, investigating/modeling tumor or any growth shape and morphology
is an area full of surprises. In a recent study Engler et. al. used multiscale mod-
eling to investigate how emergent properties of adhesion-directed multicellular
structures sculpt the tissue, promote its functionality, and maintain its home-
ostasis through spatial segregation and organization of anchored proteins and
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secreted factors and through emergent properties of tissues, including tension
fields and energy optimization [119]. Given the innumerable forms of uncer-
tainties and unknowns, Nagl et. al. coupled objective bayesian nets to integrate
wide sources of information to explore this form of modeling [362]. With re-
spect to angiogenesis, a object-oriented module-based computational integra-
tion strategy to build multiscale simulation scheme was recently used by Liu et.
al. to study exercise induced angiogenesis in skeletal muscles. State of art of
modeling multiscale phenomenon has even reached the form of software plat-
forms, e.g., Eissing et. al. recently created a computational systems biology soft-
ware platform for modeling and simulation of multiscale phenomenon [112].
They focused on integrating molecular scale reaction networks to disease biol-
ogy to whole-body physiology.
7.4 Signaling Assisted Multiscale Modeling (SAMM)
We have created a signaling assisted multiscale modeling technique (SAMM)
to study systems across multiple length scales. Key highlights of SAMM in-
clude use of detailed cellular models to regulate cellular decisions, use of an
ensemble of models to incorporate differences between cells coupling intracel-
lular markers and probabilistic rules to monitor cellular fate and cellular motil-
ity and a hybrid approach to improve speed of solving of external and internal
mass-balances. SAMM allows us the flexibility to include multiple cell types,
freedom of seeding cells with specific internal cellular machinery within com-
plex geometries, regulate multiple cellular decisions using internal and secreted
cellular markers, ease of computation and improved solving speed (complete
details in materials and methods).
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For the current study, at the molecular level, we incorporated a detailed
signaling network involving HIF1, VEGF and IL8 signaling cascades into the
multiscale framework. A similar strategy has been used successfully before to
study non-small cell lung cancer [576, 577, 578] and angiogenesis [326, 310]. The
signaling network (describing 548 protein or mRNA species interconnected by
920 interactions) has been used individually before to study the temporal phe-
nomenon involved in VEGF and IL8 signaling in hypoxia [70]. The molecular
level of the model was modeled using mass action kinetics within an ordinary
differential equation (ODE) framework. The model described the integration
between extracellular O2 levels and VEGFA, IL-8 autocrine induced intracellu-
lar gene expression, proliferation and death programs. We modeled the expres-
sion and regulation of several transcription factors: HIF1, AP1, ATF2, MEF2
and NF-κβ. AP1 dependent CYCLIND expression was used as a marker of pro-
liferation [557]. NF-κβ dependent BCL2 expression was used to characterize cell
survival while HIF-1α dependent BNIP3 expression was used as a cell death
marker [523, 58]. In addition to these markers, the expression of VEGFA, IL-8
and their respective surface receptors VEGFR2 and CXCR1/2 was also mod-
eled. These receptors were connected to transcription factor activation through
the activity of the MAPK, p38MAPK and PKC kinases. Complete details of the
interactions can be found in Chakrabarti et. al. [70] and supplementary materi-
als.
At the microscopic level, a biochemical microenvironment was constructed
to represent a virtual tissue sample in either two-dimensional (2D) (data
not shown) or three-dimensional (3D) space. In the current study, we used
a 20×20×5 grid to demonstrate SAMM. Depending on the need, homoge-
neous/heterogeneous environments could be attained by distributing external
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Figure 7.2: Overview of SAMM: (A) A 3D virtual microenvironment com-
prising of a discrete space with 20×20×5 grid points was cre-
ated. In this grid, we placed the growth factor source and
seeded cells at specific positions at the start of the simula-
tion. In the current study, the GF source was a constant source
(Ginput, in the current study Ginput = 10 A.U.) of VEGF and/or
IL-8 from the side face as shown. The tumor/endothelial cells
were seeded in the opposite face, with a maximum of NCmax
( NCmax = 20 in the current study) per grid element. Each
cell in a grid element has a self-maintained signaling network
with a randomly assigned parameter vector from the ensem-
ble (details in materials and methods). (B) Over the course
of the simulation, cells respond to cellular and environmen-
tal cues and accordingly adjust their phenotype at each time
step. Intracellular protein marker levels coupled with proba-
bilistic rules were used to characterize proliferation, survival
and death phenotypes. AP1 dependent CYCLIND expression
was used as a marker of proliferation [557]. NF-κβ dependent
BCL2 expression was used to characterize cell survival while
HIF-1α dependent BNIP3 expression was used as a cell death
marker [523, 58]. (C) Cellular mobility decisions additionally
took into account both number of available neighbors and the
cellular densities at neighbors. (D) External diffusive chemi-
cal cues (VEGF, IL-8, O2 in the current study) are regulated via
initial seeding, source terms and consumption/production via
cells. Throughout the simulation, the three chemical cues are
continuously updated at a fixed rate.
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Figure 7.3: Selection for Growth and Death rates: (A) According to the cel-
lular phenotypic ”decision” algorithm (discussed in the mate-
rials and methods), growth was dependent on the levels of CY-
CLIND (phosphorylated ERK (ppERK) in one simulation) and
a factor Gα. We sampled four orders of magnitude variations
in Gα. Final selection of Gα was made so as to have growth
behavior in the shaded grey region. (B) Similarly, cell death de-
cision was dependent on the intracellular levels of BNIP3 and
a factor Dα. We sampled four orders of magnitude variations in
Dα. Final selection of Dα was made so as to have death behav-
ior in the shaded grey region. Both selections were done with
the other decision (growth/death) happening as an unbiased
random move.
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diffusive chemical cues (e.g. growth factors, oxygen) throughout the microen-
vironmental lattice. We have the freedom/ease in controlling the sources, flow
characteristics of these chemical cues. For example, in the current study we had
VEGF and/or IL8 flow in at a constant rate (Ginput = 10 A.U. details in mate-
rials and methods) from one of the side faces (see Fig. 7.2) and we allowed it
to diffuse within the above mentioned geometry. Unless otherwise stated, we
allowed the oxygen levels to represent normoxic levels (∼ 17%) throughout the
construct. This allowed us to investigate the isolated VEGF/IL8 induced effects
on endothelial/tumor cell behavior. Throughout the simulation, the concen-
tration of the chemical cues were continuously updated at a fixed rate. Gen-
erally these diffusion process are implemented based on PDEs [578], however
we used a discretized approach to solve for extracellular states (materials and
methods), which allowed for reduced simulation time. At any position in the
construct, we could have multiple cells of the same kind and/or multiple cell
types as well. The number of cells at any position was regulated by the balance
of initial seeding, migration from neighbors, growth/death. Each cell type car-
ried a self-determined signaling pathway, as well different set of rate constants
which allowed us to capture different phenotypic behaviors as the simulation
progressed. Throughout the simulation, the internal states of the cells and re-
sulting cellular counts were continuously updated at a fixed rate. We sampled
Fα (0.25 in this study) fraction of the cells at any time (materials and methods).
In the current work, molecular and microscopic linkage was based on previ-
ously used, experimentally supported molecularly driven cellular phenotype
and mobility algorithm [578].
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7.4.1 Results
Modeling growth and flow profiles under an external dose of VEGF/IL8:
Using the tumor/endothelial cell model, we investigated growth/death dy-
namics and migratory behavior of cells upon a dose of growth factors (GF). Con-
stant source of VEGF and/or IL8 was allowed to diffuse from one side face of the
construct (grid of 20×20×5) as shown in Fig. 7.2-7.4. The construct was seeded
with an initial basal amount of growth factor. One layer of cells were seeded
at the opposite face of the construct (maximum of 20 cells per grid element) in
the beginning of the simulation (Fig. 7.2 and Fig. 7.4A). During the simulation,
cellular fate was decided using internal cellular marker levels: BNIP3 levels for
cell death, BCL2 levels for cell survival and CYCLIND levels for proliferation.
We narrowed down these rules to select the optimal balance of number of cells
growing/dying per unit time by testing a broad range (4 orders of magnitude
variations) of probability functions (materials and methods, supplementary Fig.
S7.3). Cellular movements were further coupled to probability functions based
on cell densities at neighbor locations. Upon start of simulation, cells initially
responded to basal GF levels in the construct. This elicits a GF mediated au-
tocrine signal amplification within the cells leading to cellular growth (Fig. 7.4B
time step 125 AU). However with progression in time, the GF diffusing in from
the other end elicits a second wave of amplified response marked by increased
growth (Fig. 7.4B time step 250 AU). Similar behavior with differences in time
scale is seen for a dose of VEGF (Fig. 7.4 Fig. 7.8) and IL8 (supplementary Fig.
S7.5 column B). As a control, we simulated two cases: a) GF receptor inhibi-
tion (Fig. 7.4C) b) No external dose of GF coupled with no initial seeding of
GF (Fig. 7.4D). In both cases we see no visible growth of cells (Fig. 7.4C-D).
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Subsequently, we used this set-up to study the effects of intracellular variations,
variations in external probabilistic rules upon the morphology and dynamics of
growth. In the current study, we used only one cell type seeded in a simple grid
to demonstrate functionality and utility of SAMM. However a similar approach
can very well be used to analyze a wide range of disease states.
Spatio-temporal phenotypes:
As compared to wet experiments, a multiscale computational model allows us
the freedom/ease to investigate phenotypic differences between cell popula-
tions upon growth (Fig. 7.6). To demonstrate this point, we used the base
system (VEGF dose) to analyze the functional states of the cells at three posi-
tions (abbreviated as P1, P2 and P3 in Fig. 7.6A) and identify differences if any.
We looked at the averaged (average of grid position and its neighbors (max 6))
internal and external marker levels as seen in Fig. 7.6B-F. At P1, the cells in av-
erage were exposed to higher levels of VEGF as compared to cells at P3 (Fig.
7.6B), thereby eliciting accordingly a higher VEGF induced IL8 expression at P1
as compared to P3 (Fig. 7.6F). Interestingly, cells at P2 see higher levels of VEGF
as compared to cells at P3, yet they elicit a lower VEGF induced IL8 expression
(Fig. 7.6F) highlighting the importance of increased time spent by cells at P3
at compared to cells at P2. This suggested that VEGF induced response of the
cells was a spatio-temporal phenomenon, which led to non-intuitive behavior
of cells at different positions. By comparing the levels of survival (BCL2 Fig.
7.6E), death (BNIP3 Fig. 7.6D) and proliferative (CYCLIND Fig. 7.6C) markers
we could see how cells at P2 were the ones having the most action (higher levels
as compared to P1 and P3). This suggested that the region P2 was poised at a
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Figure 7.4: Investigating growth/death dynamics and migratory behav-
ior of cells upon a dose of growth factors (GF) using SAMM.
(A) Constant source of VEGF and/or IL8 was allowed to dif-
fuse from one side face of the construct (grid of 20×20×5) while
tumor/endothelial cells (maximum of 20 cells per grid ele-
ment) were seeded on the opposite face in the beginning of the
simulation. (B) Base case simulation with VEGF (10 au dose,
details in materials and methods with rule 2): Growth profile
is shown along the left part of panel B, while the external GF
(VEGF) levels are shown in the right part of panel B. First row
in panel B corresponds to time step 1 while last row in panel B
corresponds to time step 250 (end of simulation). (C) Control
1: Simulation with GF (VEGF) receptor inhibition in all cells/at
every location in the construct. (D) Control 2: Simulation with
no external dose of GF (VEGF) coupled with no initial seeding
of GF in the construct.
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profile upon IL8 dose to demonstrate crosstalk between VEGF
and IL8 signaling.
delicate balance with optimum VEGF levels and optimum amount of time spent
in the given environment thereby acting as a proliferative core. This was further
substantiated by the additional branches initiating from this region (P2). Inter-
estingly, BNIP3 levels at P1 and P3 were quite similar (Fig. 7.6D) showing that
higher levels of VEGF for shorter time (P1) and lower levels of VEGF for longer
time (P3) both elicited similar expression of BNIP3. However, BCL2 levels at P1
were higher as compared to P3. This suggested that cells at the tip of a growth
were more pro-survival as compared to the cells at the base (P3). It has indeed
been shown in the literature that cells at the tip are specialized pro-survival cells,
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which utilize dynamic interactions between VEGF and DLL4/Notch signaling
cascades at the cellular level to regulate number of tip cells, vessel sprouting
and branching [202, 201, 229].
Effects of intracellular perturbations:
Use of detailed molecular networks to guide phenotypic decisions presents us
with the scope to analyze the effects of intracellular changes and perturbations
to growth. In the base simulations we looked at the growth profile upon a VEGF
dose under normoxic conditions (O2 levels ∼ 21%) (Fig. 7.4). However under
hypoxic conditions (O2 levels ≤ 2%), cells respond to the reduced oxygen lev-
els via hypoxia inducible factor 1 α (HIF1α) and reactive oxygen species (ROS)
[300, 355]. HIF1α signaling leads to the expression of many factors including
VEGF and IL-8 [580]. Additionally ROS promotes NF-κβ activation [355] which
further regulates both VEGF and IL-8 expression [355, 580]. Secreted VEGF and
IL-8 signals can then amplify the hypoxic response and induce proliferative sig-
nals via both autocrine or paracrine signaling mechanisms through the VEGFR
and CXCR receptor families. We explored the effects of reduced oxygen levels
(O2 levels ≤ 2%) (Fig. 7.7 column A). We saw enhanced growth due to further
amplified VEGF and IL-8 signaling mediated by the HIF1 and ROS signaling
axis. Autocrine mediated signal amplification is critical in case of VEGF and IL-
8 signaling. This positive autocrine feedback at the cellular level is mediated by
the activation of AP-1 and NF-κβ downstream of both VEGF and IL-8 signaling
cascades [70]. We simulated a case to verify this by altering the cellular ma-
chinery to prevent autocrine signaling (Fig. 7.7 column B). We saw slower and
lesser growth overall as compared to the base case (Fig. 7.4 and Fig. 7.7). To suc-
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Figure 7.6: Spatio-temporal phenotypic differences during growth: (A)
Contour plot (interpolated colors) of cells across the 3rd z-slice
at the last time point of simulation (Dose: VEGF, Rule 2). We
look at three positions (abbreviated as P1, P2 and P3) to analyze
the functional states of the cells. (B)-(F) Averaged (average of
the position and its 6 corresponding neighbors) internal and
external marker levels at P1, P2 and P3. (B) Scaled extracellular
VEGFA levels. (C) Scaled intracellular CYCLIND (marker for
proliferation) levels. (D) Scaled intracellular BNIP3 (marker for
cell death) levels. (E) Scaled intracellular BCL2 (marker for cell
survival) levels. (F) Scaled extracellular IL8 levels.
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Figure 7.7: Exploring variations in growth profile by altering internal
make-up of the cells: Column A - Growth profile upon VEGF
dose under hypoxic conditions (O2 levels ≤ 2%). Column B -
Growth profile upon VEGF dose with no autocrine signaling
within cells. Column C - Growth profile upon VEGF dose with
ERK KO in cells. Column D - Growth profile upon VEGF dose
with ATF2 KO in cells. Images in the first row correspond to
initial time point, while images at third row correspond to last
time point of simulation.
cessfully manipulate the VEGF/IL-8 mediated cellular response, it is therefore
vital to alter key regulatory cores e.g., MAPK signaling module, AP1 regulatory
module. We investigated the effects of these key nodes by simulating knockout
experiments. Upon running simulations with cells having ERK KO (materials
and methods), we saw significantly slower and lesser growth as compared to
the base case (Fig. 7.4 and Fig. 7.7). Similarly, in simulations with cells having
ATF2 KO, we saw significantly slower, lesser and disordered growth as com-
pared to the base case (Fig. 7.4 and Fig. 7.7). This could be attributed to the key
role of ATF2 mediated regulation of AP1 in maintaining the proliferative ability
of the cells via regulation of CYCLIND.
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Effect of probabilistic rules:
In case of multiscale phenomenon like tumor growth and angiogenesis, besides
spatio-temporal variations and inherent functional variations within cells, there
is an additional level of variability introduced by how cells respond to different
cellular states and how they decide to move around in the matrix. To inves-
tigate this aspect, we simulated several scenarios based on coupling internal
cellular marker levels to probabilistic moves incorporating neighboring cellular
information in the volume. In the first set of simulations, we coupled intracel-
lular CYCLIND levels (used as a marker for cell proliferation) along with the
cell densities of neighbor locations to test different growth profiles. Firstly, suc-
cessful cellular moves (based on CYCLIND levels) were modeled as random
unbiased moves with no effect of neighboring cell densities (Rule 0) (Fig. 7.8
column A). This led to bulk growth as seen in Fig. 7.8 column A. This form of
growth, with no neighborhood bias is typical of tumor growth [55]. It is impor-
tant to note here that there was always a directional bias implying that growth
was favored up the gradient of the growth factor. In case of angiogenesis, direc-
tionality up the gradient of growth factors is coupled with neighboring cellular
information [371]. We investigated this idea by exploring number of sparsely
populated neighboring positions (materials and methods). When we allowed
moves to occur when there was at least one sparsely populated neighbor (Rule
1) (Fig. S7.5 column A), we saw that we transitioned away from bulk growth
to more dendritic growth. We did not see any noticeable bias regarding start
of these dendrites from the initial seeded cell surface. However, when we al-
lowed moves to occur when there were at least two (Rule 2) (Fig. 7.8 column
B) or three (Rule 3) (Fig. 7.8 column C) sparsely populated neighbors, we saw
dendritic growth with a bias towards the edges (Rule 2) and corners (Rule 3).
218
Behavior under different rules was seen consistently over multiple repeats (10
repeats) and clear differences can be seen between different rules (Fig. 7.9). In
all simulations, a completely unbiased move was equally probable. To test the
effect of choice of internal cellular marker, we ran a simulation wherein suc-
cessful cellular moves were based on ERK levels (used earlier by Wang et. al.
[576, 577]) coupled with at least two sparsely populated neighborhoods (Rule 2
with ERK) (Fig. 7.8 column D). We saw a similar growth morphology as in case
of Rule 2, but faster growth.
7.4.2 Discussion
We present a signaling assisted multiscale modeling technique (SAMM) to
study systems across multiple length scales. Key highlights of SAMM include
use of detailed cellular models to regulate cellular decisions, use of an ensemble
of models to incorporate population based behavior of cells, coupling intracel-
lular markers and probabilistic rules to monitor cellular fate and cellular motil-
ity and a hybrid approach to improve speed of solving of external and internal
mass-balances. SAMM allows us the flexibility to include multiple cell types,
freedom of seeding cells with specific internal cellular machinery within com-
plex geometries, regulate multiple cellular decisions using internal and secreted
cellular markers coupled with probabilistic functions and improved solving
speed. This platform allows us to investigate complex multiscale phenomenon
e.g., tumor growth, angiogenesis. In the current study, we demonstrated using
SAMM the ability to capture and identify spatio-temporal effects upon growth
(Fig. 7.6), ability to model and monitor effects of internal variations in the cells
e.g., species KO’s (Fig. 7.7) and ultimately ability to monitor effects of coupling
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Figure 7.8: Exploring variations in growth profile due to probabilistic
rules and alternate use of cellular markers: Column A - Rule
0: Growth profile upon VEGF dose with complete unbiased
moves. Column B - Rule 2: Growth profile upon VEGF dose
with moves based on at least two empty neighbors. Column
C - Rule 3: Growth profile upon VEGF dose with moves based
on at least three empty neighbors. Column D - Rule 2 + ERK:
Growth profile upon VEGF dose with moves based on phos-
phorylated ERK levels instead of CYCLIND levels. Images in
the first row correspond to initial time point, while images at
third row correspond to last time point of simulation. Images
in the fourth row correspond to the contour plot of cells across
the 3rd z-slice at the last time point of simulation.
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Figure 7.9: Repeatability check: We simulated multiple repeats (10 re-
peats) for rule 1 and rule 3 to check for reproducibility and con-
sistency. (A) Number of growth events for rule 1 (mean of 10
simulations as black line and shaded light grey area demarcat-
ing one standard deviation) and rule 3 (mean of 10 simulations
as red line and shaded dark grey area demarcating one stan-
dard deviation) over the simulation time. We clearly see dif-
ferences between the two different rules over multiple repeats
while seeing consistent behavior over repeats. (B) Number of
death events.
probabilistic rules to internal marker levels and its effects on growth morphol-
ogy and growth dynamics (Fig. 7.8).
Different regions of a growing mass of cells are bound to have different func-
tionalities and thereby different phenotypic characteristics [19]. For example, in
case of angiogenesis tips of the sprouts are actually occupied by endothelial
tip cells which dynamically regulate number of tip cells, vessel sprouting and
branching [202, 201, 229]. Similar phenomenon is seen even in case of epithelial
tubulogensesis [556] and axon guidance [67]. As compared to wet experiments,
a multiscale computational model e.g. SAMM allows us the freedom/ease to
investigate phenotypic differences between cell populations at different regions
of growth (Fig. 7.6). We do not see any linear relationships between cellular
states as we move from the tip of a dendrite to the base, suggesting a complex
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Figure 7.10: Growth and death dynamics across simulations: (A-C)
Growth/death characteristics upon intracellular perturba-
tions. (D-F) Growth/death characteristics upon probabilistic
rule variations. In general, growth dynamics (linear growth
rate) was observed overall consistently throughout each sim-
ulation. We do see differences between individual cases with
respect to time of start of growth, total volume of growth, e.g.,
at low O2 growth was faster and more pronounced due to ad-
ditional effects mediated by the ROS and HIF1 signaling axis.
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spatio-temporal phenomenon at play. Cells at the tip of the dendrite are exposed
to higher GF levels and thereby elicit more pronounced GF mediated effects.
However there is an added component of how long these cells have actually
stayed in this environment. Our simulations suggest that the region towards
the center of the dendrite (Fig. 7.6A) is poised at a delicate balance with opti-
mum VEGF levels and optimum amount of time spent in the given environment
thereby acting as a proliferative core. Also cells at the tip of the dendrite are more
pro-survival as compared to the cells at the base. This idea has indeed been
recently suggested by Franco et. al., where in they speculate that growing en-
dothelial cells recruit pericytes which ultimately lead to increase anti-apoptotic
protein levels to promote survival of cells at the tip [139]. However for accurate
predictions and analysis, we do need more detailed/comprehensive intracellu-
lar cellular signaling models and additional cell type models e.g., tip cell, stalk
cell models. Using different cell type models with inherent differences in ma-
chinery might provide a clearer picture regarding heterogeneity and elucidate
spatio-temporal variations along different segments of growth.
Regulation of complex multicellular processes like tumor growth, angiogen-
esis is often done via altering internal cellular makeup directly or indirectly by
using external agents e.g., anti-angiogenic drugs. SAMM presents the scope to
analyze the effects of intracellular changes/perturbations to growth morpholo-
gies/dynamics. Crosstalk between several signaling axis e.g., HIF1 signaling,
ROS signaling, VEGF signaling and IL-8 signaling all lead to and control out-
come of VEGF/IL-8 mediated response of cells [300, 355, 580]. In this regard,
autocrine mediated signal amplification is key to the time/magnitude of the re-
sponse. We tested several cases by directly/indirectly altering internal states of
the cells. While the growth dynamics (linear growth rate) was overall consis-
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tent throughout each case (Fig. 7.10A), we did see differences between individ-
ual cases (Fig. 7.10A-C). For example, at low O2 growth was faster and more
pronounced due to additional effects mediated by the ROS and HIF1 signaling
axis. This behavior is consistent with literature evidence [188, 284, 417, 212, 53].
Similarly, ERK KO and ATF2 (transcription factor for AP1) KO lead to delayed
and lower growth as compared to the base case. It does not completely inhibit
growth due to other redundant routes of CYCLIND regulation. This demon-
strates an example of two strategies which delay growth but do not alter the
rate of growth in the long run. In the current scheme however, we did not
take several signaling components into account. For example, we did not in-
clude any signaling modules associated with cellular metabolism, EGFR signal-
ing and no nutrient dependency was taken into account. These signaling com-
ponents amongst many others play a critical role in breast cancer progression
[588, 251, 74, 222] and angiogenesis [109, 559, 420]. Incorporating intracellular
details shall be vital to exploring perturbation based experiments. However,
added size and complexity of elaborate signaling models bring with themselves
further challenges associated with solution techniques and computing time lim-
itations. Even with the obstacles we are about to face, this form of analysis could
be a valuable tool to test the effectiveness of mechanistic regulators of cellular
machinery in multiscale phenomenon like tumor growth and angiogenesis.
An interesting area of cellular growth and migration are the resultant mor-
phologies. There could be a diverse range of factors influencing the same e.g.,
concentrations of ECM proteins, gradients of growth factors, neighboring cellu-
lar densities, nutrient levels, physical stresses. SAMM allows us the flexibility
to study the influence of these external factors on growth morphologies. Just
by incorporating neighboring cellular density information we could transition
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from a bulk growth (as seen in tumors [55]) to well formed dendritic growth
with/without a bias towards corners and edges (as seen in 3D cultures [371]).
In reality there must be more at play. Looking forward, using SAMM we can
reverse engineer a particular growth morphology by sampling the probability
function landscape. This shall allow us to test the contribution and implications
of different extracellular factors in determining the nature of growth. Another
area which we barely touched upon in the current study was use of intracellular
markers to determine cellular phenotype. For example, we saw differences in
growth when we based the proliferative moves based on intracellular levels of
CYCLIND and ppERK. This begs further investigation with regards to choice of
individual or combinatorial use of intracellular marker levels to model pheno-
typic decisions. Using SAMM, we can identify the relevance/validity of these
choices.
7.5 Conclusion
Unraveling the mysteries within complex multiscale phenomenon like tumor
growth and angiogenesis, with its inherent crosstalk between molecular and
microscopic scales makes this area a challenging field of study, both experimen-
tally and computationally. Utilizing the current progress in the field of modeling
signaling networks, modeling complicated 3D constructs at tissue/organ/body
levels we are at the perfect position to make strides of progress in creating mul-
tiscale models incorporating information across multiple length scales. Mod-
eling such complicated phenomenon has come a long way over the years
[485, 110, 500, 418, 154]. Across a multiscale level, several recent advances have
been made in modeling breast cancer [531, 310, 326, 435, 434, 509, 314, 495, 17,
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631, 328, 143, 119, 362, 112]. While some studies focused on identifying the
role of point-mutations in EGFR signaling in the onset of oncogenic transforma-
tions [314, 495], others used this integrative method along with pharmacokinetic
measurements to predict resistance based on specific tumor properties and thus
improve treatment outcome [143]. We present a signaling assisted multiscale
modeling technique (SAMM) to study systems across multiple length scales.
Key highlights of SAMM include use of detailed cellular models to regulate cel-
lular decisions, use of an ensemble of models to incorporate population based
behavior of cells, coupling intracellular markers and probabilistic rules to mon-
itor cellular fate and cellular motility and a hybrid approach to improve speed
of solving of external and internal mass-balances. SAMM allows us the flexibil-
ity to include multiple cell types, freedom of seeding cells with specific internal
cellular machinery within complex geometries, regulate multiple cellular de-
cisions using internal and secreted cellular markers coupled with probabilistic
functions and improved solving speed. This form of a platform allows us to
investigate complex multiscale phenomenon e.g., tumor growth, angiogenesis,
relevant to several complex disease states like breast cancer.
7.6 Materials and Methods
7.6.1 Molecular scale: Formulation and solution of model
equations for internal cellular signaling.
The tumor/endothelial cell model was adapted from a previous study by
Chakrabarti et. al. and described 548 protein or mRNA species interconnected
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by 920 interactions [70]. The model described the integration between extra-
cellular oxygen (O2) levels and VEGFA (vascular endothelial growth factor A),
IL-8 (interleukin 8) autocrine induced intracellular gene expression, prolifera-
tion and death programs. For HIF-1α (hypoxia inducible factor 1 α), we mod-
eled oxygen-dependent PHD (prolyl-4-hydroxylase)/VHL (von hippel-lindau)-
induced HIF-1α degradation and FIH (factor inhibiting HIF)-induced inhibi-
tion. In addition to HIF-1α, we modeled the expression and regulation of four
other transcription factors: AP1 (activator protein 1), ATF2 (activating tran-
scription factor 2), MEF2 (myocyte enhancer factor-2) and NF-κβ (nuclear factor
κβ). AP1 expression was dependent upon both ATF2 and MEF2. Both ATF2
and MEF2 were constitutively expressed and regulated by phosphorylation at
T69/T71/T73 for ATF2 and T312/T319 for MEF2 by p38MAPK family mem-
bers. We modeled a single activating phosphorylation site on AP1 (S63/S73),
which was regulated by ppERK (phosphorylated ERK) which is formed down-
stream of both IL-8 and VEGFA signaling cascades. NF-κβ regulation was
more complex; NF-κβ was assumed to be sequestered by a lumped pool of IκB
family members. The regulation of this pool occurred by phosphorylation at
S32/S36 and Y42 on IκB; S32/S36 was phosphorylated by PKC (protein kinase
C) while Y42 was regulated by an unknown ROS-dependent kinase. Lastly,
protein markers downstream of these transcription factors were used to charac-
terize proliferation, survival and death phenotypes. AP1 dependent CYCLIND
expression was used as a marker of proliferation. NF-κβ dependent BCL2 ex-
pression was used to characterize cell survival while HIF-1α dependent BNIP3
expression was used as a cell death marker. In addition to these markers, the
expression of VEGFA, IL-8 and their respective surface receptors VEGFR2 and
CXCR1/2 was also modeled. These receptors were connected to transcription
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factor activation through the activity of the MAPK, p38MAPK and PKC kinases.
Complete details of the interactions in the model are enlisted in Chakrabarti et.
al. [70].
The cellular signaling model was formulated as a set of coupled ordinary
differential equations (ODEs):
dx
dt
= S · r (x,p) x (to) = xo (7.1)
The symbol S denotes the stoichiometric matrix (548 × 920). The quantity x de-
notes the concentration vector of proteins or protein complexes (548 × 1). The
term r (x,p) denotes the vector of reaction rates (920 × 1). Each row in S de-
scribed a protein or protein-protein complex, while each column described the
stoichiometry of network interactions. Thus, the (i, j) element of S, denoted by
σi j, described how protein i was involved in rate j. If σi j < 0, then protein i was
consumed in r j. Conversely, if σi j > 0, protein i was produced by r j. Lastly, if
σi j = 0, there was no protein i in rate j. All of these interactions were obtained
from the literature.
We assumed mass-action kinetics for each interaction in the network. The
rate expression for interaction q was given by:
rq
(
x, kq
)
= kq
∏
j∈{Rq}
x−σ jqj (7.2)
The set
{
Rq
}
denotes reactants for reaction q while σ jq denotes the stoichio-
metric coefficient (element of the matrix S) governing species j in reaction q.
All reversible interactions were split into two irreversible steps. The mass-
action formulation, while expanding the dimension of the model, regularized
the mathematical structure; this allowed automatic generation of the model
code using UNIVERSAL and regularized the unknown model parameters (pa-
228
rameters were one of only three types, association, dissociation or catalytic
rate constants). UNIVERSAL, an open source Java code generator, gener-
ates multiple code types from text and SBML inputs. UNIVERSAL is freely
available as a Google Code project (http://code.google.com/p/universal-code-
generator/). Thus, although mass-action kinetics increased the number of pa-
rameters and species, they reduced the complexity of model analysis. In this
study, we considered well-mixed nuclear, cytosolic and extracellular compart-
ments. The model equations were solved using the LSODE routine in OCTAVE
(v 3.1.0; www.octave.org) on an Apple workstation (Apple, Cupertino, CA; OS
X v10.6.4).
Model parameters were estimated using 20 experimental data sets taken
from literature (further details in Chakrabarti et. al. [70]). In total, 1468 un-
known parameters (920 kinetic parameters and 548 initial conditions) were
present in the cellular model. Both kinetic parameters and unspecified initial
conditions were estimated using the POETs multiobjective optimization algo-
rithm [504]. Pareto Optimal Ensemble Techniques (POETs) is a multiobjective
optimization strategy which integrates several local search strategies e.g., Sim-
ulated Annealing (SA) or Pattern Search (PS) with a Pareto-rank-based fitness
assignment [504]. POETs generated more than 40,000 probable models. For
SAMM, we selected models with Pareto rank one or less (N = 3233) similar to
the ones used in the previous study [70]. Each cell in the simulation was ran-
domly assigned a parameter set form this ensemble. This ensured diversity
between cells in the population and allowed us to explore population average
behavior. SBML file of the model along with the ensemble of parameters used
for SAMM are included in the supplementary materials.
229
7.6.2 Microscopic scale: Formulation and evolution of extracel-
lular microenvironment.
As shown in Fig. 7.2, a 3D virtual microenvironment comprising of a discrete
space with 20×20×5 grid points was created. In this grid, we placed the growth
factor source and seeded cells at specific positions at the start of the simulation.
In the current study, the GF source was a constant source (Ginput, in the current
study Ginput = 10 A.U.) of VEGF and/or IL-8 from the side face as shown in
Fig. 7.2. The tumor/endothelial cells were seeded in the opposite face, with
a maximum of NCmax ( NCmax = 20 in the current study) per grid element (Fig.
7.2). Each cell in a grid element has a self-maintained signaling network with
a randomly assigned parameter vector from the ensemble as discussed earlier.
While in the current study, we demonstrate the functionality using a simple grid
based setup, SAMM allows us the flexibility to easily create complex geometries
with intricate arrangements of GF sources and seeded cells.
Over the course of the simulation, cells respond to cellular and environmen-
tal cues and accordingly adjust their phenotype at each time step. However,
at any time step we sampled only Fα (in the current study Fα = 0.25) fraction
of cells. Sampling of cells is done randomly, so overall we should capture the
trends over the entire area. The fractional sampling is used in order to minimize
overall simulation time. A simulation run is terminated after 250 time steps (this
corresponds to ∼ 10 experimental days). We use the number of live cells at any
time for total growth volume (as shown in Fig. 7.10). We also record the number
of growth and death events at every grid element, at every time step for further
analysis (as shown in Fig. 7.10).
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External diffusive chemical cues (VEGF, IL-8, O2 in the current study) are
regulated via initial seeding, source terms and consumption/production via
cells. Unless otherwise mentioned, we maintained O2 levels to represent nor-
moxic conditions to isolate and study the GF mediated response. Throughout
the simulation, the three chemical cues are continuously updated at a fixed rate.
The concentration of extracellular variables (C) at spatial position (i, j, k) was
governed by ordinary differential equations of the form:
dCi jk
dt
= DC∇˙2Ci jk + θ(C), t = 1, . . . ,Tend (7.3)
The first-term of Eqn. (7.3) described the diffusive component with DC being
be corresponding diffusion constant for the extracellular species (C), while the
second-term described consumption/production by cells. Tend in the current
study is 250 which corresponding to ∼ 10 experimental days.
We can rewrite this equation as:
dCi jk
dt
=
6∑
f=1
T f
(
C f − Ci jk
)
+H
(
C∗ − Ci jk
)
+ θ(C), t = 1, . . . ,Tend (7.4)
where i = 1, . . . ,Nx; j = 1, . . . ,Ny; k = 1, . . . ,Nz. The first-term of Eqn. (7.4)
described the material transport between subvolumes while the second-term
described transport of material to and from the boundary and the third term
described consumption/production by cells. The advantages of this solution
strategy is drastic reduction of simulation time and ease of computation. After
each simulation step, we matched internal and external protein marker levels
for consistency.
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7.6.3 Molecular-microenvironment crosstalk: Molecularly driven
cellular phenotype and mobility calculations.
Intracellular protein marker levels coupled with probabilistic rules were used
to characterize proliferation, survival and death phenotypes. AP1 dependent
CYCLIND expression was used as a marker of proliferation [557]. NF-κβ de-
pendent BCL2 expression was used to characterize cell survival while HIF-1α
dependent BNIP3 expression was used as a cell death marker [523, 58]. Proba-
bility of growth Pg for any cell at time t was modeled as:
Pg =
Xg
Gα + Xg (7.5)
where Xg refers to intracellular growth marker levels and Gα refers to a growth
constant. In the current study, growth was dependent on the levels of CyclinD
(ERK in one simulation, similar to Wang et. al. study [576, 577]). We sampled
four orders of magnitude variations in Gα. Final selection of Gα was made so
as to have growth behavior in the shaded grey region as seen in supplementary
Fig. S7.3. Selections was done with the death decision happening as an unbiased
random move. Higher Gα would mean lower probability of growth and vice-
versa. Similarly, probability of death Pd for any cell at time t was modeled as:
Pd =
Xd
Dα + Xd (7.6)
where Xd refers to intracellular death marker levels and Dα refers to a death
constant. In the current study, death was dependent on the levels of BNIP3. We
sampled four orders of magnitude variations in Dα. Final selection of Dα was
made so as to have death behavior in the shaded grey region as seen in supple-
mentary Fig. S7.3. Selections was done with the growth decision happening as
an unbiased random move.
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Furthermore, cellular mobility decisions additionally took into account both
number of available neighbors and the cellular densities at neighbors. For ex-
ample, grid positions were characterized as body, face, edge or corner positions
which accordingly determined which available neighbors were available for a
move (as illustrated in Fig. 7.2). Cellular densities at neighborhood i were cal-
culated as:
βi =
NCi
NCmax
(7.7)
where NCi is the number of cells at neighborhood i, NCmax = 20 and i ranged from
1− 6 depending on the grid position. A neighbor was considered to be sparsely
populated if βi < βT, where βT was the threshold cellular density (in current
study βT ≤ 0.1). As shown in Fig. 7.8 and Fig. S7.5, we simulated several sce-
narios based on number of sparsely populated neighbors. Rule 0 corresponded
to the case where cellular moves were random unbiased moves with no effect
of neighboring cell densities. Rule 1 corresponded to the case where cellular
moves were allowed to occur when there was at least one sparsely populated
neighbor. Rule 2 corresponded to the case where cellular moves were allowed
to occur when there were at least two sparsely populated neighbors. Rule 3 cor-
responded to the case where cellular moves were allowed to occur when there
were at least three sparsely populated neighbors. At all times, we did have the
option for a random growth event as well.
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7.6.4 Intracellular perturbation analysis and control simula-
tions.
In this study, simulated KO experiments (e.g., ERK KO, ATF2 KO) were carried
out by setting corresponding gene levels to zero in the intracellular model for
all the cells within the construct. This allowed us to mimic the effects of the an
experimental KO in out simulations.
As control simulations, we simulated several cases to isolate and test the va-
lidity of the GF mediated response. Sample control experiments included set-
ting diffusion constants DC as zero, GF KO, GF receptor inhibition in which we
prevented GF receptors from sensing the external GF levels by setting the cor-
responding rate constants to zero over the entire ensemble, No external dose of
GF with/without initial seeding of GF across the construct. Some of the control
experiments are discussed in the manuscript (Fig. 7.4C-D).
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CHAPTER 8
TOP-DOWN ANALYSIS OF HYPOXIA INDUCED SIGNALING
DIFFERENCES IN 2D VS 3D
8.1 Abstract
Recent advancements in high-throughput methods for characterizing genomic,
transcriptomic, proteomic, and metabolomic states allow one to view the
global consequences of perturbations rather than just the usual suspects. High-
throughput experimental techniques of gathering disease state information
have created the need for specialized modeling strategies to build predictive
disease models. In case of hypoxia induced tumor growth and angiogenesis,
we employed the top-down strategy to explore the cellular behavior and iden-
tify different operational modes of cells. We created an in-house platform to an-
alyze microarray data and overlay the quantitative information on pre-curated
pathways to identify malfunctions within the cells. We coupled this to mathe-
matical analysis techniques like singular value decomposition (SVD) to identify
key mediators of the response. Using these strategies, we identified differen-
tial regulators of the cellular behavior in 2D versus 3D experimental protocols.
We also identified differential behaviors and involvement of key signaling path-
ways in mediating the hypoxic response. While this form of analysis provided
key insights in the experimental directions, which are being pursued by our
collaborators, we specifically used this insight to create proof-of-concept phys-
iochemical models to further the process of modeling these disease states. This
strategy has immense scope of development, from identifying key regulators to
forming proof-of-concept physiochemical models.
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8.2 Introduction
Recent advancements in high-throughput methods for characterizing genomic,
transcriptomic, proteomic, and metabolomic states allow one to view the global
consequences of molecular perturbations rather than just the usual suspects [508].
However, this wealth of high-throughput data creates new challenges in data in-
terpretation, because most of the measurements lack a biological context for in-
terpreting the biological relevance to the experimental perturbation. These mea-
surements give a snapshot of activity at various levels at the time of isolation
[508, 606, 166]. While this has successfully provided a detailed view in several
disease states, e.g. B cell lymphoma [5], breast tumors [426, 419]; it lacks provid-
ing us with the understanding of relationships within gene networks [606, 166].
Interactions between gene products are extremely complex and are not the
only determinant of cellular behavior [508]. There are positive and negative
feedback controls via transcription factors to begin with. To address the area
of inferring connectivity from such high-throughput data, several groups are
working to set up tools for the trade [136, 52, 51, 96, 95, 503, 594, 528, 169].
Researchers use clustering or correlation based techniques to infer information
about the topology of the connections extensively [528, 169, 303, 594, 24, 293].
These techniques help reduce the complexity of these data sets by identifying
clusters of signaling species that may either be co-regulated or that can similarly
regulate other species in a signaling network. However these techniques are in-
sufficient to determine the kinetic or dynamic parameters required to model the
dynamical behavior of the system [508]. Another strategy in extracting potential
gene relationships from such high-throughput data is by using singular value
decomposition (SVD) [568, 252, 87, 632, 607, 530, 8, 9, 104]. These approaches
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draw on the use of computational tools to identify features in the data that may
globally represent the entire data set (e.g., principal components). These ap-
proaches inherently make few/no assumptions about the data and have the ca-
pability to provide unbiased identification of unexpected correlations. These
correlations might not explain the causality between correlated components,
however they can be useful for identifying nonintuitive patterns in the data
and help guide future experiments.
In the current study, using a top-down strategy, we used these extensive
data-sets to investigate cellular signaling, identify malfunctions, create predic-
tive models to infer patient outcome. In case of hypoxia induced tumor growth
and angiogenesis, we employed this strategy to explore the cellular behav-
ior. We created an in house platform to analyze microarray data and overlay
the quantitative information on pre-curated pathways to identify malfunctions
within the cells. We coupled this to mathematical analysis techniques like singu-
lar value decomposition (SVD) to identify key mediators of the response. Using
these strategies, we identified differential regulators of the cellular behavior in
2D versus 3D experimental protocols. We also identified differential behaviors
and involvement of key signaling pathways in mediating the hypoxic response.
While this form of analysis provided key insights in the experimental direc-
tions, which are being pursued by our collaborators, we specifically used this
insight to create proof-of-concept physiochemical models to further the process
of modeling these disease states. This strategy has immense scope of develop-
ment, from identifying key regulators to forming proof-of-concept physiochem-
ical models.
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Figure 8.1: Histogram of 2D and 3D fold changes in mRNA components
(hypoxia/normoxia): We see a wider distribution in case of 2D
experiment as compared to 3D experiment. Details of the ex-
perimental protocols are in the materials and methods.
8.3 Results
8.3.1 Big Picture Analysis of the Microarray Data
Oral squamous cell carcinoma-3 (OSCC3) cells cultured in 2D and 3D (mate-
rial and methods) were exposed to normoxia (17%) and hypoxia (1%) oxygen
for 6 days and then microarray measurements were done using Affymetrix
GeneChips. Microarray measurements gave us measurements of dimensions
(54675×3 (three repeats)) for each experimental condition (hypoxia, normoxia -
2D and 3D). For further analysis, we used the mean of the measurements over
the three repeats. As in Fig. 8.1, we saw a wider distribution of fold change (hy-
poxia versus normoxia) in expression levels in case of 2D experiment as com-
pared to 3D.
Microarray arrays have multiple probes for the same IDs. So the first step
of further analysis was to remove repetitions in order to reduce dimensions of
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AI
Micro-array Data to be analyzed A1
dim(A1) = M1 ! N1
M1 = 54675, N1 = 6(2D), 9(3D)
A
Micro-array Data to be analyzed A
dim(A) = M ! N
M = 20766, N = 6(2D), 9(3D)
Combining different probes for same 
species
Figure 8.2: Microarray arrays have multiple probes for the same IDs. First
step was to remove repetitions in order to reduce dimensions.
This allowed us to consolidate multiple probes for the same
species and reduce the dimensionality of the problem from
54675 to 20766.
the measurements. This allowed us to consolidate multiple probes for the same
species and reduce the dimensionality of the problem from 54675 to 20766 as
shown in Fig. 8.2.
Qualitative comparisons of genes in 2D and 3D experiments based on fold
changes (hypoxia/normoxia) in mRNA levels showed us an interesting result
(Fig. 8.3). Against our intuition that genes might be regulated in a correlated
manner in 2D and 3D experiments (Quadrant 2 and 3 in Fig. 8.3), we find that
the number of differentially regulated genes are more widespread in number
(Quadrant 1 and 4 in Fig. 8.3).
As a matter of fact, about 1645 genes were statistically significantly differ-
entially regulated, while only 88 genes were statistically significantly similarly
239
12D Experiment
3D
 E
xp
er
im
en
t
3.0
0.36
0.001 0.01 0.1 1 10 100
Pѫ
Pѫ
Pѫ Pѫ
Q-1 (797 genes)
3D + ve
2D – ve
Q-4 (848 genes)
3D – ve
2D + ve
Q-3 (59 genes)
3D – ve
2D – ve
Q-2 (29 genes)
3D + ve
2D + ve
Figure 8.3: Qualitative comparisons of genes in 2D and 3D experiments
based on fold changes (hypoxia/normoxia) in mRNA levels:
Against our intuition that genes might be regulated in a corre-
lated manner in 2D and 3D experiments (Quadrant 2 and 3), we
find that the number of differentially regulated genes are more
widespread in number (Quadrant 1 and 4). As seen in quad-
rant 1, MMP1/10/13, BNIP3, ANG, PDGFB are some of the
key species which are differentially seen to be up-regulated in
3D as compared to 2D (down-regulated). As seen in quadrant
2, BMP5, EPHA6 are some of the key species which are con-
sistently seen to be up-regulated in 3D as well as 2D. As seen
in quadrant 3, IL11, ICAM1, IL32 are some of the key species
which are consistently seen to be down-regulated in 3D as well
as 2D.
regulated. In quadrant 1, MMP1/10/13, BNIP3, ANG, PDGFB are some of the
key species which are differentially seen to be up-regulated in 3D as compared
to 2D (down-regulated) (Fig. 8.3). In quadrant 2, BMP5, EPHA6 are some of the
key species which are consistently seen to be up-regulated in 3D as well as 2D
(Fig. 8.3).
In quadrant 3, IL11, ICAM1, IL32 are some of the key species which are
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A=U SVT
Micro-array Data to be analyzed A
dim(A) = M ! N
Row decomposition of A
dim(U) = M ! M
Column decomposition of A
dim(V) = N ! N
Singular values matrix
dim(S) = M ! N
(diagonal elements hold singular values)
Figure 8.4: Finding natural combinations of the responses within the genes
using Singular Value Decomposition (SVD) allows us to iden-
tify key regulators mediating the hypoxic response.
consistently seen to be down-regulated in 3D as well as 2D. This gives us a first
insight that different regulatory components might be controlling the hypoxic
conditions at different experimental protocols. For example, upregulation of
MMP’s in 3D differentially might suggest the importance of extracellular matrix
and its interactions playing a key role in 3D culture conditions. A similar thing
actually has been suggested in experiments before as well [130, 299].
For further analysis, we used Singular Value Decomposition (SVD) to find
natural combinations of the responses within the genes. This allowed us to
identify key regulators mediating the hypoxic response under different exper-
imental conditions (Fig. 8.4). For this analysis we again used the average fold
changes (hypoxia versus normoxia) as the matrix to decompose.
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Figure 8.5: Qualitative comparisons of genes in 2D and 3D experiments
based on SVD based importance: Using SVD analysis we can
see the differential importance of ECM interactions in 3D as
compared to 2D experiments.
The components were ranked (0-1) based on the magnitudes of the eigen-
values of the first principle component. Differentially over-expressed compo-
nents like MMPs were seen to be important in case of 3D even via SVD (Fig.
8.5). For the case of 2D experiments, we saw that internal cellular metabolism
components were the most important via SVD (Fig. 8.5). Interestingly, we saw
that certain components were equally important (marked by on or near the di-
agonal line in Fig. 8.5). These included hypoxia induced death regulators like
BNIP3, BNIP3L.
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Figure 8.6: Matching the Probe IDs to the Gene names, we curated a set
of 124 pathways with their corresponding participating com-
ponents to investigate the differences and critical components
within each pathway. For each pathway, this allowed us to
identify differences within pathway components under differ-
ent cases (2D and 3D) and use SVD to mine the key regulators
as well. This analysis supplemented what we learned from the
pathway analysis using Ingenuity Pathway Analysis.
8.3.2 Pathway Analysis of the Microarray Data
We created an in house platform to analyze microarray data and overlay the
quantitative information on pre-curated pathways to identify malfunctions
within the signaling pathways. For this purpose, we curated ∼ 124 signaling
pathways from literature and IPA (Ingenuity R© Systems, www.ingenuity.com).
For each pathway, this allowed us to identify differences within pathway com-
ponents under different cases (2D and 3D) and use SVD to mine the key regula-
tors as well specific to each pathway (Fig. 8.6).
For each pathway, in order to visualize the behavior we looked at the
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Figure 8.7: Performance of HIF1 Signaling Cascade: A) Heatmap of the
components involved in the pathway. Left column - Fold
change in mRNA levels in 2D experiment. Right column -
Fold change in mRNA levels in 3D experiment. Color: Black
- no change, Red > 1 and Green < 1. B) Cross plot of fold
changes of mRNA levels in 2D (x axis) vs 3D (y axis). Each
point indicates the mean of the ratio across multiple measure-
ment sets. The quadrants of the plot indicate the similarly or
differentially regulated components. C) Cross plot of impor-
tance based on the first principle direction using SVD analysis
2D (x axis) vs 3D (y axis). Values range from 0 (less impor-
tant) - 1 (more important). D) Tabulation of the 5 most impor-
tant components for the corresponding pathway (using abso-
lute change in expression levels and SVD based importance).
We see that MMP1/10/12 and VEGFA are some of the compo-
nents differentially regulated in 2D (fold change < 1) and 3D
(fold change > 1). Interestingly, HIF1α is implicated via SVD
analysis to equally contribute in both cases.
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heatmap of the components involved in the pathway (Color: Black - no change,
Red > 1 and Green < 1). In order to quantitatively compare the cases, we looked
at the cross plot of fold changes of mRNA levels in 2D (x axis) vs 3D (y axis).
Each point indicated the mean of the fold change (hypoxia versus normoxia)
across multiple measurement sets. The quadrants of the plot indicated the simi-
larly or differentially regulated components. We further used SVD to investigate
the key regulators at the pathway levels as well. This was seen as a cross plot
of importance based on the first principle direction using SVD analysis 2D (x
axis) vs 3D (y axis). Values ranged from 0 (less important) - 1 (more important).
Ultimately, we tried to narrow down the analysis to identification of the top 5
components within each pathway via each analysis (as in Fig. 8.7-8.11).
In case of HIF1 signaling cascade, we saw that MMP1/10/12 and VEGFA
were some of the components differentially regulated in 2D (fold change < 1)
and 3D (fold change > 1). Interestingly, HIF1α was implicated via SVD analysis
to equally (equal importance based on SVD ranking) contribute in both cases
(Fig. 8.7).
In case of VEGF signaling cascade, we saw that VEGFA/C, PDGFC, PGF
were some of the components differentially regulated in 2D (fold change < 1)
and 3D (fold change > 1) (Fig. 8.8). Interestingly BCL2 was differentially upreg-
ulated in 2D (fold change > 1) suggesting that the cells were more pro-survival
in 2D or struggling to stay alive in 2D as compared to 3D. In case of IL-8 signal-
ing cascade, we saw that several components like CCND3, BAX, HBEGF were
differentially regulated (Fig. 8.9). Interestingly, CXCL1 was downregulated in
both cases (greater magnitude change in 3D).
With respect to regulators of angiogenesis, we saw that SDC1/2 were differ-
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Figure 8.8: Performance of VEGF Signaling Cascade: We see that
VEGFA/C, PDGFC, PGF are some of the components differen-
tially regulated in 2D (fold change < 1) and 3D (fold change >
1). Interestingly BCL2 is differentially upregulated in 2D (fold
change > 1) suggesting that the cells are more pro-survival in
2D or struggling to stay alive in 2D as compared to 3D.
entially up-regulated in case of 3D (Fig. 8.10). SDC1/2 is an integral membrane
protein and participates in cell proliferation, cell migration and cell-matrix in-
teractions via its receptor for extracellular matrix proteins. Recently it has been
shown that SDC1 regulates αvβ3 and αvβ5 integrin activation during angio-
genesis [28]. We saw an interesting behavior within components in the TGFβ
signaling cascade, for example TGFβ1 was upregulated in 3D (downregulated
in 2D) where as the opposite was seen in case of TGFβR2 (Fig. 8.10).
To investigate this further, we looked at the behavior of the TGFβ signaling
pathway (Fig. 8.11). In 3D, we saw that BMP2, SMAD9/7, TGFβ1 were dif-
ferentially upregulated while SMAD1/2/6, TGFβR2/3, BMPR1A/B were dif-
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Figure 8.9: Performance of IL-8 Signaling Cascade: We see that several
components like CCND3, BAX, HBEGF are differentially reg-
ulated. Interestingly, CXCL1 is downregulated in both cases
(greater magnitude change in 3D).
ferentially upregulated in 2D. However, BMPR2 was upregulated in both the
cases. This might suggest differential operational paradigms within the TGFβ
signaling cascades operating under different experimental protocols.
8.4 Discussion
In the current study, we used a top-down strategy to investigate cellular behavior
in case of hypoxia induced tumor growth and angiogenesis. We created an in
house platform to analyze microarray data and overlay the quantitative infor-
mation on pre-curated pathways to identify malfunctions within the cells. We
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Figure 8.10: Performance of Inhibition of Angiogenesis Signaling Cascade:
We see that SDC1/2 are differentially upregulated in case of
3D. We see an interesting behavior within components in the
TGFβ signaling cascade, for example TGFβ1 is upregulated in
3D (downregulated in 2D) where as the opposite was seen in
case of TGFβR2.
coupled this to mathematical analysis techniques like singular value decompo-
sition (SVD) to identify key mediators of the response.
Using these strategies, we identified differential regulators of the cellular
behavior in 2D versus 3D experimental protocols. We identified about 1645
genes which were statistically significantly differentially regulated, while only
88 genes were statistically significantly similarly regulated. The differentially
upregulated genes in case of 3D included those interacting/influencing the cel-
lular interaction with the extracellular matrix. This is in line with the importance
of integrin and ECM interactions regulating the tumor growth and angiogenesis
[153, 93]. Zooming on to the level of pathways, we identified differential behav-
248
!"#$%&'"( )
*+,"-.*/"
01(2')2!#&
!"#%)3!",4
!"#%43%.
3+3$/'"3
%'"3!"#%) 4
0-5 $01(2'$
!"#$%$01(2 )
'6*5$!'"3
!"#&%)/*(&"
37'#.*7)0(74
3!",)0"2)
"!/'$8(9:7;
3!",$3!",;
(+5/)''"3
<'722##.05 $
!"#%) $"<:') 2
.*/2".*/22
0'"( =8*(&$4
2!#') 2#."3&
"!/01(2 4
3!6'( $!"#$%4
!"#$%=2!#$
2!#'$"<:'$ 2
3!",>!"#%) )
01.()7#4??
2<- $3!6'( )
@6*2!#') "
!"#4%A3+3)
01(2 $3!",&
:,'!"#$%)
"<:') <'6*54
*'"3/+5<;
1'2$/,"<)
"<:')!"#%B
3!",A3!",=
!"#%;.*/2<
1.;ï
(+313<
!"#%)&''"3$
2!#A"<:'$"
!"#$%&'()*+%,)%-. !"#$%&'()*+%,)%/.01+2,+3%4.
! !"# $ $"# % %"# &
!"'
!"(
!")
$
$"$
$"%
$"&
$"*
$"#
+,-%.*
/,0$
123,
454%
3/,4
6708/%
+,-%.%
6708$
/92:%
+/,4
+,-*.$4;/-12;$
60;&
4+,<$
6,8$
4+,<%
4+,<)
//,4
=/;88-
-16:%
1238,
12388
8+-/$8
6708&
+,-%.>
8+-%
8+-/%
+,-.$$
8=?%
@92
8+-/$,
+,-%.$
,=A/$=
4+,<'
4+,<>
+,-.$*
!"#$%&'()*+%,)%-.
!"
#$
%&
'(
)*
+%
,)
%/
.
/.%%0
-.%%1
/.%%1
-.%%0
/.%%1
-.%%1
/.%%0
-.%%0
Top  Change
in Expression
2D 
Top  Change
in Expression
3D 
SVD Importance 
2D
SVD Importance 
3D
PITX2 ACVR1C HDAC1 MAP2K1
MAP4K1 INHBA FOS JUN
TGFB3 INHA MAP2K1 HDAC1
SERPINE1 PITX2 NRAS SMAD2
INHBB BMP2 RAF1 TAB1
! !"# !"$ !"% !"& !"' !"( !") !"* !"+ #
!"$
!"%
!"&
!"'
!"(
!")
!"*
!"+
#
,-.$/&
0-1#
234-5
627-
891:0#
:,.&
,-./#
;,-4%
,-./%
;/6
;3;$
70-;
/0-;
,-./#%
85<$
891:0$
,-.$/$
891:#
0=2<$
,0-;,-.&/#
721&-
;>0.62>#
81>%
;,-4#
8-:#
-,70$
?1@A>+
;,-4$
;,-4+
13<7#
00-;
B0>::.
.68<$
,-./#$
-BA0#:
627:-
627::
80-1(
?21&$%
:,.0#:
.6-;&
-,7
891:%
;,=01$
,-.$/%
,-.$/(
:,.$
:,.0$
-BA0$:
;,-4'
,-./##
8961#
>.%!!
:B5$
;,=01#
C=2
:,.0#-
,-.%/)
;3;#
891:$ ;,-4&
A40
,-.$/#
-BA0#B
0=2<%
20-;
73<B+
90:$
74-B#
-BA0#
,-./*
;,-4)
;,-4(
,-./+
627:B
1.;ï
13;
9;B
,-./#&
00-;$
:,.)
-BA0$-
!"#$%&'()$*+,-./&01($*0$2#
!"
#$
%&
'(
)$
*+
,-
./&
01
($
*0
$3
#
A B
C
D
Figure 8.11: Performance of TGFβ Signaling Cascade: In 3D, we saw
that BMP2, SMAD9/7, TGFβ1 were differentially upregulated
while SMAD1/2/6, TGFβR2/3, BMPR1A/B were differen-
tially upregulated in 2D. However, BMPR2 was upregulated
in both the cases.
iors and operational paradigms of key signaling pathways within the hypoxic
response. For example, in case of TGFβ signaling different modes of operation
involving BMP2 was seen in 3D as compared to 2D. Similarly, VEGFa and IL-8
levels are differentially regulated in 2D and 3D, suggesting different operational
modes for both as well. At the same time, both in 2D and 3D we saw that HIF1α
was equally important, suggesting some basic similarities as well.
While this form of analysis provided key insights for future experimental
directions (which are being pursued by our collaborators), we specifically used
this insight to further improve the proof-of-concept physiochemical models of
these disease states. Our first generation hypoxia model was constructed by
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using data and connectivity from mostly 2D experiments (as discussed in the
previous chapters). The importance of ECM interactions, Integrin signaling and
differential regulation of TGFβ signaling to name a few, clearly stand out as im-
portant components to add to the next generation model. This study hopefully
shall be able to bridge the gap and further our understanding of differences
and similarities between 2D and 3D experimental protocols. Besides, that this
overall strategy in itself has immense scope of development, ranging from iden-
tifying key regulators to forming proof-of-concept physiochemical models.
8.5 Materials and Methods
8.5.1 2-D Studies and 3-D Alginate Tumor Models
Experiments were carried out by our collaborators in Biomedical Engineering
and Weill Cornell Medical School. For 2D, OSCC3’s were cultured at 37◦C, 5%
CO2 and either 1 or 17% O2 in controlled atmosphere incubators (Thermo Fisher
Scientific, Inc., Waltham, MA) for 6 days. Alginate hydrogels (3% [w/v]) were
used as 3-D cell scaffolds. Alginate (Protanal LF; FMC Biopolymer, Philadel-
phia, PA) was dissolved in serum-free DMEM, and OSCC3 cells were sus-
pended in this dissolved alginate at a density of 20 × 106 cell/mL. Cell-seeded
alginate gels were cast into 4 mm diameter, 200 µm thick cylinders using a plex-
iglass mold, and cross-linked with 100 mM CaCl2 for 15 min. Discs were then
cultured in 24-well plates, with a single disc and 500 µL culture media (DMEM
+ 10% FBS + 1% penicillin/streptomycin) per well. Cells were cultured at 37◦C,
5% CO2 and either 1 or 17% O2 in controlled atmosphere incubators (Thermo
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Fisher Scientific, Inc., Waltham, MA). Media was changed daily.
8.5.2 RNA Target Preparation/Affymetrix Microarray Analysis
Experiments were carried out by our collaborators in Weill Cornell Medical
School. Total RNA was extracted from the samples after exposure to 6 days
of normoxia/hypoxia. All relevant protocols involving refining and quality as-
sessment was done as well. Subsequently, total RNA was processed using a
Affymetrix GeneChip.
8.5.3 Evaluation of Affymetrix GeneChip Data
The hybridizations were normalized by using the RMA (robust multichip av-
eraging) method to obtain summary expression values for each probe set [226].
Gene expression levels were analyzed on a logarithmic scale.
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CHAPTER 9
CONCLUSIONS AND FUTURE DIRECTIONS
Eukaryotes have developed evolutionarily conserved mechanisms to respond
to diverse ranges of internal and external perturbations e.g., changes in
oxygen/nutrient levels, temperature oscillations, protein folding load, vi-
ral/bacterial attacks and graft implants. Alterations and malfunctions within
these core regulatory architectures provide a peek into shifts towards cancer-
ous and disease states. In my research, I have used a combination of bottom-
up analysis (signaling networks based analysis) and a top-down analysis (using
microarray/high throughput experimental data) to investigate stress responses
in eukaryotes. Even with the constraints in the form of biological know-how
and materials and methods, we were able to generate experimentally verifiable
hypothesis in several aspects of the eukaryotic stress responses. However, we
need to address some open areas as we move further in this field e.g., addressing
structural completeness of models, structural analysis of models, model reduc-
tion strategies, alternative model solution techniques. A better understanding
of cellular behavior and the underlying regulatory architecture will be obtained
from an integrated approach that simultaneously incorporates the individual
and contextual properties of all constituents in complex cellular networks [234].
9.1 Structural completeness for next generation models
In the bottom-up analysis scheme, structural uncertainty in the form of miss-
ing species/connections (either or both) are a huge issue. For example, in UPR
while we did an extensive search of the literature to formulate the model, we
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were missing certain key structural aspects of UPR which could provide a more
comprehensive analysis for further generations of the model. One key miss-
ing aspect is the negative regulation of the three ER-stress transducers. Given
PERK’s central role in translation attenuation, cells have evolved multiple axes
to regulate PERK activity. First, the cytosolic kinase domain of PERK can be
inhibited by the action of the DNAJ family member P58IPK . P58IPK was initially
discovered as an inhibitor of the eIF2α protein kinase PKR [292]. P58IPK , whose
expression is induced following ATF6 activation, binds to the cytosolic kinase
domain of PERK, inhibiting its activity [599, 558]. Inhibition of PERK kinase ac-
tivity relieves eIF2α phosphorylation, thereby removing the translational block.
Interestingly, P58IPK expression occurs several hours after PERK activation and
eIF2α phosphorylation. Thus, P58IPK induction may mark the end of UPR adap-
tation, and the beginning of the alarm/apoptosis phase of the response [515].
Second, PERK induces a negative feedback loop, through its downstream effec-
tor CHOP, involving the direct de-phosphorylation of eIF2α. CHOP induces the
expression of GADD34 which, in conjunction with protein phosphatase 1 (PP1),
assembles into a phosphatase which dephosphorylates the S51 residue of eIF2α
[384]. GADD34 is a member of the GADD family of genes which are induced by
DNA damage and a variety of other cellular stresses [621]. The GADD34 bind-
ing partner in this complex appears to be responsible for PP1α recognition and
targeting of the phosphatase complex to the ER. Association between GADD34
and PP1 is encoded by a C-terminal canonical PP1 binding motif, KVRF, while
approximately 180 residues, near the N-terminus of GADD34, appear to be re-
sponsible for ER localization [56]. Currently, little is known about deactivation
of ATF6. Recently, XBP1u, the unspliced form of XBP1, has been implicated as
a negative regulator for ATF6 [615]. Following, the induction of ER stress, two
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versions of XBP1 exist: XBP1u and sXBP1 [615]. In the recovery phase following
ER stress, high levels of XBP1u may play a dual role. First, XBP1u binds sXBP1,
promoting complex degradation [614, 541]. Second, XBP1u can bind ATF6α ren-
dering it more prone to proteasomal degradation [615]. Taken together, these
two steps may slow the transcription of ER chaperones and ERAD components
during the recovery phase following ER stress. IRE1α activity is regulated by
several proteins, including tyrosine phosphatase 1B (PTP-1B), ASK1-interactive
protein 1 (AIP1) and members of the Bcl2 protein family. PTP-1B has been im-
plicated in a number of IRE1α signaling events. The absence of PTP-1B reduced
IRE1α dependent JNK activation, XBP1 splicing and EDEM transcription in im-
mortalized and primary mouse embryonic fibroblasts [171]. However, no phys-
ical interaction between IRE1α and PTP-1B was established. On the other hand,
AIP1 physically interacts with both TRAF2 and IRE1α, suggesting a model in
which AIP1 facilitates IRE1α dimerization and activation [321]. The C-terminal
period-like domain (PER) of AIF1 binds the N-terminal RING finger domain of
TRAF2, followed by ASK1-JNK signaling [623]. Thus, based on these findings,
Luo et al. postulated that AIF1 may be directly involved in the IRE1α-TRAF2
complex and its activation of the ASK1-JNK signaling axis [321]. This hypothe-
sis was validated in AIP1-KO mouse studies; AIP1-knockout mouse embryonic
fibroblasts and vascular endothelial cells showed significant reductions in ER-
stress induced ASK1-JNK activation that was rescued in AIP1 knock-in cells
[321]. IRE1α has also been shown to directly interact with Bcl-2 family mem-
bers Bax and Bak. Hetz et al. showed that Bax and Bak complex with the
cytosolic domain of IRE1α and modulate IRE1α signaling [207]. Bax and Bak
double knockout mice failed to signal through the IRE1α UPR branch following
tunicamycin-induced ER stress; however, PERK signaling markers, e.g., eIF2α
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phosphorylation, responded normally [207]. This pro-activation role of Bak and
Bax may be modulated by one of the few negative regulators of IRE1α activity,
Bax inhibitor 1 (BI-1). BI-1 is an anti-apoptotic protein that enhances cell sur-
vival following several intrinsic death stimuli [593]. Bailly-Maitre et al. were the
first to suggest that BI-1 may downregulate IRE1α and possibly ATF6 activity
[21]. BI-1 deficient mice displayed increased XBP1s and enhanced JNK activity
in the liver and kidney, while eIF2α phosphorylation remained normal under
ER-stress conditions [21]. Lisbona et al. later showed that BI-1 directly inter-
acts with the cytosolic domain of IRE1α, inhibiting its endoribonuclease activity
[307]. Interestingly, BI-1 interacts with several members of the Bcl2 protein fam-
ily e.g., Bcl2 and Bcl-XL, even though it has no homology [593]. Members of
the HSP family of proteins have also been shown to regulate IRE1α. For exam-
ple, HSP90 interacts with the cytosolic domain of IRE1α, potentially protecting
it from degradation by the proteasome [332]. HSP72 interaction with the cy-
tosolic IRE1α domain has also recently been shown to enhance IRE1α endori-
bonuclease activity [175]. Taken together, these modes of IRE1α regulation with
the exception of B1-1, largely promote or enhance IRE1α signaling. Given the
importance of CHOP in regulation of Bcl2, it is vital to establish the exact con-
nectivity. However, while CHOP expression is negatively correlated with Bcl2
levels, there is no CHOP binding site in the bcl2 promoter [345]. McCullough
et al. have suggested that the bZIP domain of CHOP could act with other bZIP
transcription factors to regulate bcl2 expression [345]. Thus, it’s likely that the
connection between CHOP expression and apoptosis is more complex than sim-
ple down-regulation of Bcl2 expression. These missing structural connections
shall allow us to establish a detailed model and extract more relevant insights
into manipulating UPR.
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Similarly in case of translation initiation, model connectivity was assem-
bled from an extensive literature review. However, several potentially impor-
tant signaling mechanisms were not included. First, we should revisit the role
of PRAS40. Currently, PRAS40 acts as a cofactor that aids in pAkt(Ser473)-
mediated activation of mTORC1. Sancak et al suggested that PRAS40 sequesters
mTORC1, and only after phosphorylation by Akt does it releases from mTORC1
[469]. Other groups have also shown that mTORC1 can phosphorylate and in-
hibit PRAS40, thus providing a positive feedback mechanism for Akt-mediated
mTORC1 activation [132, 572]. A more complete description of PRAS40 will en-
hance our ability to interrogate Akt dependent mTORC1 activation. Second, we
need to refine the description of IRS-1 feedback. Currently, we assume a single
deactivating phosphorylation event at Ser308. However, several studies have
shown that IRS-1 can be phosphorylated at multiple serine sites, which are both
activating and deactivating [414, 173]. Additionally, PTEN is known to dephos-
phorylate activated PDGF receptors and attenuate their activity, a feature not in-
cluded currently [519]. A more complete description of IRS-1 phosphorylation
could help define how, and under what conditions, IRS-1 regulation attenuates
PI3K activation. Third, we modeled the regulation of 4E-BPx as a single phos-
phorylation event where phosphorylated 4E-BPx was unable to bind to eIF4E.
In reality, 4E-BPx family members, such as 4E-BP1, have several phosphoryla-
tion sites [442] and the release of eIF4E is driven only after multiple conserved
phosphorylation events [162]. Additionally, eIF4E can itself be phosphorylated
at Ser209; while there is agreement that the phosphorylation of eIF4E does have
a regulatory significance, the data is contradictory as to whether it is positive or
negative [474]. Fourth, signaling downstream of mTORC1 has also been shown
to mediate translation modes beyond those included in our model. eIF3 has
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been identified as a scaffolding protein that recruits mTORC1 to untranslated
mRNA and facilitates S6K1 and 4E-BP1 phosphorylation [214]. S6K1 can also
activate eIF4B, a protein that helps eIF4A to unwind the secondary structure
of untranslated mRNA [443]. Further, a recently discovered scaffold protein,
SKAR, has been shown to assist S6K1 recruitment to mRNA [323]. Lastly, be-
cause of mTORC1’s unique cellular role, it would be interesting to explore how
other aspects of metabolism interact with insulin signaling to mediate decisions
between translation, lipid synthesis or proliferation. In these studies, one could
imagine constructing in-vivo mouse models to explore the physiological role of
mTORC1 signaling in important diseases such as diabetes or cancer.
In case of EMT model, we lacked certain modules of signaling within EMT.
In particular, the regulation of β-catenin through the GSK3β complex is a widely
studied and intricate component of the EMT process [244]. TGFβ 3 signals
through PI3K to activate AKT [329, 618]. AKT can then phosphorylate and in-
activate the GSK3β complex [618]. GSK3β is an important target of both Snail
and β-catenin for degradation through the ubiquitin-proteasome pathway [244].
Thus, it provides a critical negative feedback mechanism which would should
be incorporated in further models. Specifically to our model, expression of Snail
increases through 72 hours. In contrast, experimental data has shown that activ-
ity of Snail peaks at 24 hours. This is possibly through the regulation of GSK3β
and should be included in future models. Addressing missing structural com-
ponents like that of GSK3β could allow us to get a more comprehensive insight
into TGFβ signaling. Given the scope of the problem and limitations imposed by
structural/parametric uncertainties, we were able to investigate into the mech-
anistic workings of EMT and present falsifiable hypothesis relevant to manipu-
lating EMT. While this study was limited to EMT, a similar framework could be
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used to understand and investigate other similar operational modes relevant to
biology.
In case of EHR, we are lacking some details in regulation of HIF-1α, which
taken into account might reveal a clearer picture [25]. In the current EHR model,
HIF-1αwas regulated only at the protein level. We only have the constitutive ex-
pression of HIF-1α and HIF-1β. In order to get a complete picture of regulation
of HIF-1α, we should include the negative regulation of HIF-1α via the regula-
tion of PHD2 protein. PHD2 mRNA and protein have been reported to be up-
regulated in case of hypoxia, leading to negative feedback [25]. Transcriptional
role of HIF-1 is mediated via binding to p300 protein. CITED2/4 proteins (in-
creased expression in hypoxia) have been identified which competitively binds
to p300 thereby operating in a negative feedback loop to down-regulate HIF-1
mediated transactivation [25]. p53 has been seen to promote Mdm2-mediated
ubiquitination and proteasomal degradation of HIF-1α [445]. Furthermore there
exists a positive feedback to HIF-1α signaling mediated by growth factor and
cytokines via Ras/Raf/MAPK and PI3-K/Akt/PKB cascades [25]. These path-
ways also play a role in regulating the HIF-1 signaling cascades in Normoxia.
Given the role of VEGF and IL-8 signaling pathways in angiogenesis, it has
rightly been targeted in several efforts in regulating tumors [591, 271, 126]. Reg-
ulation of VEGF by the humanized monoclonal antibody bevacizumab, is cur-
rently used successfully for the treatment of cancer [127]. In the current model,
VEGF mediated signal initiation has been modeled via VEGFA, VEGFR1/2/3,
heparin sulfate proteoglycans (hspg) and neuropilins. Given the importance
of VEGF signaling, we might get a clearer and more specific picture upon
inclusion of specific details regarding variants of VEGFA (VEGF-206, VEGF-
165 and VEGF-183), other ligands like VEGFB/C/D/E and the specific role of
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Neuropilin-1 [458]. Neuropilin-1 mRNA and protein have been seen to be over-
expressed in case of human colon growth and progression [409]. Downstream
effects of VEGF signaling cascade mediated by PI3K-AKT module have also not
been taken into account in the current EHR model [562, 69]. Both structurally
and functionally relevant, role of AP-1 and NF-κβ has been identified by the
model analysis to be of high importance. Rightfully so, regulation of NF-κβ has
been seen to be critically involved in cancer development and progression, as
well as in resistance to chemotherapy and radiotherapy [27]. Thereby, the ther-
apeutic potential and benefit of targeting NF-κβ and ROS in cancer holds great
promise [27, 555]. Currently, a narrow account of NF-κβ regulation has been
taken into account in the EHR model. It shall be interesting to incorporate the
detailed complexity associated with regulation of NF-κβ and then analyze the
critical aspects of the EHR model [86]. In terms of NF-kB, we have not taken
into account the regulation of IKK via PKC. IKK traditionally leads to Ser32 and
Ser36 phosphorylation of IKBα, thereby targeting it for proteosomal degrada-
tion [86]. However in case of hypoxia another alternate route of IKBα phospho-
rylation not including proteosomal degradation also plays a key part [86]. In
the current EHR model, we have AP-1 regulation via p38MAPK and ROS. We
have not taken into account the individual dimer components, namely cFOS
and cJUN. To get a comprehensive insight into the role of AP-1, we should in-
clude specific details like ERK2 mediated phosphorylation of cFOS at T232 to
establish the link between ERK and AP-1 [23]. MAP kinases ERK, JNK and p38
phosphorylate and activate Elk-1 resulting in enhanced SRE-dependent cFOS
expression [586]. JNK and p38 MAP kinases lead to activation and enhanced
expression of cJUN [586].
One problem we face currently is the reliability of network data and how
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we join them up in networks as recently talked about by Nathan Blow [45].
While POETs allows us to obtain trade-offs between competing data sets, there
is a need to deal with data reliability in such complex systems. In that regard,
Guimera et. al. recently presented a mathematical and computational frame-
work to deal with the problem of data reliability in complex networks [174].
They were able to reliably identify both missing and spurious interactions in
noisy network observations. We could use this to guide experiments, to better
characterize network data sets, and to drive new discoveries.
9.2 Modeling based experimental design
Model analysis has provided valuable insights and several experimentally ver-
ifiable hypothesis to manipulate the cellular stress responses. For example, in
case of EUPR, the key role of ATF4 was brought to light. We can test this exper-
imentally by knocking out (KO) ATF4 and studying the effect on the cellular
death/survival phenotype. Furthermore ATF4 KO shall also effect the tem-
poral response of the EUPR. This can be studied using western blots for key
markers such as BiP, CHOP and some apoptosis markers. In case of EHR, AP1
was identified as the key in regulating the delayed autocrine mediated ampli-
fication of the hypoxic response. Experimentally we can check this by either
studying an AP1 KO system or by using MAPK inhibitors to prevent AP1 acti-
vation. We can measure the response of the system by looking at key markers
like secreted VEGF, IL8 levels. In case of EMT, the balance between positive and
negative regulation of SMADs and activation of AP1/SP1 was seen as a key
regulatory aspect. We can test this experimentally by using AP1/SP1inhibitors
or AP1/SP1 KO cells to study the effect on EMT. Measurement of key markers
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like E-Cadherin, Vimentin, LEF1 shall elucidate the effect of these changes on
the response.
9.3 Structural analysis of intracellular signaling networks
Signal transduction architectures frequently contain redundancy, feedback and
crosstalk. These topological features ensure signal propagation is adaptable,
efficient and robust. However, they also make reprogramming signal flow chal-
lenging. As we progressively understand the importance of a protein as an ele-
ment in a network of protein-protein interactions having a contextual or cellular
function within functional modules, there is a growing need of development of
tools for structural analysis of complex networks [234].
Study of larger networks could be facilitated by deconstructing such com-
plex networks into conceptually simple entities. In this regard, identification
of network modules using structural and deterministic tools could be a step
forward [408]. Girvan et. al. proposed a method for detecting communities,
built around the idea of using centrality indices to find community bound-
aries [163]. Newman et. al. recently presented a set of algorithms for discov-
ering community structure in networks [373]. These techniques would allow
natural divisions of network nodes into densely connected subgroups which
could be used to shed light on the sometimes dauntingly complex structure of
networked systems. Addressing the similar problem, Yu et. al. recently pre-
sented a novel algorithm combining Molecular Complex Detection (MCODE)
with Girvan-Newman (GN) to identify modules in Protein-Protein Interaction
(PPI) networks [617]. These and others could be used as an effective, reliable
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and scalable method of identifying modules in PPI networks [41].
While the above techniques can provide modular insights, to understand the
structural basis of crosstalk and redundancy of a network, we need to look at
paths through the network. One approach is to use extreme pathways (EPs). Ex-
treme pathways (EPs) are systemic pathway vectors which describe steady-state
flux distributions through molecular networks. While EPs tell us nothing about
network dynamics, the convex combination of these vectors provides a means of
understanding possible steady-state phenotypes. Thus, extreme pathways and
elementary modes [482] have been used previously to understand the qualita-
tive features of metabolic and signaling networks [511, 406, 405]. Singular value
decomposition (SVD) of the stoichiometric matrices [121] and EPs could be a
useful tool to characterize capabilities of such large scale networks. Papin, Price
and Palsson et. al. have presented frameworks for this approach [407, 428, 408].
Dasika et. al. recently presented an alternate optimization-based framework
for elucidating the input-output structure of signaling networks [90]. This ap-
proach could be used to exhaustively identify all input-output connections im-
plied by the signaling network structure. Identification of paths through the
network could attest for structural completeness, identify missing links and also
support basis for crosstalk and redundancy within the network.
9.4 Intracellular signaling model reduction strategies
As we make leaps and bounds of progress in unraveling the underlying biolog-
ical mechanisms, modeling such signal transduction networks are affected by
the problem of combinatorial complexity [211]. For example, receptors and scaf-
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fold proteins possess a large number of distinct binding domains leading to the
formation of large multiprotein signaling complexes. Owing to this combinato-
rial reason the number of distinguishable species grows exponentially. Even by
including only a limited number of components and binding domains the re-
sulting models are very large and hardly manageable [80, 266, 211, 81]. Most of
the current modeling strategies evade this problem by assuming reduced struc-
tures which focus on restricted number of species and reactions e.g., my current
work. However, we need to incorporate more mechanistic and component de-
tails to get a clearer picture.
Faeder et. al. showed that only a relatively small part of the network is ac-
tually active in any state and eliminating the other low concentration species,
a fairly reduced model could be built [120]. However, perturbations in param-
eters over such reduced networks led to large approximation errors. Conzel-
mann et. al. have presented several alternative methods to reduce models of
combinatorial reaction networks [80, 81]. Kremling et. al. recently reviewed
several other strategies for model reduction [273]. As we move forward with in-
creased model size and complexity, we could explore some of these techniques.
9.5 Alternate modeling strategies for biological systems
As more experimental information is available thanks to improved technology,
it is becoming imperative to further modeling techniques to make full use of the
information. Gillespie et. al. have presented quite a few stochastic methodolo-
gies for systems biology [159]. Some of these methodologies currently in use are
explicit tau-leaping and the slow-scale stochastic simulation algorithm [62]. Re-
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cently petri-nets based modeling of biological networks is gaining importance as
an alternative to model complex systems [71, 569]. Heiner et. al. have used petri
nets extensively to study metabolic systems and also to infer structural informa-
tion about networks [569, 196]. Ruths et. al. used a petri net execution strategy
for characterizing the dynamics of signal flow through a signaling network us-
ing token distribution and sampling [460]. The hallmarks of this strategy is
improved speed and ease to obtain insights into the trends of species activity
based solely on network’s connectivity. Sandman et. al. recently presented a
stochastic discrete-time Markov chain method of modeling complex biological
systems [471]. This method was claimed to be more efficient computationally
to the Gillespie algorithm. Talcott et. al. have explored another approach called
Pathway Logic to model causal networks of biomolecular interactions in a logical
framework at multiple scales [197, 522]. Another aspect of modeling such bio-
logical systems is the possibility to parallelize the simulations. In this regard,
Zhou et. al. recently presented a graphics processing units (GPU) based strate-
gies of modeling biological systems [634]. Exploring these strategies might be
useful as we move further ahead in terms of model size and complexity.
9.6 Multiscale modeling techniques
Multiscale modeling strategies involving extrapolation of the molecular sig-
naling events to tissue-level/organ-level phenotypes is an emerging area of
research. We presented a signaling assisted multiscale modeling technique
(SAMM) to study systems across multiple length scales. Key highlights of
SAMM included use of detailed cellular models to regulate cellular decisions,
use of an ensemble of models to incorporate population based behavior of cells,
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coupling intracellular markers and probabilistic rules to monitor cellular fate
and cellular motility and a hybrid approach to improve speed of solving of ex-
ternal and internal mass-balances. SAMM allowed us the flexibility to include
multiple cell types, freedom of seeding cells with specific internal cellular ma-
chinery within complex geometries, regulate multiple cellular decisions using
internal and secreted cellular markers coupled with probabilistic functions and
improved solving speed. This platform allowed us to investigate complex mul-
tiscale phenomenon e.g., tumor growth, angiogenesis.
However there are several avenues of improvement in the current strategy.
For accurate predictions and analysis, we need more detailed/comprehensive
intracellular cellular signaling models and additional cell type models e.g., tip
cell, stalk cell models. Using different cell type models with inherent differences
in machinery might provide a clearer picture regarding heterogeneity and elu-
cidate spatio-temporal variations along different segments of growth. Having
detailed models will further create an avenue to improve computational capa-
bilities for the same.
There could be a diverse range of factors influencing the morphology and
dynamics of growth e.g., concentrations of ECM proteins, gradients of growth
factors, neighboring cellular densities, nutrient levels, physical stresses. SAMM
allows us the flexibility to study the influence of these external factors on growth
morphologies. Just by incorporating neighboring cellular density information
we could transition from a bulk growth (as seen in tumors [55]) to well formed
dendritic growth with/without a bias towards corners and edges (as seen in
3D cultures [371]). In reality there must be more at play. Looking forward,
using SAMM we can reverse engineer a particular growth morphology by sam-
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pling the probability function landscape. This shall allow us to test the con-
tribution and implications of different extracellular factors in determining the
nature of growth. Another area which we barely touched upon in the current
study was use of intracellular markers to determine cellular phenotype. For
example, we saw differences in growth when we based the proliferative moves
based on intracellular levels of CYCLIND and ppERK. This begs further investi-
gation with regards to choice of individual or combinatorial use of intracellular
marker levels to model phenotypic decisions. Using SAMM, we can identify the
relevance/validity of these choices.
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APPENDIX A
HYPOXIA - SUPPLEMENTARY MATERIALS
A.1 Molecular mechanisms involved in EHR
A.1.1 Oxygen sensing.
Cells use several mechanisms to sense and respond to changes in external oxy-
gen levels. Oxygen in the microenvironment is sensed by hypoxia inducible fac-
tor 1 α (HIF1α) and the generation of reactive oxygen species (ROS) [300, 355].
HIF1α mediates the initial phase of the angiogenic program by forming a tran-
scriptionally active complex with HIF1β and co-activators such as p300. The sta-
bility of the HIF1α subunit is oxygen dependent [429]. In normoxic conditions,
hydroxylation at two prolyl residues (P402 and P564) by PHD proteins pro-
motes the association of HIF1α with the Von Hippel-Lindau (VHL) E3 ubiquitin
ligase and subsequently leads to degradation. An additional hydroxylation site
at N803 near the C-terminus of HIF1α is regulated by the asparaginyl hydroxy-
lase FIH. Hydroxylation at N803 does not influence stability; rather, it blocks the
interaction of the HIF1α C-terminal domain with transcriptional co-activators
such as p300. Activated HIF1 up-regulates the expression of many factors in-
cluding VEGF and Interleukin-8 (IL-8) [580]. On the other hand, the second
oxygen dependent signaling axis, ROS, promotes nuclear factor κB (NF-κβ) acti-
vation [355]. NF-κβ also regulates both VEGF and IL-8 expression [355, 580]. The
exact relationship between ROS and NF-κβ activation is unclear. However, ROS
has been hypothesized to activate a serine kinase which in-turn phopshory-
lates the N-terminal serine residues (S32/S36) on IKK; potential mechanisms
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reviewed in [131]. Secreted VEGF and IL-8 signals can then amplify the hy-
poxic response and induce proliferative signals via both autocrine or paracrine
signaling mechanisms through the VEGFR and CXCR receptor families. HIF1
and NF-κB also play a key role in cellular fate by regulating the pro-death and
pro-survival factors BNIP3 and BCL2.
A.1.2 VEGF and IL-8 mediated growth factor signaling.
HIF1 transcriptional activity results in the production of growth factors PLGF
and VEGFA. PLGF and VEGFA are transported outside of the cell and asso-
ciate with cell surface receptor VEGFR1, a decoy receptor that does not result
in any cytoplasmic signaling in our model. However in recent experiments it
was shown that VEGFR1 signals through the eNOS pathway leading to impli-
cations in the VEGF signaling pathway [535]. VEGFA can also associate with
VEGFR2 and VEGFR3. Binding of VEGFA to VEGFR2 results in receptor phos-
phorylation and the activation of numerous signaling pathways. Phosphory-
lated VEGFR2 binds with phospholipase C γ (PLCγ) which in turn binds and
activates protein kinase C (PKC). Activated PKC phosphorylates IkBαand al-
lows NF-κB (p50-p65) mediated transcriptional regulation. Activated PKC also
leads to Ras-GDP to Ras-GTP conversion, which leads to the activation of the
traditional RAF-MEK-ERK MAPK cascade via RAF phosphorylation. Double-
phosphorylated ERK leads to cPLA2 phosphorylation which results in in fur-
ther PKC activation. Phosphorylated VEGFR2 can also associate with focal ad-
hesion kinase(FAK), Shb and p38MAPK to activate Paxillin, PI3K and HSP27,
respectively. Hypoxia induced transcriptional activity results in increased lev-
els of CXCR1 expression and IL8 secretion. Extracellular IL8 binds to CXCR1
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resulting in association of cytoplasmic G-coupled proteins and downstream sig-
naling. One route of Activated CXCR1 signaling occurs through PI3K. PI3K
subsequently activates src and FAK. CXCR1 can also signal through Janus Ki-
nase(JAK) or p38MAPK.
A.1.3 Transcription factor regulation.
In addition to HIF-1α, we modeled the expression and regulation of four other
transcription factors: AP-1, ATF2, MEF2 and NF-κβ. AP-1 expression was de-
pendent upon both ATF2 and MEF2. Both ATF2 and MEF2 were constitutively
expressed and regulated by phosphorylation at T69/T71/T73 for ATF2 and
T312/T319 for MEF2 by p38MAPK family members. We modeled a single acti-
vating phosphorylation site on AP-1 (S63/S73), which was regulated by ppERK
(phosphorylated ERK) which is formed downstream of both IL-8 and VEGFA
signaling cascades. NF-κβ regulation was more complex; NF-κβ was assumed
to be sequestered by a lumped pool of IκB family members. The regulation
of this pool occurred by phosphorylation at S32/S36 and Y42 on IκB; S32/S36
was phosphorylated by PKC while Y42 was regulated by an unknown ROS-
dependent kinase. Lastly, protein markers downstream of these transcription
factors were used to characterize proliferation, survival and death phenotypes.
AP-1 dependent Cyclin D expression was used as a marker of proliferation. NF-
κβ dependent Bcl2 expression was used to characterize cell survival while HIF-
1α dependent BNIP3 expression was used as a cell death marker. In addition
to these markers, the expression of VEGFA, IL-8 and their respective surface
receptors VEGFR2 and CXCR1/2 was also modeled.
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Figure A.1: Average coefficient of variation (CV) for the parent ensembles
lie in the range of 0.8-1.8 (marked by the black line). 100 pa-
rameter sets were selected based on CV (CV plot in red), to
be used in further analysis. Radial plot of the second norm of
the parameter sets selected show diversity in generation and
selection of parameter sets in the ensemble (Inset).
A.1.4 Transcription, translation and transport.
Genes for all species were constitutively expressed in the nucleus and were tran-
scribed at basal levels by RNA Polymerase(RNAP). The binding of transcription
factors to the promotor regions of genes resulted in increased transcriptional ac-
tivity by stabilizing RNAP-gene binding. Transcribed mRNA was transported
into the cytoplasm where it was bound and translated by assembled ribosomes.
Several cytosolic components (growth factors and cytokines) can be transported
out of the cytoplasm and into the extracellular matrix to perform autocrine sig-
naling.
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EHR. Too large to include right here.
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Figure A.4: Phenotypic behavior of EHR models upon Single Parameter
Knockout: (A)-(C) Phenotypic behavior observed as a result
of SPK. Phenotypic behavior was analyzed using downstream
markers like BNIP3 (marker for cell death), BCL2 (marker
for cell survival) and Cyclin D (marker for cell growth).
35% of SPK cases had a pro-death phenotype marked by in-
creased (robustness coefficient > 1) marker levels of BNIP3
and decreased (robustness coefficient < 1) marker levels of
BCL2. Around 20% of SPK cases had a pro-growth phenotype
marked by increased (robustness coefficient > 1) marker levels
of Cyclin D as compared to pro-death phenotype.
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pronounced effect in up-regulation.
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Figure A.6: Phenotypic behavior of EHR models upon Dual Gene Knock-
out: (A)-(C) Phenotypic behavior observed as a result of com-
binatorial gene knockouts. Sub-populations were identified
that had a pro-survival (15%), pro-growth (15%) and pro-
death (65%) phenotype. The positive correlation between pro-
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Figure A.7: Analysis of single gene overexpression study: We find that the
IL-8 overexpression has the most pronounced effect, closely
followed by regulators of AP-1, HIF-1 and NF-κβ transcrip-
tional activity.
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